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Interventions based on early intensive applied behaviour
analysis for autistic children: a systematic review and
cost-effectiveness analysis
Mark Rodgers ,1 David Marshall ,1 Mark Simmonds ,1
Ann Le Couteur ,2 Mousumi Biswas ,1 Kath Wright ,1 Dheeraj Rai ,3
Stephen Palmer ,4 Lesley Stewart 1 and Robert Hodgson 1*
1Centre for Reviews and Dissemination, University of York, York, UK
2Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK
3Bristol Medical School, University of Bristol, Bristol, UK
4Centre for Health Economics, University of York, York, UK
*Corresponding author rob.hodgson@york.ac.uk
Background: Early intensive applied behaviour analysis-based interventions are intensive interventions
for autistic children that are often delivered on a one-to-one basis for 20–50 hours per week.
Objectives: To evaluate the clinical effectiveness and cost-effectiveness of early intensive applied
behaviour analysis-based interventions for autistic children, based on current evidence.
Methods: A systematic review and individual participant data meta-analysis were conducted to evaluate
the clinical effectiveness of an early intensive applied behaviour analysis-based intervention for autistic
children. An economic analysis included a review of existing analyses and the development of a new model.
Results: Twenty studies were included in the clinical review. Individual participant data were retrieved
from 15 of these studies. Results favoured the interventions when assessing adaptive behaviour after
2 years compared with treatment as usual/eclectic interventions (mean difference 7.00, 95% confidence
interval 1.95 to 12.06). In analyses of cognitive ability (intelligence quotient), results favoured the
interventions by approximately 10 points after 1 year (mean difference 9.16, 95% confidence interval
4.38 to 13.93) and 2 years (mean difference 14.13, 95% confidence interval 9.16 to 19.10). Evidence
for other outcomes was limited and meta-analyses were generally inconclusive. There was no evidence
that the effect of the interventions varied with characteristics of the children, but data were limited.
Adopting a £30,000 per quality-adjusted life-year threshold, the results of the cost-effectiveness analysis
indicate that early intensive applied behaviour analysis-based interventions would need to generate larger
benefits or cost savings to be cost-effective. Adopting a public sector perspective and making pessimistic
assumptions about long-term effects, the incremental cost-effectiveness ratio for early intensive applied
behaviour analysis-based therapy compared with treatment as usual is £189,122 per quality-adjusted
life-year. When optimistic assumptions are made, the incremental cost-effectiveness ratio is £46,768
per quality-adjusted life-year. Scenario analyses indicated that these interventions can potentially be
cost-effective if long-term improvements persist into adulthood, or if they have significant impact on
educational placement. Care should be taken when interpreting these scenarios owing to the limited data.
Limitations: All included studies were at risk of bias, there was substantial heterogeneity and effects
varied considerably across studies. The effect of intervention on autism symptom severity, language
development and school placement remains uncertain because of the limited data. The long-term
effects are unclear owing to a lack of follow-up data.
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Conclusions: This review found limited evidence that early intensive applied behaviour analysis-based
interventions may improve cognitive ability and adaptive behaviour, but the long-term impact of the
interventions remains unknown. The economic analysis is constrained by the limited effectiveness
evidence, but suggests that these interventions are unlikely to be cost-effective unless clear long-term
benefits, or a substantial change in which schools children attend, can be identified.
Future work: Further studies into the effectiveness of early intensive applied behaviour analysis-based
interventions may be warranted if they include well-defined, alternative interventions as comparators
and collect relevant outcomes. Consideration should be given to future studies that not only address
whether or not early intensive applied behaviour analysis-based interventions are clinically effective,
but also aim to identify which components of early intensive applied behaviour analysis-based
interventions might drive effectiveness.
Study registration: This study is registered as PROSPERO CRD42017068303.
Funding: This project was funded by the National Institute for Health Research (NIHR) Health
Technology Assessment programme and will be published in full in Health Technology Assessment;
Vol. 24, No. 35. See the NIHR Journals Library website for further project information.
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Glossary
Aberrant Behaviour Checklist A standardised caregiver report checklist designed to assess challenging
behaviours in children and adults with developmental disabilities. Its age range is 5 years to adult and it
includes normative data for populations with learning disabilities.
Adverse effect An abnormal or harmful effect caused by, and attributable to, exposure to an intervention,
such as a medication or a psychosocial or psychoeducation intervention, which is indicated by some
symptom(s), such as illness or death.
Applied behaviour analysis An applied psychological approach with an established theoretical basis
designed to analyse and change behaviour through an array of behavioural techniques, including operant,
classical and relational conditioning.
Autism Diagnostic Interview – Revised A standardised semistructured diagnostic interview for a
parent or carer of individuals with suspected autism spectrum disorder. The age range is from 18 months
through adulthood.
Autism Diagnostic Observation Schedule A standardised structured play- and activity-based assessment
for the direct observation and assessment of individuals with suspected autism spectrum disorder.
It consists of four modules for children and adults of differing developmental and language levels.
The age range is from 12 months through to adulthood.
Autism spectrum disorder/autism A lifelong neurodevelopmental disorder characterised by impairments
in social communication and a pattern of restricted, repetitive repertoire of interests, behaviours
and activities.
Child Behaviour Checklist A parent- or teacher-reported standardised measure that assesses for
a wide range of emotional and behavioural problems in children. It has preschool and school age
versions, allowing it to cover an age range of between 18 months and 18 years.
Childhood Autism Rating Scale A behavioural rating scale that is widely used in the diagnosis and
screening of autistic children aged ≥ 2 years.
Confidence interval The confidence interval associated with a value indicates the estimated range
within which the ‘true’ value (i.e. the size of the effect of an intervention) is expected to lie if sampling
could be repeated a large number of times. Generally, 95% confidence intervals are reported.
Cost-effectiveness acceptability curve A graph describing the impact of uncertainty on the result of a
cost-effectiveness model. The graph plots a range of cost-effectiveness thresholds on the horizontal
axis against the probability that the intervention will be cost-effective at that threshold on the vertical
axis. It can usually be drawn directly from the results of a probabilistic sensitivity analysis.
Cost-effectiveness model A cost-effectiveness or decision model seeks to answer questions about
how to deploy resources in a health-care system. A model is a simplified representation of a real-world
condition and treatment pathway, which aims to estimate the costs and consequences arising from
making a particular policy decision (i.e. whether or not the NHS should fund a new procedure or drug).
All relevant alternative courses of action and their long-term costs and consequences are compared to
inform a decision on which option to adopt.
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xvii
Cost-effectiveness threshold Represents the maximum amount a health-care system is willing to pay to
provide a new technology or intervention. National Institute for Health and Care Excellence guidance
(National Institute for Health and Clinical Excellence. Guide to the Methods of Technology Appraisal 2013.
London: NICE; 2013) typically considers interventions with an incremental cost-effectiveness ratio of
between £20,000 and £30,000 per quality-adjusted life-year as cost-effective.
Cycle The smallest period of time measured in an economic model.
Deterministic sensitivity analysis Explores the impact on model results of varying one or two input
parameters at a time.
Developmental trajectory The rate of development of a child when compared with that of their peers.
Diagnostic and Statistical Manual of Mental Disorders A publication by the American Psychiatric
Association that defines the criteria for the classification of mental health disorders, including autism
spectrum disorders. The fifth edition was published in 2013.
Discrete trial training A highly structured training technique that requires the therapists to break
down skills into small, achievable tasks or behaviours using a series of learning opportunities or trials.
Each trial has a clear beginning and end, which is why it is described as discrete.
Dominance In the field of health economics, a treatment option is said to be ‘dominant’ when it is both
less costly and produces better health outcomes than the comparator strategy. Thus, a treatment that
is both more expensive and results in poorer health outcomes is referred to as ‘dominated’.
Early intensive applied behaviour analysis-based therapy The term we have used in this report to
collectively describe early intensive behavioural interventions and naturalistic developmental behavioural
interventions with an intensity of > 15 hours per week.
Early intensive behavioural intervention An umbrella term used to describe a range of interventions
that are based on the principles of applied behavioural analysis with young preschool children. The term
has become most well known when linked with the work of Lovaas in the 1980s with young autistic
children (Lovaas OI. Behavioral treatment and normal educational and intellectual functioning in young
autistic children. J Consult Clin Psychol 1987;55:3–9).
Early start Denver model An early intervention model combining developmental and behavioural
approaches that is designed to help the development of very young children. It incorporates both early
intensive behavioural intervention and naturalistic developmental behavioural intervention elements.
EuroQol-5 Dimensions A generic measurement of quality of life used in many clinical trials. This
instrument is easy to use and has been extensively validated across many disease areas. The benefit
of the EuroQol-5 Dimensions is the availability of utility scores (generated through large population
surveys) for each possible combination of questionnaire responses; these can be combined with the
time individuals reside in particular health states to calculate the quality-adjusted life-years associated
with an intervention.
Expressive language The ability to put thoughts into words and sentences in a way that makes sense
and is accurate. Expressive language also informs an individual’s writing.
Gilliam Autism Rating Scale A developmental checklist to assist in the identification of autism,
developed to discriminate individuals who are autistic from those with other developmental disabilities.
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Inclusion The practice of educating all or most children in the same classroom, including children with
physical, mental and developmental disabilities. Inclusion classes often require a special assistant to the
classroom teacher.
Incremental cost-effectiveness ratio A measure that represents the economic value of an intervention
compared with an alternative, and is generally the primary outcome of an economic evaluation.
An incremental cost-effectiveness ratio is calculated by dividing the difference in costs between two
interventions by the difference in quality-adjusted life-years. The incremental cost-effectiveness ratio is
the cost of generating an additional quality-adjusted life-year using the intervention we are interested
in compared with an alternative, usually current clinical practice.
Individualised education plan A yearly education plan written by a multidisciplinary team and the
child’s parents for school-age children who need special education. The individualised education plan
attempts to address the student’s needs and outlines the educational supports and services necessary
to meet those needs.
Intellectual disability A condition characterised by low cognitive ability, as measured by an
intelligence quotient score (< 70) and associated difficulties in adaptive functioning presenting before
the age of 18 years.
Intelligence quotient A score calculated from a set of standardised tests developed to assess a
person’s cognitive abilities compared with others in their age group. It is calculated as the ratio of
tested mental age to chronological age and expressed as a quotient multiplied by 100.
Intention to treat An analysis in which all participants enrolled in a trial are analysed according to
the intervention to which they were initially allocated, regardless of whether or not they went on to
receive it. This type of analysis is considered best at providing an unbiased comparison of effectiveness
across treatment groups.
Leiter International Performance Scale A non-verbal assessment of cognitive ability through assessing
fluid reasoning, visuospatial memory and attention. It is used primarily with children with communication
difficulties. It gives an intelligence quotient score and has an age range of between 2 and 20 years.
Merrill–Palmer Scale of Mental Tests A standardised test of intellectual ability validated for use with
preschool children. Many of its range of tests consist of concrete stimuli (e.g. puzzles) and rely less on
children’s language skills when assessing non-verbal intelligence quotient to other tests of cognitive ability.
These factors combined with a more liberal way to determine when to end testing means it tends to yield
higher scores for autistic children. Its age range is between 1 and 78 months of age.
Meta-analysis and network meta-analysis Meta-analysis is a set of statistical techniques in which data
from multiple studies on the effects of two interventions are combined to provide an overall estimate
of the relative effects of the two interventions. Network meta-analysis is similar to standard meta-analysis,
but allows comparative effects to be assessed for more than two alternative interventions.
Mullen Scales of Early Learning An individually administered, multidomain measure of early
development for children from birth to 68 months, assessing visual reception, receptive language,
expressive language and fine motor skills.
Naturalistic developmental behavioural intervention A collection of intervention models that adapt
the early intensive behavioural intervention approach to incorporate the principles of applied behaviour
analysis in a more naturalistic and developmentally informed framework. These interventions include
child-led and incidental training opportunities. Examples of these models are pivotal response treatment,
the Denver model and the Denver model’s derivative, the early start Denver model.
DOI: 10.3310/hta24350 Health Technology Assessment 2020 Vol. 24 No. 35
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Rodgers et al. under the terms of a commissioning contract issued by the Secretary of State
for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
xix
Opportunity cost The opportunity cost associated with an intervention is the benefits we could have
obtained if we spent the money elsewhere. In a health-care system with a fixed budget, existing
services must be displaced to fund the new intervention; this means that the ability of the system to
generate health will be reduced if the opportunity costs outweigh the benefits of the new intervention.
Picture exchange communication system A visual augmentative communication system developed to
help individuals quickly acquire a functional means of communication.
Pivotal response training A systematic applied behaviour analysis-based approach that targets pivotal
skills to produce collateral improvements across related skills, theorised to lead to improvements in the
quality of social and communicative interactions. Pivotal response treatment is considered an example
of the naturalistic developmental behavioural intervention approach.
Prevalence A measure of the number of cases of a disorder in a defined population at a particular
point in time.
Probabilistic sensitivity analysis Assesses the joint uncertainty across all input parameters in the
model. This is done by assigning probability distributions to each input parameter and making random
draws from each of these distributions. This process is then repeated many thousands of times,
resulting in a distribution of outputs that describe the uncertainty in the results of the model.
Psychoeducational Profile – Revised A measure used to assess the developmental level and emerging
skills of young children with autism and communication disabilities. The tool consists of a developmental
scale and a behavioural scale. It has an age range of between 6 months and 7 years.
Quality-adjusted life-year An index of health gain, on which survival duration is weighted or adjusted
according to the patient’s quality of life over the time they are alive. Quality-adjusted life-years are
based on utilities, which are valuations of quality of life measured on a scale between full health
(1) and death (0). These valuations are multiplied by the number of years that an individual spends in
a health state with that particular utility score, and the quality-adjusted life-years are summed over the
modelled time horizon.
Quality of life A broad concept incorporating all of the factors that might have an impact on an
individual’s physical, mental and social well-being. Health-related quality of life refers to the specific impact
a medical condition or treatment has on an individual’s functioning and general well-being. Health-related
quality of life is generally measured in clinical trials alongside other outcomes to assess the impact of
an intervention from a patient’s perspective, typically using questionnaires completed by patients, their
families or clinicians, such as the EuroQol-5 Dimensions and Short Form questionnaire-36 items.
Randomised controlled trial An experiment in which investigators randomly allocate eligible people
into groups that are each assigned a different intervention, to compare their relative effectiveness
and safety.
Receptive language Refers to the comprehension of information provided to us and is the input
system of language. It is the information we take in from what we see, hear and read.
Reinforcement The provision of a pleasant consequence (positive reinforcement) or removal of an
unpleasant consequence (negative reinforcement) after a behaviour to increase or maintain the likelihood
of that behaviour occurring when it is preceded by a specific antecedent stimulus (the situation or context
in which the behaviour occurs).
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Reynell Developmental Language Scales A widely used standardised assessment for identifying
language development and impairment in young children. It contains subscales for both expressive
and receptive language, which can be combined into a comprehensive score. Its age range is between
2 years and 7 years, 5 months.
Scenario analysis A process of exploring alternative future outcomes by selection of different
assumptions used in the economic model. Scenarios can represent outcomes ranging from optimistic,
for which input variables are changed to their most optimistic values, to their most pessimistic. These
types of analyses test the cost-effectiveness and safety of an intervention in the best and worst cases,
and in other plausible ‘alternative worlds’.
Sensitivity analysis In cost-effectiveness modelling, many of the parameter values are often estimated
with a degree of uncertainty. Sensitivity analysis is used to explore the impact of this uncertainty. This
is done by varying assumptions and inputs used in the model and recording their impact on the results.
Short Form questionnaire-36 items A patient-reported set of generic, coherent and easily administered
quality-of-life measures. Different combinations of answers can be assigned utility weights and used to
calculate quality-adjusted life-years.
Stanford–Binet Intelligence Scales A test of general cognitive ability, widely used for clinical and
research purposes. The test yields a full-scale intelligence quotient, a non-verbal intelligence quotient
and a verbal intelligence quotient. The age range is 2 years to adulthood.
Statistical significance A result in which the reported p-value falls below the selected significance
level; this value represents the probability that the observed result could have occurred due to chance
alone if the ‘null hypothesis’ is true (i.e. there was no true difference between the groups).
Time horizon In an economic model, the duration over which costs and health outcomes are calculated.
The choice of time horizon is important and generally depends on the nature of the condition for which
an intervention is being assessed. A long time horizon is preferred in chronic or long-term conditions for
which there are likely to be important ongoing management costs and consequences well into the future.
The use of a long-term time horizon often involves the extrapolation of short-term data into the future
and the use of assumptions about the persistence of treatment effects due to a lack of long-term data.
Treatment and Education of Autistic and Related Communication-Handicapped Children A model
of early intervention revolving around a philosophy of recognising autism as a lifelong condition and
responding to it as a culture. Teaching is designed around individual strengths, skills, interests and
needs, working in collaboration with parents and families. Intervention strategies are largely based
around physical and visual structure, schedules, work systems and task organisation.
Vineland Adaptive Behaviour Scale A tool used extensively as a measure of adaptive behaviour in
autistic people. Adaptive behaviour refers to the social, communication, behavioural and self-help skills
needed by individuals to function and be self-sufficient within their everyday environments. It has an
age range of birth through to adulthood.
Wechsler Intelligence Scale for Children A psychological assessment that measures aspects of cognitive
ability. It contains a range of tests to measure different aspects of a child’s abilities, which can be combined
to yield a full-scale intelligence quotient. It has an age range of 6 to 16 years.
Wechsler Preschool and Primary Scale of Intelligence A standardised assessment of cognitive ability for
young children. It contains a range of subtests that yields scores for full-scale intelligence quotient, verbal
intelligence quotient and performance intelligence quotient. It has an age range of 2 years, 6 months,
to 7 years, 7 months.
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Plain English summary
Autism is a lifelong condition that affects how people understand the world and interact with others.Early intensive applied behaviour analysis-based interventions are an approach designed to help
young (preschool) autistic children. This approach is often delivered on a one-to-one basis, for 20–50 hours
per week, over a period of several years.
This project obtained and analysed the original data from studies of early intensive applied behaviour
analysis-based interventions, to determine whether or not these interventions are beneficial. It also
investigated whether or not the interventions represent good value for money.
The results suggest that early intensive applied behaviour analysis-based interventions may improve
children’s intelligence, communication, social and life skills more than standard approaches. However,
some results could be inaccurate or incorrect, and there was no evidence about other important
outcomes, such as the severity of autism and where children went to school. Most studies lasted for
around 2 years, which means that it is not known if early intensive applied behaviour analysis-based
interventions have meaningful long-term benefits.
It was not possible to fully assess whether or not these interventions provided value for money, as
the benefits of early intensive applied behaviour analysis-based interventions were unclear, although
the available evidence suggested that they did not. Early intensive applied behaviour analysis-based
interventions may, however, provide value for money if their effects were to last into adulthood,
or if receiving early intensive applied behaviour analysis had a large impact on the type of school
children attended.
Future studies of early interventions may be helpful, but should consider looking at which components
of early applied behaviour analysis-based interventions are the most important, rather than at whether
or not they work better than other interventions. Future studies should also follow best current
research practice and evaluate outcomes that matter to autistic people and their families.
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Scientific summary
Background
Autism spectrum disorder (henceforth referred to as ‘autism’) is a lifelong neurodevelopmental
condition characterised by impaired reciprocal social communication and a pattern of restricted,
often repetitive, behaviours, interests and activities. As it is a spectrum condition, individual
presentation is usually a combination of difficulties and strengths, which vary considerably. Those who
are diagnosed in early childhood are typically those with more severe symptoms and appear more likely
to have an intellectual impairment.
The prevalence of diagnosed autism in the UK is around 1% of the population and is higher (2%) in men
than in women (0.3%). The relatively high prevalence of autism and the reduced ability of individuals
to achieve their individual potential means that autism has significant economic and social impacts for
individuals, their families and wider society. The estimated cost to the UK of supporting people with
autism and related conditions has been estimated to be as high as £34B per year.
Early intensive applied behaviour analysis-based interventions, first described by Lovaas (Lovaas OI.
Behavioral treatment and normal educational and intellectual functioning in young autistic children.
J Consult Clin Psychol 1987;55:3–9), are a well-established, early intervention for autistic children.
These principles promote a range of techniques (such as the breaking down of skills into their basic
components) that emphasise discrimination, learning and positive reinforcement. This intensive
approach is often delivered on a one-to-one basis for 20–50 hours per week.
Objectives
The aim of this study was to evaluate the clinical effectiveness and cost-effectiveness of early intensive
applied behaviour analysis-based interventions for preschool autistic children based on current evidence.
The key objectives were to:
l evaluate the effects of early intensive applied behaviour analysis-based interventions in young
autistic children by conducting a systematic review and individual participant data meta-analyses
of data from all available comparative studies
l investigate potential study- and patient-level modifiers of treatment effect
l evaluate the cost-effectiveness of early intensive applied behaviour analysis-based interventions in
young autistic children by developing a new economic model
l identify key uncertainties in the evidence base and highlight important areas for future research.
Methods
Individual participant data review and meta-analysis
A systematic review and individual participant data meta-analysis was conducted based on a
prospectively agreed protocol and following recommended systematic review methods.
Relevant databases, including MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials,
were searched to identify relevant studies.
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Studies were included in the review if they recruited autistic children and compared early intensive
(> 15 hours) applied behaviour analysis-based therapy with any other therapy. Studies of interventions
delivered to parents rather than children were excluded. Non-comparative single-arm studies were
also excluded.
Individual participant data were sought from all identified studies and, when received, were recoded
to a common data dictionary. The individual participant data were then reanalysed in accordance
with a prespecified analysis plan, using one- and two-stage meta-analytic models. A supplemental
meta-analysis was also conducted to include studies that did not provide individual participant data.
Risk of bias in randomised controlled trials was assessed using the Cochrane Risk of Bias 2.0 tool
and non-randomised controlled study designs were critically appraised using the Risk Of Bias In
Non-randomised Studies – of Interventions (ROBINS-I) tool.
Economic evaluation
A new model was developed to evaluate the cost-effectiveness of early intensive applied behaviour
analysis-based therapy in a UK context. Given that implementation of an effective early intensive
intervention for young autistic children would likely impact across multiple sectors, the model
considered several perspectives relevant for the UK. These included a health-care and social services
perspective and a broader public sector perspective, which included costs falling on the education
sector. The economic model used a 15.5-year time horizon, representing the period from diagnosis in
early childhood to adulthood. Scenario analysis also explored a lifetime time horizon. Costs and health
outcomes were discounted at a rate of 3.5% per annum. Costs were valued at 2016/17 prices.
The economic model drew on the individual participant data meta-analysis results to estimate the
treatment effect associated with early intensive applied behaviour analysis-based therapy. The limited
availability of appropriate effectiveness data, however, meant that this analysis was primarily exploratory,
with a view to identifying key drivers of cost-effectiveness. The model structure was designed around
the two most commonly recorded measures (cognitive ability and adaptive behaviour), and adopted a
cohort approach to capture changes in these measures linking them to health-related quality of life and
costs. Owing to the uncertainty in the long-term effects of early intensive applied behaviour analysis-
based interventions, two scenarios were explored in the main analysis: an optimistic scenario, in which
the observed benefits of early intensive applied behaviour analysis-based interventions were assumed
to persist; and a pessimistic scenario, in which the proposed benefits dissipated over time.
Results
Systematic review and individual participant data meta-analysis
The review identified 20 studies comparing early intensive applied behaviour analysis-based
interventions with alternative interventions (mostly ‘eclectic’ treatment or treatment as usual)
and obtained 82% (n/N = 654/800) of individual participant data from published studies.
All included studies were at risk of bias on at least one domain in the Cochrane Risk of Bias or Risk Of
Bias In Non-randomised Studies – of Interventions tools. Few studies were randomised. Most allocated
interventions were based on parental preference. Outcome assessors were often not independent of
treatment. In some studies, outcome data were missing or available for only one treatment group.
The meta-analyses of Vineland Adaptive Behaviour Scale composite score showed no clear evidence of
a benefit of early intensive applied behaviour analysis-based intervention after 1 year (mean difference
2.93, 95% confidence interval –1.90 to 7.76, I2 = 80%), but a seven-point difference in favour of the
applied behaviour analysis-based intervention (half of a standard deviation) after 2 years, with less
heterogeneity (mean difference 7.00, 95% confidence interval 1.95 to 12.06; I2 = 34%). Studies varied
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substantially in their estimated mean differences, from 32 points in favour of early intensive applied
behaviour analysis, to five points in favour of alternative interventions. In analyses of cognitive
ability (intelligence quotient), results also favoured early intensive applied behaviour analysis-based
interventions by around 10 points after 1 year (mean difference 9.16, 95% confidence interval 4.38 to
13.93; I2 = 0) and 2 years (mean difference 14.13, 95% confidence interval 9.16 to 19.10; I2 = 15%).
Evidence for other outcome measures, such as language development, was limited and meta-analyses
were generally inconclusive. There was no evidence that the effect of these interventions varied with
key characteristics of the children (such as baseline intelligence quotient), but data were limited.
Autism symptom severity was not measured in most studies and the results were too limited to be
conclusive, with no clear evidence that early intensive applied behaviour analysis-based interventions had
any effect. There were limited data on language (comprehension and/or expression) and challenging
behaviours, with no statistically significant effects found. Adverse effects were rarely recorded in the
individual participant data. Two included studies (by one group of authors) recalled that no adverse effects
were observed, but adverse effects were not routinely collected in any of the included studies.
There was no evidence that any child- or study-level covariate moderated the treatment effect; however,
there were very limited data on covariates, so only a subset of the planned analyses could be implemented.
Economic evaluation
Adopting a public sector perspective and making pessimistic assumptions about the long-term effectiveness,
early intensive applied behaviour analysis-based interventions are associated with £58,940 in additional
costs and generate 0.24 additional quality-adjusted life-years. The resulting incremental cost-effectiveness
ratio was £189,122 per quality-adjusted life-year. When optimistic assumptions are made about the
long-term effectiveness, scenario early intensive applied behaviour analysis-based interventions are
associated with £58,496 in additional costs and generate 0.84 additional quality-adjusted life-years,
with a resulting incremental cost-effectiveness ratio of £46,768 per quality-adjusted life-year.
Using National Institute for Health and Care Excellence decision rules to benchmark the results of
the cost-effectiveness analysis and adopting a £30,000 per quality-adjusted life-year threshold, these
results indicate that early intensive applied behaviour analysis-based interventions would need to
generate either further benefits or cost savings to be considered cost-effective. In the pessimistic
scenario, it would be necessary for early intensive applied behaviour analysis-based interventions to
generate either a further 1.29 additional quality-adjusted life-years or produce £38,790 in additional
cost savings to be considered cost-effective at a threshold of £30,000 per quality-adjusted life-year.
In the optimistic scenario, these values fall to 0.47 additional quality-adjusted life-years or £14,066 in
additional cost savings.
The results of the scenario analyses identified a number of drivers of value and showed that early
intensive applied behaviour analysis-based interventions were more likely to be cost-effective if either
the comparative benefits of therapy continued into adulthood, or it can have a significant impact on
the type of school attended, as was observed in a small number of the effectiveness studies. The value
generated by early intensive applied behaviour analysis-based interventions are, however, contingent
on treatment effects persisting over a long period of time and it is much less likely that early intensive
applied behaviour analysis-based interventions represent value for money if comparative benefits are
realised only for a short period of time.
Limitations and uncertainties
A number of important limitations were identified in the studies included in the systematic review and
individual participant data meta-analysis.
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All of the included studies were at risk of bias on at least one domain, with the majority of studies
at risk of bias on multiple domains. Randomisation was possible (as shown in a minority of studies),
but rarely conducted.
The effect of therapy on many key outcome domains, including autism symptom severity, language
development, challenging behaviours and education, remains uncertain because of the very limited
data available for these outcomes.
The lack of long-term follow-up data in most studies means that, even when data were available
(e.g. for adaptive behaviour score), the long-term effect of early intensive applied behaviour
analysis-based interventions on these outcomes is uncertain, including the impact in later childhood
and into adulthood.
These concerns carry through to the economic modelling and the results of the economic analysis
should be interpreted in the context of these limitations. The restrictive focus on cognitive ability and
adaptive behaviour scores means that other outcome measures, which plausibly affect both quality of
life and costs, could not be included in the economic analysis.
Conclusions
Implications for service provision
Although individual participant data meta-analyses have shown small to moderate improvements in
child cognitive ability and adaptive behaviour for early intensive applied behaviour analysis-based
interventions relative to treatment as usual or eclectic approaches, all of the identified studies were
at risk of bias, limiting the strength of conclusions that can be drawn from these results. Furthermore,
results from individual studies varied considerably, with some showing no relative benefit of early
intensive applied behaviour analysis-based interventions.
The concerns about bias in evidence of effects, together with the other limitations in the available
evidence, mean that it is not possible to make strong judgements about the cost-effectiveness of early
intensive applied behaviour analysis-based interventions. The restricted outcomes assessed in the
research studies required the model to focus on cognitive ability and adaptive behaviour scores. This
may mean that the results of the economic analysis do not fully reflect the impact of early intensive
applied behaviour analysis-based interventions on outcomes and costs. Taken at face value, however,
the results of the main economic analysis indicate that early intensive applied behaviour analysis-based
interventions are unlikely to represent value for money, based on thresholds typically adopted by the
National Institute for Health and Care Excellence.
The results of the economic analysis also highlighted the importance of assumptions made regarding
the long-term effects of early applied behaviour analysis-based interventions, as this was the most
significant driver of cost-effectiveness. Crucially, there are few reliable longer-term follow-up data from
children who have received these interventions and therefore no clear evidence on whether or not any
comparative benefits are retained through childhood and into adulthood.
Further implications of this research are constrained by the lack of high-quality evidence to support
the clinical effectiveness and cost-effectiveness of early intensive applied behaviour analysis-based
interventions. Service providers, families with young autistic children and those funding the provision
of services in collaboration with the autism community need access to better evidence to decide how
early intensive applied behaviour analysis-based interventions compare with other early interventions,
and what the effective interventions are to achieve good outcomes for young autistic children in the
short, medium and longer term.
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Suggested research priorities
Researchers should consider carefully whether or not further evaluations of early intensive applied
behaviour analysis-based interventions, compared with treatment as usual or eclectic approaches, are
appropriate. The relative clinical effectiveness of other behavioural and developmental-social-pragmatic
interventions lay outside the scope of this analysis, but many require substantially less resource to
implement than early intensive applied behaviour analysis-based interventions and may represent
better value. Future research should therefore focus on which interventions for young children currently
have the best evidence of clinical effectiveness and cost-effectiveness, and which are worthy of
further investigation.
Future studies of autism interventions should evaluate outcomes that matter most to autistic children
and their families, including assessment of potential adverse effects or harms. Efforts to establish
internationally agreed core outcomes and standardised measurements would be valuable, as would a
priority-setting exercise involving the autism community.
A range of methodologies are likely to be required to address evidence gaps, particularly given the
long-term time frames over which effects may operate. These might include intervention trials
undertaken in developmental sequence, additional or structured follow-up of children recruited to
existing effectiveness studies and the use of retrospective case–control analyses looking at any early
intervention received.
Any future studies of comparative effectiveness should address the methodological limitations of the
historical evidence base, as identified by this report. These would preferably be randomised controlled
trials with prespecified outcome measures, collected by trained researchers blind to intervention
received. Data should be collected on fidelity to treatment received. Data should be collected and,
when possible, analysed for all randomised participants. Withdrawals should be carefully monitored,
documented and reported. Preferably, independent groups who have no financial interest in, or strong
views about, any of the interventions being evaluated should conduct new studies.
Study registration
This study is registered as PROSPERO CRD42017068303.
Funding
This project was funded by the National Institute for Health Research (NIHR) Health Technology
Assessment programme and will be published in full in Health Technology Assessment; Vol. 24, No. 35.
See the NIHR Journals Library website for further project information.
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Chapter 1 Background
Autism spectrum disorder
Autism spectrum disorder (ASD) (henceforth referred to as autism) is a lifelong neurodevelopmental
condition, characterised by impairments in reciprocal social communication and a pattern of restricted,
repetitive behaviours, interests and activities.1 The prevalence of diagnosed autism in the UK is around
1% of the population and is higher (2%) in men than in women (0.3%).2,3 A feature of autism is that
individuals present with a combination of strengths and difficulties, which can vary considerably over
time and between individuals.
Furthermore, the presence of additional difficulties, including general or specific learning disabilities,
other neurodevelopmental conditions, and mental and physical health conditions, may have additional
detrimental impacts on everyday life.4 The nature of the skills and needs of autistic people, their families
and the consequences for the wider society is highly variable but, for some, the behavioural characteristics
of a possible autism diagnosis may be evident from an early age, often in the preschool years. Those who
are diagnosed in early childhood are typically those with more severe symptomatology5,6 and appear
more likely to have an intellectual impairment,7 although this assertion is complicated by other factors,
such as geographical region,5 consistency of care,6 language delay8 and socioeconomic status.7
Autism in childhood
The developmental trajectory of autistic children is varied and complex, and they may experience
improvements over time in some areas but not in others.9 The literature highlights some characteristics
potentially associated with a more positive trajectory, such as milder autism symptoms, better social and
linguistic skills,10 and higher cognitive ability [intelligence quotient (IQ)].11 However, no clear predictive
factors have emerged. In one recent study11 assessing children at age 2 years and again in middle
childhood, one-third of children experienced significant improvements in intellectual abilities. In contrast,
other studies have reported that a similar proportion of autistic children do not develop sufficient useful
speech to meet their daily communication needs.12
As autistic children move into social networks beyond their family, there is evidence to suggest they
are at increased risk of victimisation and bullying, and social and emotional exclusion,13 compared with
typically developing children. Furthermore, it has been reported that autistic children who are able
to communicate their experiences identify feeling lonely significantly more frequently than children
without autism.14
Autism in adulthood
Impairments in social reciprocity, communication and behaviour may have a profound effect on
children’s social development into adulthood.15,16 However, to date, relatively little is known about
the everyday experiences of autistic adults and there have been few well-conducted studies of adult
outcomes.17 The available evidence suggests that autistic adults (including those of average intellectual
ability) are likely to experience poorer educational attainment, lower rates of employment, are less
likely to be living independently, and experience higher rates of mental and physical health problems,
compared with both the general population and adults with other disabilities.18–20 Additionally,
relatively few autistic adults report that they are married, in long-term relationships or have at least
one friend, compared with the general population.16 However, evidence suggests that the experiences
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of autistic adults vary considerably. For example, an examination of cohort studies reported that the
average percentage of autistic adults in some form of employment (paid, sheltered or voluntary) or
educational programmes was 49%, but this percentage ranged between 6% and 94% between
cohorts.16,17
Early interventions for autism
The relatively high prevalence of autism,2,3,21,22 and the range and impact of possible impairments,21
means that autism has significant economic and social impacts for individuals, their families and wider
society. The estimated total costs to the UK of supporting people with autism and related conditions
has been estimated at £34B per year, with high lifetime care costs reported for individuals with
co-occurring intellectual disability.23 Thus, an effective treatment that can support the child before they
reach school age (defined in the review as ‘early’), maximise the child’s strengths, enhance quality of life
and reduce factors associated with less favourable outcomes in the short-, medium- and especially the
longer-term course of autism could have considerable benefits.24,25
Early intensive behavioural intervention (EIBI), first described by Lovaas,26 is a well-established, early
intervention based on the theoretical principles of applied behaviour analysis (ABA). These principles
promote a range of techniques (such as the breaking down of skills into their basic components) that
emphasise discrimination, learning and positive reinforcement. This intensive approach is often delivered
on a one-to-one basis, for 20–50 hours per week.27 However, criticisms have been made of this approach.
These include concerns that the use of highly structured, primarily adult-led sessions could increase
the risk of behaviours that challenge. In addition, it may reduce opportunities to encourage a child’s
spontaneity and interactive communication, resulting in an over-reliance on prompts, with the potential
to further restrict the child’s capacity to develop generalisation skills.28 Additionally, it has been suggested
by some in the autistic community29 that the rigid nature of ABA-based interventions could potentially
increase the risk of later additional mental health problems,30 although this has yet to be effectively
researched and there is little reliable published evidence confirming this.31
In response to these concerns, a number of adaptations of the original model have been developed,
which incorporate the principles of ABA within a more naturalistic and developmentally informed
framework. Known collectively as naturalistic developmental behavioural interventions (NDBIs),28
these interventions include child-led and incidental training opportunities. Prominent examples of these
models are pivotal response treatment (PRT)32 and the Denver model33 and its derivative the early
start Denver model (ESDM).34 These models still encompass the fundamentals of ABA methodology,
such as discrete trial training, and take a comprehensive approach to skills development. However,
their proponents assert that the revisions create a more multifaceted intervention able to meet the
individual needs of autistic children and their families.28 Throughout this report the term ‘early intensive
ABA-based interventions’ is used as an umbrella term to describe both EIBI and NDBI approaches.
Early interventions for autism in the UK
In the UK, there is little in the way of published literature to delineate what is usual UK practice for access
to early interventions for preschool autistic children. Advice from clinical experts and service providers
within local authorities, obtained through our advisory group (see Appendix 1), suggests that the majority
of preschool autistic children currently receive a combination of generic or autism-specific early years
health- and education-based interventions. These can be delivered in a nursery or home setting, with input
from generic community health-care and specialist services, such as speech and language therapists,
educational psychologists, occupational therapists, mental health workers and third-sector organisations,
such as the National Autistic Society (NAS) or locally organised parent support groups.
BACKGROUND
NIHR Journals Library www.journalslibrary.nihr.ac.uk
2
In some areas, there has been demand for early intensive ABA-based interventions, although these
interventions are not specifically recommended in National Institute for Health and Care Excellence (NICE)
guidelines.35 In some areas, ABA schools for both preschool and school-aged children, as well as dedicated
ABA classrooms in both special and mainstream school settings, have been established.36 Availability of
funding and places is highly variable and dependent on the local authority. There are also a number of
private providers delivering ABA-based intervention services in the home, as well as providing training
to enable parent- and carer-mediated therapy.37–39 The parents of some children have used litigation
through the local education authority appeals process to secure funding for ABA-based provision.40
Existing evidence on clinical effectiveness and cost-effectiveness
The existing research evidence evaluating the clinical effectiveness of early intensive ABA-based
interventions derives from both comparative and non-comparative studies, often using opportunistic
samples. There is a large body of published research based on single-case experimental designs to
investigate the techniques and practices employed in ABA-based interventions. This methodology has
the advantage that it enables the operationalisation (defining variables into measurable factors) of specific
behaviours, settings and participants, which in turn provides a framework for tracking the progress of
individual children.41 However, operationalisation to this degree may impinge on the ability to generalise
these findings to broader research questions. Together with the strong potential for publication bias
in this type of research, larger adequately powered controlled studies are required to understand the
overall effectiveness of the wide range of published manualised early intensive ABA-based interventions.
Controlled studies are necessary to estimate how much of the change on an outcome can be attributed
to the intervention of interest. Without a comparator group, it would not be possible to determine the
extent to which an outcome is attributable to developmental or other changes.
Several well-conducted systematic reviews of published studies comparing early intensive ABA-based
interventions with treatment as usual (TAU) or other interventions have been published.4,24,25,42–49 These
have, in general, reported early intensive ABA-based interventions to be beneficial for autistic children,
suggesting improvements in developmental functioning, decreased maladaptive behaviour and reduced
symptom severity.4,24,25,42–45,47–49 These findings have been heavily caveated by the review authors for a
variety of reasons, including the potential difference in supervision and training between groups,42 the
need for more randomised controlled trial (RCT)-based evidence,24,25,42,45,47 the poor range of consistently
reported outcome measures,4,24,49 the meaningfulness of cognitive ability as an outcome measure24 and
the small sample sizes of the included studies.4 One caveat to these findings, of particular relevance,
is the considerable variation in the reported outcome scores both within and between studies.24,42,45
An approach common to all of these reviews is that they have used a narrow interpretation of
early intervention models and focused on either EIBI4,24,25,42–48 or ESDM alone.49 To the best of our
knowledge, to date, there are no systematic reviews that have evaluated the effectiveness of the
broad range of early intensive ABA-based interventions available and none that have compared the
relative effectiveness of different early intensive ABA-based interventions. Furthermore, most of
these reviews have not investigated the considerable variation in the response of children to the
intervention. Of those that investigated factors that may influence the response to the interventions,
child characteristics such as age, IQ, adaptive behaviour and verbal ability at intake were cited as
possible moderators of effectiveness.4,24,44,47,48 However, these analyses were based on limited aggregate
data, with little power to detect differences and the potential to mislead, instead of a more detailed
approach using individual participant data (IPD). One review collected IPD, providing an opportunity
to examine potential effect modifiers in more detail,42 but the authors requested only four data items
(age, IQ and adaptive behaviour scores at intake and after 2 years). Using these data, the authors were
unable to isolate potential moderators of the treatment effect.
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As well as systematic reviews assessing comparative effects, a small number of economic evaluations of
early intensive ABA-based interventions have been undertaken. These evaluations have been relatively
simplistic and have drawn data on intervention effects from a limited sample of studies. They also tended
to focus on costs and, in general, ignored value generated via improvements in health-related quality of
life (HRQoL) and other important outcomes.44,50–54 To our knowledge, no previous studies have assessed
value in a UK context.
BACKGROUND
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Chapter 2 Aims and objectives
The aim of this study was to evaluate the clinical effectiveness and cost-effectiveness of earlyintensive ABA-based interventions for preschool autistic children and to estimate the value of
undertaking additional research in this area.
The key objectives were to:
l evaluate the effects of early intensive ABA-based interventions in young autistic children by conducting
a systematic review and IPD meta-analyses of data from all available comparative studies
l use the collected IPD to investigate potential study- and participant-level modifiers of treatment effect
l evaluate the cost-effectiveness of early intensive ABA-based interventions in young autistic children
by developing a new economic model
l identify uncertainties in the evidence base, highlight important areas for future research and
estimate the value of further research.
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Chapter 3 Collaboration details
SCABARD
The Synthesising Comprehensive Applied Behaviour Analysis interventions – Research for children
with autism spectrum Disorders (SCABARD) IPD meta-analysis was carried out as an international
collaborative project.
The project was carried out on behalf of the SCABARD Advisory Group. All study investigators who
shared data were active participating members of this group.
SCABARD individual participant data meta-analysis research team
The IPD meta-analysis was carried out by a research team based at the Centre for Reviews and
Dissemination and Centre for Health Economics at the University of York, in collaboration with the
Institute of Health & Society at Newcastle University and the School of Social and Community
Medicine at the University of Bristol.
Protocol development and registration
At the start of the project, a publicly available review protocol was submitted to the international
prospective register of systematic reviews (PROSPERO) (URL: www.crd.york.ac.uk/PROSPERO/
display_record.php?ID=CRD42017068303).
Stakeholder engagement
To ensure that a wide range of views was represented during the planning, conduct and interpretation
of the analyses, the research team established the SCABARD Advisory Group (see Appendix 1).
This included representation from the NAS, research study investigators, parents of autistic children,
autistic adults, UK-based ABA practice specialists, IPD research specialists, health economists, together
with international and UK expert clinical academics from psychiatry, and clinical and educational
psychology (see Appendix 1).
A Project Steering Group advised and supported the research team on strategic decisions over the
course of the project.
Ethics approval
The SCABARD IPD meta-analysis utilised existing data provided by contributing studies and addressed
the same clinical question to which study participants consented originally. Data contained no identifying
names or numbers and were held securely under controlled access.
The chairperson of the University of York Health Sciences Research Governance Committee confirmed
that additional ethics review was not required.
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Author consultation
A draft report containing results of the IPD meta-analysis was made available to study investigators
who provided data for analysis. Study investigators were also invited to a meeting in which preliminary
results of the IPD meta-analysis were shared and interpretations of the evidence discussed.
Public and patient involvement
Patient and public involvement (PPI) has been integral to the SCABARD trial, from inception to completion.
The PPI group consisted of six individuals who formed a part of the Advisory Group (see Appendix 1).
The PPI group included a representative from the NAS, two parents or carers of autistic people and two
autistic adults. Members were involved through the Advisory Group and had direct communication via
e-mail and telephone.
The PPI group contributed at every stage of the research (as outlined below) except the data collection
and analysis stage. This exception was deemed important to preserve the independence of the research
team reviewers.
Design of the research
A protocol was written and circulated to the members of the PPI group prior to the first of three
Advisory Group meetings. This first meeting outlined the purpose and nature of the project and sought
input on the study design, as a result of which we adapted our project design by:
l developing a list of relevant baseline characteristics that were important to include for the analyses
l listing which outcomes were important to relevant stakeholder groups
l further developing a definition of early intensive ABA-based treatments and narrowing the
inclusion criteria
l further developing search terms to ensure that they were comprehensive.
Design of the analyses
The original intent of the second meeting of the Advisory Group was to focus on the design of
the economic model to ensure that it reflected key elements of autism and had face validity.
However, we extended the remit of this meeting to give an update on progress and outline the
quality of the studies, the interventions used and the types of outcomes that we were able to
collect. The discussions of this group formed the basis of both the structure of the eventual
analyses and the economic model.
Analysis of the results
The PPI group and the other members of the Advisory Group were not involved at the analysis stage
to retain a measure of independence owing to the strong beliefs that many members of the public and
service providers already held about the effectiveness of the intervention. We did, however, include
them in the interpretation of these results. These results were circulated prior to the final Advisory
Group meeting, which discussed the potential interpretations, how far we should extend the economic
model and what scenarios to include.
Reporting of the research
Patient and public involvement members, as part of the Advisory Group, had an opportunity to
contribute to drafts of the final report before submission. They provided extensive comments on the
document via e-mail.
COLLABORATION DETAILS
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External stakeholder consultation
After submission, relevant external organisations and groups were also consulted in a consultation
exercise. When possible, we have amended the report based on these comments and in the interests of
full transparency we have included the unaltered feedback from these individuals and organisations in
Appendix 20. We also included the comments of one member of the PPI group in this section who was
not able to provide feedback at an earlier stage. Full permission has been received from those who
made these comments to reproduce them in this report.
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Chapter 4 Systematic review and
meta-analysis of effectiveness: methods
Literature searches
The aim of the literature search was to identify comparative studies of comprehensive early intensive
ABA-based interventions for children with autism and related conditions. An information specialist
developed the search strategy in MEDLINE (via Ovid). No date, language, geographical or study design
limits were applied to the strategy. The MEDLINE strategy was adapted for use in all resources searched.
The searches were conducted during August 2017. The following databases were searched: Cochrane
Central Register of Controlled Trials (CENTRAL), Cumulative Index to Nursing and Allied Health
Literature (CINAHL), EMBASE, Education Resources Information Center, MEDLINE, PsycINFO and
Social Science Citation Index. Records identified from the database searches were downloaded and
imported into EndNote bibliographic software (version X9, Clarivate Analytics, Philadelphia, PA, USA)
and de-duplicated. Reference lists of relevant systematic reviews were also searched manually.
As publication bias has been identified as a concern in relation to early intensive ABA-based interventions
in autism, we attempted to identify grey literature by searching for conference papers (using EMBASE
and Conference Proceedings Citation Index) and dissertations and theses [using PsycINFO and The British
Library’s Electronic Theses Online Service (EthOS) database]. Advisory Group members and authors of
identified studies were asked to identify any additional potentially relevant studies, particularly those that
are unpublished. ClinicalTrials.gov and the World Health Organization International Clinical Trials Registry
Platform were also searched in an attempt to identify unpublished studies and any studies in progress.
Full details of the search strategies are presented in Appendix 2.
Inclusion criteria
Population
Studies that included children with a diagnosis of ASD, including any of the following terms: autism,
Asperger syndrome, pervasive developmental disorder – not otherwise specified (PDD-NOS), atypical
ASD or ASD1 based on Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, or International
Statistical Classification of Diseases and Related Health Problems, Tenth Revision, criteria (ICD-10). Inclusion
was not restricted by age, although the primary focus of the review is on children of preschool age
(aged < 5 years in the UK). If studies with a broader age were identified, preschool age children could
be identified within the IPD.
Intervention
Studies of early intensive interventions based on ABA principles were eligible for inclusion in the review.
Intensive behavioural interventions:
l included > 15 hours per week of planned intervention
l used a comprehensive approach, targeting a range of behaviours, skills and developmental domains
l used ABA-based teaching strategies as the core components
l were delivered face to face by qualified or trained individuals
l were delivered at least initially on a one-to-one basis
l included qualified supervision of the therapists/trained staff/parents delivering the intervention.
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Studies of interventions delivered to parents rather than children and studies of narrowly targeted
interventions aimed at a single behaviour (e.g. joint attention) were excluded.
Comparators
Inclusion was not restricted by study comparator.
Relevant comparators included all other forms of early intervention, such as augmented forms of
communication [e.g. the Picture Exchange Communication System (PECS)];55 other speech and language
therapy interventions; support programmes led by independent providers, such as charitable and
third-sector organisations; educational-based structured teaching approaches, such as Treatment and
Education of Autistic and Communication related handicapped CHildren (TEACCH);56 and ‘eclectic’
approaches, as well as placebo, waiting list or TAU groups.
Outcomes
All studies that met the above criteria were included and, when available, contributed data for the
prespecified IPD meta-analysis outcomes (see Chapter 6).
Study design
Prospective randomised and non-randomised controlled studies meeting all other inclusion criteria
were eligible for inclusion. Non-comparative, single-arm studies were excluded.
Study selection
Two researchers independently screened all titles and abstracts retrieved from electronic databases
and other searches. Full-paper publications were then obtained for potentially relevant studies. If no full
paper existed and study eligibility was uncertain, study authors were contacted and asked to provide
further information.
Two researchers independently assessed the relevance of each full study using the fullest available
information. Any discrepancies in screening decisions were resolved by consensus and discussion with
a senior team member or clinician with expertise in autism, as required. Authors were contacted for
further information, when necessary. Full details of the screening criteria are presented in Appendix 4.
Data collection
Published data
Two researchers independently extracted data from published and unpublished study reports. Data
were extracted on study design, intervention and comparator characteristics, baseline characteristics
and results. Any discrepancies were resolved by discussion and, when necessary, cross-referencing IPD
or contacting study authors.
Individual participant data
Study investigators were invited to supply data in a standardised coding format developed for
SCABARD. However, data were accepted in any reasonable format and recoded as necessary by
the research team. Data were requested for all recruited children, including any who were excluded
from original study analyses. Study protocols were also requested from authors.
When the intervention or its components were unclear from publicly available sources, study authors
were asked to provide these details alongside their IPD.
The SCABARD data dictionary, listing all data items requested, is given in Appendix 3.
SYSTEMATIC REVIEW AND META-ANALYSIS OF EFFECTIVENESS: METHODS
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We requested that all participant names and identifying numbers were removed prior to supplying data.
Secure file transfer and encrypted e-mail were offered as secure methods for transferring IPD. All data
were anonymous and held in a password-protected area of the University of York servers.
Critical appraisal, data checking and quality assurance
Critical appraisal of studies
Critical appraisal of included studies was based on assessment of trial publications, protocols (if available)
and by checking received data sets.
Risk of bias in RCTs was assessed using the Cochrane Risk of Bias tool.57 Non-randomised controlled
study designs were assessed using the Cochrane Risk Of Bias In Non-randomised Studies – of
Interventions (ROBINS-I) tool.58
As well as assessing aspects of bias (such as blinding and/or independence of outcome assessors), when
possible, the critical appraisal also assessed the fidelity of delivered interventions to the underlying
treatment model. Assessment was undertaken independently by two researchers, with any discrepancies
resolved by consensus or recourse to a third researcher, if necessary.
Checking and quality assurance of individual participant data
All IPD were checked on receipt. Baseline data were tabulated and compared with the study
publication, with any inconsistencies noted. Data were checked for internal consistency and integrity of
randomisation (if conducted). Patterns of missing data were examined. One researcher ran data checks,
which were independently cross-checked by a second researcher. Findings of all data checking were
discussed with senior members of the research team.
The impact these checks had on the potential quality of the studies and data was considered (e.g. whether
or not there was evidence of non-random allocation). This was used alongside the critical appraisal and
could upgrade or downgrade the findings of the overall quality assessment.
Comparison of data available from published and individual participant data sources
The appraisal of included evidence was also informed by comparing the variables and outcomes collected in
the IPD against those (1) requested by the SCABARD team (see Appendix 3), (2) reported in corresponding
publications and (3) reported in original study protocols (if available).
Individual participant data meta-analysis methods
Analysis framework and structure
Types of intervention and control
Two general classes of early intensive interventions based on ABA emerged from the literature:
1. EIBI, including the University of California, Los Angeles (UCLA)/Lovaas model26 or intensive
ABA-based adult-led interventions (e.g. discrete trial training or separate learning units with
a clear beginning and end).
2. EIBI with NDBI, incorporating some aspects of the developmental social pragmatic model that seeks
to reinforce social communication and interaction by engaging with child-initiated activities. The ESDM
emerged as a prominent form of EIBI with NDBI.
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The two key comparator interventions were:
1. ‘eclectic’ treatment, which may include a range of school-, clinic- or home-based interventions,
sometimes incorporating lower-intensity ABA-based approaches
2. TAU, which consisted of standard local provision or waiting list controls.
Some studies compared early intensive ABA-based interventions of differing intensity.
The main meta-analyses combined all types of early intensive ABA-based interventions and both types
of control arm, assuming equivalence between intervention types, to obtain overall estimates of the
effectiveness of early intensive ABA-based interventions. Clinical expertise within the SCABARD team
and Advisory Group suggested that the various classes of early intensive ABA-based interventions
may be essentially equivalent in methodology and efficacy, so this was considered a reasonable
primary approach.
Whether or not the interventions were truly equivalent was investigated by considering each intervention
and comparator separately, and conducting pairwise meta-analyses for each intervention/comparator
combination. This was followed by analyses that combined interventions and comparators as follows:
l combined comparators (eclectic and TAU), keeping interventions separate
l combined early intensive ABA-based interventions (EIBI, EIBI and NDBI), keeping comparators separate.
These meta-analyses were performed for each outcome measure using both one- and two-stage
meta-analysis methods (see Statistical details of individual participant data meta-analyses). The different
meta-analyses were compared to identify whether or not there was any evidence of differences between
interventions and comparators. This informed the decision of if and how to combine interventions and
comparators in all subsequent analyses. Statistical significance (at 5% level) was not the sole driver of this
decision; observed size of the effect estimates was also considered, so groups could potentially be kept
separate even if there was no statistically significant evidence of difference.
Outcome domains
The meta-analyses focused on key domains of development in autistic children, which might be
measured on a range of different scales.
These domains were:
l adaptive behaviour
l cognitive ability
l language development
l autism symptom severity
l presence of behaviours that challenge
l placement into mainstream or specialist schools.
The intention was to analyse these domains at 6 months, 1 and 2 years after randomisation or
intervention initiation, but, given the data received, this was amended to 1 and 2 years, with limited
analyses at 3, 4 and 7 years for some domains. Mean differences (MDs) [i.e. not standardised mean
differences (SMDs)] between early intensive ABA and comparator arms were used as the main
outcome measure, because, generally, all studies used equivalent measurement scales [e.g. Vineland
Adaptive Behaviour Scale (VABS)].59 Analyses using SMDs were performed as a sensitivity analysis
for each outcome domain.
SYSTEMATIC REVIEW AND META-ANALYSIS OF EFFECTIVENESS: METHODS
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Specific outcome measures
The outcomes analysed were the individual measurement scales from each of the main outcome
domains. The included studies collected a large number of outcome measures, but most were collected
in only one study or with insufficient data to assess effectiveness (i.e. collected for only one study arm
or no baseline data reported).
The following outcome measures were assessed by at least one study, with sufficient data to estimate
effectiveness of early intensive ABA-based interventions:
l adaptive behaviour:
¢ composite VABS59
¢ each component of the VABS composite score –
¢ communication
¢ daily living skills
¢ socialisation
¢ motor skills
¢ maladaptive behaviour (not always recorded)
l cognitive ability (IQ):
¢ as assessed in the study (regardless of exact test used)
¢ based on specified test –
¢ Bayley Scales of Infant Development (BSID) (I, II or III)60–62
¢ Wechsler Intelligence Scale for Children – Revised (WISC-R)63–65
¢ Wechsler Preschool and Primary Scale of Intelligence – Revised (WPPSI-R)66–68
¢ Stanford–Binet Intelligence Scale (S–B)69
l non-verbal IQ:
¢ Merrill–Palmer Scale of Mental Tests (MPSMT)70
l language development:
¢ expressive, receptive, comprehension and overall using scales –
¢ expressive one-word picture vocabulary test71,72
¢ British Picture Vocabulary Scale73
¢ Reynell Developmental Language Scales (RDLS)74,75
¢ Mullen Scales of Early Learning (MSEL) (expressive and receptive language subscales)76
¢ Social Communication Questionnaire (SCQ)77
l autism symptom severity:
¢ Autism Diagnostic Observation Schedule (ADOS)78
¢ Autism Diagnostic Interview – Revised (ADI-R)79
l presence of behaviours that challenge:
¢ Conners’ Rating Scales – Revised80
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l additional outcomes:
¢ other components of MSEL:
¢ composite score
¢ fine motor
¢ visual reception.
When these outcome measures were available in two or more studies at consistent time points, they
were combined in one- and two-stage meta-analyses. When available from only one study, results were
tabulated. Other outcome measures were described in the protocol, but not collected by any eligible
studies, so are not listed here.
Covariates modifying applied behaviour analysis effectiveness
The following potential effect modifiers were investigated to explore whether or not they altered the
effectiveness of early intensive ABA-based interventions, and were specified in the protocol. These were
only considered when suitable data were recorded in the IPD provided, or in publications, protocols or
otherwise provided by triallists (for intervention characteristics).
Study-level intervention characteristics
l Allocation method (parental choice, location based, cohort).
l Delivery setting (home, school, specialist centre).
l Parental involvement in ABA (none, encouraged, some).
l Use of ABA methods in control intervention (none, partial).
Participant-level characteristics
l Age at enrolment.
l Sex.
l Baseline IQ.
l Baseline composite VABS score.
Other characteristics were listed in the protocol, but there were insufficient data to analyse them.
The impact that these covariates have on early intensive ABA-based intervention effectiveness was
assessed by using one-stage meta-analyses with the covariate included as a treatment–covariate
interaction in a regression model (see Impact of covariates on treatment effect).
A separate model was fitted for each main outcome and covariate combination, when sufficient data
were available.
Statistical details of individual participant data meta-analyses
Both one- and two-stage meta-analyses were performed for each outcome, provided that data were
available for at least two studies. When these thresholds were not reached, a narrative summary of
study results was produced.
Two-stage meta-analysis
In a two-stage meta-analysis, estimates of intervention effect (SMD or relative risk) are estimated
separately for each study and are then pooled across studies to calculate a summary effect estimate.
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The main within-study analysis for continuously distributed outcomes (e.g. IQ, VABS composite score)
was the analysis of covariance (ANCOVA) model,81 which adjusts the outcome at time of analysis for
the baseline value. This model was used to estimate the MD in outcome between intervention and
control arms [with its standard error (SE)] for use in the meta-analysis.
Results were then combined across studies using both fixed-effect and DerSimonian–Laird random-effects
meta-analysis, to account for possible heterogeneity. Forest plots were produced for each meta-analysis.
Effect estimates (SMDs, MDs or relative risks) and 95% confidence intervals (CIs) were calculated for
each study and for the combined result. Heterogeneity was also assessed using I2. If only two studies
presented data, a fixed-effect meta-analysis was used, as heterogeneity cannot be reliably estimated
from only two studies.
One-stage meta-analysis
A one-stage meta-analysis takes advantage of the availability of IPD by including all data from all
studies in a single regression analysis (while taking account of/stratifying by study). This enables
greater flexibility in the modelling structure.
A linear regression analysis was used for continuous outcomes (e.g. VABS composite score), and
proportional odds regression for categorical outcomes (school placement). As for the two-stage models,
the ANCOVA approach was used to estimate MDs. The models regressed final outcome against treatment
and baseline value, with random intercept and intervention effects (to account for heterogeneity).
There are currently no well-tested methods available for one-stage analyses of SMD, so only two-stage
analyses of SMD were performed.
All available data from all studies were included in a regression analysis; studies were excluded when
they did not include data for the outcome measure of interest. As for two-stage analyses, meta-analyses
were performed provided that at least two studies, with a minimum of 50 participants, provided data for
the specified outcome. If only two studies provided data, a fixed-effect regression was used.
Heterogeneity assessment
All one-stage models were fitted using mixed-effects regression, with random effects, varying by study,
applied to the treatment parameter. Heterogeneity was quantified in terms of the observed statistical
heterogeneity in the model (τ2 estimate).
When available, results of one- and two-stage analyses were compared.
Impact of covariates on treatment effect
Access to IPD means that the analysis can potentially go beyond looking only at whether or not early
intensive ABA-based interventions are effective, to consider whether or not child-level characteristics
(including parental and intervention factors specific to each child) might alter how effective the intervention
is. For example, whether or not IQ at time of recruitment alters how effective EIBI is in changing outcomes.
The impact the covariate may have on effectiveness is called the intervention–covariate interaction.
Two-stage analyses
For study-level characteristics (such as parental involvement in ABA provision, setting and duration),
subgroup analyses were used to investigate the impact of covariates. Studies were placed into groups
according to the value of the characteristic (e.g. some parental involvement, involvement encouraged
or no involvement, with exact groupings decided once it was known what data were available) and
meta-analyses performed, as described above, within each group. Subgroups were then compared to
identify any differences in effect.
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One-stage analyses
For individual-level characteristics, the one-stage regression analyses described earlier were extended
to include a parameter for the covariate of interest and one for the intervention–covariate interaction.
To ensure model convergence, these parameters were assumed common to all studies (i.e. a fixed effect),
but models with random effects for these parameters were tested to ensure the validity of making a
fixed-effect assumption. A statistically significant intervention–covariate interaction parameter in these
models indicates that the covariate alters the effect of the early intensive ABA-based interventions.
These models were fitted for each possible combination of outcomes and covariate to assess the
associations between intervention and covariates, provided sufficient data were available (at least two
studies and 50 participants reporting both outcome and covariate).
Time of measurement
Analyses were performed at 1 and 2 years after recruitment for each outcome. A tolerance of ± 6 months
was used for each analysis. This means that, for example, measurements made from between 18 and
30 months could contribute to analyses at 2 years.
In a few studies, IPD were provided at times other than 1 or 2 years. To incorporate those additional
data captured at other times, repeated measures analyses were performed. Repeated measures models
analyse all time points simultaneously, so there is a single model estimating effects for all reported
years. They also account for the fact that each child may have repeated measurements of the same
outcome over time, which are likely to be correlated, by including a correlation term for each child.
When the data permitted, exploratory analyses were performed, including an assessment of whether
outcomes varied linearly or log-linearly over time (i.e. assuming a trend over time rather than separate
analyses). The choice of these models depended on the results of the analyses at each specific time point.
Studies not supplying individual participant data
When studies identified as eligible for inclusion in the meta-analysis did not supply IPD to the SCABARD
team, relevant outcome data were extracted from study publications. Data were extracted as means and
standard deviations (SDs) in each study arm, as 2 × 2 tables (numbers of events and participants by arm)
or as relative risks, odds ratios or MDs if full data were unavailable.
Mean differences or SMDs for each outcome measure were calculated from extracted data. These were
combined with the results for each study estimated from the IPD in exploratory two-stage meta-analyses,
following the same process as described in Statistical details of individual participant data meta-analyses.
Meta-analyses combining IPD with published data from studies not supplying IPD were treated as
sensitivity analyses and used to assess whether or not there are any differences between studies that
did not supply IPD and those that did.
Missing data
When a study did not examine or record an outcome measure or a covariate, the study was excluded
from all relevant analyses.
If > 20% of participants in the IPD had no record for an outcome measure, a best- and worse-case analysis
was planned as a sensitivity analysis. All included studies had < 20% of participants with missing outcome
data (when the outcome was collected), so this analysis was not required.
Complete-case analysis (excluding all participants with missing covariate data) was used for all analyses.
Imputation analyses were considered in the protocol as a way of handling missing covariates, but were
not performed, given the limited number of covariate analyses that were feasible and because data were
largely complete for the analyses performed.
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Sensitivity analysis
Although a number of sensitivity analyses were identified in the statistical analysis plan, the limitations
of the IPD meant that the only sensitivity analysis performed was one limited to an analysis of only
UK-based studies.
Network meta-analysis
Network meta-analyses (NMAs) analysed all types of intervention and control simultaneously. The one-stage
repeated measures meta-analysis models described above were extended to include multiple arms and
incorporated random effects to account for heterogeneity. Potential network inconsistency was investigated
by comparing NMA results with results from direct pairwise meta-analyses.
Multivariate meta-analysis
The analysis included many outcomes that are likely to be highly correlated both within domains
(e.g. different IQ scoring methods) and between domains (e.g. VABS score and autism symptom severity).
Multivariate analysis of these correlated outcomes may improve estimation, particularly in cases in
which some studies do not report one outcome, but do report a correlated outcome.
One-stage models of multivariate analysis were considered. Given the limited availability of outcomes,
only bivariate analyses of composite VABS score with each other outcome were feasible. These analyses
were done but are not reported here, owing to uncertainty as to their validity, given data limitations, and
little evidence of any difference from the main univariate analyses.
Software
All data management and meta-analyses were performed at the Centre for Reviews and Dissemination,
using the R software package (2016; The R Foundation for Statistical Computing, Vienna, Austria).
Additional libraries in R were used as follows:
l data management and manipulation: tidyr, dplyr, tidyverse libraries
l two-stage analyses: meta and metafor libraries
l one-stage models: lme4 library
l forest plots: using in-house R code and meta library
l other graphics: ggplot2 library.
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Chapter 5 Systematic review and
meta-analysis of effectiveness: results
Study selection
Of the 6881 records identified from the literature searches, a total of 64 studies were considered
potentially eligible for inclusion on the basis of information available in record titles and abstracts.
After screening full-text publications and/or contacting authors for clarification of study details, a total
of 20 studies from 33 articles were included in the review (Figure 1). Studies that were not included
and the reason for their rejection are included in Table 29 in Appendix 5.
Included studies
Figure 2 shows the included studies by treatment comparison. Fifteen studies compared some form
of ABA-based early intensive intervention against a comparator treatment (typically characterised as
‘eclectic’ or TAU).82–97,104–110 Three studies26,90,91,98,103,111 compared ABA-based early intensive interventions
of different intensity, two studies99,100 compared clinic-based with parent-managed ABA-based early
intensive interventions, and one study101 compared two different forms of ABA-based early intensive
behavioural therapy. Table 1 summarises the characteristics of the included studies. Twenty studies
(reported in 33 publications26,82–101,103–112) published between 1987 and 2017 were identified. The majority
of these were published in academic journals, although one was a Doctor of Philosophy (PhD) thesis112 and
another was a conference abstract that met the review inclusion criteria but did not report any results.88
Full details of all studies are provided in Table 30 in Appendix 6.
Children in the included studies were aged on average from 2483,106,107,112 to 6685,95 months at intake
(median 37.4 months) and had a diagnosis of autism, ASD or (in some earlier studies) pervasive
developmental disorder, as confirmed by the Diagnostic and Statistical Manual of Mental Disorders,
Third or Fourth Edition,26,82,105,108 the ICD-10,84 the ADI-R,85,86,89,92,95,96,104,109,110 the ADOS93 or some
Records retrieved by searches
(n = 6881)
Included based on title/abstract
(n = 64)
Included based on full text
[n = 20 studies (33 papers)]
Rejected on title/abstract
(n = 6817)
Rejected on full text
(n = 31)
Reasons for exclusion
• Parent focused, n = 2
• Low intensity, n = 7
• Not comprehensive, n = 1
• Non-comparative study, n = 6
• Duplicates, n = 2
• Abstract or protocol only, n = 12
FIGURE 1 Flow of included studies.
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Studies meeting review inclusion criteria 
n = 20 studies
Early intensive ABA-based
interventions vs. non-ABA based
comparators 
n = 15 studies
ABA-based early interventions
of different intensity 
n = 3 studies
Clinic- vs. parent-direct EIBI
n = 2 studies
Different forms of early intensive
ABA-based intervention
n = 1 study
IPD provided
(3 studies)
IPD unavailable
(5 studies)
IPD provided (10 studies)
Rogers 2019102  (IPD unavailable)
One study comparing ESDM vs. electric
intervention published after completion
of the SCABARD review and meta-analysis
IPD provided
(2 studies)
IPD provided
(1 study)
Cohen 2006104
Eikeseth 2002/785,95
Eikeseth 201284
Eldevik 201286
Magiati 2007/1189,96
aReed 200790,91
Remington 200792/Kovshoff 2011110
Vivanti 201493
Zachor 200794
Zachor 201097
Birnbrauer 199382
Dawson 201083
Farrell 200587
bHaglund 201788
Howard 2005/14105,108
Lovaas 198726/McEachin 199398
aReed 200790,91
Smith 2000103
Hayward 200999
Sallows 2005100
Stock 2013101
FIGURE 2 Studies and comparisons. a, Included multiple arms, so included in two comparisons; and b, unpublished study.
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TABLE 1 Baseline characteristics of included studies
First study
author and
year
Intensive ABA-
based intervention
name
Comparator
name
Number of
intervention
participants
(number
followed up)
Number of
comparator
participants
(number
followed up)
Treatment
duration
(months)
(SD)
Actual delivered
treatment
intensity (hours/
week) (SD)
Mean (SD or range)
age at baseline
(months unless
otherwise stated)
Sex
(M/F)
Baseline autism
symptom
severity
[measure] (SD)
Baseline full-
scale IQ (SD)
[measure]
Mean (SD)
baseline
VABS score
EIBI vs. TAU/eclectic intervention(s)
Birnbrauer
199382
Murdoch Early
Intervention
Program
Control 11
(9 followed up)
8
(5 followed up)
I NR; C NR I 18.72 (range
8.7–24.6); C NR
I 39 (32–47);
C 33 (22–47)
I 4/5;
C 5/0
I NR; C NR I 20; C 18
[BSID mental
age in months]
I 18; C 17
[VABS
adaptive
behaviour age
in months]
Cohen
2006104
EIBI TAU 21 21 I 36; C 36 I NR; C NR I NR; C NR I 18/3;
C 17/4
I NR; C NR I 61.6 (16.4);
C 59.4 [BSID]
I 69.8; C 70.6
Dawson
201083
ESDM TAU 24 24 I 24; C 24 I 31.5 total 1 :
1 (15.2 therapist,
16.3 parent)+
5.2 other
therapies (e.g.
speech therapy,
developmental
preschool);
C 18.4 (9.1
individual,
9.3 group)
I 23.9 (4.0);
C 23.1 (3.9)
I NR;
C 18/6
I 7.2 (1.7); C 6.9
(1.7) [ADOS
severity score]
I 61 (9.2);
C 59.4 (8.6)
[MSEL composite]
I 69.5 (5.7);
C 69.9 (7.3)
Eikeseth
201284
Community school-
based EIBI
Eclectic special
education
teaching
35 24 I 24; C 24 I NR; C NR I 3.9 years;
C 4.4 years
I 31/5;
C 20/4
I 37.2 (7.7);
C NR [CARS]
I NR; C NR I 67 (10.3);
C 63.6 (8.1)
Eikeseth
2002/785,95
EIBI Intensive
eclectic special
education
13 12 I 36; C 36 I 28 (1 year),
18 (3 years);
C 29 (1 year),
16 (3 years)
I 66.31; C 65 I 8/5;
C 11/1
I NR; C NR I 61.92; C 65.17
[WPPSI-R,WISC-R
or BSID]
I 55.77 (8.96);
C 60 (13.2)
Eldevik
201286
EIBI TAU (eclectic) 31 12 I 25.1 (6.3);
C 24.6
(10.8)
I 13.6 (5.3)
(hours spent
on weekly
goals during
preschool);
C ≥ 5 (actual
hours not
specified)
I 42.2 (26–70);
C 46.2 (24–67)
I 25/6;
C 8/4
I NR; C NR I 51.6 (16.9);
C 51.7 (18.1)
[BSID, S–B or
WPPSI]
I 62.5 (8.2);
C 58.9 (7.8)
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TABLE 1 Baseline characteristics of included studies (continued )
First study
author and
year
Intensive ABA-
based intervention
name
Comparator
name
Number of
intervention
participants
(number
followed up)
Number of
comparator
participants
(number
followed up)
Treatment
duration
(months)
(SD)
Actual delivered
treatment
intensity (hours/
week) (SD)
Mean (SD or range)
age at baseline
(months unless
otherwise stated)
Sex
(M/F)
Baseline autism
symptom
severity
[measure] (SD)
Baseline full-
scale IQ (SD)
[measure]
Mean (SD)
baseline
VABS score
Farrell
200587
EIBI Eclectic (LUFAP) 8 9 I 26; C 20 I NR; C NR I NR; C NR I 7/2;
C 6/2
I NR; C NR I 15.6 months;
C 21.8 months
(BSID)
I NR; C NR
Haglund
201788
CIEI TAU 67 27 I NR; C NR I NR; C NR I NR; C NR I NR;
C NR
I NR; C NR
[ADOS-R]
I NR; C NR
[WPPSI-III]
I NR; C NR
Howard
2005105
Early IBT C1: autism
educational
programming –
eclectic autism-
specific
classroom-based
intervention;
C2: general
educational
programming –
generic special
education
classroom
intervention
29 C1 16; C2 16 I 14; C1
14; C2 14
I 25–40; C1
25–30; C2 15
I 30.86 (5.16);
C1 37.44 (5.68);
C2 34.56 (6.53)
I 25/4;
C1 13/
3; C2
16/0
I 7.55 (1.39);
C1 7.27 (1.56);
C2 7.33 (2.02)
[number of DSM-
IV criteria met]
I 58.54 (18.15);
C1 53.69 (13.5);
C2 59.88 (14.85)
[BSID, WPPSI
or S–B]
I 70.46
(11.85);
C1 69.81
(10.48);
C2 71.62
(10.47)
Remington
200792
EIBI TAU 23 21 I 24; C 24 I 25.6 (4.8);
C NR
I 35.7 (4.0);
C 35.7 (4.4)
I NR;
C NR
I NR; C NR I 61.43 (16.43);
C 62.33 (16.64)
[BSID, S–B]
I 60.22 (5.82);
C 57.17 (7.05)
Magiati
200789
EIBI Autism-specific
nursery (school
provisions)
28 16 I 23–27;
C 23–27
I 32.4 (6.4);
C 25.6 (6.4)
I 38 (7.2);
C 42.5 (7.8)
I 27/1;
C 12/4
I 36.4 (6.7);
C 40 (6.9) [ADI-R]
I 83 (27.9);
C 65.2 (26.9)
[BSID, MP,
WPPSI-R]
I 59.6 (6.2);
C 55.4 (5.4)
Vivanti
201493
ESDM ‘Generic’
intervention
27 30 I 11.9;
C 11.8
I 15–25; C NR I 40.3; C 41.97 I 23/4;
C 27/3
I 6.78; C 6.31
[ADOS calibrated
score]
I 53.46; C 49.01
[MSEL total]
I 68.74;
C 68.5
Zachor
200794
‘ABA’ Eclectic
development
approach
20 19 I NR; C NR I NR; C NR I 27.7; C 28.8 I 19/1;
C 18/1
I NR; C NR I NR; C NR I NR; C NR
Zachor
201097
‘ABA’ ‘Eclectic’ 45 33 I NR; C NR I NR; C NR I 25.1 (3.9);
C 26.0 (4.6)
I NR;
C NR
I 20.9 (4.3);
C 20.1 (4.6)
[ADOS new
algorithm]
I 72.2 (19.2);
C 73.3 (22.2)
[MSEL cognitive
composite]
I 66.2 (9.6);
C 68.6 (6.3)
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First study
author and
year
Intensive ABA-
based intervention
name
Comparator
name
Number of
intervention
participants
(number
followed up)
Number of
comparator
participants
(number
followed up)
Treatment
duration
(months)
(SD)
Actual delivered
treatment
intensity (hours/
week) (SD)
Mean (SD or range)
age at baseline
(months unless
otherwise stated)
Sex
(M/F)
Baseline autism
symptom
severity
[measure] (SD)
Baseline full-
scale IQ (SD)
[measure]
Mean (SD)
baseline
VABS score
EIBI vs. lower-intensity ABA-based intervention
Lovaas
198726
EIBI Lower-intensity
ABA-based
treatment
19 19 I > 24
(estimated
≈ 49);
C > 24
(estimated
≈ 43)
I NR; C NR I 34.6; C 40.9 I 16/3;
C 11/8
I NR; C NR I mental age
18.8; C mental
age 17.1 [BSID,
Cattell, S–B,
Gesell]
I NR; C NR
Smith
2000103
IBT Parent training 15 13 I 33.44
(11.0);
C NR
I 24.52 (3.69);
C NR
I 36.07 (6.0);
C 35.77 (5.37)
I 12/3;
C 11/2
I NR; C NR I 50.53 (11.18);
C 50.69 (13.88)
[BSID, S–B]
I 63.44 (9.35);
C 65.17 (9.44)
Reed
200790,91
High-intensity ABA-
based interventions
(Lovaas,26 CABAS
and verbal
behaviour)
C1 low-intensity
ABA-based
intervention; C2
special nursery
placements
(TAU); C3
portage
14 C1 13; C2 20;
C3 16
I 9–10;
C1 9–10;
C2 9; C3 9
I 30.4 (5.0);
C1 12.6 (2.3);
C2 12.7 (3–23);
C3 8.5 (2–15)
I 42.9 (14.8);
C1 40.8 (5.6);
C2 43 (41–48);
C3 38 (30–45)
I 14/0;
C1 13/
0; C2
18/2;
C3 NR
I 89.1 (14.7);
C1 95.1 (11.6);
C2 96.8 (10.4);
C3 91.3 (14.3)
[GARS]
I 57.2 (17.8);
C1 49.3 (13.2);
C2 51.9 (20.1);
C3 53.3 (16.1)
[PEP-R]
I 59.3 (10.1);
C1 56.5 (4.4);
C2 53 (4.6);
C3 58.6 (6.0)
Clinic- vs. parent-managed EIBI
Hayward
200999
EIBI: clinic managed EIBI: parent
managed
23 21 I 12; C 12 I 37.4 (3.47);
C 34.2 (5.29)
I 35.7 (6.2);
C 34.4 (5.7)
I 19/4;
C 15/6
I NR; C NR I 53.5 (15.1);
C 54.1 (15.1)
[BSID/WPPSI-R]
I 62.3 (6.8);
C 65.1 (10.4)
Sallows
2005100
Clinic-directed
UCLA-based EIBI
Parent-directed
UCLA-based
EIBI
13 10 I 24; C 24 I 38.6 (2.91)
1 : 1 in year 1;
C 31.67 (5.81)
in year 1
I 33.23 (3.89);
C 34.2 (5.06)
I 11/2;
C 8/2
I NR; C NR I 50.85 (52.1);
C 52.1 (8.98)
[BSID]
I 59.54 (5.31);
C 60.9 (5.94)
Group-based verbal behaviour intervention vs. PRT-based intervention
Stock
2013101
Nova Scotia EIBI Group ABA 14 14 I 12; C 12 I NR; C 20 I 46.7 (9.23);
C 46 (8.12)
I 12/2;
C 12/2
I NR; C NR I NR; C NR I NR; C NR
ADOS-R, Autism Diagnostic Observation Schedule – Revised; C, comparator; CABAS, Comprehensive Application of Behaviour Analysis to Schooling; CARS, Childhood Autism Rating Scale; CIEI, comprehensive
intensive early intervention; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; F, female; GARS, Gilliam Autism Rating Scale; I, intervention; IBT, intensive behaviour-analytic treatment;
LUFAP, Lancashire Under fives Autism Project; M, male; MP, Merrill–Palmer Scales of Development; NR, not reported; PEP-R, Psychoeducational Profile – Revised; WPPSI, Wechsler Preschool and Primary Scale
of Intelligence; WPPSI III, Wechsler Preschool and Primary Scale of Intelligence III.
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combination of these.83,88,94,97,99,101,106,107,112 As would be expected, the majority of participants in the
included studies (from 71% to 100%) were boys. Many included studies did not record the severity
of baseline autism symptoms and those that did used a range of different measures (see Chapter 6,
Individual participant data received from included studies). Across all included treatment arms, mean
baseline VABS composite score ranged from 55.8 to 71.6 and mean baseline standard cognitive ability
scores ranged from 51 to 83 (see Table 1).
Studies recruited participants from the USA,26,83,98,100,103–108,111,112 the UK,87,89–92,96,99,109,110 Norway,84–86,88,95
Australia,82,93 Israel94,97 and Canada.101
One additional study102 comparing an ABA-based early intensive intervention against eclectic intervention
was published during the writing of the current report, after the completion of the systematic review
and meta-analyses. Although there was insufficient time available to integrate this study into the
body of the report, a separate description of this study and meta-analyses incorporating its aggregate
outcome data can be found in Appendix 12.
Applied behaviour analysis-based early intensive intervention versus treatment as usual
and eclectic comparators
Fifteen studies (14 published26,82–87,89–101,103–112 and one unpublished88) compared some form of EIBI with
a TAU or eclectic intervention.
Applied behaviour analysis-based early intensive interventions of different intensity
Three studies compared EIBI with a lower-intensity variation of the same approach, requiring fewer
one-to-one contact hours between child and therapist.26,90,91,98,103,111 The original UCLA study by Lovaas26
compared 40 hours per week of EIBI against the same kind of treatment for < 10 hours per week
(this study also included a retrospective cohort of children not receiving any ABA-based treatment, but
insufficient data were available in either publications or IPD to inform the current meta-analysis).26,98 A
later US study compared 30 hours per week of planned intensive EIBI (plus 5 hours/week of parental
treatment) against parental training in EIBI techniques alone.103 One UK study compared 20–40 planned
hours of ABA-based intervention with around 10–20 hours per week of the same approach.90
Clinic- versus parent-directed applied behaviour analysis-based early intensive interventions
Two studies compared clinic-directed EIBI against some form of parent-directed EIBI.99,100 In these
studies, children in both treatment arms received similarly intensive intervention with therapists
(30–40 hours/week), but the parent-directed groups either received less frequent supervision by
senior therapists and clinical supervisors,100 or required parents to recruit and manage therapists.99
Different forms of applied behaviour analysis-based early intensive behavioural therapy
One Canadian study, including 28 children, compared two forms of ABA-based intervention in young
autistic children.101 One treatment arm consisted of ‘Nova Scotia EIBI’, in which children received
15 hours per week of one-to-one instruction based on the PRT approach (a NDBI approach that targets
‘pivotal’ areas of a child’s development and emphasises natural reinforcement). The comparator arm was a
group ABA preschool programme, based on the verbal behaviour method (a structured approach focused
on teaching communication and language). Children in the group ABA group received 15–25 hours per
week of training, of which 3–5 hours consisted of one-to-one discrete trial training.
Characteristics of early intensive applied behaviour analysis-based interventions
All included studies evaluated some form of early intensive ABA-based intervention. All such interventions
were rooted in ABA and incorporated replications, extensions, adaptations or variations of teaching
techniques originally described by Lovaas et al. at the UCLA during the 1970s and 1980s.26,98 Early studies
closely resembled the original UCLA method, although without physical aversives.82,103 Subsequent studies
have incorporated additional manualised ABA procedures into the original UCLA EIBI intervention
model.85,86,90,91,94,95,97
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Several studies incorporated some or all the aspects of NDBI approach into the EIBI model.83,84,88,92,93,99,
100,104,106,107,110,112 This included approaches such as the ESDM.83,93,106,107,112
Children in the included studies received these early intensive ABA-based interventions for a period of
9–36 months, at a planned intensity of 15–40 hours per week of mostly one-to-one teaching (when
recorded). Comparator treatments were delivered for a similar duration, although treatment intensity
was more variable, ranging from 2 to ≥ 30 hours per week (when recorded), with considerably less
one-to-one contact.
Characteristics of comparator interventions
As stated in Chapter 4, Individual participant data meta-analysis methods, comparator treatments could be
broadly classified as ‘eclectic’ or TAU. Comparators were classified as ‘eclectic’ when individual children
were known to have received a mix of teaching approaches, such as TEACCH, PECS, other behavioural
or development programmes, speech and language therapy, music therapy or occupational therapy.
Ten studies included eclectic comparator intervention arms, eight of which were delivered in a school
or nursery classroom setting84–86,89–93,95,96,105,108,110 and two of which were delivered in a university or
specialist centre setting.94,97 As well as an eclectic arm, one study included a portage treatment arm
[a home-visiting educational service for preschool children with special educational needs (SEN) and
disability].90,91
Other comparators were classified as TAU when children received non-autism-specific special
education or other forms of standard local provision. Six studies included TAU arms, of which one was
delivered in a school/nursery,105,108 three were delivered in a range of settings83,92,104,106,107,110,112 and two
did not provide clear information about setting.82,88 Study investigators were not typically involved in
the provision of TAU comparator treatments, so often did not have detailed information on the exact
interventions received by individual children (see Study quality and risk of bias).
Study quality and risk of bias
The following section illustrates some of the core issues concerning risk of bias among studies included
in the review, and primarily references studies comparing early intensive ABA-based with comparator
interventions as examples. A full detailed assessment of the risk of bias for each meta-analytic
comparison is presented in Appendix 9.
Three included studies were RCTs83,100,103,106,107,112 and were assessed using the Cochrane Risk of Bias
2.0 tool.57 Risk of bias in the remaining non-randomised studies was assessed using the ROBINS-I
tool.58 All non-randomised studies were rated as being at ‘serious’ or ‘high’ risk of bias for at least one
outcome on one domain on the relevant assessment tool. All three randomised studies83,100,103,106,107,112
were rated as having ‘some concerns’ about risk of bias.
Bias due to a range of confounding factors
All of the non-randomised studies were at serious risk of bias due to confounding. In five studies, the
type of treatment received by children was explicitly based on parental preference,82,87,92,104,105,108,110
with parents actively seeking or lobbying for early intensive ABA-based treatment and, in some cases,
paying for it themselves.87,92,110
In other studies, the type of treatment received was primarily based on location84,86,90,91 or staff
availability,26,85,95,98 for which the influence of parental preference was unclear.
In some studies, baseline differences in parental education, family composition or socioeconomic status
were observed between treatment groups.89,92,96,104,105,108–110
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Bias due to deviation from intended interventions
Some studies described the methods used to assess treatment fidelity in the early intensive ABA-based
intervention arm. These included monitoring, observation and feedback to tutors,83,93,104–108,112
or obtaining congruent descriptions of the intervention from parents and supervisors.90,91 In other
studies, early intensive ABA-based interventions were supervised, but without explicit monitoring for
treatment fidelity. Studies noted difficulties, such as high tutor turnover resulting in the intervention
being delivered for fewer hours per week than intended,92,110 high proportions of children not
completing the intervention,104 unreliable recording of weekly hours of EIBI,84 and families changing
between different EIBI organisations or supervisors and consultants during the study period.89,96,109
The delivery and content of comparator arms was not closely monitored in the available studies,
although three studies84–86,95 did report a high proportion of children receiving ABA techniques as part
of ‘eclectic’ therapy or TAU comparators.
Studies rarely recorded whether or not children received any co-interventions alongside those being
evaluated. One study appeared to compare groups in terms of independently procured co-interventions,
finding that children receiving EIBI received more dietary and other biological interventions, extracurricular
educational interventions and alternative treatments, than children receiving TAU.89,96,109
Bias in measurement of outcomes
Truly independent and blinded measurement of outcomes were rarely achieved in the evaluation of early
intensive ABA-based intervention studies. In some cases, the participants in the ABA-based intervention
and the comparison intervention arm were assessed by treatment supervisors84 or study investigators,86
sometimes with an independent second evaluator. Although some studies described employing outcome
assessors who were independent of direct intervention delivery,82,85,89,92,95,96,104,105,108–110 the assessments
typically involved interaction with children and parents who were not blinded to intervention. Assessors
who were blinded to allocation could potentially have been unblinded by the assessment location (if this
differed between intervention arms or – when delivered in the family home – provided contextual
information about likely treatment allocation). Consequently, all of the included studies were considered
to be at moderate or serious risk of bias for this domain.
Summary
Although randomisation is clearly feasible, most studies used convenience samples, with the allocation
to early intensive ABA-based interventions being based on location or parental preference. Although
some attempts were made to avoid bias in the measurement of outcomes, the nature of the intervention
can make true blinded assessment difficult to achieve. There is evidence from some studies to
suggest differences between the two intervention groups in terms of socioeconomic status and use of
co-interventions, but this information was not consistently recorded across studies. In some cases,
outcome data were missing or available for only one treatment group. It is also important to note that
despite requesting them, we did not receive any protocols for the included studies. The original Lovaas
study,26 in particular, was at risk of several forms of bias, including the comparator groups differing on
the few available baseline variables.26,98 Taken together, these concerns increase our uncertainty about
the results observed in several included studies, making it possible that the effects observed in the
meta-analysis may overestimate the true effects of early intensive ABA-based interventions.
Study variability and relevance to the current UK context
The data in the included studies were collected over a period of > 40 years (from around 1968 to 2011),
during which time the understanding, diagnosis and management of autism has evolved significantly.
Consequently, there is noticeable variation between individual studies in terms of the delivery of
interventions and comparators, the conceptualisation of autism and the outcomes of interest. As well
as differences between the studies, there may be important differences between this body of evidence
and the context in which early intensive ABA-based interventions and other treatment alternatives may
be delivered in the UK in the future.
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Interventions
Content, delivery and expertise
The original EIBI study by Lovaas at UCLA26,98 mainly employed discrete trial training, with some
generalisation activities and community outings. Contingent physical aversives (the delivery of a loud
‘no’ or slap on the thigh) were employed as a last resort. As noted in Chapter 9, later variations in early
intensive ABA-based interventions have incorporated more naturalistic components in their delivery
and discontinued the aversive contingencies used in the original UCLA EIBI approach. Corporal
punishment has been illegal in the UK for > 30 years and physical aversives have long been abandoned
as part of ABA-based intervention delivery. Although all interventions included in this review had a
theoretical basis in ABA, their content and delivery has evolved over time.
The UCLA EIBI intervention was delivered by trained student therapists, overseen by the study authors
who were based at a specialised university centre, ensuring a high level of resource and expertise being
made available to children and their families.26 Smith et al.103 reported 10 years’ experience working at
the UCLA Young Autism Project. Similar expertise was available in the randomised study of the ESDM,
which also involved the authors who developed the intervention method.83,106,107,112
The original narrow definition of what once constituted ‘true’ EIBI may not resemble very closely what
is delivered in the current UK context, in which the intervention is more likely to be informed by more
naturalistic approaches and delivered in a home or community setting, without the resources of an
expert university research centre to train and supervise treatment staff.
Intensity and duration
The original UCLA EIBI was highly intensive. In addition to children receiving an average of 40 hours per
week of one-to-one contact with therapists in their home, school and community for at least 2 years,
parents were asked to take a year off from their current employment103 and were trained so that ‘treatment
could take place for almost all of the subjects’ waking hours, 365 days a year’.26 Although actual treatment
intensity and duration data were not recorded for individuals, it would appear that children had around
4 years of treatment on average (based on reported age at recruitment and follow-up), with children
who had not ‘recovered’ continuing to receive > 40 hours per week of one-to-one teaching with
therapists for > 6 years.26
As stated in Included studies, subsequent studies of early intensive ABA-based interventions were more
varied in intensity and duration. Interventions rarely exceeded Lovaas’ minimum requirement of
40 weekly hours of one-to-one teaching.26 For example, authors who had been involved in the UCLA
programme have delivered forms of EIBI that are deliberately less intensive than originally proposed
(30 hours/week rather than 40 hours/week, with treatment phased out after 18 months if progress
was slow).103 Other studies have shown intervention hours to substantially reduce after the first
2 years of treatment83,106,107,112 or when children started school.85,95 Although IPD on actual intensity
were largely unavailable, the average weekly hours of teaching reported in UK studies ranged from
25.692,110 to 37.499 hours per week, and ranged from 13.6 to 38.6 hours per week in other studies.
As well as a possible impact on effectiveness, the duration and intensity of ABA-based treatment has
implications for resource use (e.g. staffing costs) and possibly setting. Children in the UK typically start
school at 5 years of age, whereas much of the evidence included in the current meta-analysis is from
countries in which the primary or elementary school starting age is 6 years (USA, Norway, Canada,
Israel). So in other countries, EIBI has been delivered in home and/or nursery or preschool settings,
but in the UK it may be given in a primary education environment.
Another issue is that of the intervention supervision and management model. Several EIBI studies described
the intervention being delivered by tutors who received ongoing training and feedback from supervisors,
who in turn were overseen by a consultant or clinic director.26,103 However, this form of management is
not always applied in the delivery of early intensive ABA-based interventions in UK practice.
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Comparators
Comparator interventions for autistic children have also evolved over time, with the emergence of
autism-specific rather than generic special needs care. More recently, ‘eclectic’ comparators have
explicitly incorporated some ABA techniques.83,84,86,89,93,94,96,97,105,108,109 In most studies, children in the
eclectic or TAU comparator arms received fewer hours of intervention and/or less one-to-one contact.
However, this was not always the case: Howard et al.105,108 compared EIBI against an eclectic autism-
specific classroom, with ≈30 hours per week of one-to-one or one-to-two intensive intervention; and
Zachor et al.94,97 reported both intervention groups receiving similar levels of funding per child, hours in
preschool setting, support for parents and staff, and individual one-to-one treatments.
Although we did not restrict inclusion by comparator, all of the identified comparators were eclectic
intervention or TAU; no studies compared early intensive ABA-based interventions with discrete
medical or educational interventions.
It is difficult to map the comparators in the available evidence to the current UK standard provision
for two reasons. First, most studies had very limited available information on the content of eclectic
interventions or TAU, as the study investigators were rarely involved in their delivery. Second, there is
evidence that standard provision in the UK differs substantially between local authorities, although
information obtained from York local authority suggests a mix of therapies not dissimilar to those cited in
the studies (Ruth Horner, City of York Council, York, 2018, personal communication).
Participants
The studies included in this review cover a period when a large increase in the annual incidence of autism
has been observed (more than fivefold from 1988 to 1995).113,114 Part of that increase has been attributed
to changing and broadening diagnostic criteria,115,116 as well as increased medical and public awareness.117
This raises concerns about whether or not children receiving early intervention ABA-based interventions
in included studies are similar to those currently eligible for intervention in the UK.
The overall population of children for whom IPD were provided were young (mean age 38 months) with
mild-to-moderate intellectual disability (mean IQ 57) (see Chapter 6, Individual participant data received
from included studies). As all children had to have an established diagnosis of autism or related condition
to participate in the included studies, the study populations ought to be comparable to those who would
be eligible for treatment in the current UK context. However, some of the more highly controlled studies
excluded children with comorbidities, so it is plausible that typical UK treatment populations are more
heterogeneous than those in the available evidence.
Outcomes
Although we accepted any outcomes for the IPD meta-analysis, only a small number of outcome domains
were consistently collected across the included studies (most commonly, verbal and non-verbal IQ,
adaptive behaviour and language measures; less commonly, autism symptom severity, behaviours that
challenge and school placement).
The original Lovaas study26,98 was almost entirely focused on IQ and mainstream schooling placement as
measures of treatment success. Children who achieved IQ in the average range were considered ‘recovered’
and the authors made ‘considerable effort’ to keep these children in mainstream preschool. In some cases,
this involved withholding the child's diagnosis of autism. The authors stated, ‘If the child became known as
autistic (or as “a very difficult child”) during the first year in pre school, the child was encouraged to enrol
in another, unfamiliar school (to start fresh)’.26 Apart from any ethics and bias concerns it may raise,
this excerpt shows how different the goals of early autism interventions were 30–40 years ago.
Subsequent studies incorporated behavioural measures, such as adaptive behaviour, while retaining
IQ or cognitive development measures. Schooling as an outcome was only collected in a minority of
studies and did not use consistent classifications.26,89,92,96,98,103,104,109,110
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Outcomes relating to social participation, well-being and quality of life were not measured among the
included studies. Although measures of cognitive development and adaptive behaviour can be used to
track progress and development, no studies investigated how these measures correlate with measures
of well-being, either during treatment or in the long term. In fact, any measurement of outcome
beyond the end of the early intervention treatment period was rare.
With the exception of one study stating that ‘no serious adverse effects related to the intervention
were reported during the 2-year period’,83,106,107,112 adverse or unintended effects of intervention were
not addressed in the available evidence, with no study providing IPD on adverse effects.
The selection of measurement tools used for the collected outcomes varied within and between studies.
Different measures of IQ and cognitive development were used at baseline and follow-up, based on the
relevant normative populations [e.g. the WPPSI-R67 or BSID scales at baseline and Wechsler Intelligence
Scale for Children (WISC)65 at follow-up]. At baseline, in particular, decisions about which measure to use
are also informed by children’s developmental skills and ability to meaningfully be assessed in particular
tests. The IPD meta-analyses separate measures of non-verbal skills (such as the MPSMT)70 from
standard intelligence tests, which include verbal and non-verbal scales, as the former are known to
yield higher scores.100
Several studies reported difficulties when using standardised measures in the evaluation of interventions
in young autistic children, including floor and ceiling effects on different tests at different ages. Authors
dealt with these difficulties by recording minimum or maximum scores,103 reporting age-equivalent
scores,101 raw scores89,92,96,109,110 or the number of children capable of achieving a score.92,110 Although the
provision of IPD facilitated the harmonisation and synthesis of scores across some of these studies, this
was not always possible or appropriate.
Most studies provided standard scores when these were available and these scores informed the IPD
meta-analyses. However, although standard scores allow comparisons with typically developing populations,
it has been argued that they may miss information about changes that are relevant within the autism
population specifically.118 This problem is not limited to early intensive ABA-based interventions, but is
one of several barriers to valid and reliable outcome measurement in young autistic children in general.119
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Chapter 6 Results of individual participant
data meta-analysis
Individual participant data received from included studies
Of the 20 studies identified, we received data from the authors of 15 studies. Of the five remaining
studies, two no longer had access to the data82,87 and two declined to participate in the project.88,105,108
The authors of one study83,106,107,112 indicated that the terms under which families consented to be in
the study prevented the sharing of IPD, except through the US National Database for Autism Research
(NDAR). The SCABARD research team therefore obtained the relevant data sets via NDAR (URL:
www.ndar.nih.gov). However, it was not possible to identify participants from the study of interest
within the wider group of participants included in the NDAR data set. The study authors reiterated
that the consent terms of the study precluded them from being able to assist in identifying the
participants and variables of interest.
The authors of one study94,97 indicated that they had continued to collect data following the same protocol
as their included studies and therefore provided data for more participants than had been published.
Therefore, we ultimately collected 75% (669/894) of all known (published or unpublished) data from
individual study participants, or 82% (654/800) of published data.
Individual participant data: participant characteristics
Table 2 shows the characteristics of participants within the studies for which IPD were available.
On average across all studies, children were aged 37.9 months at intake; 86% of participants were boys.
Although studies used different methods to assess IQ, all used the usual standardisation of a mean IQ
of 100, with a SD of 15. Across studies, the mean baseline IQ was 56.8. The mean baseline composite
VABS score was 63.3.
Studies that compared intensive ABA-based interventions with comparator early interventions had
similar baseline characteristics. However, it also shows some degree of between-study variation in
baseline age (from around 2 to 5.5 years) and IQ (from 46 to 65). It can be seen that autism symptom
severity scores were rarely available in the IPD, with ADOS calibrated severity score values available
for two studies at baseline (see Table 2).
Individual participant data meta-analysis of early intensive ABA versus
treatment as usual or eclectic interventions
This section considers the main meta-analyses: those comparing early intensive ABA-based interventions
(EIBI, EIBI with NDBI) with TAU or eclectic interventions. Analyses including other studies (such as low
vs. high intensity) are considered in Studies making other comparisons.
Participant and study characteristics
Ten studies provided IPD for the comparison of early intensive ABA with TAU or eclectic
interventions.84–86,89–97,104,109,110 These studies reported a wide range of different eligible outcomes.
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Appendix 7 shows which of the variables specified in the SCABARD data dictionary were available as
IPD for each included study. The only individual-level variables that were available for every study
were age at baseline, sex and assigned treatment arm. The majority of other variables were not
consistently collected across studies. In some cases, study investigators clarified that these variables
were not collected at all, collected for the early intensive ABA-based intervention arm only, or were
otherwise unavailable. However, in most cases, variables were absent from the IPD data sets, without
any definitive explanation being provided.
For a comparison of the outcome domains and measures in the IPD with those in the published
literature, see Appendix 8.
A variety of scales were used to measure IQ and cognitive development, most commonly versions of the
BSID62 S–B,69 WISC65 and Wechsler Preschool and Primary Scale of Intelligence (WPPSI).67 When different
scales were used in studies, this was typically due to the need to select an age-appropriate scale.
As all these scales were standardised (to an average IQ of 100 with SD of 15), in the primary analysis of
IQ we have not differentiated between the methods and consider them as equivalent.
TABLE 2 Baseline characteristics of participants in IPD data sets
First study
author and year
Age at baseline
(months) Male (%) IQa
VABS
composite
ADOS
CSS % IQ < 70 % VABS < 60
Average by study
Cohen 2006104 31.5 83.3 60.7 70.2 73.8 4.9
Eikeseth 200285 66 76 64.5 57.8 72 56
Eikeseth 201284 49.3 83.1 65.6 25.4
Eldevik 201286 43.3 76.7 51.6 61.5 86 48.8
Hayward 200999 35.1 77.3 54.1 63.6 79.5 34.1
Lovaas 198726 37.3 71.1 49.1 66.5 81.6 42.4
Magiati 200789 39.5 88.6 46.3 58.1 92 57.5
Reed 200790,91 41.5 93.7 52.9 56.5 87.3 77.8
Remington 200792 37.1 87.8 62.5 58.9 70.7 53.7
Sallows 2005100 32.7 82.6 50.8 62 95.7 43.5
Smith 2000103 35.9 82.1 50.6 60 89.3 50
Stock 2013101 45.8 89.3 65.8 32.1
Vivanti 201493 41.2 87.7 68.6 6.5 22.8
Zachor 200794 26.9 96.2 75 62.9 41.7 29.3
Zachor 201097 25.2 90.9 67 7.3 14.5
Average over all studies 37.9 85.6 56.8 63.3 7 77.6 38.3
Average in ABA vs.
non-ABA (main) studies
38.4 87.5 59.4 63.1 7 74.2 37.8
ADOS CSS, Autism Diagnostic Observation Schedule calibrated severity score.
a IQ standardised with mean 100 and SD 15.
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Non-verbal intelligence was most commonly measured using the MPSMT70 and autism symptom severity
with the ADOS.78 Although adaptive behaviour was consistently measured using the VABS,59 language was
measured using a variety of scales, most commonly the RDLS74 and the expressive and receptive subscales
of MSEL.76 Parental outcomes were not measured frequently or consistently across studies, and school
placement IPD were available for only one study.89,96,109
Data were provided at baseline and at least one follow-up time (as required for meta-analysis) for only
a minority of outcomes. Table 3 summarises the outcomes recorded across studies. This shows that,
for most outcomes and outcome domains, there were few studies and limited data for meta-analysis.
For a comparison of the outcome domains and measures in the IPD against those in the published
literature, see Appendix 8.
A further issue is that studies were not consistent in the times at which outcomes were recorded.
Table 4 shows the number of studies reporting at each time for the outcomes listed in Table 3. This shows
that, although several studies reported an outcome, not all studies reported it at consistent times.
For example, several outcomes were reported only in one study, and only one study reported data at
7 years (precluding any meta-analysis).
Meta-analyses by outcome domains
This section presents results of meta-analyses for each outcome domain. Given the small numbers of
studies involved, meta-analyses of any early intensive ABA-based intervention compared with TAU or
eclectic interventions are presented.
Adaptive behaviour
Adaptive behaviour was assessed using the VABS composite and component scores, with results available
for all 10 included studies.84–86,89–97,104,109,110 Here, we consider the meta-analyses of the composite VABS
score. The complete data on the composite score are shown in Figure 3. The points show the scores for
each child, with the lines connecting each child’s score over time. Figure 4 shows the mean (average)
change in score from baseline.
These plots suggest no consistent trend in scores across studies. Indeed, there is considerable variation
in how VABS changes over time. In some studies, scores remained largely unchanged over time, in some
there was little change in the control arm but increases in early intensive ABA-based interventions, and
in some the scores decreased in both arms.
The meta-analyses of VABS composite score at 1 and 2 years are shown in Figures 5 and 6, respectively.
These showed no clear evidence of a benefit of early intensive ABA-based interventions after 1 year,
with substantial heterogeneity (MD 1.82, 95% CI –2.79 to 6.43, I2 = 80%), and a 7-point difference in
favour of the ABA-based intervention (half of a SD) after 2 years, with less heterogeneity (MD 7.74,
95% CI 1.87 to 13.61, I2 = 72%). Studies varied substantially in their estimated MDs. One extreme outlier,
with seven children, found a 32-point difference in favour of early intensive ABA-based interventions.
In the opposite direction, one trial found a 5-point difference in favour of TAU or eclectic interventions.
Data beyond 2 years were limited. Only two small studies95,104 reported outcomes at 3 years and one study
at 4 years,110 and so forest plots are not presented here. The data at 7 years came from only one study,96
which found no difference between groups at 7 years (MD –0.99, 95% CI –12.80 to 10.83).
Cognitive ability
Intelligence quotient (measured using any scoring method) was reported in the majority of
studies.85,86,89–92,94,96,104,109,110 We analysed IQ scores whatever assessment method was used.
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TABLE 3 Outcome measures recorded
Outcome domain Outcome
Cohen
2006104
Eikeseth
200285
Eldevik
201286
Magiati
200789
Vivanti
201493
Eikeseth
201284
Reed
200790,91
Remington
200792
Zachor
200794
Zachor
201097
Autism symptom
severity
ADOS repetitive
behaviours
No No No No Yes No No No No Yes
ADOS severity
score
No No No No Yes No No No No Yes
IQ IQ any scale Yes Yes Yes Yes No No Yes Yes Yes No
IQ BSID scale No Yes No Yes No No No No No No
Non-verbal IQ
(MPSMT)
Yes Yes No Yes No No No No No No
Language MSEL expressive No No No No Yes No No No No Yes
MSEL receptive No No No No Yes No No No No Yes
RDLS
comprehension
Yes Yes No Yes No No No No No No
RDLS expressive Yes Yes No Yes No No No No No No
Adaptive
behaviour
VABS
communication
Yes Yes Yes Yes Yes Yes No Yes Yes Yes
VABS composite Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
VABS DLS Yes Yes Yes Yes Yes Yes No Yes Yes Yes
VABS maladaptive No Yes No No No Yes No No No No
VABS motor skills No Yes Yes Yes Yes Yes No Yes Yes Yes
VABS socialisation Yes Yes Yes Yes Yes Yes No Yes Yes Yes
School placement School placement No No No Yes No No No No No No
Other MSEL composite No No No No Yes No No No No Yes
MSEL fine motor No No No No Yes No No No No Yes
MSEL visual
reception
No No No No Yes No No No No Yes
DLS, daily living skills.
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Figure 7 shows the mean change from baseline in IQ, by study and intervention. As for VABS score,
the pattern of changes varied across trials. Some trials had IQ improvements with both early intensive
ABA-based and comparator groups, some showed improvement only with the early intensive ABA-based
interventions and some showed no improvement at all.
The meta-analyses of IQ at 1 and 2 years are shown in Figures 8 and 9, respectively. These show clear
evidence of a difference in favour of early intensive ABA-based interventions of around 10 IQ points
after 1 year (two-thirds of a SD, MD 10.12, 95% CI 5.81 to 14.44, I2 = 0) and after 2 years (MD 11.97,
95% CI 6.74 to 17.20, I2 = 15%).
Data beyond 2 years were limited. Only two small studies104 reported outcomes at 3 years and one
reported outcomes at 4 years,92,110 and so forest plots are not presented here. The data at 7 years comes
from only one study,96 which found no evidence of a difference between groups at 7 years (MD –1.92,
95% CI –15.17 to 11.32).
Autism symptom severity
Only two studies reported data on autism symptom severity,93,97 in terms of ADOS calibrated severity
score. Meta-analyses of these two studies could be performed only at 1 year after intervention initiation.
The meta-analysis (see Appendix 11, Figure 24) suggests a possible effect with both studies favouring
TAU or eclectic intervention (MD 0.27, 95% CI –0.19 to 0.73), but the sample size is small and results
are not statistically significant.
TABLE 4 Number of studies reporting outcomes at different times
Outcome
Time of reporting
Baseline
(10 studies84–86,
89–97,104,109,110)
1 year
(eight studies84,85,
90–95,97,104)
2 years (eight
studies84–86,89,92,
94–97,104)a
7 years
(one study96)
ADOS repetitive behaviours 2 2 1 0
ADOS severity score 2 2 1 0
IQ BSID scale 2 1 2 1
IQ MPSMT 3 2 3 1
IQ any scale 7 5 6 1
MSEL composite 2 2 1 0
MSEL expressive 2 2 1 0
MSEL fine motor 2 2 1 0
MSEL receptive 2 2 1 0
MSEL visual reception 2 2 1 0
RDLS comprehension 3 2 3 1
RDLS expressive 3 2 3 1
VABS communication 9 7 8 1
VABS composite 10 8 8 1
VABS DLS 9 7 8 1
VABS maladaptive 2 2 1 1
VABS motor skills 8 6 7 1
VABS socialisation 9 7 8 1
DLS, daily living skills.
a In one study, data at 2 years were available for only a subset of children.85,95
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FIGURE 4 Mean change in VABS composite score from baseline, by study and intervention.
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FIGURE 3 Reported VABS composite scores for each child, by study and intervention.
RESULTS OF INDIVIDUAL PARTICIPANT DATA META-ANALYSIS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
38
Language development
Two different language tools were used: RDLS and MSEL (expressive and receptive language subscales).
No studies used both tools. Results were inconsistent between studies using RDLS, which generally
showed a benefit of early intensive ABA-based intervention, and those using MSEL, for which there was
no evidence of a benefit on language. Given the risk of confounding that would arise from combining
these two different scales in a single meta-analysis, we decided not to perform a joint meta-analysis of
language development. For meta-analyses of these scales separately, see Impact of study-level covariates.
Presence of behaviours that challenge
As only one study90 reported data on behaviours that challenge, no meta-analysis was performed.
It reported results at 1 year using the Conners’ Rating Scales – Revised measure.
School placement
As only one comparative study89,96,109 reported sufficient data on school placement, no meta-analysis
was performed. See School placement for an analysis of all data on school placement.
Meta-analyses of all outcome measures
This section considers the meta-analysis of all reported outcomes for which there were sufficient data for
a meta-analysis comparing any early intensive ABA-based interventions with TAU or eclectic interventions
(see Tables 2 and 4). This includes meta-analyses of subscales, such as the subscales of VABS.
Given the large number of analyses, only summary results from the one-stage repeated measures
meta-analyses are presented here. Forest plots for all meta-analyses are available on request.
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FIGURE 5 Meta-analysis of composite VABS score at 1 year.
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FIGURE 6 Meta-analysis of composite VABS score at 2 years.
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FIGURE 8 Meta-analysis of IQ at 1 year.
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FIGURE 9 Meta-analysis of IQ at 2 years.
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Figure 10 presents a summary of the results of the one-stage repeated measures meta-analyses.
Each subplot represents a separate outcome scale (e.g. ADOS repetitive behaviours in the top left).
The vertical axis shows the MD in effect between early intensive ABA-based interventions and TAU
or eclectic interventions, and the horizontal axis indicates the year after recruitment at which each
meta-analysis was performed. Each dot is the summary MD in effect between the interventions from
the relevant one-stage analysis of variance meta-analysis, with the vertical line being its 95% CI.
Note that each dot and line represents an independent meta-analysis for each year; no time trends
are assumed or modelled here.
A positive result (above the blue line) indicates results favouring the early intensive ABA-based
intervention, except for ADOS scores, for which results below the line favour the early intensive
ABA-based intervention.
The results for VABS composite score, IQ and ADOS severity score in Figure 10 are broadly similar to
those shown in the forest plots in Meta-analyses by outcome domains (see Figures 5, 6, 8, 9 and 24).
For IQ 1 year after follow-up, the meta-analysis favoured the early intensive ABA-based intervention,
with a MD between groups of around 9 points (MD 9.16, 95% CI 4.38 to 13.93). After 2 years, this
increased to a 134-point difference (MD 14.13, 95% CI 9.16 to 19.10).
Results after 7 years are presented here for ease of reference, but are based on only one study.17
This study found no statistically significant evidence of a difference between interventions at 7 years
(MD 4.39, 95% CI –8.17 to 16.95).
0 1 2 3 4 5 6 7 8 0 1 2 3 4 5 6 7 8
0 1 2 3 4 5 6 7 8 0 1 2 3 4 5 6 7 8 0 1 2 3 4 5 6 7 8
–5
0
0
5
10
–10
10
20
–2
–1
0
1
0
15
20
25
5
10
–5
0
0
10
–10
–5
10
5
–2
–1
0
1
0
20
5
10
–10
0
5
–10
–5
5
–2
–3
–1
0
1
0
10
15
–5
0
5
–5
5
10
0
10
20
0
10
–5 0
5
–20
–20
–10
10
0
20
40
60
80
0
10
15
ADOS –
repetitive behaviours
MSEL – composite
RDLS – comprehension
VABS – motor skills
ADOS – social
MSEL – expressive
RDLS – expressive
VABS – socialisation
ADOS severity score
MSEL – fine motor
VABS – communication
Years after recuitment
M
D
 b
e
tw
e
e
n
 in
te
rv
e
n
ti
o
n
sa
IQ
MSEL – receptive
VABS – composite
IQ (MPSMT)
MSEL – visual reception
VABS – DLS
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The meta-analysis results for non-verbal IQ measured using the MPSMT approach were broadly similar to
general IQ at both 1 year (MD 9.45, 95% CI 0.33 to 18.59) and 2 years (MD 10.13, 95% CI 1.58 to 18.68),
with MDs between groups of around 10 points after 2 years.
Composite VABS score showed no clear evidence of a difference between groups at 1 year (MD 2.93,
95% CI –1.90 to 7.76) and a statistically significant difference of around 7 points in favour of the early
intensive ABA-based intervention after 2 years (MD 7.00, 95% CI 1.95 to 12.06). VABS subscale scores
followed the same pattern. Socialisation and daily living scores showed no clear evidence of a difference at
1 year, and about a 5- to 8-point difference in favour of early intensive ABA-based interventions at 2 years.
Communication showed a 6- to 8-point difference in favour of early intensive ABA-based interventions
after 1 and 2 years (at 2 years: MD 8.03, 95% CI 1.11 to 14.97). Results for motor skills were inconclusive.
The single study17 reporting data after 7 years found no difference between interventions.
For ADOS severity score, there was a MD of about 0.4 points between arms, with results favouring TAU
or eclectic interventions at 1 year, but this was not statistically significant (MD 0.43, 95% CI –0.23 to
1.08). Results at 2 years were based on a single study, but showed a non-significant MD of about 1 point
between arms, with results favouring early intensive ABA-based interventions (MD –1.33, 95% CI
–2.81 to 0.14). There were similar results for the repetitive behaviour and social subscales.
For language development, RDLS comprehension scores after 1 year had a MD of about 12 points
between arms, with results favouring early intensive ABA-based interventions (MD 12.96, 95% CI 2.01
to 23.91) and similarly at 2 years (MD 11.78, 95% CI 2.12 to 21.45). Results were similar for expressive
language, although these did not achieve statistical significance. By contrast, MSEL receptive and expressive
language subscales showed no evidence of any difference between early intensive ABA-based interventions
and control arms after 1 or 2 years. Similarly, there was no evidence of any effect of early intensive
ABA when assessed using composite MSEL score, or its fine motor or visual reception subscales.
The figure includes some estimates of effect at 3 and 4 years. These are derived from limited data from
three studies,95,104,110 so should be treated with caution, but are generally consistent with effect estimates
at other times, with similar estimated MDs. The exception is a large effect on non-verbal IQ (MPSMT)
after 4 years, but this is based on one study110 with very few children.
Impact of child-level covariates
As described in the methods section (see Chapter 4, Impact of covariates on treatment effect), we intended to
explore a range of child- and parent-level covariates. Unfortunately, the IPD supplied from most studies
were too limited to permit investigation of child-level covariates. The only covariates with sufficient data for
analysis were age and sex. To these covariates, we added baseline IQ and baseline composite VABS score.
To assess whether or not these covariates alter the effectiveness of early intensive ABA-based
interventions, the repeated measures models were extended to include the relevant covariates and the
interaction between covariate and early intensive ABA-based interventions, as set out in Chapter 4,
One-stage analyses. It should be noted that these analyses test whether or not the MD between
interventions varies with the covariate of interest (e.g. is the difference between VABS scores using
early intensive ABA-based interventions compared with using TAU or eclectic interventions larger in
girls than in boys?). We are not investigating whether or not the actual values of the outcomes vary with
the covariates (e.g. if children with higher initial IQ have greater improvements in IQ or VABS after
intervention). The results of these analyses for the outcomes IQ and composite VABS score (where there
are most data) are shown in Table 5. Full results from all outcomes are given in Appendix 11 (see Table 45).
The main point to note from these results is that CIs are very wide, spanning no effect (a value of zero),
and so all p-values are well above 0.05. Therefore, there is no clear evidence of any interaction between
these factors and either IQ or VABS score (e.g. no evidence that older children gain greater benefit from
early intensive ABA-based interventions than with alternative interventions than younger children).
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Impact of study-level covariates
A number of study-level covariates were investigated to determine if they had any impact on the
effectiveness of early intensive ABA-based interventions. Owing to the large numbers of possible
analyses, we considered only two outcomes, IQ and composite VABS score, at 1 and 2 years after
recruitment, as these were the only outcomes with sufficient studies for reliable analysis.
Categorical covariates were assessed using subgroup analyses. Factors considered were:
l allocation method (parental choice, location based, cohort)
l delivery setting (home, school, specialist centre)
l parental involvement in ABA (none, encouraged, some)
l use of ABA methods in control intervention (none, partial).
Table 6 presents a summary of these subgroup analyses for outcomes at 2 years. For IQ, all p-values
are > 0.05 and there are no clear patterns of variation in treatment effect across analyses. For VABS
composite score, all p-values are < 0.1, but these are a consequence of extreme results in a single
subgroup, driven by extreme results in a single trial,85,95 and are unlikely to represent genuine
differences between subgroups.
TABLE 5 Results of child-level interaction models
Outcome Interacting factor Variation in MD 95% CI p-value
IQ Age at recruitment 0.08 –0.26 to 0.42 0.64
Sex –1.3 –13.36 to 10.76 0.83
IQ at baseline 0.09 –0.13 to 0.31 0.44
VABS at baseline –0.11 –0.58 to 0.35 0.63
VABS composite Age at recruitment –0.05 –0.29 to 0.18 0.65
Sex 3.28 –3.08 to 9.65 0.31
IQ at baseline 0.09 –0.06 to 0.23 0.24
VABS at baseline –0.05 –0.28 to 0.18 0.66
TABLE 6 Results of study-level subgroup analyses
Outcome Factor Subgroup MD 95% CI p-value of interaction
IQ ABA in control arm No 14.72 6.84 to 22.61 0.53
Partially 10.99 2.49 to 19.5
Allocation Cohort 14.44 5.57 to 23.31 0.52
Other 20.49 3.72 to 37.27
Parental choice 10.2 1.97 to 18.43
Delivery setting Home 10.2 1.97 to 18.43 0.62
School 15.91 7.95 to 23.86
Specialist centre 10.82 –35.91 to 57.56
Parental involvement 4 hours/week 20.49 3.72 to 37.27 0.52
Encouraged 14.58 5.54 to 23.61
Some 10.2 1.97 to 18.43
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Continuously distributed covariates were assessed using meta-regression. Covariates considered were:
l planned duration of early intensive ABA-based intervention
l planned intensity (hours/week) of early intensive ABA-based intervention
l year of study publication (to test for variation in effects over time).
Table 7 presents the results of the meta-regression analyses at 2 years. There is some suggestion that
older studies had larger effects on the VABS composite scale than more recent studies (by 1.82 points
on the VABS scale/year). This might suggest biased results in early studies, or that changes in how
early intensive ABA-based interventions are given has led to changes in effectiveness. There was no
evidence to support an impact of any other of the covariates on the effectiveness of early intensive
ABA-based interventions. It should, however, be remembered that these analyses are based on few
studies, and may be prone to bias.
Sensitivity analyses
The main analyses combined all forms of high-intensity early intensive ABA-based interventions
compared with TAU or eclectic interventions. Subgroup analyses were performed to compare studies
using TAU as a control with those using eclectic treatments, and to compare studies using EIBI only
(e.g. Lovaas/UCLA model) with those using EIBI with NDBI. A summary of the results for IQ and VABS
composite score at 2 years is shown in Table 8.
TABLE 6 Results of study-level subgroup analyses (continued )
Outcome Factor Subgroup MD 95% CI p-value of interaction
VABS composite ABA in control arm No 6.22 –2.98 to 15.42 0.09
Partially 11.31 2.66 to 19.97
Unclear –4.79 –16.34 to 6.76
Allocation Cohort 2.77 –11.29 to 16.84 0
Location 5.13 0.38 to 9.87
Other 31.89 18.73 to 45.05
Delivery setting Parental choice 5.73 0.84 to 10.62 0
Home 5.73 0.84 to 10.62
School 14.34 0.8 to 27.87
Specialist centre –4.79 –16.34 to 6.76 0.1
Parental involvement 10 hours/week 5.13 0.38 to 9.87
4 hours/week 31.89 18.73 to 45.05
Encouraged 2.77 –11.29 to 16.84
Some 5.73 0.84 to 10.62
TABLE 7 Results of meta-regression analyses
Outcome Factor Slope 95% CI p-value
IQ Duration (planned, per year) –1.61 –12.24 to 9.02 0.77
Intensity (planned, hours/week) –0.11 –1.39 to 1.17 0.87
Publication year –0.21 –2.29 to 1.86 0.84
VABS composite Duration (planned, per year) –1.59 –11.99 to 8.82 0.77
Intensity (planned, hours/week) –0.46 –1.54 to 0.62 0.4
Publication year –1.82 –3.65 to 0.01 0.05
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There was no clear evidence that the type of intervention or the type of control used leads to different
results. In theory, results may be confounded as studies using only EIBI were generally compared with
‘eclectic’ control, whereas studies using EIBI with NDBI were generally compared with TAU. However,
as noted previously, these comparator labels can be used somewhat interchangeably.
UK-based studies
Three of the included studies were conducted in the UK.89–92,96,109,110 To assess whether or not the
performance of early intensive ABA-based interventions in the UK was consistent with the overall
meta-analysis, we performed a sensitivity analysis in the UK-based studies, repeating the main
one-stage repeated measures analysis from Figure 10. The results of this analysis are shown in Figure 11,
restricted to IQ and VABS subscales, as there were insufficient data for analysis of other outcomes.
TABLE 8 Results of sensitivity analyses by intervention and control used
Outcome Analysis Group MD 95% CI p-value for interaction
IQ Control arm Eclectic only 10.99 2.49 to 19.5 0.53
TAU only 14.72 6.84 to 22.61
Intervention EIBI only 10.99 2.49 to 19.5 0.53
EIBI and NDBI only 14.72 6.84 to 22.61
VABS composite Control arm Eclectic only 8.57 0.49 to 16.65 0.71
TAU only 6.22 –2.98 to 15.42
Intervention EIBI only 10.03 –2.11 to 22.16 0.49
EIBI and NDBI only 5.45 1.22 to 9.69
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The results suggest slightly smaller effects in the UK-based studies, particularly for composite VABS
score, for which the MD between early intensive ABA-based and comparator arms at 2 years was 2.78
(95% CI –1.98 to 7.54), compared with 6.33 in the main analysis. For IQ, at 2 years the MD was 9.34
(95% CI 0.91 to 17.86) in the UK studies, compared with 13.64 in the main analysis. The smaller sample
size also means that CIs were wider and results were not generally statistically significant.
Longer-term data at 4 and 7 years were reported in only one study in each case. At 7 years there was
no evidence of any difference between early intensive ABA-based intervention and control, as discussed
in Adaptive behaviour and Cognitive ability, with most effect estimates close to 1 and no statistically
significant results.96 At 4 years, there was similarly no evidence of any difference, except for VABS daily
living score (MD 9.89, 95% CI 0.87 to 18.91).110
However, there is insufficient evidence to assert that UK studies are different from others, and the
reasons for observed differences may be varied and not due to study location.
Standardised mean difference
All meta-analyses presented above have used the MD between early intensive ABA-based arms and
comparator arms as the outcome. This assumes that all studies are using the same scale to measure
the outcome; however, for example, studies used different IQ tests. To investigate whether or not
studies were consistent when different tests were used, the meta-analyses were repeated using SMDs
(i.e. Cohen’s d).
Appendix 11 includes the results of two-stage ANCOVA meta-analyses of all outcomes using SMD
(see Figure 25). The results are consistent with the MD analyses. For example, IQ showed results
favouring early intensive ABA at both 1 year (SMD 0.61, 95% CI 0.32 to 0.91; I2 = 13%) and 2 years
(SMD 0.76, 95% CI 0.46 to 1.035; I2 = 0). Composite VABS score showed no difference between early
intensive ABA-based interventions and control interventions at 1 year (SMD 0.18, 95% CI –0.35 to 0.71;
I2 = 80%), but results favoured early intensive ABA at 2 years (SMD 0.95, 95% CI 0.30 to 1.61; I2 = 64%).
Inclusion of studies not providing individual participant data
Of the five studies that did not provide IPD, four have been published82,83,87,105–108 and collected a
similar variety of outcome domains and measures as studies that provided IPD. Additional outcomes
included measures of repetitive behaviours, shared positive affect, gesture use, and the visual reception
and fine motor subscales of the MSEL (see Appendix 8).
Two of the studies did not report outcome data in a form that could be used in the meta-analysis.82,87
Two studies comparing high-intensity ABA-based interventions with comparator interventions have
published usable outcome data.83,105–108,112 Included also is one study that was published after IPD
collection had closed.102 To investigate the impact of these studies on the meta-analyses we extracted
data from their publications and combined them with the IPD to perform two-stage change-from-baseline
meta-analyses (in which the mean change in outcome between observation time and baseline is analysed).
The full results are presented in Appendix 11 (see Figures 27–32 and Table 42). Figures 12 and 13 show
the forest plots for IQ and composite VABS score at 2 years. These forest plots present sensitivity
meta-analyses, in which the two studies with data extracted from publications are analysed with studies
that provided IPD.
Both analyses produce larger differences between the two groups in favour of early intensive ABA-based
interventions than observed in the main analyses using only IPD (see Figures 6 and 9). This is because
of the very large effects found by Howard et al.,105 which are approximately double those estimated
from the IPD meta-analysis. The other studies that did not provide IPD83,102 had results more consistent
with the IPD meta-analysis.
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Narrative synthesis of other outcomes
Meta-analyses were performed for all outcomes reported by at least two studies at a common follow-up
time. There were a number of other outcomes reported in only one study, or in two studies at inconsistent
times. The results of these further outcomes are summarised in Appendix 11 (see Table 43).
Data on these outcomes are too limited to draw any meaningful conclusions. However, most results
were in the direction of favouring early intensive ABA-based interventions, suggesting small reductions
in autism symptom severity, behaviours that challenge, and improvements in IQ and language development.
These are consistent with the meta-analyses of other outcomes.
Studies making other comparisons
Some of the included studies did not compare high-intensity ABA-based interventions with a TAU or
eclectic intervention, instead comparing it with lower-intensity EIBI. These studies are considered in
this section.
High- versus low-intensity early intensive behavioural intervention
Three studies compared high-intensity EIBI (> 15 hours/week) with lower-intensity EIBI.26,90,91,98,103
IQ was the only outcome recorded consistently in all three studies. A repeated measures meta-analysis
of IQ comparing high- with low-intensity early ABA-based intervention is shown in Figure 14. This suggests
that high-intensity ABA-based interventions produced much larger improvements in IQ than low-intensity
ABA-based interventions, with differences of between 10 and 20 points from 1 to 4 years after
recruitment, although results are not statistically significant at 1 and 3 years.
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FIGURE 14 Mean difference in IQ between high- and low-intensity EIBI. DLS, daily living skills.
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Parental-managed compared with other applied behaviour analysis
Two studies compared parent-directed or managed early intensive ABA-based interventions (specifically
EIBI with NDBI) with clinician or other management of the same intervention.99,100 The repeated
measures meta-analysis of these two studies is summarised in Figure 15. There is no indication of
difference in any outcome, with all CIs including no effect and effect estimates are inconsistent in the
direction of effect. There is therefore little evidence based on these data that parental management
of early intensive ABA-based intervention alters its effectiveness.
Other comparisons
One study (28 participants) specifically compared two forms of ABA-based early intervention: PRT-based
intervention (Nova Scotia EIBI) compared with a group-based verbal behaviour intervention (group ABA).
Over 1 year, results for cognitive development, receptive and expressive language, adaptive behaviour,
problem behaviour and parenting stress, all indicated small and statistically non-significant differences
between the two treatment arms (see Table 41 in Appendix 10).
School placement
Three studies provided IPD on the school placement of children.26,89,96,98,103,109 Only the study by
Magiati et al. compared early intensive ABA-based interventions with TAU or eclectic interventions;89,96,109
the other two studies compared high- with low-intensity EIBI.26,98,103 To analyse school placement
we considered low-intensity EIBI to be equivalent to eclectic treatment (see Network meta-analysis
for the justification for this).
The results suggest that generally only children receiving high-intensity EIBI proceed to mainstream
education. Children receiving low-intensity or eclectic interventions are more likely to go to
specialist schools.
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The regression model found very large and statistically significant odds in favour of going to more
mainstream education with high-intensity intervention. These odds appear implausibly large. Further
regression models adjusting for IQ and VABS composite score (results not shown) found that, even
after adjusting for these factors, there were substantial odds in favour of going to more mainstream
education with high-intensity intervention. This suggests that school placement is not dependent on
improvements in IQ or behaviour. So difference in school placement could potentially be driven by
knowledge of the intervention received and by parental selection, values, preferences and priorities,
among other factors. Therefore, it is not clear whether or not high-intensity ABA-based intervention
improves chances of going to a mainstream school.
Figure 16 shows the distribution of school placement by study and intervention arm. Figure 17 shows the
result of a proportional odds regression to estimate the odds of being placed in a ‘more mainstream’
school if receiving high-intensity ABA-based intervention. The results suggest that generally only
children receiving high-intensity ABA-based intervention proceed to mainstream education and children
receiving low-intensity or eclectic interventions are more likely to go to specialist schools.
Network meta-analysis
A one-stage repeated measures NMA model was fitted to compare all the various intervention arms
included in the review (EIBI, EIBI with NDBI, ESDM, eclectic, TAU, portage, low-intensity EIBI and
parent-managed EIBI). The baseline intervention for comparison was taken to be eclectic treatment.
Figure 18 shows the results of this analysis for IQ and composite VABS score. Results for all outcomes
are available in Appendix 11 (see Figure 26 and Table 44).
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There was considerable variation across the results, but they did suggest that, overall, children receiving
any form of high-intensity ABA-based early intervention (EIBI, EIBI with NDBI, parent-managed EIBI)
have greater gains than eclectic treatment (after 1 year for IQ, but after 2 years for VABS score), and
different forms of high-intensity ABA-based early intervention are of similar effectiveness to each other.
Similarly, all lower-intensity interventions (TAU, portage and low-intensity ABA-based intervention)
appeared to be similar to, or possibly less effective than, eclectic intervention.
The results of this NMA agreed with previous analyses, including finding no evidence of difference
between traditional EIBI and EIBI with NDBI, no difference between eclectic treatment and TAU,
and no difference between patient-managed and other forms of EIBI. As with earlier analyses, there
was evidence that high-intensity ABA-based intervention was more effective than low-intensity EIBI.
High- compared with low-intensity intervention
Given the evidence from the NMA that, in general, all high-intensity interventions appear to have similar
effectiveness (likewise, for all low-intensity interventions), we performed a further post hoc meta-analysis
of all studies comparing any high-intensity intervention with any low-intensity intervention. This allowed
the studies comparing high- and low-intensity ABA-based interventions to be meta-analysed along with
those comparing high-intensity ABA-based interventions with alternative interventions, increasing the
sample size.
The results of one-stage repeated measures meta-analyses are shown in Figure 19. They were generally
very similar to the meta-analysis presented in Figure 10. The MD in IQ between high-intensity interventions
and low-intensity interventions is around 17 points (at 2 years: MD 16.76, 95% CI 10.60 to 22.93).
Communication, as measured by the VABS subscale, also favoured high-intensity intervention from
1 year (MD 8.18, 95% CI 0.54 to 15.85). For other VABS components, results favoured high-intensity
ABA from 2 years onwards, with a MD compared with low-intensity ABA of around 5–8 points (VABS
composite at 2 years: MD 8.60, 95% CI 2.86 to 14.34).
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As in the main meta-analyses (see Figure 10), results favoured high-intensity intervention for language
comprehension measured using RDLS (comprehension at 2 years: MD 11.66, 95% CI 2.00 to 21.33).
There was no evidence of any difference between high- and low-intensity intervention if using the
MSEL expressive and receptive language subscales. There remains little evidence on autism symptom
severity, but there was a suggestion (not statistically significant) that results favoured high-intensity
intervention at 2 years (ADOS severity score at 3 years: MD –1.34, 95% CI –2.82 to 0.14).
Summary of the individual participant data meta-analysis
Intelligence quotient and Vineland Adaptive Behaviour Scale
The main conclusion from all the meta-analyses is that receiving early high-intensity ABA-based intervention
leads to somewhat greater improvements in IQ and VABS scores than if receiving low-intensity, TAU or
eclectic interventions. IQ scores were higher by at least 9 points (about 0.6 of a SD) from 1 year after
initiation of intervention onwards (MD 9.16, 95% CI 4.38 to 13.93). Scores on the VABS components
were higher in the ABA intervention arms by 6–8 points on average (0.8 of a SD) after 2 years (composite
score: MD 7.00, 95% CI 1.95 to 12.06). Improvements at 1 year appeared to be smaller and were not
generally statistically significant.
Heterogeneity, estimated by I2, was generally low, but this was a consequence of the small size of most
included studies, which makes it difficult to conclusively identify heterogeneity. There was, however,
considerable variation in effect estimates across studies for some outcome measures. For example,
MDs in composite VABS at 2 years ranged from –4.79 to > 33. There was also variation across studies
in how the outcome measures changed over time. This raises some concerns of whether or not studies
are comparable.
There were few data on the longer-term impact of early intensive ABA-based interventions beyond the
end of the main intervention period. Only one study reported results at 7 years after initiation, which
found no difference between early intensive ABA-based and comparator arms. It is therefore not possible
to determine the long-term impact of early intensive ABA-based interventions, including whether or not
any benefits observed at 2 years persist.
Other outcomes
Results for other outcomes were limited due to the small numbers of studies reporting them. Data on
autism symptom severity were too limited to be conclusive, with no clear evidence that early intensive
ABA-based interventions improved the severity of autism compared with TAU or eclectic interventions.
There were, similarly, limited data on language comprehension. Three studies85,89,104 that used the RDLS
scale found some evidence that language scores favoured the early intensive ABA-based group compared
with TAU or eclectic interventions by around 11 points (RDLS comprehension at 2 years: MD 11.78,
95% CI 2.12 to 21.44). By contrast, two studies93,97 that reported the MSEL expressive and receptive
language subscales found no difference in scores between the two groups. There were insufficient data
on behaviours that challenge to permit any meta-analysis. The limited data from one study90 suggested
that early intensive ABA-based interventions could reduce behaviours that challenge, but results were
not statistically significant.
School placement was available in only one study89 comparing early intensive ABA-based interventions
with TAU and eclectic interventions, and in two studies26,103 comparing high- with low-intensity ABA-based
interventions. These studies suggested that children receiving a high-intensity ABA-based intervention
were much more likely to be in mainstream education (possibly with support) than children receiving TAU,
eclectic or low-intensity ABA-based interventions. This analysis, however, may be confounded by parental
preference for early intensive ABA-based treatment and mainstream schooling placement, and the
practice in Lovaas26 of encouraging children to change school if teachers became aware of their autism.26
Consequently, there is no good-quality evidence to suggest that early intensive ABA-based interventions
independently influences school placement.
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Participant and study characteristics
Studies reported limited data on child and parent characteristics, or details of how early intensive
ABA-based interventions were administered. It was therefore not possible to investigate most of
the protocol-specified covariates and how they might influence the effectiveness of early intensive
ABA-based interventions. We found no conclusive evidence that age, sex, baseline IQ or baseline
VABS score had any impact on the effectiveness of early intensive ABA-based interventions when
compared with other interventions.
There was no generally clear evidence that study-level covariates, including delivery setting, allocation,
parental involvement, duration and intensity of early intensive ABA-based treatment, had any clear or
observable impact on the MDs between these interventions and comparator groups. A possible exception
was that trials from earlier years found larger impacts on VABS composite score than later trials, although
the power to detect such differences was limited as there were few studies in the analysis.
Comparison of applied behaviour analysis-based interventions
Sensitivity analyses and the NMA both found no evidence of any difference in effectiveness between
TAU and eclectic interventions or any difference in effectiveness between different types of ABA-based
early intervention (EIBI alone or with NDBI). There was no evidence that parent-managed interventions
differed in effectiveness from other forms of management.
There was some evidence that high-intensity EIBI may be more effective than low-intensity EIBI,
and that high-intensity ABA-based intervention, in general, may be more effective than low-intensity
interventions (whether low-intensity ABA based or eclectic interventions). This may suggest that it is
the high intensity of the intervention that causes the greater benefits, rather than the precise nature
of the intervention received.
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Chapter 7 Economic analysis
Overview
This section outlines the development of a new economic model assessing the cost-effectiveness of
implementing early intensive ABA-based interventions in a UK context.
The cost-effectiveness model built on the IPD meta-analysis presented in Chapter 6, using its results to
inform the model parameters for the effectiveness of early intensive ABA-based interventions. Most of
the available evidence focused on cognitive ability (IQ) and adaptive behaviour (VABS), with few data
on other outcomes. In developing the model, we therefore sought to link these two outcomes to both
cost and benefits.
This narrow focus on these two outcomes has important implications for the interpretation of the
economic model. It means that the model does not account for effects on other outcomes and may not
fully capture the benefits of early intensive ABA-based interventions. The economic model is therefore
only valid to the extent that the benefits of early intensive ABA-based interventions can be captured
by changes in cognitive ability and adaptive behaviour scores.
The IPD meta-analysis also identified a number of important limitations in the effectiveness data.
In particular, the review raised concerns about the reliability of treatment effect estimates, given the
weakness in the methods used in the primary studies. The interventions and comparators assessed also
varied and it not clear how well they reflect how early intensive ABA-based interventions or other
interventions are used in the UK.
In consequence of these limitations, the presented economic model should not be viewed as a
comprehensive assessment of the cost-effectiveness of early ABA-based therapy, as the data currently
available are insufficient to make inferential judgements. Instead, it is more appropriate to view
the model as an exploratory analysis that provides a vehicle with which to explore key drivers of
cost-effectiveness, while also providing indicative results of any potential cost-effectiveness of early
intensive ABA-based interventions.
Economic evaluation of interventions in autism
Evaluation of cost-effectiveness examines the cost and benefits of interventions that are directly relevant
to decision-makers, with the aim of informing policy decisions.Within conventional health technology
assessment (HTA), which evaluates the effectiveness and value of implementing health-care interventions,
it is typically assumed that decisions are taken from a health-care perspective. The perspective of
economic analysis is important, as it determines the boundaries of an analysis, and which benefits and
costs will be considered. In health care, these are typically costs to the NHS or social care and benefits
are measured in terms of HRQoL.
Autism is defined as a long-term neurodevelopmental disability and, as such, the approach of focusing
exclusively on a health perspective may be too narrow because the relative costs and benefits of
interventions are likely to extend beyond the health-care system. This is demonstrated in the previous
economic evaluations of early intensive ABA-based interventions44,50–54 (see Appendix 13 for a review of
these studies), all of which highlighted significant cost offsets outside the health-care system (e.g. in
education provision). Similarly, defining benefits in terms of HRQoL may also be too restrictive, as
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there are a range of non-health outcomes that may be important to decision-makers, including those
related to education, the employment market and other relevant dimensions, such as changes in
well-being and quality of life (not related directly to health).
Figure 20 illustrates how an intervention, such as early intensive ABA-based interventions, may impact
on both health and non-health outcomes, and how it may have wider implications than those summarised
by the cost per quality-adjusted life-year (QALY) metric typically used as an outcome measure in HTAs.
In the context of autism, it is also worth noting that both health and non-health effects are likely to
impact not only on the autistic individual, but also on families and carers. For example, there is significant
literature on parental stress.120–125
Building on the list of potential outcomes presented in Figure 20, Figure 21 illustrates how the impact of
early intensive ABA-based interventions may fall on different sectors. In Figure 21, three perspectives
are defined: (1) a health and social services perspective, (2) a public sector perspective and (3) a societal
perspective. The health and social services perspective includes all health benefits along with costs
incurred by the health sector; this would include any costs incurred by the NHS, such as direct medical
costs, speech and language provision and social care (e.g. day care or drop-in centres). The public sector
perspective adds all costs borne by the state, as well as benefits that can be attributable to a function
of the state. These may include, for example, the costs of providing education, as well as any benefits
received by autistic people or their families. Finally, a societal perspective includes all costs and benefits
of early intensive ABA-based interventions regardless of where they accrue; this includes productivity
losses that may result from care requirements for autistic children and out-of-pocket expenses incurred
(e.g. travel costs for appointments).
Autism
Cognitive ability
Health sector
• Physical health
• Mental health
• QALYs
• Medical costs
• Social care
Non-health sectors
• Educational attainment
• Education costs
• Employment/productivity
• Friendships and relationships
• Independence
• Tax and benef its
• Out-of-pocket expenses
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FIGURE 20 Possible impact of ASD on health and non-health outcomes.
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FIGURE 21 Categorisation of impacts of intervention.
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Reflecting the above, the main analyses were undertaken using an NHS and social care perspective, as
well as a public sector perspective. The public sector perspective included local authorities and other
government agencies not covered by an NHS and social care perspective.We also sought to implement
a scenario analysis considering societal perspective, but we were unable to find appropriate data to
implement this analysis. Evidence from Barrett et al.,126 however, suggests that out-of-pocket expenses are
small for very young children and, therefore, although potentially important to affected families, these are
unlikely to be a driver of any decision about cost-effectiveness. To simplify these analyses, it was assumed
that the costs of providing early intensive ABA-based interventions are incurred by the health sector,
although, in reality, therapy costs may be borne by multiple sectors. It is our understanding that current
provision for young children is covered by education, health and social care budgets. Furthermore, it is
also common for some families to seek private provision to supplement that provided by the public sector.
Model development
In developing the new economic model our three broad aims were to:
1. adopt a cost–utility approach, that value judgements could be based not only on costs, but also on
any benefits generated
2. include all benefits and costs, including those falling outside the health sector
3. model the effects of the intervention based on the results of IPD meta-analysis.
In committing to these aims, the central challenge of economic analysis was to link the results of the
IPD meta-analysis to relevant measures of benefits and costs. As described in Chapter 6, the outcomes
reported in the effectiveness studies did not include quality-of-life or other holistic measures and,
therefore, there is no direct evidence to inform wider benefits. To capture such benefits within the
model, it was therefore necessary to try to link the outcomes reported in the effectiveness studies
to more holistic measures that could be used to inform policy. To do this, a systematic review of
relevant quality-of-life studies was conducted (details of which are presented in Appendix 14). This
review identified a large number of studies, including a small number that measure preference-based
measures of HRQoL. Of the studies identified, only one reported HRQoL in a way that could be linked
meaningfully with the outcomes reported in the IPD meta-analysis. This study, Payakachat et al.,127
recruited 224 children (aged 4–17 years) with autism and related conditions, including children with
co-existing intellectual disability. Its aim was to map outcomes, such as VABS, to the Health Utilities
Index Mark 3 (HUI3) quality-of-life measure. See Appendix 14 for further details of the population
recruited and the algorithms developed. The Payakachat et al.127 algorithm therefore formed the basis
of our model structure and was used to map changes in cognitive ability (IQ) and adaptive behaviour
(VABS) scores to HRQoL.
An implication of this approach was that it was necessary to track the two outcome domains, cognitive
ability and adaptive behaviour scores, over time. However, one of the key limitations of the available
effectiveness data is that there are very few studies with long-term follow-up data. In previous economic
evaluations,50–54 this issue has been solved by assuming trajectory effects on the basis of short-term
outcomes reported in the effectiveness studies (see Appendix 13 for further details). However, this is
a very strong assumption, given the limited long-term follow-up in the effectiveness studies and the
limitations of the supporting epidemiological evidence, which provides only evidence of correlations
between childhood outcomes and adult outcomes. This issue is further compounded by the evidence
available in the epidemiological and observational studies, which report on the prognostic value of only
a small number of outcomes (primarily measures of cognitive ability and language comprehension, but
not adaptive behaviour scores). See Appendix 15 for an overview of the relevant epidemiological and
observational studies.
Given the substantial uncertainty of extrapolating short-term benefits identified in the IPD meta-analysis
into later childhood and adulthood, two assumptions were agreed with our Advisory Group.
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First, it was agreed that the primary (base-case) analysis would use a time horizon of 15.5 years,
the model therefore covers the period from early childhood, ages 3–18.5 years, rather than a longer
lifetime horizon, which may be more appropriate given autism is a lifelong condition. This assumption
reflects strongly held views within the Advisory Group that we should not seek to extrapolate any
potential benefits of early intensive ABA-based interventions over TAU or eclectic interventions into
adulthood, unless there was appropriate supporting evidence to do so. The age threshold of 18.5 years
was selected as this represents when children transition to adult services. To explore the potential
for early intensive ABA-based interventions to continue to provide benefits over TAU or eclectic
interventions in the long term, an exploratory scenario analysis is presented in which a lifetime time
horizon is adopted using evidence from observational studies to link childhood outcomes to adult
outcomes; see Sensitivity and scenario analyses for details.
Second, because assumptions about long-term effectiveness are likely to be important drivers of
cost-effectiveness, two scenarios were explored within the base-case analysis: (1) an optimistic one, in
which the observed benefits of early intensive ABA-based interventions were assumed to persist; and
(2) a pessimistic one, in which the suggested benefits dissipate over time.
In the previous economic analyses of early intensive ABA-based interventions, educational placement
was a significant driver of cost-effectiveness and the main way in which cost offsets were generated
in childhood. Educational placement is a potentially important source of costs (savings), as there is
considerable additional costs associated with the providing of specialist services required by some
autistic children.128 Capturing the potential cost offsets in the education sector was therefore
considered to be central to accurately estimating the cost-effectiveness of early intensive ABA-based
interventions and consistent with the public sector perspective adopted. Of the studies identified
in the IPD meta-analysis, only three26,89,103 reported directly on educational placement (type of
school attended), one89 that compared early intensive ABA-based interventions with TAU or eclectic
interventions and two26,103 that compared early intensive ABA-based interventions with low-intensity
ABA-based therapy. The evidence to support the effects of early intensive ABA-based interventions on
education placements was therefore very limited. Furthermore, as explained in Chapter 6, the observed
treatment effects appear to be implausibly large and may be driven by knowledge of the intervention
received and parental and family values and priorities about the education settings their child would
attend, rather than any benefits gained from intervention. An alternative approach was therefore taken to
model educational placement, in which the impact of early intensive ABA-based interventions is mediated
through changes in cognitive ability and adaptive behaviour. This approach, outlined further in Model
structure, was adopted to mitigate the impact of any bias in the effectiveness studies and is also a more
consistent approach, as it avoids one set of studies being used to predict quality of life and non-education
costs, while another set is used to predict educational placement.
Model structure
The economic model was constructed in Microsoft Excel® (Microsoft Corporation, Redmond, WA, USA)
and uses a simple cohort model to capture changes in outcomes over time. It uses a cycle length of
1 month; no half-cycle correction was applied in the calculation of outcomes given the short cycle length
relative to the time horizon. In line with the NICE methods guide,129 the decision model uses a discount
rate of 3.5% per annum for both costs and benefits.
As explained in Model development, the model structure is based on cognitive ability (IQ) and adaptive
behaviour (VABS) scores which are used to predict per cycle benefits (QALYs) and costs. Changes in
the outcome measures (cognitive ability and adaptive behaviour) are incorporated as mean changes
in each measure per month (Figure 22). Changes in outcomes are based on the IPD meta-analysis;
see Treatment effect for details. As outcome data included in the IPD meta-analysis were available
only at 1 and 2 years, a simple linear interpolation was used to estimate between-group differences
at intervening time points.
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The time horizon in the main analysis is divided into two phases, representing different stages of an
individual’s childhood. The first phase ‘preschool’ (up to age 4.5 years) reflects the period when early
interventions are delivered, whereas the second ‘school age’ phase covers the period in which children
attend primary (age 4.5–11.5 years) and secondary education (age 11.5–18.5 years). To accommodate
educational placement and the associated resource implications, the model distinguishes between three
education settings: (1) mainstream, (2) mainstream with support and (3) special education provision.
Estimation of the proportion of children receiving each type of education is based on cognitive ability
and adaptive behaviour; see Education for details.
Scenario analysis exploring adult outcomes
Although the main (base-case) analysis limits the time horizon to childhood (15.5 years), an exploratory
scenario analysis considered the potential impact of incorporating adult outcomes into the model. In
this scenario, an additional phase is added to the model structure. The adult phase of the model is a
distinct phase in which a different model structure is used. This was done because the costs of care for
autistic adults are very different from those for autistic children.
In several of the economic evaluations identified in the cost-effectiveness review (see Appendix 13), adult
outcomes were defined in terms of levels of independence, often with three levels defined (e.g. independent,
semi-independent and dependent). The definitions attached to each of these levels varied across the
different models, but generally adopted one of two approaches. In the first most commonly used approach,
levels of independence were defined with reference to special education and in some cases special
education needs were also used to predict adult outcomes. The second approach used evidence from
the epidemiological and observational literature, which has categorised adult outcomes based on normative
evaluations of independence and social outcomes (see Appendix 13 for an overview of these studies).
This approach has important strengths, as it focuses on the support an individual needs and therefore
the categorisation systems are useful in terms of reflecting costs. For example, Penner et al.54 use a
classification system reported in Howlin et al.,15 which is widely adopted within the epidemiological and
observational literature. This classification system is useful because it describes a number of important
elements of care, with the definitions for each category, including references to residential status
and daily needs, both of which are significant drivers of cost in adulthood. In the context of the Penner
et al.54 model, this also allowed them to link the short-term outcomes reported in the effectiveness
studies to long-term adult outcomes.
This approach, however, has important limitations, as several studies have noted poor correlations
between HRQoL and indicators of independence in autistic populations.130 Furthermore, a number of
studies have been critical of this type of categorisation of adult outcomes, noting that a more nuanced
approach is needed to best define ‘standard concepts of what constitutes a “good” social outcome,
[as these] may not always be relevant for people with ASD’.131
Adaptive
behaviour
Cognitive
ability
Adaptive
behaviour
Initiation of
therapy Death
AdulthoodSecondary schoolPrimary schoolPreschool
Cognitive
ability
Adaptive
behaviour
Cognitive
ability
Adaptive
behaviour
Adult outcomes
Educational
placement
Educational
placement
Cognitive
ability
FIGURE 22 Model structure.
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The structure adopted in the adult scenario was therefore based on the classification system developed
in Howlin et al.,15 similar to the approach used in Penner et al.54 However, noting the cited limitations,
and in an attempt to mitigate these, independence levels are only used to indicate care needs and
costs in adulthood. HRQoL, instead, continues to be based on the Payakachat et al.127 algorithm used to
estimate quality of life in children.
The structure adopted in the adult phase to estimate costs is based on five levels of independence:
(1) ‘completely independent’, (2) ‘mostly independent’, (3) ‘some independence’, (4) ‘mostly dependent’
and (5) ‘completely dependent’. The definitions used for each category are based on those used in
Howlin et al.15 and are described in Table 9, and the costs attached to each independence level are
described in Resource use.
Independence levels are determined on entering the adult phase of the model based on adaptive
behaviour scores at 18.5 years of age. Owing to limitations in the epidemiological and observational
evidence base, the adult phase of the model is static (i.e. once individuals enter the adult part of the
model, the same level of independence is assumed throughout adulthood). This simplifying assumption is
made because of lack of data regarding changes in independence over time. This may or may not reflect
real life, and does not include any consideration of an individual’s potential for change or the impact
of any additional health or mental health needs, life events or changes in the wider family or social
community. This assumption therefore necessarily represents an important limitation of this scenario.
Model inputs
The following sections outline the key assumptions and data sources used to populate the model structure
outlined above. In addition to data drawn from the IPD meta-analysis, modelled assumptions and inputs
were primarily informed by three literature reviews. These included a review of observational studies
to help characterise the prognosis of autistic children and adults; a utilities review to identify studies
reporting on the HRQoL of autistic children and adults; and a resource review to identify resource and
cost data relating to the care needs of autistic children. Details of all three of these reviews, including
searches undertaken, inclusion criteria and findings, can be found in Appendices 14–16.
Furthermore, additional searches of the literature were also undertaken to identify any other input
parameters not covered by these three reviews. Inputs were also informed by discussions with UK
ABA practitioners, clinical academic experts, autistic adults and parents of autistic children, who
provided feedback on the model assumptions, including current provision of services for autistic
TABLE 9 Description of independence levels
Independence level Description
Completely independent Achieving a high level of independence; has some friends/acquaintances; maintained
reciprocal relationships; employed at some level (worked on voluntary/supported
basis), now or in the past
Mostly independent Achieving a good level of independence, but may require some support in daily living;
has some friends/acquaintances; maintained reciprocal relationships; likely to be
employed at some level (worked on voluntary/supported basis), now or in the past
Some independence Some degree of independence, but requires support and supervision; does not need
specialist residential provision; no close friends but some acquaintances; reciprocal
relationships with reduced sharing; may have been employed now or in the past
Mostly dependent Specialist residential provision/high level of support; no friends outside of residence;
no enduring relationships; never in paid employment
Completely dependent Needs high-level hospital care; no friends; no autonomy; never in paid employment
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children, the delivery of ABA-based therapies in the UK and resource use. Information was also obtained
from social care teams in several local authorities (York, Leeds and Newcastle) to ensure that we accurately
reflected the current provision of services for autistic children and adults.
Treatment effect
In the TAU and eclectic arm of the model, changes in cognitive ability and adaptive behaviour scores
are modelled using autism-specific natural history data to predict changes over time. To model the
treatment effect, in the early intensive ABA-based arm, cognitive ability and adaptive behaviour
scores are modelled by applying the treatment effect derived from the IPD meta-analysis. Outcome
scores in the early intensive ABA-based interventions arm of the model are therefore the sum of
the score predicted from the natural history data plus the treatment effect.
Natural history
To model changes in cognitive ability and adaptive behaviour scores over time, data were extrapolated
from four studies95,96,107,110 identified in the systematic review with extended follow-up. These data were
used to estimate change in baseline scores on usual care over time and were extrapolated assuming a
simple linear trend. The studies identified in the systematic review of effectiveness studies was used in
favour of data reported in observational studies, because few children with intellectual disability were
recruited to the observational studies reporting changes in both cognitive ability and adaptive behaviour
scores. See Appendix 15 for details of the review of observational evidence. The data from the effectiveness
studies were therefore considered more consistent with the population modelled, although both sources
reported similar patterns of change. To explore the impact of this assumption on model outcomes,
sensitivity analyses were conducted using alternative rates of change in cognitive ability and adaptive
behaviour scores. The mean changes in cognitive ability and adaptive behaviour scores used in the base
case are presented in Table 10.
Treatment effect
The treatment effect was modelled in two phases: (1) a short-term phase, covering the first 2 years,
and (2) a long-term phase, covering 2 years and onwards. This distinction is made to reflect the fact
that most of the studies included in the IPD meta-analysis had a follow-up of ≤ 2 years.
Short-term treatment effect
In the first 2 years of the model (up to cycle 24), the treatment effect applied was drawn from the
IPD meta-analysis and was based on analyses conducted at 1 and 2 years (Table 11). As discussed in
Chapter 6, UK-based studies, the average treatment effect observed in the UK studies was somewhat
TABLE 10 Mean change in cognitive ability and adaptive behaviour scores per year
Outcome measure Mean SE
Adaptive behaviour –0.28 1.24
Cognitive ability –2.69 1.27
TABLE 11 Short-term treatment effect
Outcome measure
Base case (all studies with IPD) UK scenario
Year 1 Year 2 Year 1 Year 2
MD SE MD SE MD SE MD SE
Adaptive behaviour 2.92 2.46 7.00 2.58 1.70 2.36 2.78 2.42
Cognitive ability 9.16 2.44 14.13 2.54 6.27 4.04 9.39 4.32
DOI: 10.3310/hta24350 Health Technology Assessment 2020 Vol. 24 No. 35
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Rodgers et al. under the terms of a commissioning contract issued by the Secretary of State
for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
61
smaller than that observed when combining all studies, and although these differences are not statistically
significant, it is plausible that, because of either the differences in setting or the precise interventions
compared, the benefits of early intensive ABA-based interventions may differ in the UK from those
observed elsewhere in the world. A scenario analysis was therefore conducted using treatment
effectiveness data drawn only from the UK studies.
Long-term treatment effect
Evidence on the longer-term effects of early intensive ABA-based interventions on cognitive ability
and adaptive behaviour scores, and in particular the degree to which any early benefits are sustained,
is very limited, with few studies reporting outcomes post end of therapy; see Chapter 6, Individual
participant data meta-analysis of early intensive ABA versus treatment as usual or eclectic interventions.
Given the lack of evidence on long-term effects, it was not felt that following the norm of developing a
single base-case analysis would be reasonable. Two scenarios were therefore explored:
1. an optimistic scenario, which assumed that the treatment effect persists throughout the time
horizon of the model
2. a pessimistic scenario, which assumed that the treatment effect dissipates over time, such that at
7 years no treatment effect remains.
In both scenarios, these increases or decreases in the size of the treatment effect are modelled as a
linear trend, as evidence from intermediate time points is unavailable. Furthermore, no changes in the
size of the treatment effect are assumed after 7 years. This time limit reflects the maximum follow-up
of Magiati et al.,96 which was the study with the longest follow-up, and attempts to acknowledge that
any further changes in the treatment effect are unknown. Pragmatically, it also prevents the magnitude
of the treatment effect trending to extreme values (e.g. negative scores).
Mapping childhood outcomes to levels of independence used in the adult scenario analysis
Evidence linking adult levels of independence (see Appendix 15) to childhood cognitive ability and adaptive
behaviour is somewhat limited. Although a number of studies report strong correlations between adult
cognitive ability, adaptive behaviour scores and adult levels of independence,15,131–134 none reports results
in a way that would allow contemporaneous predictions about adult outcomes (e.g. an appropriate
regression analysis). However, one study, Farley et al.,134 does report mean adaptive behaviour scores
for several of the independence levels described in Scenario analysis exploring adult outcomes (see also
Appendix 18 for further details).
To generate an algorithm with which to predict independence levels, the summary data reported in
Farley et al.134 were used to simulate IPD; details of methods used to do this are reported in Appendix 18.
An ordinal logistic regression was then implemented to generate a regression model that could be used
to predict adult outcomes. The coefficients generated from this analysis are reported in Table 12, along
with the appropriate cut-off points.
TABLE 12 Estimated coefficients based on simulated sample
Parameter Coefficient SE
Adaptive behaviour 0.07 0.01
Cut-off point 1 (very poor) 0.98 0.29
Cut-off point 2 (poor) 2.74 0.51
Cut-off point 3 (fair) 4.51 0.77
Cut-off point 4 (good) 6.55 1.05
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Education
Few studies identified in the IPD meta-analysis reported educational placement and there is significant
potential that this outcome was subject to significant bias, as predicted effects were implausibly large
(see Model development). We therefore modelled educational outcomes indirectly by using regression
models to predict educational placement using cognitive ability and adaptive behaviour scores.
Two regression models were generated, one to predict primary educational placement and a second to
predict secondary educational placement. The proportion of children attending each of the three types
of school described in Model structure is therefore determined at two points in the model, once in cycle
3 (age 4.5 years) and again in cycle 10 (age 11.5 years), with the probabilities of attending each type of
educational placement estimated using two separate data sets.
The first regression model, used to predict primary educational placement, was based on pooled data from
two of the studies identified in IPD meta-analysis: Smith et al.103 and Magiati et al.31 Secondary placement
was based on data from Barret et al.,135 a costing study identified in the resource review. As data from
Barret et al.135 were not reported in a form that allowed cognitive ability and adaptive behaviour to be
linked with educational placement, we requested IPD, which were kindly provided by the authors to
allow appropriate reanalysis. Both analyses used ordinal logistic analysis, with appropriate adjustments
for repeated measures. Regression coefficients from these analyses are reported in Table 13.
To acknowledge the potential impact of utilising an indirect approach to estimating the impact of early
intensive ABA-based interventions on educational placement, a scenario analysis used the direct evidence
available in the three effectiveness studies26,89,103 reporting subsequent educational placement. In this
scenario analysis, children are assumed to attend the same type of education throughout childhood
(see Appendix 18 for the proportions used).
Adverse effects
Adverse effects of ABA-based interventions were not reported in the studies included in the IPD
meta-analysis and available information from other sources is limited, and largely anecdotal.30,31,136
It was therefore not possible to include adverse effects in the economic model.
Mortality
A number of epidemiological studies have shown that autistic people experience reduced life expectancy
compared with the general population.137–142
To account for this reduction in life expectancy, mortality rates were estimated by applying a relative
risk drawn from Hirvikoski et al.138 to general population mortality rates adjusted for age and sex
from UK life tables.143 This study was selected because it is the largest study identified in the literature
and included 27,122 autistic people and a further 2,672,185 controls. For males without intellectual
disability (IQ ≥ 70), a relative risk of 1.69 was applied and a relative risk of 7.71 was applied for those
with intellectual disability. For females without intellectual disability (IQ ≥ 70), a relative risk of 2.47
was applied and a relative risk of 4.75 for those with intellectual disability.
TABLE 13 Education type regression coefficients
Parameter
Primary school Secondary school
Coefficient SE Coefficient SE
Adaptive behaviour –0.08 0.02 –0.04 0.02
Cognitive ability –0.02 0.01 –0.06 0.02
Cut-off point 1 (mainstream with support) –8.75 0.02 –9.37 1.58
Cut-off point 2 (specialist schooling) –6.10 0.86 –6.60 1.39
Note
Reference category is mainstream schooling.
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Mortality was not linked to intervention effectiveness. Given the observed effects of early intensive
ABA-based interventions on cognitive ability scores and the observed differences in mortality rates in
autistic people with and without intellectual disability, it is possible that early intensive ABA-based
interventions may influence mortality. However, as agreed with our Advisory Group, extending any
impact of early intensive ABA-based interventions to mortality was considered too strong an assumption,
given the lack of evidence, and therefore no such benefits were included within the model.
Modelled population
In line with the IPD meta-analysis, the modelled population was assumed to consist of preschool
children with a diagnosis of autism. Baseline characteristics modelled included age and sex, as well as
the following outcome measures: autism symptom severity (ADOS), cognitive ability (IQ) and adaptive
behaviour (VABS). Baseline characteristics were drawn from a pooled analysis of the studies comparing
early intensive ABA-based interventions with TAU or eclectic interventions.84–86,89–94,97,104 The exception to
this is age, which was rounded down from 38 months to 36 months to ensure that the time horizon is a
constant 15.5 years (this has a negligible impact on the predictions of the model). Note that because the
model assumes that children will receive early intensive ABA-based interventions for 2 years, the starting
age implies that some children will receive early intensive ABA-based interventions in place of regular
schooling. Children in the UK are mandated to attend school by their fifth birthday144 but typically
start in the September after their fourth birthday. This assumption was validated by the authors of the
effectiveness studies and experts within our Advisory Group, who agreed that at least a proportion
of children would receive early intensive ABA-based interventions in a school setting. In a scenario
analysis in which effectiveness data were drawn from only UK studies, baseline characteristics were
(when possible) drawn from the UK studies only. Starting characteristics used in the base-case analysis
and in the UK studies only scenario are summarised in Table 14.
Subgroup analysis
The results of the subgroup analysis presented in Chapter 6 show little evidence of differential effects
in the groups investigated. The economic model therefore does not explore subgroups any further.
Intervention and comparators
Reflecting the main comparison in the IPD meta-analysis, the model compares early intensive ABA-based
interventions with TAU or eclectic interventions.
TABLE 14 Baseline characteristics of children in the model
Characteristic
Base case
(10 studies84–86,89–97,104,109,110)
UK scenario
(three studies89–92,96,109,110)
Mean SE Mean SE
Proportion male (%) 87.57 1.47 91.59 2.70
Proportion with intellectual
disability (IQ < 70) (%)
59.43 1.08 82.95 3.32
Age (months) 36 0 36 0
Adaptive behaviour (VABS) 63.19 0.43 57.60 0.55
Cognitive ability (IQ) 59.43 1.08 54.66 1.50
Autism symptom severity (ADOS)a 6.98 0.18 6.98 0.18
a Based on four studies reporting scores.
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Early intensive applied behaviour analysis-based interventions
Modelled early intensive ABA-based interventions reflected our understanding of current UK provision
following advice from the authors of the effectiveness studies and several UK practitioners. Data were
also sourced from a UK study by Griffith et al.,36 which described provision of ABA-based therapy in
14 UK ABA schools. In the base-case analysis it was therefore assumed that children will receive 30 hours
of early intensive ABA-based interventions per week for a period of 24 months. Intensity was based on a
consultation exercise with study authors and UK practitioners, who, although not in complete consensus,
suggested that 30 hours would represent a typical programme. This also aligns with the average of
27 hours per week reported by the effectiveness studies and data reported in Griffith et al.36 Duration
of therapy was conservatively assumed to be 24 months on the basis that this aligns with the maximum
follow-up period for the bulk of the available effectiveness evidence. However, consultation with study
authors and data reported in Griffith et al.36 suggest that it is common for children to continue receiving
intensive ABA-based therapy in a school setting and the number of previous economic evaluations assumed
a longer duration of therapy. A scenario analysis was therefore run assuming that children receive an
intervention for a period of 36 months.
Comparator interventions
Comparator interventions included in the IPD meta-analysis were very diverse and the wider literature
reveals few details about service provision in the UK. Advice from expert advisors suggested significant
variability in current provision and highlighted that it usually consists of a mixture of activities delivered in
a nursery or home setting. These services may also be supplemented by additional input from specialist
services, such as speech and language therapists, educational psychologists, occupational therapists
and mental health workers. To help provide further details on TAU and eclectic interventions, service
providers in York and Newcastle local authorities kindly provided insight into provision in these areas,
suggesting that TEACCH and PECS are used regularly, and that approximately one-third of children attend
specialist nurseries, with the remainder supported in local authority mainstream nurseries. The model
defined TAU and eclectic interventions based on York and Newcastle local authority provision, with
costs also based on funding provided in these localities.
Health-related quality-of-life data used in cost-effectiveness analysis
As described in Model development, a systematic review was undertaken to identify appropriate utility
data with which to populate the model. The studies identified in this review led to the adoption of a
statistical algorithm developed in Payakachat et al.127 to predict HRQoL benefits.
Application of the Payakachat and colleagues algorithm
Quality of life was estimated at each time point in the model based on the algorithms presented in the
Payakachat et al.127 study, using adaptive behaviour, age, baseline cognitive ability (IQ scores) and
baseline autism symptom severity (ADOS scores). Quality-of-life scores therefore changed in accordance
with changes in cognitive ability and adaptive behaviour scores, and with increasing age over time. Table 15
gives the coefficients applied in the model.
TABLE 15 Regression model used to predict quality of life in children
Parameter
Scenario analysis
Coefficient SE
Constant −0.2438 0.2015
Age 0.0119 0.0186
Age79 0.0003 0.0010
ADOS score 0.0079 0.0078
IQ (log) 0.0304 0.0478
VABS composite score 0.0103 0.0016
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Quality of life for autistic adults (scenario analysis only)
Health-related quality of life in adulthood is also based on the Payakachat et al.127 algorithm, with two
adjustments made to reflect the fact that the algorithm is based on a paediatric population. The age
parameter is held constant at 18.5 years and age-related decrements are applied to account for the
natural effects of ageing on HRQoL. These decrements were calculated based on Szende et al.,145 which
described the health utilities of healthy populations of adults for different age groups. Decrements were
applied as multiplier to the mean utility of the cohort from the age of 25 years onwards (see Appendix 18).
Quality of life for parents and carers
A number of studies reported lower (health-related) quality of life in parents and carers of autistic
children compared either with parents of typically developing children or with population norms.120–125
This literature has shown that child behavioural difficulties and lack of social support are particularly
important drivers of quality of life in parents of children with autism and related conditions. The
evidence in the IPD meta-analysis provides only very limited evidence that early intensive ABA-based
interventions have any comparative advantage over other early interventions on problem behaviours,
with few studies recording appropriate outcomes. Furthermore, the quality-of-life literature does not
show any consistent relationship between other clinical outcomes, such as child cognitive ability,123,125
adaptive behaviour121 and autism symptom severity.121,123–125 It is therefore not clear what, if any,
effect early intensive ABA-based interventions has on parent and carer quality of life. The economic
analysis therefore does not include any analysis of any possible impact of early intensive ABA-based
interventions, either positive or negative, on parent or carer quality of life, although it is acknowledged
that these potentially exist.
Resource use
Relevant costs and resources were identified in a systematic review of the literature and appropriate
routine sources, such as Personal Social Services Research Unit (PSSRU).146 The studies identified in
this review were used to assign appropriate costs associated with the delivery and care of autistic
children and adults. Information on the precise description of resources required for each individual
therapy was partially based on data derived from the IPD review, and augmented with further
information obtained from relevant experts and data sourced from local authorities. The price year of
the analysis was 2016/17, as this was the most recent year of publication for PSSRU146 and inflation
indices for 2017/18 were not available at the time of writing. Prices reported in alternative cost years
were inflated using inflation indices reported in PSSRU.146
Intervention and comparator costs
Costs of early intensive applied behaviour analysis-based interventions
Costs of early intensive ABA-based interventions were derived from a number of sources. To estimate
staffing costs, data reported in Griffith et al.36 were used to estimate staff pupil ratios. This study
collected data from 14 schools delivering ABA-based interventions and recorded both the number of
children attending and the numbers of teaching staff. Four types of staff were recorded: (1) consultants
(senior staff members who are responsible for overall ABA programmes), (2) lead ABA tutors (staff
members who are in an ABA supervisory role within a classroom), (3) ABA tutors (staff members who
provide ABA therapy for children) and (4) non-ABA staff (professionals and teachers whose primary
role is not ABA based, such as specialist music teachers and speech and language therapists). For each
type of staff, the number of full-time equivalents per pupil was estimated, assuming that part-time
members of staff worked 50% time. Staff costs were estimated using NHS and social care pay scales
reported in PSSRU.146 The appropriate point on the salary scale was selected for each of the four staff
types by matching advertised salaries for relevant job vacancies listed on Indeed.co.uk to NHS and
social care pay scales reported in PSSRU.146 Only salary, national insurance and pension contributions
were included from PSSRU,146 as other costs were estimated separately. Table 16 summaries the
assumptions and cost data used to estimate staff costs per child per year.
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Capital costs and other indirect costs were estimated from costing information reported by the
Department for Education, which estimates non-teaching staff costs per primary aged pupil to be
£2303. The total cost of providing early intensive ABA-based interventions was therefore estimated at
£36,682.78 per annum. This cost was considered to be in line with expectation from clinical experts
and aligned with pricing from private providers, which typically advertise programmes at a cost of
£35,000–50,000 per year.37–39
Costs of treatment as usual
Costs of TAU and eclectic interventions were primarily based on national funding structures and
information obtained from York and Leeds local authorities on SEN funding. In the UK, SEN funding is
based on a three-tiered system. Element 1 refers to funding for mainstream places and in the context of
early years provision refers to 30 hours of free teaching for 38 weeks per year. The amount paid is
dependent on age and is derived from a national funding formula. For the 2017/18 year, this formula
paid £5.39 per hour for 2-year-olds and £4.88 per hour for 3- to 4-year-olds. Element 2 is to support
children with SEN and is paid either from local authority or the education funding agency. This funding
is, however, not available for preschool children. Element 3 funding is top-up funding provided by the
local authority for children with the highest needs, and is based on the needs of the child and is often
determined through an additional banding system that classifies children according to levels of
disability. Figures obtained on preschool autistic children known to York local authority suggest that
45% of children will receive element 3 funding, with the remainder receiving only element 1 funding.
Of the children receiving element 3 funding, 43% received additional support as part of enhanced
resource provision, which is attendance at a specialist centre, such as a specialist nursery, whereas the
remainder received additional support via an education and health-care plan. Neither local authority
was able to provide precise figures on funding attached to these forms of support, but provided broad
estimates of £5000 per annum for enhanced resource provision and £8000 per annum for education,
health and care plans (EHCP). Based on these figures, estimated nursery provision cost was £8634.33
per annum and the model assumed that two in every three children would be aged ≥ 3 years.
Costs of autism in childhood
Aligning with the model structure outlined in Model structure, costs in the model were split between
education costs and those accruing to other sectors, including the health sector.
Education costs
Costs associated with each type of education were drawn from a reanalysis of IPD obtained from Barret
et al.,135 who recorded education costs in a sample of adolescents with autism and Asperger syndrome.
Costs applied per annum for each education type are summarised in Table 17. These costs were applied
throughout childhood despite being drawn from adolescent-aged children, as no education costs were
identified in primary-aged children. Provision of education services is, however, based on the same
costing formula, regardless of the age of the child, and therefore costs of providing primary-aged education
are likely to be broadly similar to those of providing secondary education.
TABLE 16 Staff costs per child
Staff type FTE staff/child Salary band assumed Salary (£) Salary oncosts (£) Cost per child (£)
Consultant 0.11 7 38,550 9605 5506.09
Supervisor 0.23 4 20,279 4602 5834.50
ABA tutors 0.86 3 18,777 4179 19,663.86
Others 0.14 4 20,279 4602 3375.33
Total staff 1.34 n/a n/a n/a 34,379.78
FTE, full-time equivalent; n/a, not applicable.
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Social care and health-care costs
Costs accruing to social and medical (NHS) care were also drawn from a reanalysis of IPD obtained
from Barret et al.135 Costs were linked to outcomes in the model using a regression equation in which
cognitive ability and adaptive behaviour scores were used to predict total social care and medical
costs. As with education costs, social care and medical costs were applied throughout childhood
despite being drawn from an adolescent population, due to the lack of other appropriate sources.
Coefficients from this analysis are reported in Table 18.
It is plausible that social care and medical costs change throughout childhood; however, the impact of
this is likely to be minimal, as total costs accruing to social care and the NHS are small, relative to
education costs. Furthermore, mean predicted social care and medical costs for the TAU and eclectic
arm were comparable to those estimated in the Barret et al.126 study, which reported mean care costs
for preschool- and primary school-aged children. Note that access to the IPD from Barret et al.126 was
made available to the research team; however, this was not utilised, as costs could not be linked with
VABS and IQ scores and these were not recorded in this data set.
Care costs in adulthood
Care costs in adulthood were identified in the resource review (see Appendix 16). This review identified
a limited number of sources of resource use and cost data. The most comprehensive was a study by
Knapp et al.,147 later updated in Buescher et al.,23 which estimated the full costs of autism and related
conditions in the UK. This study drew on data from 185 adults and was supplemented by routinely
collected data and figures reported in other research studies. The Knapp et al.147 and Buescher et al.23
studies outlined several cost categories that showed the economic impact of autism on a range of
sectors. These were accommodation; social services, including day services, respite care, employment
support and education services; and medical costs, including both primary and secondary care.
These categories were adopted to characterise adult care costs within the model, using the resource
use and costing data reported in Knapp et al.,147 and were mapped to the five adult health states
described in Scenario analysis exploring adult outcomes. To ensure that assumptions made about resource
use were appropriate, advice was sought from service delivery providers in York local authority, with
additional resource and costing data drawn from PSSRU.146
Total costs, including and excluding productivity losses and family out-of-pocket expenses for each
level of independence, are reported in Table 19. Details of sources and assumptions made to assign
costs are presented in Appendix 18.
TABLE 17 Annual costs of education
Education type Cost per annum (£)
Mainstream education 4417.70
Mainstream with support 8689.78
Special education 15,702.78
TABLE 18 Social care and medical costs
Education type Cost per annum (£)
Intercept 1900.09
Adaptive behaviour –8.78
Cognitive ability –7.81
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Budget impact
The budget impact of implementing early intensive ABA-based interventions was estimated for a period
of 5 years using the estimated unit costs and resource savings predicted by the cost-effectiveness
model. The budget impact model was run for both the optimistic and the pessimistic assumptions
about the long-term effects of early intensive ABA-based interventions. Costs and resource savings
were classified based on the budget they accrue to and allocated to education or social services and
NHS budgets.
The budget impact analysis assumed that all children diagnosed with autism before the age of 4 years
would be eligible to receive early intensive ABA-based interventions. To model uptake of early intensive
ABA-based interventions, data were drawn from a US study of early intensive ABA-based interventions
services in an insured population,148 in which 94.6% of children aged < 5 years received ABA-based therapy.
Expansion of early intensive ABA-based services in the UK is also likely to take some time; therefore, the
budget impact model assumed a linear increase in the provision of early intensive ABA-based interventions
over time, from 18.9% of eligible children in year 1 to 94.6% of eligible children in year 5.
Eligible population
The prevalence of diagnosed autism was estimated to be 3.8 per 1000 for boys and 1.5 per 1000 for
girls, with estimates drawn from Taylor et al.149 Taylor et al.149 estimated the prevalence of diagnosed
TABLE 19 Summary of costs by level of independence
Resource type
Completely
independent (£)
Mostly
independent (£)
Some
independence (£)
Mostly
dependent (£)
Completely
dependent (£)
Accommodation
Own home/parents 0.00 0.00 0.00 0.00 0.00
Supported: low intensity 0.00 0.00 17,758.29 0.00 0.00
Supported: high intensity 0.00 0.00 33,112.15 49,668.22 49,668.22
Residential 0.00 0.00 0.00 57,776.50 57,776.50
Social services
Day services 0.00 17,728.57 5850.43 0.00 0.00
Respite care 0.00 1927.00 635.91 0.00 0.00
Employment support 169.48 169.48 169.48 0.00 0.00
Adult education 1800.00 1800.00 1067.00 4159.00 4159.00
Medical costs
Hospital 109.00 109.00 188.00 43.00 43.00
Other health services 887.00 887.00 587.00 726.00 726.00
Societal costs
Family expenses 2731.00 2731.00 901.23 0.00 0.00
Lost employment
(parents)
3840.75 3840.75 1280.25 0.00 0.00
Lost employment
(person with autism)
17,351.07 17,351.07 17,351.07 29,689.61 29,689.61
Total NHS and social 2965.48 22,621.05 59,368.26 112,372.72 112,372.72
Total societal costs 26,888.30 46,543.87 78,900.81 142,062.33 142,062.33
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autism using data from a large and representative sample of UK general practices. Note that this is
lower than estimated prevalence of autism at about 1%,1 as this figure is based on adults and includes
undiagnosed cases. The Taylor et al.149 study estimated prevalence at 8 years of age; therefore, to estimate
the proportion of these children who would be diagnosed before the age of 4 years, data on diagnosis
patterns were drawn from Brett et al.150 This was combined with the prevalence rate reported in
Taylor et al.149 by assuming that diagnosis was log-normally distributed, with mean and SD based on
data reported in Brett et al.150 This exercise predicted prevalence of diagnosed autism in children aged
< 4 years of 2.5 per 1000 boys and 0.8 per 1000 for girls.
The incident population each month was estimated as one-twelfth of the prevalent population, assuming
that children are diagnosed at equal rates throughout the year, with constant prevalence over time.
The total number of children aged < 4 years was drawn from Office for National Statistics mid-2018
population30 estimates, with no population growth assumed for future years.
Validation
Excel formulas, model logic and input data were verified for accuracy as part of quality control procedures
by a health economist not involved in the project. This included the use of a checklist to carry out a series
of black-box tests and to evaluate the internal validity of the model, and pressure testing, when parameters
were set to extreme values to ascertain whether or not the changes were consistent with expectations.
The code of the model was also examined for potential errors. This included tracking how the parameters
fed into the model and an examination of the main calculation sheets, with a view to understanding how
the QALYs and costs were accumulated in the model.
To ensure external validity, the model’s predictions were compared with observed data and epidemiological
reporting on the medium- and long-term costs and outcomes of autistic children.
Analytical approach, and scenario and sensitivity analyses
Although the economic analysis developed is purely exploratory, given the substantial limitations in
the available data, it is necessary to consider how to interpret the results, particularly given that, as a
neurodisability, autism impacts on multiple sectors. In health-care decision-making in the UK, a decision
rule is often employed (based on methods developed by NICE) to provide an objective basis on which
to determine the value of implementing a new intervention. This decision rule sets a willingness to pay
for additional health benefits.
The benefits of an intervention are usually quantified in terms of QALYs gained, a measure of health
incorporating improvements in both length and quality of life. The willingness to pay is a threshold that
must be met for an intervention to be considered cost-effective. In assessments made by NICE, this is
generally £20,000–30,000 per QALY gained.129
For a technology or intervention to be considered cost-effective, it must generate 1 additional QALY
per £20,000–30,000 of additional cost. Metrics of cost-effectiveness are measured in terms of the
incremental costs of generating an additional QALY and is estimated as an incremental cost-effectiveness
ratio (ICER), which is the ratio of incremental costs to incremental QALYs.
The threshold used by NICE can be interpreted as the opportunity costs of generating benefits in the
health sector (i.e. the efficiency with which the NHS is capable of generating health per £1 spent).
However, as discussed in Economic evaluation of interventions in autism, the impacts of early intensive
ABA-based interventions are likely to be realised in multiple sectors, not just the health sector.
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This complicates the interpretation of an ICER, as the opportunity cost of generating benefits and, by
extension, the implied cost-effectiveness threshold, may differ across sectors. For example, the opportunity
cost of generating benefits in the health sector may not be the same as the opportunity costs of generating
benefits in the education sector. This issue is further complicated by the fact that it is not clear how
opportunity costs differ across sectors. In the light of this uncertainty, and for simplicity, it is assumed
that benefits and costs are valued equally across sectors, implying a common threshold.
Two types of economic analysis were performed: (1) a deterministic analysis and (2) a probabilistic analysis.
A deterministic analysis calculates the result using point estimates for all the parameters in the model,
whereas in a probabilistic analysis values are entered as distributions. This allows uncertainty around
model parameters to be incorporated into the model, reflecting that the inputs used in the model are
measured with uncertainty. Relevant distributions for each parameter input were informed by the
IPD meta-analysis, additional literature and expert opinion. The probabilistic analysis ran the model
10,000 times, with each iteration making random draws from the distributions used to describe input
parameters. An incremental cost-effectiveness analysis was conducted based on the estimated costs
and QALYs, as described above.
The probability that early intensive ABA-based intervention is a cost-effective intervention at a
particular cost-effectiveness threshold was estimated by calculating the proportion of simulations
in which the ICER was below the willingness-to-pay threshold. A cost-effectiveness frontier was
also produced, which presents the probability of early intensive ABA-based interventions being
cost-effective at different cost-effectiveness thresholds.
Sensitivity and scenario analyses
To explore the impact of alternative model assumptions and the sensitivity of results to changes in
parameter inputs, a series of scenario and sensitivity analyses were performed. These scenarios were
considered important by the project Advisory Group. The specific analyses undertaken have been
introduced throughout this section and are listed below. Details of the assumptions made in each of
these analyses are presented in Chapter 8.
Scenario analysis
l UK evidence used to estimate short-term intervention effect.
l Time horizon extended to a lifetime time horizon to incorporate adult outcomes.
l Educational placement estimated directly from the effectiveness studies.
l Duration of early intensive ABA-based intervention increased to 36 months.
Sensitivity analysis
l Change in cognitive ability and adaptive behaviour natural history scores per annum.
l Effects of early intensive ABA-based interventions (cognitive ability and adaptive behaviour scores)
at 2 years.
l Costs of early intensive ABA-based interventions and TAU and eclectic interventions per annum.
l Costs of education categories, supported placement and specialist schooling.
Value-of-information analysis
One of the aims of the economic analysis was to identify key uncertainties in the evidence base and to
implement a value-of-information analysis to consider the value of carrying out further research to
address these uncertainties. Implementation of value-of-information analysis, however, relies on being
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able to adequately parameterise the uncertainty associated with any decision. In the present context,
this is very difficult to do. First, the potential for bias in the underlying effectiveness studies means
that the reported CIs are overly narrow and do not represent the true uncertainty in effectiveness
estimates. Second, as described in Overview, there are a number of structural uncertainties relating to
the appropriateness and completeness of the outcome measures modelled, as well as issues relating
to the long-term impact of early intensive ABA-based interventions. Any estimate of the decision
uncertainty based on the presented model structure and reported CI would therefore be likely to
represent an underestimate of the true level of decision uncertainty and, thus, the value of further
research. For these reasons, it was decided not to implement a value-of-information analysis, but
instead to present a purely qualitative assessment of the future research needs.
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Chapter 8 Cost-effectiveness and budget
impact results
This section outlines the results for the developed cost-effectiveness model and budgetimpact analysis.
Base-case results
This section presents the results of the base-case analysis for the deterministic and probabilistic models.
These analyses set out the most plausible estimates of cost-effectiveness, given the limited evidence
available and taking the results of the IPD meta-analysis at face value. As described in Chapter 7, Long-term
treatment effect, there is significant uncertainty about the long-term benefits of early intensive ABA-based
interventions. Therefore, two scenarios are presented in the base-case analysis: an optimistic scenario,
in which the comparative advantage of early intensive ABA-based interventions are assumed to persist
throughout the time horizon of the model, and a pessimistic scenario, in which the treatment effect
dissipates to zero.
Deterministic results
Initial results are presented assuming a narrow health-care perspective and therefore only costs
and benefits accruing to the health-care system are included. Results of this analysis are presented
in Table 20. Full results with a break down of costs are presented in Appendix 19.
In the pessimistic scenario, early intensive ABA-based interventions are associated with £57,879 in
additional costs and generates 0.24 additional QALYs. The resulting ICER is £236,837 per additional
QALY. In the optimistic scenario, early intensive ABA-based interventions are associated with £57,233
in additional costs and generates 0.84 additional QALYs. The resulting ICER is £68,362 per additional
QALY. Using NICE decision rules to benchmark the results of the cost-effectiveness analysis and
adopting a £30,000 per QALY threshold, these results indicate that for early intensive ABA-based
interventions to be considered cost-effective in the pessimistic scenario, it would be necessary for
there to be a further 1.68 QALYs or £50,547 in additional cost savings not captured by the economic
model. In the optimistic scenario, early intensive ABA-based interventions would be cost-effective at
a threshold of £30,000 per QALY if there were a further 1.07 QALYs or £32,117 in additional cost
savings not captured by the model.
A comparison of the incremental costs in the pessimistic and optimistic scenarios shows only a relatively
small difference. This reflects the lack of scope for early intensive ABA-based interventions to generate
significant cost savings in the health service sector. This similarity in incremental costs, however, contrasts
with a comparison of health benefits produced, which are significantly larger in the optimistic scenario.
Building on this initial scenario, Table 21 presents results considering a wider public sector perspective.
TABLE 20 Base-case results: NHS and social services perspective
Scenario Therapy Cost (£) QALYs Incremental cost (£) Incremental QALYs ICER (£)
Pessimistic ABA 76,622 4.61 57,879 0.24 236,837
TAU/eclectic 18,743 4.37
Optimistic ABA 75,976 5.21 57,233 0.84 68,362
TAU/eclectic 18,743 4.37
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In the pessimistic scenario, early intensive ABA-based interventions are associated with £43,940 in
additional costs and generates 0.24 additional QALYs. The resulting estimated ICER is £179,799 per
additional QALY. In the optimistic scenario, early intensive ABA-based interventions are associated
with £36,242 in additional costs and generates 0.84 additional QALYs. The resulting estimated ICER is
£43,289 per additional QALY. The adoption of a public sector perspective has a significant impact on
incremental costs in both the pessimistic and optimistic scenarios, with incremental costs falling by
£13,939 and £20,991, respectively. This is because improvements in cognitive ability and adaptive
behaviour could have a large impact in public sector cost savings, which are predominantly caused by
changes in education placement.
These differences in incremental costs have a significant impact on the resulting ICER, which fall
appreciably in both the pessimistic and optimistic scenarios. However, in both scenarios they remain
firmly above the NICE threshold of £20,000–30,000 per QALY. Assuming a threshold of £30,000 per
QALY, and making pessimistic assumptions about the long-term treatment effect, it would be necessary
for early intensive ABA-based interventions to generate either a further 1.22 QALYs worth of additional
health or non-health benefits, or a further £36,608 in additional costs savings. In the optimistic scenario
these fall to either a 0.37 QALYs worth of benefits or £11,126 in cost savings.
Probabilistic results
A probabilistic sensitivity analysis was conducted to account for the effects of parameter uncertainty
and cost-effectiveness acceptability generated. The base-case results for the probabilistic model are
shown in Table 22.
The results of the probabilistic analysis broadly correspond with those of the deterministic analysis and
indicate that further health or non-health benefits or cost savings would need to be generated for early
intensive ABA-based interventions to be cost-effective at a threshold of £30,000 per QALY. Assuming a
TABLE 21 Base-case results: public sector perspective
Scenario Therapy Cost (£) QALYs Incremental cost (£) Incremental QALYs ICER (£)
Pessimistic ABA 195,310 4.61 43,940 0.24 179,799
TAU/eclectic 151,370 4.37
Optimistic ABA 187,612 5.21 36,242 0.84 43,289
TAU/eclectic 151,370 4.37
TABLE 22 Base-case results: probabilistic analysis
Scenario Therapy Cost (£) QALYs Incremental cost (£) Incremental QALYs ICER (£)
NHS and social services perspective
Pessimistic ABA 76,587 5.02 58,940 0.24 240,868
TAU/eclectic 17,648 4.77
Optimistic ABA 76,341 5.60 58,630 0.85 69,385
TAU/eclectic 17,711 4.75
Public sector perspective
Pessimistic ABA 191,264 5.00 46,103 0.24 189,122
TAU/eclectic 145,161 4.75
Optimistic ABA 184,411 5.61 39,233 0.84 46,768
TAU/eclectic 145,178 4.77
COST-EFFECTIVENESS AND BUDGET IMPACT RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
74
public sector perspective, in the pessimistic scenario it would be necessary for early intensive ABA-based
interventions to generate either a further 1.29 additional QALYs or produce £38,790 in additional cost
savings. In the optimistic scenario, these values fall to 0.47 additional QALYs and £14,066 in additional
cost savings.
Assuming an NHS and social services perspective, the probabilistic results indicate that the probability
of early intensive ABA-based interventions being cost-effective at a threshold of £30,000 per QALY is
< 1% in the pessimistic scenario and 2.6% in the optimistic scenario. The probability that early intensive
ABA-based interventions are cost-effective when assuming a public sector perspective is < 1% in the
pessimistic scenario and 23% in the optimistic scenario. Taken at face value, these probabilities of
cost-effectiveness indicate that there is relatively little chance that early intensive ABA-based therapy
is cost-effective when pessimistic assumptions are made about the long-term effectiveness of early
intensive ABA-based interventions, and a modest probability in the scenario when optimistic assumptions
are made. Care should, however, be taken not to overinterpret these results, given the limitations of the
economic model and the scope for further benefits or cost saving to alter this result.
The degree of decision uncertainty is illustrated in Figure 23, which presents the cost-effectiveness
acceptability curve taking an NHS and social services perspective and a public sector perspective,
respectively. The probability that early intensive ABA-based interventions are cost-effective when
taking an NHS and social services perspective remains close to zero up to a threshold of £84,000 per
QALY in the pessimistic scenario and up to £25,000 per QALY in the optimistic scenario. When a public
sector perspective is adopted, the probability that early intensive ABA-based interventions are cost-
effective begins to depart from zero at a threshold of around £30,000 per QALY under the pessimistic
scenario and £1000 per QALY in the optimistic scenario.
Scenario and sensitivity analysis results
To explore the impact of alternative inputs and assumptions on the results, a range of sensitivity and
scenario analyses were undertaken. These sensitivity and scenario analyses were conducted using the
deterministic model and assumed a public sector perspective. As in the base-case analysis, scenarios
were run making both pessimistic and optimistic assumptions about the long-term treatment effect.
Scenario analysis
Four scenario analyses were undertaken:
1. UK evidence used to estimate short-term intervention effect
2. time horizon extended to a lifetime time horizon to incorporate adult outcomes
3. educational placement estimated directly from the effectiveness studies
4. duration of early intensive ABA-based intervention increased to 36 months.
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In each scenario a key model parameter or assumption was varied, with all other parameters fixed at
base-case values. Each scenario is presented in turn, along with a short summary of the impact the
analysis had on the base-case results. Results of the scenario analysis are summarised in Table 23.
Scenario 1: UK evidence
A substantial proportion of the evidence identified on the relative effectiveness of early intensive
ABA-based interventions was from non-UK studies. Scenario 1 therefore draws baseline and
short-term (years 1 and 2) treatment effects from a pooled IPD analysis of the UK studies only.
Using data from only UK studies results in the ICER increasing to £449,488 per QALY when pessimistic
assumptions are made regarding the long-term treatment effect, whereas in the optimistic scenario
the ICER increases to £124,945 per QALY. The results of this scenario analysis highlight the sensitivity
of the model to even relatively small changes in the size of treatment effect and the importance of
uncertainties in the generalisability of the results of the non-UK based studies to a UK setting.
Scenario 2: extending to include adult outcomes
Owing to the substantial uncertainty regarding the long-term impact of early intensive ABA-based
interventions and the weak evidence linking childhood outcomes to adult outcomes, the base-case
analysis uses a time horizon of ≈15 years. It is, however, plausible that the effects of early intensive
ABA-based interventions extend beyond childhood into adulthood. Scenario 2 therefore implements an
exploratory analysis to consider the potential impacts of early intensive ABA-based therapy on adult
outcomes and further extends the time horizon to a lifetime horizon (77 years), allowing the cohort to
transition to the adult phase of the model.
TABLE 23 Scenario analysis results: public sector perspective
Scenario Therapy Cost (£) QALYs Incremental cost (£) Incremental QALYs ICER (£)
Scenario 1: UK evidence
Pessimistic ABA 200,257 4.48 48,887 0.11 449,488
TAU/eclectic 151,370 4.37
Optimistic ABA 196,181 4.73 44,811 0.36 124,945
TAU/eclectic 151,370 4.37
Scenario 2: adult outcomes
Pessimistic ABA 1,800,040 6.87 43,940 0.24 179,799
TAU/eclectic 1,756,100 6.62
Optimistic ABA 1,705,806 8.49 –50,294 1.86 Dominant
TAU/eclectic 1,756,100 6.62
Scenario 3: educational outcomes
Pessimistic ABA 170,113 4.61 12,325 0.24 50,435
TAU/eclectic 157,788 4.37
Optimistic ABA 169,467 5.21 11,680 0.84 13,951
TAU/eclectic 157,788 4.37
Scenario 4: duration of therapy equal to 36 months
Pessimistic ABA 222,892 4.61 71,522 0.24 292,664
TAU/eclectic 151,370 4.37
Optimistic ABA 213,603 5.21 62,233 0.84 74,335
TAU/eclectic 151,370 4.37
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The impact of extending the time horizon depends substantially on the assumptions made about the
long-term treatment effect. In the pessimistic scenario, the ICER does not change from the one generated
in the base-case analysis, as this scenario assumes no further benefit of early intensive ABA-based
interventions beyond 7 years. In the optimistic scenario, this scenario produces substantially different
results from the base-case analysis, with early intensity ABA-based interventions generating substantially
more QALYs and greater cost savings. A substantial change to both incremental QALYs and costs. The
changes to incremental costs are so large that early intensive ABA-based interventions now dominates
TAU and eclectic interventions (i.e. it generates greater benefits at lower cost). These results highlight
the sensitivity of the model results to the assumptions made regarding the long-term benefits of early
intensive ABA-based interventions and the potential for significant benefits and cost savings to be
generated in adulthood (should the effects of interventions persist into adulthood and alter the life
paths of autistic people). It is also notable that these results very broadly match those reported in the
previous economic evaluations of early intensive ABA-based interventions. These previous economic
evaluations similarly reported costs savings from implementing early intensive ABA-based interventions,
although the estimated savings were much greater in the previous analyses (see Appendix 13 for an
overview of these studies).
Scenario 3: changing educational outcomes
The available evidence linking early intensive ABA-based interventions with schooling outcomes is very
limited, as this was rarely available for the studies included in the IPD meta-analysis. The base-case
model therefore takes an indirect approach to modelling schooling outcomes by using cognitive ability
and adaptive behaviour scores to predict schooling outcomes, rather than using the direct evidence
reported in the effectiveness studies. Scenario 3 therefore explores this assumption by using the effects
estimates generated directly by the effectiveness studies.
The impact of using the direct evidence is significant in both the pessimistic and the optimistic scenarios,
resulting in substantially lower incremental costs in both. In the pessimistic scenario using the direct
evidence on educational placement reduces the ICER to £50,435 per additional QALY, whereas in the
optimistic scenario it lowers the ICER to £13,951 per additional QALY. These large changes suggest that
an indirect approach to model school outcomes may not capture some of the benefits of ABA-based
therapy on schooling outcomes, or alternatively that the potential selection biases documented in
Chapter 6 have a very significant impact on schooling outcomes.
Scenario 4: increasing duration of the intervention
One of the key assumptions made in the base-case model is that children in the early intensive ABA-based
interventions arm receive therapy for a fixed period of 24 months. Scenario 4 extends the duration of
therapy to 36 months. This increases incremental costs significantly for both the pessimistic and the
optimistic scenarios. This is because early intensive ABA-based interventions are implemented for longer,
resulting in substantially higher therapy costs. The ICER increases to £292,664 per additional QALY when
pessimistic assumptions are made and £74,335 per QALY when optimistic assumptions are made.
Two-way sensitivity analysis
Two-way and multiway sensitivity analyses were undertaken to explore uncertainty in key input values.
This analysis allows assessment of the impact of changing two parameters in the model at the same
time. Four analyses were conducted, each considering the following pairs of parameter values:
1. change in cognitive ability and adaptive behaviour natural history scores per annum
2. effects of early intensive ABA-based interventions (cognitive ability and adaptive behaviour scores)
at 2 years
3. costs of early intensive ABA-based interventions and TAU or eclectic interventions per annum
4. costs of education categories, supported placement and specialist schooling.
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For each analysis, a heat map was generated, depicting the parameter space over which early intensive
ABA-based interventions would be considered cost-effective based on NICE thresholds. Cells shaded
light blue display ICERs < £20,000 per QALY, orange shading displays ICERs between £20,000 and
£30,000 per QALY and purple shading displays ICERs > £30,000 per QALY.
Sensitivity analysis 1: change in natural history of outcomes
The two-way scenario analysis reporting ICERs for per annum cognitive ability and adaptive behaviour
natural history scores is presented in Table 24. The results of this analysis show that the model is
largely insensitive to these input parameters and even the most extreme values do not impact sizably
on the resulting ICER. This is because changing these values does not have a direct impact on the size
of the benefits of early intensive ABA-based therapy.
Sensitivity analysis 2: change in the effect of applied behaviour
analysis-based intervention
Table 25 displays the analysis exploring different treatment effects at 2 years. The results show that the
model results are particularly sensitivity to these parameters. In particular, they show that when optimistic
assumptions are made about the long-term treatment effect, there is a large and plausible parameter
space over which early intensive ABA-based interventions could be considered cost-effective at NICE
TABLE 24 Two-way sensitivity analysis: natural history
Pessimistic
Natural history: VABS (£)
–4.69 –4.19 –3.69 –3.19 –2.69a –2.19 –1.69 –1.19 –0.69
Natural
history: IQ
–2.28 182,228 181,324 180,464 179,650 178,882 178,171 177,509 176,899 176,340
–1.78 182,450 181,556 180,706 179,903 179,148 178,449 177,800 177,203 176,656
–1.28 182,645 181,760 180,921 180,130 179,387 178,701 178,065 177,480 176,946
–0.78 182,814 181,940 181,112 180,333 179,603 178,930 178,307 177,735 177,214
–0.28a 182,962 182,099 181,283 180,516 179,799 179,139 178,529 177,970 177,462
0.22 183,091 182,238 181,434 180,681 179,976 179,330 178,733 178,187 177,691
0.72 183,203 182,362 181,570 180,829 180,138 179,505 178,921 178,389 177,905
1.22 183,300 182,471 181,691 180,964 180,286 179,667 179,096 178,576 178,105
1.72 183,384 182,567 181,800 181,086 180,422 179,816 179,259 178,752 178,293
Optimistic
Natural history: VABS (£)
–4.69 –4.19 –3.69 –3.19 –2.69a –2.19 –1.69 –1.19 –0.69
Natural
history: IQ
–2.28 48,846 48,185 47,482 46,738 45,949 45,129 44,276 43,403 42,525
–1.78 48,698 47,959 47,178 46,355 45,493 44,610 43,709 42,809 41,930
–1.28 48,343 47,526 46,668 45,776 44,856 43,933 43,015 42,126 41,290
–0.78 47,811 46,920 45,997 45,053 44,101 43,171 42,276 41,443 40,696
–0.28a 47,126 46,173 45,205 44,238 43,289 42,395 41,569 40,838 40,222
0.22 46,322 45,332 44,349 43,397 42,497 41,684 40,972 40,380 39,923
0.72 45,437 44,443 43,487 42,595 41,789 41,100 40,536 40,109 39,819
1.22 44,526 43,570 42,686 41,900 41,232 40,696 40,300 40,040 39,907
1.72 43,650 42,779 42,012 41,370 40,864 40,498 40,267 40,159 40,153
a Indicates base-case values.
Note
Shading displays ICERs > £30,000 per QALY.
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thresholds. Notably, the changes to the size of treatment required for the ICER to drop below £30,000
per QALY are well within the CIs for cognitive ability and adaptive behaviour scores generated by the
IPD meta-analysis, as well as being well within the range of treatment effects observed in the individual
studies. The scenarios in which pessimistic assumptions are made, by contrast, paint a much bleaker
picture and show that there is no plausible treatment effect that would enable early intensive ABA-
based interventions to be considered cost-effective at NICE thresholds on the basis of the captured
benefits and costs.
Sensitivity analysis 3: change in intervention costs
The impact of varying the costs of early intensive ABA-based interventions, TAU and eclectic interventions
is explored in Table 26. When pessimistic assumptions are made about the long-term treatment effect,
the results of this analysis show that even substantial changes to the costs of early intensive ABA-based
interventions, TAU and eclectic interventions do not bring the ICER < £30,000 per QALY. Therefore, even
in the most extreme of these scenarios, early intensive ABA-based interventions would need to generate
either substantial further benefits or cost savings. This contrasts with the analysis making optimistic
assumptions. In this scenario, there is a sizable and plausible range of values under which early intensive
ABA-based therapy would be considered cost-effective at NICE thresholds. This is important, as there is
TABLE 25 Two-way sensitivity analysis: treatment effect
Pessimistic
Treatment effect: VABS (£)
1.95 3.22 4.48 5.74 7.00a 8.27 9.53 10.79 12.06
Treatment
effect: IQ
9.16 500,438 362,233 280,965 227,469 189,601 161,400 139,598 122,252 108,133
10.40 489,669 355,790 276,573 224,227 187,079 159,363 137,907 120,819 106,898
11.64 479,310 349,540 272,290 221,056 184,605 157,362 136,244 119,407 105,681
12.88 469,335 343,473 268,112 217,952 182,179 155,397 134,608 118,018 104,481
14.13a 459,721 337,580 264,035 214,913 179,799 153,465 132,998 116,649 103,298
15.37 450,447 331,852 260,054 211,937 177,462 151,565 131,414 115,300 102,131
16.61 441,494 326,281 256,165 209,022 175,169 149,698 129,854 113,971 100,981
17.85 432,844 320,862 252,366 206,165 172,916 147,861 128,318 112,660 99,846
19.10 424,479 315,585 248,651 203,364 170,704 146,054 126,805 111,369 98,726
Optimistic
Treatment effect: VABS (£)
1.95 3.22 4.48 5.74 7.00a 8.27 9.53 10.79 12.06
Treatment
effect: IQ
9.16 161,532 106,506 78,010 60,581 48,819 40,349 33,959 28,969 24,967
10.40 155,504 103,086 75,681 58,831 47,423 39,189 32,968 28,105 24,200
11.64 149,709 99,746 73,387 57,099 46,036 38,034 31,980 27,241 23,434
12.88 144,127 96,482 71,126 55,383 44,658 36,885 30,994 26,379 22,668
14.13a 138,741 93,288 68,897 53,684 43,289 35,741 30,012 25,520 21,904
15.37 133,539 90,161 66,700 52,001 41,930 34,602 29,034 24,663 21,142
16.61 128,506 87,098 64,533 50,334 40,580 33,470 28,060 23,809 20,383
17.85 123,631 84,096 62,395 48,685 39,241 32,345 27,091 22,959 19,627
19.10 118,906 81,154 60,288 47,052 37,913 31,227 26,128 22,114 18,875
a Indicates base-case values.
Notes
Cells shaded light blue display ICERs < £20,000 per QALY, orange shading displays ICERs between £20,000 and
£30,000 per QALY, and purple shading displays ICERs > £30,000 per QALY.
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considerable variation in the models of early intensive ABA-based interventions assessed in the
IPD meta-analysis, specifically in a number of factors that would have a direct impact on the costs of
providing early intensive ABA-based interventions (e.g. intensity and staffing ratios). These results
therefore suggest that if similar treatment effect sizes could be obtained either at lower intensity or
with lower staff-to-child ratios, then it is plausible that early intensive ABA-based interventions could
be cost-effective on the basis of captured benefits and costs.
Sensitivity analysis 4: change in education costs
Table 27 presents a two-way sensitivity analysis exploring different costs of providing special needs
education. As in sensitivity analyses 2 and 3, the results of this analysis very much depend on the
assumptions made with respect to the long-term benefits of early intensive ABA-based interventions.
In the pessimistic analysis, no value set results in early intensive ABA-based interventions being cost-
effective on the basis of captured benefits and costs. In the optimistic scenario, however, there is a
parameter space in which early intensive ABA-based interventions would be considered cost-effective.
The results show that this is most likely when the costs of supported placements are low and the costs
of specialist education are high. This is because it is the difference between the costs of supported
placements and specialist education that matter. This occurs because the main impact of early intensive
ABA-based interventions on schooling placement in the model is to shift children from specialist
education to supported placements.
TABLE 26 Two-way sensitivity analysis: costs of therapy
Pessimistic
ABA therapy costs (£)
18,341 22,927 27,512 32,097 36,683a 41,268 45,853 50,439 55,024
TAU/
eclectic
costs (£)
4317 60,815 97,005 133,195 169,385 205,576 241,766 277,956 314,146 350,336
5396 54,370 90,561 126,751 162,941 199,131 235,322 271,512 307,702 343,892
6476 47,926 84,116 120,307 156,497 192,687 228,877 265,068 301,258 337,448
7555 41,482 77,672 113,862 150,053 186,243 222,433 258,623 294,814 331,004
8634a 35,038 71,228 107,418 143,608 179,799 215,989 252,179 288,369 324,560
9714 28,594 64,784 100,974 137,164 173,354 209,545 245,735 281,925 318,115
10,793 22,149 58,340 94,530 130,720 166,910 203,100 239,291 275,481 311,671
11,872 15,705 51,895 88,086 124,276 160,466 196,656 232,846 269,037 305,227
12,951 9261 45,451 81,641 117,832 154,022 190,212 226,402 262,592 298,783
Optimistic
ABA therapy costs (£)
18,341 22,927 27,512 32,097 36,683a 41,268 45,853 50,439 55,024
TAU/
eclectic
costs (£)
4317 8558 19,122 29,686 40,250 50,814 61,378 71,942 82,506 93,070
5396 6676 17,241 27,805 38,369 48,933 59,497 70,061 80,625 91,189
6476 4795 15,359 25,924 36,488 47,052 57,616 68,180 78,744 89,308
7555 2914 13,478 24,042 34,606 45,171 55,735 66,299 76,863 87,427
8634a 1033 11,597 22,161 32,725 43,289 53,853 64,418 74,982 85,546
9714 Dominant 9716 20,280 30,844 41,408 51,972 62,536 73,101 83,665
10,793 Dominant 7835 18,399 28,963 39,527 50,091 60,655 71,219 81,783
11,872 Dominant 5954 16,518 27,082 37,646 48,210 58,774 69,338 79,902
12,951 Dominant 4073 14,637 25,201 35,765 46,329 56,893 67,457 78,021
a Indicates base-case values.
Notes
Cells shaded light blue display ICERs < £20,000 per QALY, orange shading displays ICERs between £20,000 and
£30,000 per QALY, and purple shading displays ICERs > £30,000 per QALY.
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Budget impact analysis
The estimated budget impact of implementing early intensive ABA-based interventions is summarised
in Table 28. As with the cost-effectiveness analysis, two competing scenarios are run, making pessimistic
and optimistic assumptions about the long-term effects of early intensive ABA-based interventions.
Results of the budget impact model show that assumptions about long-term effectiveness have little
impact on the results of the budget impact model. This occurs because the impact of these assumptions
on benefits and costs begin to take effect only over longer time horizons than the 5 years used in the
budget impact model. The results of the budget impact analysis show that expenditure on ABA-based
interventions increases significantly over time, from just £5.6M in year 1 to £33.9M in year 5. This
increase largely reflects the increase in assumed uptake over time. Cost offsets from early intensive
ABA-based interventions almost exclusively accrue to the education sector and increase from £0.9M in
year 2 to £3.5M in year 5. Total net budget impact is estimated to be £4.3M in the first year, rising to
≈£31.2M per year in year 5. Total cumulative budget after 5 years is ≈£88M.
TABLE 27 Two-way sensitivity analysis: costs of schooling
Pessimistic
Supported placement costs (£)
4345 5431 6517 7604 8690a 9776 10,862 11,948 13,035
Special
education
costs (£)
7851 211,015 213,041 215,067 217,093 219,119 221,145 223,172 225,198 227,224
9814 201,185 203,211 205,237 207,263 209,289 211,315 213,341 215,368 217,394
11,777 191,354 193,381 195,407 197,433 199,459 201,485 203,511 205,537 207,564
13,740 181,524 183,550 185,577 187,603 189,629 191,655 193,681 195,707 197,733
15,703a 171,694 173,720 175,746 177,773 179,799 181,825 183,851 185,877 187,903
17,666 161,864 163,890 165,916 167,942 169,969 171,995 174,021 176,047 178,073
19,628 152,034 154,060 156,086 158,112 160,138 162,165 164,191 166,217 168,243
21,591 142,204 144,230 146,256 148,282 150,308 152,334 154,361 156,387 158,413
23,554 132,373 134,400 136,426 138,452 140,478 142,504 144,530 146,557 148,583
Optimistic
Supported placement costs (£)
4345 5431 6517 7604 8690a 9776 10,862 11,948 13,035
Special
education
costs (£)
7851 56,918 58,573 60,227 61,882 63,537 65,191 66,846 68,500 70,155
9814 51,856 53,511 55,166 56,820 58,475 60,129 61,784 63,439 65,093
11,777 46,795 48,449 50,104 51,758 53,413 55,068 56,722 58,377 60,031
13,740 41,733 43,387 45,042 46,697 48,351 50,006 51,660 53,315 54,970
15,703a 36,671 38,326 39,980 41,635 43,289 44,944 46,599 48,253 49,908
17,666 31,609 33,264 34,918 36,573 38,228 39,882 41,537 43,191 44,846
19,628 26,548 28,202 29,857 31,511 33,166 34,820 36,475 38,130 39,784
21,591 21,486 23,140 24,795 26,449 28,104 29,759 31,413 33,068 34,722
23,554 16,424 18,079 19,733 21,388 23,042 24,697 26,351 28,006 29,661
a Indicates base-case values.
Notes
Cells shaded light blue display ICERs < £20,000 per QALY, orange shading displays ICERs between £20,000 and
£30,000 per QALY, and purple shading displays ICERs > £30,000 per QALY.
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Summary of cost-effectiveness and budget impact analysis
In this section, a series of analyses exploring the potential cost-effectiveness of early intensive ABA-based
interventions are presented. The base-case analysis was run considering two perspectives: (1) an NHS and
social services perspective, and (2) a wider public sector perspective. As outlined in Chapter 7, Economic
evaluation of interventions in autism, this reflects the fact that the impacts of early intensive ABA-based
interventions are likely to include both health and non-health benefits, as well as cost savings for both
the health service and other sectors. Assuming an NHS and social services perspective, the results of
cost-effectiveness analysis suggest an ICER of £240,868 per QALY when pessimistic assumptions are
made about long-term effects and an ICER of £69,386 per QALY when optimistic assumptions are made.
When a broader public sector perspective was adopted, the ICER in respective scenarios was £189,122
per QALY and £46,768 per QALY (reported figures based on probabilistic analysis).
Care should be taken when drawing inferences from this analysis owing to significant limitations in the
available effectiveness evidence and the contrasting possibilities that additional benefits or cost savings
are not captured by the model, or that effect estimates generated by the IPD meta-analysis and used
in the model may be inflated owing to bias in the included studies.
The results of the scenario analyses identified a number of drivers of value and showed that early
intensive ABA-based intervention was more likely to be cost-effective if the benefits of therapy continued
into adulthood or, alternatively, if it could have significant impact on the type of school attended. Little
empirical evidence is available to support or refute the assumptions made in these scenarios, which are
subject to significant limitations in the underlying data. More generally, the results of the scenario and
sensitivity analysis highlight that early intensive ABA-based interventions must produce lasting benefits
if they are to be cost-effective.
TABLE 28 Budget impact
Scenario
Year
1 2 3 4 5
Pessimistic
Total costs of ABA (£) 5,649,222 13,178,526 18,826,751 26,357,052 33,887,354
Savings to education budget (£) 0 –927,606 –1,471,944 –2,403,755 –3,492,183
Savings to NHS and social care (£) –4052 –15,990 –34,000 –56,820 –83,967
Net budget impact (£) 4,323,570 11,684,606 16,787,185 23,942,596 31,258,953
Cumulative net budget impact (£) 4,323,570 16,008,177 32,795,362 56,737,958 87,996,911
Optimistic
Total costs of ABA (£) 5,649,222 13,178,526 18,826,751 26,357,052 33,887,354
Savings to education budget (£) 0 –927,606 –1,476,480 –2,414,335 –3,511,829
Savings to NHS and social care (£) –4052 –15,990 –35,431 –62,799 –98,967
Net budget impact (£) 4,323,570 11,684,606 16,793,152 23,959,156 31,293,599
Cumulative net budget impact (£) 4,323,570 16,008,177 32,801,328 56,760,484 88,054,084
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Chapter 9 Discussion
Statement of principal findings
Systematic review and individual participant data meta-analysis
We identified 20 studies, including a total of 894 participants, comparing early intensive ABA-based
interventions with alternative interventions (mostly ‘eclectic’ treatment or TAU). Fifteen studies,26,84–86,89–99,
103,104 representing 82% of published IPD (n = 654), were received and recoded to a common format, as set
out in the project data dictionary, and then reanalysed in accordance with a prespecified analysis plan. One
additional study,102 identified in initial searches but not published until after completion of our analyses,
was also incorporated into aggregate meta-analyses (see Appendix 12 for details).
All children in the included studies had a diagnosis of autism, ASD or (in some earlier studies) pervasive
developmental disorder, and were aged between 24 and 66 months at baseline. The majority of studies
recruited participants from the USA, with studies also conducted in the UK, Norway, Australia and
Canada. The most commonly reported outcomes were measures of cognitive ability (both verbal and
non-verbal) and adaptive behaviour measured using VABS. Studies also less frequently reported
measures of autism symptom severity, language comprehension and educational placement.
All of the included studies were at risk of bias on at least one domain using the Cochrane Risk of Bias
or ROBINS-I tools,58 with the majority of studies at risk of bias in multiple domains. Randomisation
was possible (as shown in a minority of studies) but rarely conducted. Most studies used convenience
samples, with allocation to early intensive ABA-based interventions often based on parental preference.
There is evidence to suggest that the use of convenience samples may have led to imbalances in
participant characteristics between the intervention and comparator groups, with differences in terms
of socioeconomic status and the use of co-interventions noted in some studies.
The nature of the interventions meant that blinding of education staff and participants was not possible,
but outcome assessors were also often not blinded to intervention. This is particularly problematic when
parent-reported measures were used, as the use of convenience samples often meant that parents had
actively sought for their child to receive early intensive ABA-based interventions and in some studies
parents may also be the source of funding for the intervention. As such, they are likely to have pre-existing
expectations about the effectiveness of early intensive ABA-based interventions, which may influence their
assessment of parent-reported outcome measures.
It was not possible to assess whether or not these issues and others have had an impact on the results
of the included studies or, indeed, the direction of any biases. However, there is a risk that the magnitude
of effects observed in our IPD meta-analysis may overestimate the true effects of early intensive
ABA-based interventions.
Compared with ‘eclectic’ intervention or TAU, early intensive ABA-based interventions had minimal or
no impact on parent-reported adaptive behaviour scores after 1 year (MD 2.93, 95% CI –1.90 to 7.76),
but showed an average 7-point difference after 2 years (MD 7.00, 95% CI 1.95 to 12.06). This effect
was, however, variable across studies, with treatment effects ranging from a 32-point difference in
favour of early intensive ABA-based interventions to a 5-point advantage for TAU and eclectic comparators.
An average improvement in measures of cognitive ability of around 10 points was observed at
1 year (MD 9.16, 95% CI 4.38 to 13.93) and 2 years (MD 14.13, 95% CI 9.16 to 19.10) for early
intensive ABA-based interventions relative to TAU and eclectic comparators. Only one study96
provided longer-term follow-up, reporting outcomes at 7 years. In this study no differences between
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early intensive ABA-based interventions and eclectic treatment were observed on adaptive behaviour
(parent-rated VABS) or cognitive ability (IQ) scores.
Results for other outcomes were limited owing to the small numbers of studies reporting them.
Autism symptom severity was not measured in most studies and therefore the data available were too
limited to be conclusive, with no clear evidence of a difference between early intensive ABA-based
interventions and TAU and eclectic groups. There were similarly limited data on language (comprehension
and/or expression). Three studies that used the RDLS scale found some evidence that comprehension
scores improved by around 12 points when using early intensive ABA-based interventions (MD 11.78,
95% CI 2.12 to 21.45), relative to TAU and eclectic interventions. By contrast, two studies that used the
MSEL scale found no difference in scores between early intensive ABA-based arms and TAU or eclectic
arms. Only one study90 reported data on behaviours that challenge. The limited data available from this
single study showed no clear evidence of any benefit.
A small number of studies reported primary education placement and suggested that children receiving
early high-intensity ABA-based intervention were much more likely to be in mainstream education
(possibly with support) than children receiving TAU or eclectic interventions or low-intensity ABA-based
interventions. However, there is a possibility that this finding was biased by study procedures, such as in
Lovaas,26 in which all children receiving early intensive ABA-based interventions were placed in mainstream
schools and major efforts were made to avoid authorities subsequently moving them to specialist
education placements. Parental choice may also have influenced educational placement, and so these
results may also be biased by parental expectations of ABA-based interventions. Additionally, local
contextual detail was not available for most studies, so we could not establish the extent to which, for
example, inclusive education policies would influence school placement outcomes. This raises questions
about the usefulness of school placement as an outcome.
Interpreting the meaningfulness of these observed effects in terms of their impact on the everyday
lives of autistic children and parents is not straightforward. Reference to conventions in interpreting
effect sizes would imply that the observed effects on both cognitive ability and adaptive behaviour
represent small to medium effects. Furthermore, it should be noted that the outcome measures
included were considered by the stakeholders in our Advisory Group to be limited in terms of both
their ability to reflect benefits and their relevance to practice.
The results of this meta-analysis were consistent with results in previous reviews. For example,
Reichow et al.,45 a recent review published by the Cochrane and Campbell Collaborations, identified
similar statistically significant effects on both cognitive ability and adaptive behaviour, and a lack of
evidence to support treatment effects on other measures, including behaviours that challenge and autism
symptom severity. Similar findings have also been reported in other previous reviews.4,24,42–44,46–49
A major advantage of conducting IPD meta-analysis is the ability to examine potential moderators of
the treatment effect. There were, however, sufficient baseline data to examine only a few factors,
namely age, sex, IQ at baseline and VABS composite score at baseline, and, at the study level, classification
of intervention type (clinic or community), delivery setting, planned treatment intensity and duration,
and year of publication. There was no evidence that any factor moderated any outcome at any time
point. This result may reflect the limited data available to detect such effects. However, the magnitude
of effects estimates did not suggest that any factor could be a potential moderating factor. Analysis of
only UK-based studies suggested smaller treatment effects in these studies. These differences were,
however, not statistically significant and could be due to a variety of factors other than location.
Cost-effectiveness
The limitations in the evidence available to the IPD meta-analysis had an important role in shaping the
economic model, as a number of potentially relevant outcomes were not captured in the included
studies. The structure of the model was therefore designed around the two most commonly measured
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outcomes, (1) cognitive ability and (2) adaptive behaviour, and so may have missed costs or benefits
associated with other outcomes. The economic model adopted a cohort approach to capture changes
in these measures and drew on the IPD meta-analysis results to link these outcomes to HRQoL and
costs. Furthermore, given the limited evidence about long-term effectiveness, the model explored two
scenarios: (1) an optimistic scenario, in which the observed benefits of early intensive ABA-based
interventions were assumed to persist; and (2) a pessimistic scenario, in which the proposed benefits
dissipate over time.
Given that the implementation of an effective early intensive ABA-based intervention for young
autistic children would be likely to have an impact across multiple sectors, the model considered
several perspectives relevant to a UK setting, including a health-care and social services perspective
and a broader public sector perspective, which included costs falling on the local authority and
education sector.
In line with the results of the IPD meta-analysis, the results of the cost-effectiveness model indicated
that early intensive ABA-based intervention is more effective (higher incremental QALYs) than TAU or
eclectic interventions. The model also indicated that it is more costly. Interpretation of whether or not
these additional costs represent value is not straightforward, as the typical decision rules commonly
employed in the context of health-care decision-making do not necessarily apply to autism owing to
its impact on multiple sectors. These decision rules do, however, provide a useful benchmark against
which the results of the cost-effectiveness analysis can be compared. On this basis, and adopting a
public sector perspective, the results of the cost-effectiveness analysis indicate that early intensive
ABA-based interventions would not meet the decision criteria for implementation used by NICE.
This is irrespective of what assumptions are made about the long-term effectiveness of early intensive
ABA-based interventions. For early intensive ABA-based interventions to be considered cost-effective
according to these criteria, they would need to generate either further benefits or cost savings beyond
those captured by the model. In monetary terms, the value of these benefits would need to be £38,790
when pessimistic assumptions were made and £14,066 when optimistic assumptions were made. Care,
however, should be taken not to overinterpret the results, as the limitations of the available evidence
may mean that it is plausible that uncaptured costs and benefits could alter this result.
The results of the scenario analyses identified a number of drivers of value and showed that early
intensive ABA-based interventions would be cost-effective at NICE thresholds only if either significant
benefits were accrued in adulthood or the intervention could significantly affect the type of school
attended, as was observed in a small number of the effectiveness studies.17,26,103 The value generated
by early intensive ABA-based interventions is, however, contingent on treatment effects persisting for
the time horizon of the model and it is much less likely that early intensive ABA-based interventions
represent value for money if benefits are realised for only a short period of time.
The magnitude of gains in both cognitive ability and adaptive behaviour scores predicted by the IPD
meta-analysis was also a significant driver of cost-effectiveness. This may be of significance when
interpreting the results of the economic analysis, given both the significant variations in treatment
effects observed across studies included in the IPD meta-analysis and the concerns about bias in
these studies. The scenario analysis conducted showed that, conditional on treatment effects
persisting, early intensive ABA-based interventions could represent value for money (at thresholds
used by NICE) if treatment effect sizes were in line with the more positive studies included in the
IPD meta-analysis. Equally, if treatment effects align with the less positive studies or have been
exaggerated by confounding and other biases, it is unlikely that early intensive ABA-based interventions
represent value for money.
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Strengths
To the best of our knowledge, the IPD meta-analysis presented here is the most comprehensive
investigation of the comparative evidence on the effects of early intensive ABA-based interventions
for young autistic children to date, and only the second review and meta-analysis to use IPD. It is the
only systematic review and meta-analysis to have been conducted by an international collaboration of
investigators, including original study authors and an Advisory Group (with representation from autistic
people, and parents and practitioners), and the only one to have been carried out in tandem with
development of a cost-effectiveness model, which was informed by the IPD meta-analysis results.
The IPD meta-analysis is based on 75% of all known IPD, including data from 669 participants (with
sensitivity analyses incorporating aggregate data generated from a further 93 participants in published
analyses). The SCABARD requested data on 41 demographic and outcome variables, and provides a
detailed assessment of the risk of bias for all included studies. By obtaining IPD, we have been able to
benefit from access to the raw study data and from contact with the study authors. This has allowed us
to ensure greater consistency in outcome measures and we have been able to adopt a consistent and
more appropriate statistical approach to analysing the available data. Furthermore, it has also allowed
us to clarify the extent of any unpublished data, as well as to consult with the authors of original
studies to confirm study details.
The principal strength of the cost-effectiveness analysis was the ability to draw on the most comprehensive
and up-to-date effectiveness data for early intensive ABA-based interventions. The model developed
and reported in this report is, to the best of our knowledge, the first assessment of value in a UK context,
drawing on both international and UK data, and supplementing these with expertise in the research team,
in the Advisory Group and from UK service providers.
The thorough searches for relevant literature to populate the model and development of the economic
model around the available effectiveness evidence highlighted specific areas of uncertainty, as well as
drivers of cost-effectiveness. Explicit assumptions were made about the impact that early intensive
ABA-based intervention may have on HRQoL and costs and, in particular, the impact that assumptions
about the persistence of any treatment effect are likely to have on estimates of cost-effectiveness.
The identification of these key uncertainties and drivers represents an important first step in defining
what research is needed to more fully address whether or not early intensive ABA-based interventions
are cost-effective.
To ensure that conclusions were unbiased, the SCABARD analyses were undertaken by an independent
research team who were not involved in the original studies and did not have a pre-existing position on the
effects of early intensive ABA-based interventions in autism. Throughout the project, the research team
consulted a project Advisory Group, who provided a wide range of expertise and viewpoints. To capture
the widest possible range of perspectives, all participants were encouraged to contribute to Advisory
Group meetings, regardless of their background, experiences or perceptions of the interventions being
evaluated. No major decision about the conduct of the project was undertaken without first consulting
with, and taking into account the views of, the Advisory Group. All decisions were nonetheless taken by
the project team.
To further engage with the diversity of opinions about early intensive ABA-based interventions in
autism, we also conducted a wider consultation on the draft project report during the period that it
was under funder peer review. This consultation process included interested groups or individuals who
contacted the research team during the course of the project, as well as other groups identified by
the project team as likely to have an interest in the project findings. To ensure transparency, the full
responses of all consultees are included in Appendix 20.
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Limitations
Despite our best efforts, we were not able to obtain data from five of the identified studies, representing
18% of participants with published outcomes. For two of these studies, data had been lost and therefore
were no longer available82,87 (36 participants). Two authors declined to participate: one declined early in
the project105,108 (61 participants) without further explanation, and another declined after several months
of participation88 (94 participants), as they wanted to await full publication of their study. The final
study83,107,112 (48 participants) deposited data in the US NDAR, to which we gained access. However,
IPD for the participants of interest could not be separated from a much larger data set (and the study
investigators felt unable to share which individuals in the larger data set were the study participants).
In addition to these studies, we were not able to obtain IPD on the Rogers et al.102 trial, which was
published during the writing of this report. However, details of this study based on the publicly available
information are included in Appendix 12.
The limitations of the economic analysis largely reflect the limitations of available research evidence.
Robust evidence was lacking for several of the key model parameters. In particular, there was limited
evidence to link outcomes reported in the effectiveness studies with adult outcomes and we had to
rely on data from a single US cohort,134 which may not reflect outcomes in a typical UK setting. This is
important in the context of interpreting scenario analyses, which illustrated the potential significance
of adult outcomes on the cost-effectiveness of early intensive ABA-based interventions. Lack of robust
data on the costs of standard care in the UK was also a significant barrier, and, although estimates were
generated from data kindly provided by a number of local authorities, it is not clear how representative
these are of wider current practice across the UK.
Further to the above, the systematic review and cost-effectiveness are somewhat limited by their focus
on early intensive ABA-based interventions, as opposed to other models of ABA-based intervention
aimed at primary aged children or other groups of children. This focus reflected the scope of the
National Institute for Health Research (NIHR) commissioning call, but does mean that some evidence
on the effectiveness of less individually intensive ABA-based interventions were excluded from the review
(e.g. data from studies that focused exclusively on group-based interventions or data in a school setting).
The latter may be of particular relevance to decision-makers in the UK owing to the fact that children in
the UK start school at a younger age than in many other countries and therefore opportunities to deliver
interventions in preschool settings are likely to be more limited.
Limitations and uncertainties in the identified evidence
Many of the limitations of this study reflected the limitations of the primary studies identified in the
systematic review and included in the IPD meta-analysis. These are discussed in turn below.
Study quality
As discussed above, most studies were rated as being at risk of bias on one or more domains of the
Cochrane Risk of Bias or ROBINS-I tools.58 In particular, most studies were not randomised, with
intervention assignment often based on parental preference. Studies rarely conducted blinded outcome
assessments, and other steps that safeguard against bias, such as prospective registration and/or
publication of study protocols, were also not undertaken (many studies pre-date the era when
registration became established practice); we requested but did not receive any protocols for the
studies providing IPD. The potential impact of these weaknesses in study design is difficult to ascertain,
but they are particularly concerning given the results of a recently published randomised trial replicating
the ESDM evaluation by Dawson et al.83 This study is notable as the trial design and conduct addresses
some (but not all) of the concerns about risk of bias in earlier studies.102 The results of this trial are less
favourable towards the early intensive ABA-based intervention, reporting only nominal statistically
non-significant effects on measures of cognitive ability and adaptive behaviour. As a result, even within
the narrow context of cognitive ability and adaptive behaviour, we cannot be certain of the comparative
effectiveness of early intensive ABA-based interventions. Nor can we rule out the possibility that the
observed effects could be either partly or entirely attributable to bias in the effectiveness studies.
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Importantly, concerns about the validity of the results from the identified studies carry through to the
economic modelling, which is based on the results of the IPD meta-analysis. The results of both the
IPD meta-analysis and the economic model should therefore be interpreted in the context of these
limitations in the effectiveness evidence, noting the potential that the observed intervention effects
may partially or completely reflect weaknesses in methodology.
Outcomes measured
Despite our considerable efforts and success in obtaining full IPD from the majority of the studies,
data on only a small number of outcomes were collected consistently across the primary studies
(most commonly verbal and non-verbal IQ, adaptive behaviour, as measured using parent-rated VABS,
and language development). Other outcome domains, such as autism symptom severity, presence
of co-occurring conditions, including behaviours that challenge, and education placement, were
infrequently collected. Early studies focused on IQ, whereas later studies more commonly measured
language development and adaptive behaviour measures, such as VABS. Other outcomes, such as
early communication, social interaction and emerging play skills, were not prioritised in the included
comparative studies. Furthermore, the vast majority of the participant, family, treatment and data
handling variables listed in the SCABARD data dictionary were not collected in the identified studies
or were otherwise missing from the available IPD. The absence of IPD on key variables severely
curtailed our ability to conduct our proposed analyses of potential moderators of effect.
The narrow focus on a limited number of outcome domains also had significant implications for the
economic analysis and forced us to adopt a model structure based only on changes in cognitive ability
and adaptive behaviour scores. Although links were created between these scores to both HRQoL
and costs, it is plausible that other individual participant domains, such as autism symptom severity,
co-occurring conditions, behaviours that challenge and language comprehension, are equally or more
important drivers of both (health-related) quality of life and costs. The relative importance of these
aspects of functioning together with the need for information about other relevant family and contextual
factors were emphasised by the members of the Advisory Group. The lack of information on such domains
means that their impact cannot be captured within the economic analysis. To the extent that early
intensive ABA-based interventions may have an impact on these domains of function, the economic
model may under- or overestimate benefits.
Limitations of outcome measurement tools
The tools utilised to measure each outcome domain varied, both across studies and within studies.
This was often, but not always, because certain measures were appropriate only for certain developmental
ages. When appropriate, we combined data measured using different tools but measuring the same
underlying outcome domain in the meta-analyses. However, such decisions are not necessarily
straightforward [e.g. Wechsler scales, S–B and British Ability Scales provide a cognitive ability quotient
expected theoretically to stay stable over time; the MSEL and Psychoeducational Profile – Revised
(PEP-R) tools list a number of competencies that accrue with age; and the BSID are structured as an ‘IQ’
measure but are used in very young children]. Furthermore, although the SCABARD data dictionary
allowed study authors to provide outcome values in the form in which they were available, without
restriction, most investigators provided derived scores at domain and subdomain levels, rather than
raw scores. Both raw and domain scores have limitations when applied to the longitudinal evaluation
of interventions for young autistic children. Raw scores can be problematic when age is differently
distributed between the groups being compared or when comparing outcomes collected at different
time points. Conversely, although standard scores allow comparisons against peers in the general
population, some included studies reported difficulties in obtaining standard scores (including floor
and ceiling effects) for certain outcomes. Although the provision of IPD facilitated the harmonisation
and synthesis of scores across some of these studies, this was not always possible or appropriate.
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Duration of follow-up
It has been suggested in the literature that the aim of early intensive ABA-based intervention is not
specifically to effect change over these short time horizons, but instead to build core skills that can allow
children to continue to progress and achieve more developmentally appropriate trajectories.26,151,152
Evidence investigating longer-term outcomes are, however, notably missing, with most of the studies
identified in the systematic review and IPD meta-analysis measuring only outcomes from intake to the
end of the initial early intervention treatment period (mostly between 1 and 2 years). Furthermore, the
only study with longer-term follow-up showed no clear evidence of initial comparative benefits persisting.
This is of particular concern when reflecting on the results of economic analysis, as the persistence of
short-term benefits is central to establishing whether or not investment in early intensive ABA-based
interventions is likely to represent value for money.
Weakness in the epidemiological and observation literature further compounds the problems of establishing
long-term effects of early intervention. Although a number of studies have sought to characterise patterns
of change in important clinical characteristics over time, the considerable heterogeneity in longer-term
outcomes for autistic individuals means that uncertainties remain, perhaps most particularly for young
children with significant impairment.17 There remains limited understanding of prognostic factors and how
changes in clinical outcomes in early childhood impact on long-term trajectories.17 Importantly, the evidence
from the epidemiological and observational literature has not been able to establish links between proximal
behavioural measures and the types of long-term outcomes that might be valued by autistic adolescents
and adults, such as well-being, quality of life, autonomy, independence, relationships and employment.17
This severely limits any assessment of how early interventions might impact on individuals beyond their
childhood and prevents a robust characterisation of long-term effects.
Relevance of studies to current UK practice
The available data were collected over a relatively long time period (children were recruited from
1968 to 2011), during which the understanding and management of autism evolved significantly and
estimates of diagnosed autism and related conditions increased significantly.2,153 For example, in the
later studies, more naturalistic components were incorporated into the delivery of early intensive
ABA-based interventions and the aversive contingencies used in the original UCLA EIBI approach had
long since been abandoned. Comparator treatments also evolved during this period, with the emergence
of psychoeducational support for families with young autistic children, psychosocial interventions focusing
on the core social communication symptoms and a range of autism-specific educational interventions in
addition to the generic special needs care provision.
There are also uncertainties about the generalisability of the overall results to the current UK context,
as most of the available evidence to date is from other countries. Although the included study populations
are likely to be similar to young children diagnosed with autism in the early preschool period in the UK,
additional child-related factors or parental attitudes, particularly those relating to education provision,
may differ. Similarly, differences in the models of delivery of early intensive ABA-based interventions and
what constitutes eclectic intervention or TAU in a UK setting may well be important contextual factors.
For example, our Advisory Group suggested that UK ABA-based services are likely to focus on ‘problem-
solving’ of day-to-day challenges, rather than necessarily addressing core autism symptoms. This approach
aligns more with the subset of early intensive ABA-based interventions studies included in the systematic
review, which are informed by naturalistic approaches. However, the interventions included in the
research studies – unlike UK community provision – were often resourced by an expert university
clinic and/or the originators of the intervention were available to train and supervise the staff delivering
the interventions.
Interventions and comparators assessed
The broad scope of this review, which included any form of early intensive ABA-based intervention,
also exposes other uncertainties. The studies included in the IPD meta-analysis assessed a heterogeneous
set of interventions that varied in terms of setting, intensity and duration. Indeed, when we asked the
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authors and UK practitioners to define early intensive ABA-based interventions, we received a range of
different responses, which perhaps indicates that the term is now used to cover a variety of interventions
based on the original underpinning psychological behavioural principles. It has also become clear that
there are other differences, with some studies evaluating early intensive ABA-based intervention services
that include highly structured hierarchies of oversight from senior practitioners and therapists, whereas
in other studies much less detail is provided about the training, maintenance of fidelity and delivery of
the intervention. However, whether or not these differences between interventions are important is
largely unknown.
The NMA and meta-regression analysis undertaken in this study do not provide any evidence that one
form or intensity is superior to another. These analyses are, however, constrained by the very small
sample sizes and other differences between the studies. This means that there remain important
questions, not only about whether or not early intensive ABA-based interventions are more effective
than more generic interventions (such as those included in the TAU/eclectic arms of the identified
studies), but also about which components of early intensive ABA-based interventions may potentially
drive effects. Furthermore, we do not know if other individual participant characteristics, family or
other contextual factors (such as the impact of any co-interventions) may be relevant as potential
moderators of effect. All this information is important when considering cost-effectiveness, as some of
these factors have significant implications for costs, particularly intensity and staffing ratios, as well as
how to target children and families most likely to respond and, perhaps most importantly, what might
be the optimal duration of the interventions.
Evidence on adverse effects
Almost no data were collected in the identified studies on possible adverse effects of intervention
and comparator therapies, with none of the included studies systematically collecting data on adverse
effects. This is potentially an important omission, as some members of the autism community have
raised concerns about the possible long-term mental health consequences of early intensive ABA-based
interventions. However, in the absence of any systematically collected data, the nature and extent of any
potential risks, adverse effects or harms of early intensive ABA-based intervention in the short, medium
or longer term cannot currently be determined.
DISCUSSION
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Chapter 10 Conclusions
Implications for service provision
The existing evidence cannot provide service providers with clear guidance on the value of implementing
early intensive ABA-based interventions alongside, or in place of, current practice. Although the IPD
meta-analyses have shown small to moderate improvements in child cognitive ability and adaptive
behaviour for early intensive ABA-based interventions relative to TAU or eclectic interventions, all of
the identified studies were at risk of bias, limiting the conclusions that can be drawn from these results.
Furthermore, individual study results varied considerably, with some showing no relative benefit of
early intensive ABA-based interventions compared with TAU or eclectic interventions. Crucially, there
is also a paucity of reliable longer-term follow-up data from children who have received early intensive
ABA-based interventions. There is no clear evidence on whether or not any comparative benefits of
intervention are retained through childhood, if interventions alter the course of a child’s education,
or if it has any impact in adulthood. Using the limited data available, none of the tested individual
participant characteristics moderated the size of the intervention effect, meaning that there is no
strong evidence to identify subgroups of children who might benefit more or less from early intensive
ABA-based interventions.
Concerns about potential bias, together with the other limitations in the available evidence, mean
that the cost-effectiveness of early intensive ABA-based interventions cannot be estimated reliably.
The restricted range of outcomes addressed in existing research studies required that the economic
model focus on cognitive ability and adaptive behaviour scores, which is of particular concern and
may mean that the results of the economic analysis do not fully reflect the impact of early intensive
ABA-based interventions on outcomes and costs. Taken at face value, however, the results of the main
economic analysis indicate that early intensive ABA-based interventions are unlikely to represent value
for money, based on thresholds typically adopted by NICE. In interpreting the findings of this study,
service providers and funders should consider whether or not their priorities align with the outcomes
used in the economic analysis; whether or not the interventions and comparators described in the
economic analysis match with the intervention options that are available; and whether or not early
intensive ABA-based therapy represents good value for money, given the likely extra costs associated
with its implementation.
Sensitivity and scenario analyses identified a number of drivers of value and highlighted the need for
early intensive ABA-based interventions that produce lasting benefits, as estimates of incremental cost-
effectiveness were very high across a range of scenarios when only short-term benefits were assumed.
Further implications of this research are constrained by the lack of high-quality evidence to support
the clinical effectiveness and cost-effectiveness of early intensive ABA-based interventions. Service
providers, families with young autistic children, the autism community and those funding the provision
of services need access to better evidence to inform decision-making. New high-quality research
studies comparing early intensive ABA-based interventions with other early interventions are needed
to establish which interventions achieve good outcomes for young autistic children in the short,
medium and longer term.
Suggested research priorities
As discussed above, no strong conclusions should be drawn from the results of the existing evidence
owing to considerable uncertainty in estimates of effects and high risk of bias.
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Researchers may therefore wish to consider further evaluations of early intensive ABA-based interventions
compared with TAU or eclectic approaches; however, whether or not this is an appropriate next step
should be carefully considered, given both the findings from the recent Rogers et al.102 RCT and the range
of alternative preschool autism interventions that fall outside the scope of this review. The relative
effectiveness of the various different behavioural and developmental–social–pragmatic interventions
both to each other and to early intensive ABA-based interventions is not clear. However, implementation
of many of these other interventions requires substantially less resource and, as a result, may represent
better value.154–156 Future research might therefore more productively focus on which interventions
have the best evidence of effectiveness and which are worthy of further investigation. Before conducting
any new comparative primary studies, a high-quality systematic review might be able to identify the most
promising candidate interventions.
Future research should also consider whether or not the focus of the existing literature on questions
about comparative effectiveness of early ABA-based therapy and TAU or eclectic approaches is helpful.
The existing literature is heavily focused on whether early intensive ABA-based therapy is more
effective than TAU or eclectic approaches; however, the heterogeneous nature of both populations,
interventions and methods used in previous studies makes the interpretation of such evidence difficult,
as the generalisability of results from such studies is often not clear. Alternative approaches may therefore
be warranted. For example, both early intensive ABA-based interventions and eclectic interventions have
multiple components, yet there is no clear evaluative evidence on which components are important.
An approach such as that discussed in Green et al.,157 whereby greater focus is placed on mechanisms
of action and components of interventions rather than just on whether or not a treatment worked, may
therefore be appropriate and could help provide insights that aid the development of new and better
optimised interventions.
Should future studies evaluating the effects of early intensive ABA-based interventions relative to TAU
and eclectic approaches be required, these would need to address the methodological limitations of
the existing evidence. Such a study would preferably include a RCT design with prespecified agreed
outcome measures collected by trained researchers blind to intervention received, and data collected on
both fidelity to treatment received (in both arms) and withdrawals. As well as being methodologically
rigorous, any future trial should adhere to the standards of governance laid out in the NIHR’s Clinical
Trials Toolkit [URL: www.ct-toolkit.ac.uk/ (accessed 30 January 2020)].
Any future evaluation of early intensive ABA-based interventions should also take into account the
UK context. The UK does not have a long history of using early intensive ABA-based interventions and,
therefore, any planned effectiveness trial would need to be designed to evaluate a contemporary,
fully specified and appropriately tailored version of early intensive ABA-based intervention suitable
for delivery in the UK. This could mean, for example, a home- or an education-based format. Similarly,
comparator interventions should reflect current best practice. It should be noted that consensus on
current or usual practice may be difficult to establish, considering that current provision varies
considerably across the country.
In designing any evaluations in early autism, careful consideration should be given to both measures
of the baseline characteristics of children and their families and to the outcomes collected to ensure
that the measures are relevant to children, families and decision-makers. Current studies have focused
primarily on cognitive ability and adaptive behaviour, and, although future studies may also want to
collect further evidence in relation to these outcomes, it is clear from our consultations with the
autism community, experts, researchers and practitioners that these measures are limited in terms
of both their ability to reflect benefits and their relevance to practice. This issue reflects a wider
problem of measurement of progress and outcomes in young autistic children and is not limited to the
evaluation of early intensive ABA-based interventions. Groups such as the Core Outcome Measures
in Effectiveness Trials (COMET) initiative have sought to promote the development of core outcome
sets that represent the minimum that should be measured and reported in all clinical trials of a specific
CONCLUSIONS
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condition. The development of such a core outcome set would be hugely beneficial in the context of
autism research and we note that work has been done in studies, such as the Measurement in Autism
Spectrum disorder Under Review (MeASURe),119 to develop such a set of core outcomes, although no
agreed set of core outcomes exists presently.
The length of follow-up of any future studies of early intervention in autism also needs to be considered
carefully, as there is substantial uncertainty regarding the durability of early benefits. Ideally, the longest
possible follow-up in any future studies of effectiveness is desirable, but there are both financial and
pragmatic constraints that prevent studies from collecting very long follow-up information. Other
types of research may therefore need to be employed to address these uncertainties. This may include
planned follow-ups of children recruited to existing effectiveness studies, or retrospective case–control-
type analyses looking at any early intervention received. Work on prognostic factors and potential
mediators and moderators of effect may also be of benefit. Such studies also need to carefully consider
outcomes, as the literature focusing on autistic adolescents and adults has primarily adopted the use
of social normative valuations of independence and social outcomes to characterise what constitutes a
‘good outcome’. However, such an approach has significant limitations, not only because quality of life
does not necessarily correlate well with such characterisation, but also because it does not include
any consideration of how best to define a nuanced approach to help us understand what constitutes
successful achievements for different individuals across the autism spectrum. This is particularly true for
people with intellectual impairment and/or a limited capacity to express their own needs and ambitions.
Future studies of any interventions in autistic children should include assessment of potential adverse
effects or harms. Studies should record and document evidence of possible adverse effects. Consideration
of harms in the context of future effectiveness studies alone, however, may be insufficient owing to the
long time frames over which they may become apparent. Alternative designs may be more appropriate,
such as case–control studies looking at rates of mental health issues in autistic children who have
received early interventions.
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Emma Jenner Parent n/a
Helen McConachie Academic advisory (autism research) Newcastle University
Anne McLaren Parent n/a
Dean McMillan Clinical academic University of York
Damian Milton Representative with ASD/NAS representative NAS
Roo Philip ABA practitioner Tailor Ed Foundation
Tristram Smith Clinical academic and expert in ABA therapy University of Rochester Medical Center
Peter Szatmari Academic advisory (autism research) McMaster University
Emma Truelove Education psychologist York City Council
Colin Wilson Representative with ASD n/a
Anne-Marie Wood Parent n/a
Suzy Yardley ABA practitioner Child Autism UK
n/a, not applicable.
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Appendix 2 Clinical effectiveness
search strategies
Early intensive applied behaviour analysis-based interventions
effectiveness literature searching
Searched August 2017.
Databases searched: CENTRAL, CINAHL, Conference Papers Citation Index, EMBASE, Education
Resources Information Center, Electronic Theses Online Service (EthOS) (British Library Dissertations
database), MEDLINE, PsycINFO, Social Sciences Citation Index.
Trials registers searched: ClinicalTrials.gov and World Health Organization International Clinical Trials
Registry Platform.
A total of 10,843 records identified. After importing into EndNote bibliographic software and
deduplicating, there were a total of 6698 records.
Cochrane Central Register of Controlled Trials via Wiley’s The Cochrane Library
Search date: 3 August 2017.
Date range searched: inception to 3 August 2017.
Records retrieved: 193.
Search name: ABA autism.
Last saved: 3 August 2017.
Search strategy
#1 MeSH descriptor: [Autistic Disorder] explode all trees
#2 MeSH descriptor: [Autism Spectrum Disorder] explode all trees
#3 MeSH descriptor: [Asperger Syndrome] explode all trees
#4 autism or autistic or ASD or ASDs or ASC or AAC:ti,ab,kw (Word variations have been searched)
#5 asperger*:ti,ab,kw (Word variations have been searched)
#6 #1 or #2 or #3 or #4 or #5
#7 MeSH descriptor: [Applied Behavior Analysis] explode all trees
#8 MeSH descriptor: [Early Intervention (Education)] explode all trees
#9 MeSH descriptor: [Behavior Therapy] explode all trees
#10 “early intervention therapy”:ti,ab,kw or :early intervention therapies”:ti,ab,kw (Word variations
have been searched)
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#11 intensive* near/2 (analys* or behavior* or behaviour* or intervention* or program* or therap* or
treat*):ti,ab,kw or intensity near/2 (analys* or behavior* or behaviour* or intervention* or program* or
therap* or treat*):ti,ab,kw or high-intensity near/2 (analys* or behavior* or behaviour* or intervention*
or model* or program* or therap* or treat*):ti,ab,kw or low-intensity near/2 (analys* or behavior* or
behaviour* or intervention* or model* or program* or therap* or treat*):ti,ab,kw (Word variations have
been searched)
#12 “high intensity” near/2 (analys* or behavior* or behaviour* or intervention* or model* or
program* or therap* or treat*):ti,ab,kw or “low intensity” near/2 (analys* or behavior* or behaviour* or
intervention* or model* or program* or therap* or treat*):ti,ab,kw or “intensive behavior*” near/2 (analys* or
intervention* or model* or program* or therap* or treat*):ti,ab,kw or “intensive behaviour*” near/2 (analys*
or intervention* or model* or program* or therap* or treat*):ti,ab,kw (Word variations have been searched)
#13 “early behavior*” near/2 (analys* or intervention* or model* or program* or therap* or treat*):ti,
ab,kw or “early behaviour*” near/2 (analys* or intervention* or model* or program* or therap* or
treat*):ti,ab,kw or “comprehensive behavior*” near/2 (analys* or intervention* or model* or program* or
therap* or treat*):ti,ab,kw or “comprehensive behaviour*” near/2 (analys* or intervention* or model* or
program* or therap* or treat*):ti,ab,kw (Word variations have been searched)
#14 “applied behavior*” near/2 (analy* or intervention* or model* or program* or therap* or treat*):ti,
ab,kw or “applied behaviour*” near/2 (analy* or intervention* or model* or program* or therap* or
treat*):ti,ab,kw or ABA* near/2 (analy* or intervention* or model* or program* or therap* or treat*):ti,
ab,kw (Word variations have been searched)
#15 NDBI*:ti,ab,kw or “Naturalistic Developmental Behav* Intervention*”:ti,ab,kw or IBI or EIBI or
ABA:ti,ab,kw or Lovaas*:ti,ab,kw (Word variations have been searched)
#16 “Early Start Denver Model”:ti,ab,kw or “Denver Model”:ti,ab,kw or ESDM or ESDM-I or ESDM-PD
or P-ESDM:ti,ab,kw (Word variations have been searched)
#17 “Pivotal Response” near/2 (treat* or train* or program*):ti,ab,kw or “PRT train*” or “PRT
program*” or “PRT model*”:ti,ab,kw or “discrete trial train*”:ti,ab,kw (Word variations have been
searched)
#18 #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17
#19 #6 and #18
Cumulative Index to Nursing and Allied Health Literature via EBSCOhost
Search date: 8 August 2017.
Date range searched: inception to 8 August 2017.
Records retrieved: 1530.
Search strategy
Search
term Search option Result
S1 (MH “Autistic Disorder”) 16,208
S2 (MH “Asperger Syndrome”) 1328
S3 TX (autism or autistic or ASD or ASDs or ASC or AAC) OR asperger* 25,580
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Search
term Search option Result
S4 S1 OR S2 OR S3 25,580
S5 (MH “Applied Behavior Analysis”) 3
S6 (MH “Early Childhood Intervention”) OR (MH “Early Intervention”) 13,508
S7 (MH “Behavior Therapy”) 8718
S8 TX “early intervention therap*” 19
S9 TX intensive* N2 (analys* or behavior* or behaviour* or intervention* or program* or therap* or
treat*)
8836
S10 TX intensity N2 (analys* or behavior* or behaviour* or intervention* or program* or therap* or
treat*)
4820
S11 TX high-intensity N2 (analys* or behavior* or behaviour* or intervention* or model* or program*
or therap* or treat*)
544
S12 TX low-intensity N2 (analys* or behavior* or behaviour* or intervention* or model* or program*
or therap* or treat*)
535
S13 TX “high intensity” N2 (analys* or behavior* or behaviour* or intervention* or model* or
program* or therap* or treat*)
544
S14 TX “low intensity” N2 (analys* or behavior* or behaviour* or intervention* or model* or
program* or therap* or treat*)
534
S15 TX “intensive behavior*” N2 (analys* or intervention* or model* or program* or therap* or
treat*)
173
S16 TX “intensive behaviour*” N2 (analys* or intervention* or model* or program* or therap* or
treat*)
24
S17 TX “early behavior*” N2 (analys* or intervention* or model* or program* or therap* or treat*) 18
S18 TX “early behaviour*” N2 (analys* or intervention* or model* or program* or therap* or treat*) 4
S19 TX “comprehensive behavior*” N2 (analys* or intervention* or model* or program* or therap* or
treat*)
41
S20 TX “comprehensive behaviour*” N2 (analys* or intervention* or model* or program* or therap*
or treat*)
5
S21 TX “applied behavior*” N2 (analy* or intervention* or model* or program* or therap* or treat*) 238
S22 TX “applied behaviour*” N2 (analy* or intervention* or model* or program* or therap* or treat*) 36
S23 TX ABA* N2 (analys* or intervention* or model* or program* or therap* or treat*) 750
S24 TX NDBI* OR TX “Naturalistic Developmental Behav* Intervention* “ OR TX (IBI or EIBI or
ABA) OR TX Lovaas* OR TX “Early Start Denver Model” OR TX “Denver Model” OR TX (ESDM
or ESDM-I or ESDM-PD or P-ESDM)
1441
S25 TX (“Pivotal Response” N2 (treat* or train* or program*)) OR TX (“PRT train*” or “PRT program*”
or “PRT model*”) OR TX “discrete trial train*”
73
S26 S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR
S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25
37,370
S27 S4 AND S26 1530
Conference Papers Citation Index via Web of Science
Search date: 8 August 2017.
Date range searched: inception to 8 August 2017.
Records retrieved: 46.
DOI: 10.3310/hta24350 Health Technology Assessment 2020 Vol. 24 No. 35
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Rodgers et al. under the terms of a commissioning contract issued by the Secretary of State
for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
117
Search strategy
Set Results Search options
# 7 46 #6 AND #1
Indexes = CPCI-S Timespan = All years
# 6 11,151 #5 OR #4 OR #3 OR #2
Indexes = CPCI-S Timespan = All years
# 5 27 TOPIC: (Lovaas*) OR TOPIC: (“Early Start Denver Model”) OR TOPIC: (“Denver Model”) OR TOPIC:
(ESDM or ESDM-I or ESDM-PD or P-ESDM) OR TOPIC: (“Pivotal Response” NEAR/2 (treat* or train*
or program*)) OR TOPIC: (“PRT train*” or “PRT program*” or “PRT model*”) OR TOPIC:(“discrete trial
train*”)
Indexes = CPCI-S Timespan = All years
# 4 3285 TOPIC: (“applied behavior*” NEAR/2 (analy* or intervention* or model* or program* or therap* or
treat*)) OR TOPIC: (“applied behaviour*” NEAR/2 (analy* or intervention* or model* or program* or
therap* or treat*)) OR TOPIC: (ABA* NEAR/2 (analys* or intervention* or model* or program* or
therap* or treat*)) OR TOPIC: (NDBI) OR TOPIC: (“Naturalistic Developmental Behav* Intervention*”)
OR TOPIC: (IBI or EIBI or ABA)
Indexes = CPCI-S Timespan = All years
# 3 29 TOPIC: (“intensive behavior*” NEAR/2 (analys* or intervention* or model* or program* or therap* or
treat*)) OR TOPIC: (“intensive behaviour*” NEAR/2 (analys* or intervention* or model* or program*
or therap* or treat*)) OR TOPIC: (“early behavior*” NEAR/2 (analys* or intervention* or model* or
program* or therap* or treat*)) OR TOPIC: (“early behaviour*” NEAR/2 (analys* or intervention* or
model* or program* or therap* or treat*)) OR TOPIC: (“comprehensive behavior*” NEAR/2 (analys*
or intervention* or model* or program* or therap* or treat*)) OR TOPIC: (“comprehensive behaviour*”
NEAR/2 (analys* or intervention* or model* or program* or therap* or treat*))
Indexes = CPCI-S Timespan = All years
# 2 7833 TOPIC: (“early intervention therap*”) OR TOPIC: (intensive* NEAR/2 (analys* or behavior* or
behaviour* or intervention* or program* or therap* or treat*)) OR TOPIC: (intensity NEAR/2 (analys*
or behavior* or behaviour* or intervention* or program* or therap* or treat*)) OR TOPIC: (high-
intensity NEAR/2 (analys* or behavior* or behaviour* or intervention* or model* or program* or
therap* or treat*)) OR TOPIC: (low-intensity NEAR/2 (analys* or behavior* or behaviour* or
intervention* or model* or program* or therap* or treat*)) OR TOPIC: (“high intensity” NEAR/2
(analys* or behavior* or behaviour* or intervention* or model* or program* or therap* or treat*)) OR
TOPIC: (“low intensity” NEAR/2 (analys* or behavior* or behaviour* or intervention* or model* or
program* or therap* or treat*))
Indexes = CPCI-S Timespan = All years
# 1 7148 TOPIC: (autism or autistic or ASD or ASDs or ASC or AAC) OR TOPIC: (asperger*)
Indexes = CPCI-S Timespan = All years
EMBASE via OVID
Search date: 3 August 2017.
Date range searched: inception to 3 August 2017.
Date range searched: 1974 to 2017 week 31.
Records retrieved: 2127.
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Search strategy
1. Autism/(47,419)
2. Asperger Syndrome/(4044)
3. (autism or autistic or ASD or ASDs or ASC or AAC).ti,ab. (68,497)
4. Asperger$.ti,ab. (2656)
5. 1 or 2 or 3 or 4 (79,183)
6. Behavior Modification/(7275)
7. Behavior Therapy/(41,005)
8. early intervention therap$.ti,ab. (78)
9. (intensive$ adj2 (analys$ or behavior$ or behaviour$ or intervention$ or program$ or therap$ or
treat$)).ti,ab. (36,345)
10. (intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or program$ or therap$ or
treat$)).ti,ab. (10,909)
11. (high-intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or model$ or program$
or therap$ or treat$)).ti,ab. (1466)
12. (low-intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or model$ or program$
or therap$ or treat$)).ti,ab. (1364)
13. (high intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or model$ or program$
or therap$ or treat$)).ti,ab. (1466)
14. (low intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or model$ or program$
or therap$ or treat$)).ti,ab. (1364)
15. (intensive behavior$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat
$)).ti,ab. (339)
16. (intensive behaviour$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat
$)).ti,ab. (66)
17. (early behavior$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,
ab. (58)
18. (early behaviour$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,
ab. (13)
19. (comprehensive behavior$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or
treat$)).ti,ab. (145)
20. (comprehensive behaviour$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or
treat$)).ti,ab. (21)
21. (applied behavior$ adj2 (analy$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,
ab. (391)
22. (applied behaviour$ adj2 (analy$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,
ab. (74)
23. (ABA$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,ab. (4837)
24. NDBI$.ti,ab. (13)
25. Naturalistic Developmental Behav$ Intervention$.ti,ab. (5)
26. (IBI or EIBI or ABA).ti,ab. (9873)
27. Lovaas$.ti,ab. (43)
28. (Early Start Denver Model or Denver Model).ti,ab. (54)
29. (ESDM or ESDM-I or ESDM-PD or P-ESDM).ti,ab. (65)
30. (Pivotal Response adj2 (treat$ or train$ or program$)).ti,ab. (58)
31. (PRT train$ or PRT program$ or PRT model$).ti,ab. (66)
32. discrete trial train$.ti,ab. (35)
33. 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or
23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 (107,960)
34. 5 and 33 (2173)
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Education Resources Information Center via EBSCOhost
Search date: 8 August 2017.
Date range searched: inception to 8 August 2017.
Records retrieved: 2070.
Search strategy
Search
term Search option Result
S1 (DE “Autism” or DE “Asperger Syndrome”) 11,905
S2 (DE “Pervasive Developmental Disorders”) 5920
S3 TX (autism or autistic or ASD or ASDs or ASC or AAC) OR asperger* 14,033
S4 S1 OR S2 OR S3 14,161
S5 (DE “Early Intervention”) 7149
S6 (DE “Behavior Modification”) 9498
S7 TX “early intervention therap*” 8
S8 TX intensive* N2 (analys* or behavior* or behaviour* or intervention* or program* or therap* or
treat*)
2510
S9 TX intensity N2 (analys* or behavior* or behaviour* or intervention* or program* or therap* or treat*) 404
S10 TX high-intensity N2 (analys* or behavior* or behaviour* or intervention* or model* or program*
or therap* or treat*)
39
S11 TX low-intensity N2 (analys* or behavior* or behaviour* or intervention* or model* or program*
or therap* or treat*)
31
S12 TX “high intensity” N2 (analys* or behavior* or behaviour* or intervention* or model* or
program* or therap* or treat*)
39
S13 TX “low intensity” N2 (analys* or behavior* or behaviour* or intervention* or model* or
program* or therap* or treat*)
31
S14 TX “intensive behavior*” N2 (analys* or intervention* or model* or program* or therap* or
treat*)
209
S15 TX “intensive behaviour*” N2 (analys* or intervention* or model* or program* or therap* or treat*) 9
S16 TX “early behavior*” N2 (analys* or intervention* or model* or program* or therap* or treat*) 19
S17 TX “early behaviour*” N2 (analys* or intervention* or model* or program* or therap* or treat*) 3
S18 TX “comprehensive behavior*” N2 (analys* or intervention* or model* or program* or therap*
or treat*)
27
S19 TX “comprehensive behaviour*” N2 (analys* or intervention* or model* or program* or therap*
or treat*)
0
S20 TX “applied behavior*” N2 (analy* or intervention* or model* or program* or therap* or treat*) 2099
S21 TX “applied behaviour*” N2 (analy* or intervention* or model* or program* or therap* or treat*) 44
S22 TX ABA* N2 (analys* or intervention* or model* or program* or therap* or treat*) 251
S23 TX NDBI* OR TX “Naturalistic Developmental Behav* Intervention* “ OR TX (IBI or EIBI or
ABA) OR TX Lovaas* OR TX “Early Start Denver Model” OR TX “Denver Model” OR TX (ESDM
or ESDM-I or ESDM-PD or P-ESDM)
477
S24 TX (“Pivotal Response” N2 (treat* or train* or program*)) OR TX (“PRT train*” or “PRT program*”
or “PRT model*”) OR TX “discrete trial train*”
125
S25 S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR
S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24
20,716
S26 S4 AND S25 2070
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Electronic Theses Online Service (The British Library)
Search date: 2 August 2017.
Date range searched: inception to 2 August 2017.
URL: http://ethos.bl.uk/Home.do
Search strategy
1. Intensive behavioural analysis (5)
2. Applied behavioural analysis (10)
3. 1 and 2 (15)
MEDLINE via OVID
Search date: 3 August 2017.
Date range searched: inception to 3 August 2017.
Records retrieved: 1626 (after deduplication).
Search strategy
1. Autistic Disorder/ (18,816)
2. Autism Spectrum Disorder/ (2942)
3. Asperger Syndrome/ (1735)
4. (autism or autistic or ASD or ASDs or ASC or AAC).ti,ab. (52,030)
5. Asperger$.ti,ab. (1995)
6. 1 or 2 or 3 or 4 or 5 (55,402)
7. Applied Behavior Analysis/ (5)
8. “Early Intervention (Education)”/ (2461)
9. Behavior Therapy/ (26,715)
10. early intervention therap$.ti,ab. (40)
11. (intensive$ adj2 (analys$ or behavior$ or behaviour$ or intervention$ or program$ or therap$ or
treat$)).ti,ab. (26,198)
12. (intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or program$ or therap$ or
treat$)).ti,ab. (7977)
13. (high-intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or model$ or program$
or therap$ or treat$)).ti,ab. (1064)
14. (low-intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or model$ or program$
or therap$ or treat$)).ti,ab. (1102)
15. (high intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or model$ or program$
or therap$ or treat$)).ti,ab. (1064)
16. (low intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or model$ or program$
or therap$ or treat$)).ti,ab. (1102)
17. (intensive behavior$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat
$)).ti,ab. (244)
18. (intensive behaviour$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat
$)).ti,ab. (49)
19. (early behavior$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,ab. (39)
20. (early behaviour$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,ab. (13)
21. (comprehensive behavior$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or
treat$)).ti,ab. (119)
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22. (comprehensive behaviour$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or
treat$)).ti,ab. (14)
23. (applied behavior$ adj2 (analy$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,
ab. (452)
24. (applied behaviour$ adj2 (analy$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,
ab. (39)
25. (ABA$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,ab. (3478)
26. NDBI$.ti,ab. (12)
27. Naturalistic Developmental Behav$ Intervention$.ti,ab. (5)
28. (IBI or EIBI or ABA).ti,ab. (10137)
29. Lovaas$.ti,ab. (37)
30. (Early Start Denver Model or Denver Model).ti,ab. (33)
31. (ESDM or ESDM-I or ESDM-PD or P-ESDM).ti,ab. (31)
32. (Pivotal Response adj2 (treat$ or train$ or program$)).ti,ab. (45)
33. (PRT train$ or PRT program$ or PRT model$).ti,ab. (46)
34. discrete trial train$.ti,ab. (33)
35. 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23
or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 (75,387)
36. 6 and 35 (1717)
PsycINFO via OVID
Search date: 3 August 2017.
Date range searched: 1806 to July week 5 2017.
Records retrieved: 2248.
Search strategy
1. Autism Spectrum Disorder/ (35,797)
2. (autism or autistic or ASD or ASDs or ASC or AAC).ti,ab. (43,559)
3. Asperger$.ti,ab. (3376)
4. 1 or 2 or 3 (45,868)
5. Behavior Modification/ (10,208)
6. Behavior Therapy/ (13,232)
7. early intervention therap$.ti,ab. (18)
8. (intensive$ adj2 (analys$ or behavior$ or behaviour$ or intervention$ or program$ or therap$ or
treat$)).ti,ab. (5950)
9. (intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or program$ or therap$ or
treat$)).ti,ab. (1911)
10. (high-intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or model$ or program$
or therap$ or treat$)).ti,ab. (177)
11. (low-intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or model$ or program$
or therap$ or treat$)).ti,ab. (334)
12. (high intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or model$ or program$
or therap$ or treat$)).ti,ab. (177)
13. (low intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or model$ or program$
or therap$ or treat$)).ti,ab. (334)
14. (intensive behavior$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat
$)).ti,ab. (381)
15. (intensive behaviour$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat
$)).ti,ab. (64)
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16. (early behavior$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,
ab. (81)
17. (early behaviour$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,
ab. (13)
18. (comprehensive behavior$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or
treat$)).ti,ab. (140)
19. (comprehensive behaviour$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or
treat$)).ti,ab. (9)
20. (applied behavior$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,
ab. (1683)
21. (applied behaviour$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat
$)).ti,ab. (118)
22. (ABA$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,ab. (847)
23. NDBI$.ti,ab. (3)
24. Naturalistic Developmental Behav$ Intervention$.ti,ab. (4)
25. (IBI or EIBI or ABA).ti,ab. (1410)
26. Lovaas$.ti,ab. (123)
27. (Early Start Denver Model or Denver Model).ti,ab. (44)
28. (ESDM or ESDM-I or ESDM-PD or P-ESDM).ti,ab. (35)
29. (Pivotal Response adj2 (treat$ or train$ or program$)).ti,ab. (127)
30. (PRT train$ or PRT program$ or PRT model$).ti,ab. (17)
31. discrete trial train$.ti,ab. (97)
32. 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or
22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 (33,512)
33. 34 and 32 (2248)
Social Science Citation Index via Web of Science
Search date: 8 August 2017.
Date range searched: inception to 8 August 2017.
Records retrieved: 978.
Search strategy
Set Results Search options
# 7 978 #6 AND #1
Indexes = SSCI Timespan = All years
# 6 11,712 #5 OR #4 OR #3 OR #2
Indexes = SSCI Timespan = All years
# 5 250 TOPIC: (Lovaas*) OR TOPIC: (“Early Start Denver Model”) OR TOPIC: (“Denver Model”) OR TOPIC:
(ESDM or ESDM-I or ESDM-PD or P-ESDM) OR TOPIC: (“Pivotal Response” NEAR/2 (treat* or train*
or program*)) OR TOPIC: (“PRT train*” or “PRT program*” or “PRT model*”) OR TOPIC:(“discrete trial
train*”)
Indexes = SSCI Timespan = All years
# 4 2864 TOPIC: (“applied behavior*” NEAR/2 (analy* or intervention* or model* or program* or therap* or
treat*)) OR TOPIC: (“applied behaviour*” NEAR/2 (analy* or intervention* or model* or program* or
therap* or treat*)) OR TOPIC: (ABA* NEAR/2 (analys* or intervention* or model* or program* or
therap* or treat*)) OR TOPIC: (NDBI) OR TOPIC: (“Naturalistic Developmental Behav* Intervention*”)
OR TOPIC: (IBI or EIBI or ABA)
Indexes = SSCI Timespan = All years
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Set Results Search options
# 3 584 TOPIC: (“intensive behavior*” NEAR/2 (analys* or intervention* or model* or program* or therap* or
treat*)) OR TOPIC: (“intensive behaviour*” NEAR/2 (analys* or intervention* or model* or program*
or therap* or treat*)) OR TOPIC: (“early behavior*” NEAR/2 (analys* or intervention* or model* or
program* or therap* or treat*)) OR TOPIC: (“early behaviour*” NEAR/2 (analys* or intervention* or
model* or program* or therap* or treat*)) OR TOPIC: (“comprehensive behavior*” NEAR/2 (analys*
or intervention* or model* or program* or therap* or treat*)) OR TOPIC: (“comprehensive behaviour*”
NEAR/2 (analys* or intervention* or model* or program* or therap* or treat*))
Indexes = SSCI Timespan = All years
# 2 8714 TOPIC: (“early intervention therap*”) OR TOPIC: (intensive* NEAR/2 (analys* or behavior* or
behaviour* or intervention* or program* or therap* or treat*)) OR TOPIC: (intensity NEAR/2 (analys*
or behavior* or behaviour* or intervention* or program* or therap* or treat*)) OR TOPIC: (high-
intensity NEAR/2 (analys* or behavior* or behaviour* or intervention* or model* or program* or
therap* or treat*)) OR TOPIC: (low-intensity NEAR/2 (analys* or behavior* or behaviour* or
intervention* or model* or program* or therap* or treat*)) OR TOPIC: (“high intensity” NEAR/2
(analys* or behavior* or behaviour* or intervention* or model* or program* or therap* or treat*)) OR
TOPIC: (“low intensity” NEAR/2 (analys* or behavior* or behaviour* or intervention* or model* or
program* or therap* or treat*))
Indexes = SSCI Timespan = All years
# 1 36,199 TOPIC: (autism or autistic or ASD or ASDs or ASC or AAC) OR TOPIC: (asperger*)
Indexes = SSCI Timespan = All years
Searches of trials registers
ClinicalTrials.gov
Via: https://clinicaltrials.gov/ct2/home
Search date: 8 August 2017.
Date range searched: inception to 8 August 2017.
Ran a series of searches, downloaded records and deduplicated within EndNote bibliographic software.
Search strategy
Autism AND applied behavioural analysis = 20 records
Autism spectrum disorder AND applied behaviour analysis = 13 records
Autism AND ABA = 12 studies
Autism spectrum disorder AND ABA = 8 studies
Asperger syndrome AND applied behaviour analysis = 0
Asperger syndrome AND ABA = 0
Total of 53 records, deduplicated to 22 unique records.
World Health Organization International Clinical Trials Registry Platform
Via: http://apps.who.int/trialsearch/Default.aspx.
Search date: 8 August 2017.
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Date range searched: inception to 8 August 2017.
Ran a series of searches, downloaded records and deduplicated within EndNote bibliographic software.
Search strategy
Autism AND applied behavior analysis = 2 records
Autism AND applied behaviour analysis = 1 record
Autism AND ABA = 2 studies
Asperger AND applied behaviour analysis = 0
Asperger syndrome AND ABA = 0
Total of five records, deduplicated to three unique records.
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Appendix 3 Data coding dictionary
Sheet 1: participant and family characteristics and treatment details
If possible, please complete the ‘participant, family, treatment’ spreadsheet using the suggested coding
below (this coding can also be found in comments on the relevant variable names in the spreadsheet itself).
If you use an alternative coding format please provide details of the coding used.
Please provide information on all study participants, even if individuals were excluded from analysis.
Variable Variable name in data file Suggested coding
Participant
characteristic
Participant ID ChildID Any unique coding may be used
Date of randomisation or
allocation to treatment
DateRandom Date in dd/mm/yyyy format
Age at baseline AgeBaseline Numeric value (in months)
777 = not collected in trial
999 =missing for this participant
Sex Sex 1=male
2= female
777 = not collected in trial
999 =missing for this participant
Ethnicity Ethnicity 11=African-American
12=Afro-Caribbean
13=African or other black ethnicity
21= East Asian (e.g. Chinese/Japanese)
22= South Asian (e.g. Indian/Pakistani)
31=Hispanic or Latino
32=Hispanic black
33=Hispanic white
41=Middle Eastern or North African
51=Native American or First Nations
52= Pacific Islander
61=white European or North American
62= other Caucasian/white
81=mixed ethnicity (any)
82= other
777 = not collected in trial
999 =missing for this participant
DOI: 10.3310/hta24350 Health Technology Assessment 2020 Vol. 24 No. 35
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Rodgers et al. under the terms of a commissioning contract issued by the Secretary of State
for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
127
Variable Variable name in data file Suggested coding
Diagnosis of ASD ASDDiagnosis 1=ASD (DSM-5 or unspecified)
2=Autistic disorder/childhood autism
(DSM-IV/ICD-10)
3=Asperger’s disorder/Asperger’s
syndrome (DSM-IV/ICD-10)
4= PDD-NOS/atypical autism/other
pervasive developmental disorders
(DSM-IV/ICD-10)
777 = not collected in trial
999 =missing for this participant
Age (in months) at
‘first mention’ diagnosis
AgefirstDiag Numeric value (in months)
777 = not collected in trial
999 =missing for this participant
Age (in months) at final
confirmed diagnosis
AgeConfDiag Numeric value (in months)
777 = not collected in trial
999 =missing for this participant
Intellectual impairment
at baseline
ASDIntel 0= no
1= yes
777 = not collected in trial
999 =missing for this participant
Language impairment
at baseline
ASDLang 0= no
1= yes
777 = not collected in trial
999 =missing for this participant
Comorbidities at baseline Comorbid 1= anxiety disorders
2=mood disorders
3= attention deficit hyperactivity
disorder
4= obsessive compulsive disorder/tic
disorders (e.g. Tourette’s syndrome)
5= oppositional defiant disorder/
conduct disorder
6= psychosis
7= recognised genetic disorders,
including chromosomal disorders
8= seizures/epilepsy
9= sensory sensitivities
10= sleep disorders
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Variable Variable name in data file Suggested coding
11= gastrointestinal symptoms
(including feeding difficulties and
food selectivity)
12= other physical health problems
(asthma, diabetes, immune disorders, etc)
13= other (not mentioned above);
please specify
777 = not collected in trial
888 = none/participants with
comorbidities were excluded
999 =missing for this participant
Participant nursery/education
setting
ChildEdu 1=mainstream setting (without
specialist support)
2=mainstream setting with specialist
support
3= specialist setting
4= home educated
5= none
777 = not recorded in trial
999 =missing for this participant
Family
variable
Number of parents in
the household
ParN Numeric value
777 = not collected in trial
999 =missing for this participant
Number of siblings in
the household
SiblingN Numeric value
777 = not collected in trial
999 =missing for this participant
Parent conditions
(present for any parent)
ParCond 1=ASD/Asperger’s syndrome
2= intellectual disability
3= depression or anxiety disorder
4= other mental health condition
5= physical health condition
6= none
777 = not recorded in trial
999 =missing for this participant
Sibling conditions
(present for any sibling)
SiblingCond 1=ASD/Asperger’s syndrome
2= intellectual disability
3= other developmental disorder
4= depression or anxiety disorder
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Variable Variable name in data file Suggested coding
5= other mental health condition
6= physical health condition
7= none
777 = not recorded in trial
999 =missing for this participant
Parental education
(highest level for any
parent in the household)
ParEdu 1= high school/secondary school
2= post-secondary vocational or
professional education
3= Bachelor’s degree or equivalent
level
4=Master’s degree or equivalent level
5=Doctoral degree or equivalent level
777 = not recorded in trial
999 =missing for this participant
Parental employment ParWork 1= higher managerial, administrative
or professional
2= intermediate managerial,
administrative or professional
3= supervisory or clerical and junior
managerial, administrative or
professional
4= skilled manual occupations
5= semi-skilled and unskilled manual
occupations
6= casual or lowest grade occupations,
pensioners and others who depend on
the welfare state for their income
777 = not recorded in trial
999 =missing for this participant
Treatment
variable
Treatment arm assigned Arm 0= comparator
1=ABA-based arm 1
2=ABA-based arm 2 (if applicable)
3=ABA-based arm 3 (if applicable)
999 =missing for this participant
Did the child receive discrete
trial training techniques?
DTT 0= no
1= yes
777 = not done in trial
999 =missing for this participant
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Variable Variable name in data file Suggested coding
Did the child receive
incidental training
techniques?
IT 0= no
1= yes
777 = not done in trial
999 =missing for this participant
Did the child receive verbal
behaviour techniques?
VB 0= no
1= yes
777 = not done in trial
999 =missing for this participant
Did the child receive
PRT techniques?
PRT 0= no
1= yes
777 = not done in trial
999 =missing for this participant
Did the child receive CABAS
techniques?
CABAS 0= no
1= yes
777 = not done in trial
999 =missing for this participant
Did the child receive aversive
techniques?
Aversive 0= no
1= yes
777 = not done in trial
999 =missing for this participant
Number of interventionists
(paid, professional, parental
or volunteer) delivering the
treatment to the child
InterN Numeric value
777 = not collected in trial
999 =missing for this participant
Who delivered the
intervention?
InterDeliv 1= professional/specialist delivery alone
2= parental delivery alone
3= joint specialist/parental delivery
777 = not recorded in trial
999 =missing for this participant
Primary interventionist
qualifications/experience
(highest level for anyone
delivering the intervention)
InterQual 1= RBT or equivalent
2= BCaBA/relevant degree-level
training or equivalent
3= BCBA/relevant masters-level
training or equivalent
4=Doctoral-level BCBA-D/relevant
PhD or equivalent
777 = not recorded in trial
999 =missing for this participant
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Variable Variable name in data file Suggested coding
Were interventionist(s)
supervised?
Supervision 0= no
1= yes
777 = not collected in trial
999 =missing for this participant
Supervisor qualification SuperQual 1= RBT or equivalent
2= BCaBA/relevant degree-level
training or equivalent
3= BCBA/relevant masters-level
training or equivalent
4=Doctoral-level BCBA-D/relevant
PhD or equivalent
5= parental supervision
6= joint parental and professional
supervision
777 = not recorded in trial
999 =missing for this participant
Average weekly treatment
intensity (hours/week)
Intensity Numeric value (in hours/week)
777 = not collected in trial
999 =missing for this participant
Total number of hours of
treatment received (over the
entire treatment period)
TotalHours Numeric value (total hours of active
treatment)
777 = not collected in trial
999 =missing for this participant
Total number of hours of
treatment delivered by
interventionist(s) (over the
entire treatment period)
InterHours Numeric value (hours of active
treatment)
777 = not collected in trial
999 =missing for this participant
Total number of hours of
treatment delivered by
parent(s) (over the entire
treatment period)
ParentHours Numeric value (hours of active
treatment)
777 = not collected in trial
888 = not applicable (no patient
delivery)
999 =missing for this participant
Length of time over which
the intervention was
delivered to the child in the
study (total number of
weeks)
Duration Numeric value (total in weeks)
777 = not collected in trial
999 =missing for this participant
Treatment setting Setting 1= home exclusively
2= school exclusively
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Variable Variable name in data file Suggested coding
3= clinic or specialist setting
exclusively
4= clinic and home
5= school and home
6=multiple settings
777 = not recorded in trial
999 =missing for this participant
Were co-intervention(s)
received alongside
treatment?
CoIntYN 0= no
1= yes
777 = not collected in trial
999 =missing for this participant
Which co-interventions
were received?
CoIntDetail Free text (150 characters maximum)
For example, speech and language
therapy; respite
Discontinuation of study
treatment
DiscontinueTreat 0= no discontinuation
1= discontinued due to lack of efficacy
2= discontinued for reason other than
lack of efficacy
3= discontinued but reason not known
777 = not recorded in trial
999 =missing for this participant
Data handling Whether or not participant
was excluded from original
study analysis
Exclusion 0= not excluded
1= excluded
999 = unknown
Reason for exclusion ReasonExcluded Free text (50 characters maximum).
Please give brief description of reason
for exclusion (e.g. lost to follow-up)
888 = not applicable (participant was
not excluded)
BCaBA, board certified associate behaviour analyst; BCBA, board certified behaviour analyst; BCBA-D, board certified
behaviour analyst – doctoral; CABAS, Comprehensive Application of Behaviour Analysis to Schooling; dd/mm/yyyy,
date/month/year; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; DSM-5, Diagnostic and
Statistical Manual of Mental Disorders, fifth Edition; PhD, Doctor of Philosophy; RBT, registered behaviour technician;
VB, Verbal Behaviour.
Sheets 2 and 3: baseline and outcome data (with key to
collected outcomes)
Please describe the measures and types of scores that were used to collect baseline and follow-up data
in the ‘key to collected outcomes’ spreadsheet. Please then add the values for these outcomes in the
corresponding cells in the ‘baseline and outcome data’ sheet.
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An illustration for each of these is given below and in the Excel workbook.
Illustration A: study-level details
Illustration B: participant, family and treatment characteristics at baseline
Illustration C: key to collected outcome measures
Illustration D: outcome measure values at baseline and follow-up
Whenever possible for continuous data, please provide exact rather than categorical values
[e.g. ‘64’ rather than ‘≤70’ for WISC, Fourth Edition, full-scale IQ].
Please include the full name and version of each outcome measure that was used.
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Appendix 4 Screening criteria
Participants, interventions, comparisons, outcomes, study design
Participants
Studies that include children with a diagnosis of autistic disorder, Asperger syndrome, PDD-NOS,
atypical ASD or ASD.
Interventions
Intensive behavioural interventions based on ABA, defined as:
l > 15 hours per week
l comprehensive, targeting a range of behaviours not a single behaviour (e.g. joint attention)
l ABA-based teaching strategies by qualified and trained staff
l delivered at least initially on a one-to-one basis
l qualified supervision of the therapist delivering the intervention.
Studies that involve a degree of parental involvement will be included if the other criteria are satisfied.
Comparators
Relevant comparators will include all other forms of early intervention.
Outcomes
Inclusion will not be restricted by outcome.
Study designs
Prospective RCTs and non-RCTs meeting all other inclusion criteria will be eligible for inclusion.
Coding options
l Include: all criteria met.
l Reject x: clearly outside scope. Give numbered reason(s) (e.g. non-comprehensive
intervention = Reject 2B).
l Borderline (explain reason): unclear based on available information. May include studies in which
some but not all participants appear to meet inclusion criteria.
l Contact: contact authors for missing information.
l Review: systematic review.
l Cost: potentially relevant to cost-effectiveness.
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Appendix 5 Excluded studies
TABLE 29 Table of excluded studies with reasons
Study Reason for exclusion
Azarbehi AC. The effectiveness of early intervention programs for children
with autism: A one-year follow-up study of Intensive Behavioural
Intervention versus pre-school integration. Diss Abstr Int B Sci Eng 2012;73
Abstract only and could not contact
authors
Brian J. Evaluation of Social ABCs with Attention Training Intervention for
Toddlers with Suspected Autism (NCT03215394). Bethesda, MD:
ClinicalTrials.gov; 2017
Abstract only and could not contact
authors
Duifhuis EA, den Boer JC, Doornbos A, Buitelaar JK, Oosterling IJ, Klip H.
The effect of pivotal response treatment in children with autism spectrum
disorders: a non-randomized study with a blinded outcome measure.
J Autism Dev Disord 2017;47:231–42
Parent-focused intervention
Fava L, Strauss K, Valeri G, D’Elia L, Arima S, Vicari S. The effectiveness of
a cross-setting complementary staff- and parent-mediated early intensive
behavioral intervention for young children with ASD. Research Autism
Spectr Disord 2011;5:1479–92
Low-intensity intervention
Ghamari Kivi H, Nasoudi R. Efficacy of applied behavioral analysis
in reducing symptoms of stereotyped behavior, interaction and
communicational problems in autistic children. Iran J Psychiatry
2012;1:106–7
Abstract only and could not contact
authors
Goods KS, Ishijima E, Chang YC, Kasari C. Pre-school based JASPER
intervention in minimally verbal children with autism: pilot RCT. J Autism
Dev Disord 2013;43:1050–6
Intervention did not satisfy inclusion
criteria for comprehensiveness
Granpeesheh D, Kenzer A, Tarbox J. Comparison of Two-Year Outcomes
for Children with Autism Receiving High Versus Low-Intensity Behavioral
Intervention. European Psychiatry Conference: 19th European Congress of
Psychiatry, EPA, 2011
Abstract only and could not contact
authors
Hayati M, Pelleshahi SR, Farrokhi N. Effect of multi-dimensional training
program, using a combination method of TICH and ABA, on improve
autistic children’s behavior. Eur Psychiatry 2017;41:S440
Abstract only and could not contact
authors
Howard J, Sparkman C, Cohen H, Green G, Stanislaw H. Correction
concerning Howard et al. (2005). J Speech Lang Pathol Appl Behav Anal
2007;2:144–5
Non-comparative study
Martin CN, Winter JM, Kim SH, Lord C. Integrated naturalistic
developmental behavioral interventions for toddlers with autism: a pilot
study of treatment efficacy and program feasibility within a community
based setting. J Dev Behav Pediatr 2017;38:S10
Abstract only and could not contact
authors
Martsenkovsky I, Bikshaieva I, Vashenko O, Kazakova S. Efficacy of special
early behavioral intervention (SEBI) in toddlers with autism spectrum
disorders (ASD). Eur Child Adolesc Psychiatry 2011;20:S145
Abstract only and could not contact
authors
Mohammadzaheri F, Koegel LK, Rezaee M, Rafiee SM. A randomized
clinical trial comparison between pivotal response treatment (PRT) and
structured applied behavior analysis (ABA) intervention for children with
autism. J Autism Develop Disord 2014;44:2769–77
Low-intensity intervention
Molnar C, Eldevik S. [Behavioral intervention for pre-school children with
autism – outcome of parent-based intervention.] Zeitschrift fur Kinder-und
Jugendpsychiatrie und Psychotherapie 2017;45:181–91
Non-comparative study
Nasoudi Ghareh Bolagh R, Zahednezhad H, Ilkhchi SV. The effectiveness
of applied behavior analysis and treatment-education methods in children
with autism disorders. Iran J Psychiatry 2012;1:106
Abstract only and could not contact
authors
continued
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TABLE 29 Table of excluded studies with reasons (continued )
Study Reason for exclusion
Reed P, Osborne LA, Corness M. Effectiveness of special nursery provision
for children with autism spectrum disorders. Autism 2010;14:67–82
Low-intensity intervention
Reed P, Osborne LA, Makrygianni M, Waddington E, Etherington A,
Gainsborough J. Evaluation of the Barnet early autism Model (BEAM)
teaching intervention programme in a ‘real world’ setting. Res Autism Spec
Disord 2013;7:631–8
Low-intensity intervention
Rogers S. Intervention Effects of Intensity and Delivery Style for Toddlers with
Autism (NCT02272192). Bethesda, MD: ClinicalTrials.gov; 2014
Protocol only and could not contact
authors
Schoneberger T. Autism research controversy: a response to Howard et al.’s
(2005) defenders. J Speech Lang Pathol Appl Behav Anal 2007;2:242–50
Non-comparative study
Shade-Monuteaux DM. An innovative approach for children with autism
spectrum disorders: a preliminary outcome evaluation. Diss Abstr Int B Sci
Eng 2003;63:6107
Abstract only and could not contact
authors
Sheinkopf SJ, Siegel B. Home-based behavioral treatment of young
children with autism. J Autism Develop Disord 1998;28:15–23
Non-comparative study
Smith T. Randomized Study of Intensive One-on-One Behavioral Treatment for
Pre-School Aged Children with Autism (NCT00004449). Bethesda, MD:
ClinicalTrials.gov; 1999
Patient data already included
Soltanifar A, Hojati M, Mashhadi A, Reebye P. A Comparative Efficacy of
HOLISTIC Multidimensional Treatment Model (HMTM) and Applied Behavioral
Analysis (ABA) in the Treatment of Children with Autism Spectrum Disorder
(ASD). European Psychiatry Conference, 19th European Congress of
Psychiatry, EPA, 2011
Abstract only and could not contact
authors
Strauss K, Esposito M, Polidori G, Vicari S, Valeri G, Fava L. Facilitating
play, peer engagement and social functioning in a peer group of young
autistic children: comparing highly structured and more flexible behavioral
approaches. Res Autism Spect Disord 2014;8:413–23
Low-intensity intervention
Strauss K, Vicari S, Valeri G, D’Elia L, Arima S, Fava L. Parent inclusion in
early intensive behavioral intervention: the influence of parental stress,
parent treatment fidelity and parent-mediated generalization of behavior
targets on child outcomes. Res Dev Disabil 2012;33:688–703
Low-intensity intervention
Tang JC, Lee SH, Wang MC. The effects of pivotal response training on
communicative behavior of pre-schoolers with autism. Int J Psychol
2008;43:592
Non-comparative study
Wetherby AM, Guthrie W, Woods J, Schatschneider C, Holland RD,
Morgan L, Lord C. Parent-implemented social intervention for toddlers
with autism: an RCT. Pediatrics 2014;134:1084–93
Parent-focused intervention
Xu Y, Yao J, Yang J. Application of Early Start Denver Model for early
intervention on autistic children. Chin J Clin Psychol 2017;25:188–91
Low-intensity intervention
Young HE, Falco RA, Hanita M. Randomized, controlled trial of a
comprehensive program for young students with autism spectrum
disorder. J Autism Dev Disord 2016;46:544–60
Low-intensity intervention
Yuan Q, Wang RC, Wu ZF, Zhao Y, Bao XJ, Jin R. [Observation on clinical
therapeutic effect of Jin’s 3-needling therapy on severe autism.] Zhongguo
Zhenjiu 2009;29:177–80
Abstract only and could not contact
authors
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Appendix 6 Study characteristics tables
TABLE 30 Characteristics of included studies
General Intervention details Comparator details
First author (year)
Birnbrauer (1993)82
Sampling frame/population
Children who were 24–48 months of
age, met DSM-II criteria for pervasive
developmental disorder or PDD-NOS,
had attained intellectual and adaptive
behaviour functioning levels of less
than borderline and were free of
sensory or physical impairments that
would require special materials.
Referrals were received from
agencies concerned with autism and
developmental disabilities, child
health centres and medical
practitioners in the Perth
Metropolitan area
When were participants recruited?
NR
How was autism diagnosed?
Met the DSMIII-R criteria for
pervasive developmental disorder
autistic disorder and PDD-NOS
How were participants allocated to
intervention?
Non-randomised. Allocated on the
basis of location and when enrolled;
families who met the selection
criteria but lived too far away were
invited to join the control group
Intervention name
Murdoch Early Intervention Program
Is it based on a previous model?
Yes
If yes, which model is it based on?
Based on Lovaas 198726 model, but
differs in several aspects
Was the intervention manualised?
No
Who delivers the intervention?
Volunteer trainers with support from
programme co-ordinator and mother
Qualifications of the interventionist(s)
Recruited from university students.
On-the-job training
Length of interventionist(s) experience
None required
Number of people delivering the
intervention
24
Was the interventionist supervised?
Yes
Qualifications of the supervisor
Experience with delivering
behavioural techniques to children
with disabilities
Extent of parental involvement in
delivery
Supervisory role
Where was the intervention delivered?
Home based
Comparator 1 name
Not clearly described
Is the comparator ABA based?
No
Is it based on a previous model?
No
Which model(s) is it based on?
TAU
Who delivers the comparator?
NR
Qualifications of the interventionist
NR
Length of interventionist experience
n/a
Number of people delivering the
intervention
n/a
Extent of parental involvement in
delivery
n/a
Where was the comparator delivered?
n/a
What was the planned intensity of the
comparator?
n/a
What was the planned duration of the
comparator?
Approximately 24 months
Were any co-interventions given?
NR
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TABLE 30 Characteristics of included studies (continued )
General Intervention details Comparator details
What was the planned intensity of
intervention?
9–25 hours/week
What was the planned duration of
intervention?
Approximately 24 months
Were any co-interventions given?
NR
First author (year)
Cohen (2006)104
Sampling frame/population
Children with a diagnosis of autistic
disorder or PDD-NOS, with a pre-
treatment IQ > 35 on the BSIDR,
chronological age between 18
and 42 months at diagnosis and
< 48 months at treatment onset,
with no severe medical limitation or
illness that would preclude a child
from participating and residence
within 60 km of the treatment agency
When were participants recruited?
1995–2000
How was autism diagnosed?
Based on an evaluation by an
independent licensed psychologist
and confirmed by the ADI-R
How were participants allocated to
intervention?
Parental choice
Intervention name
EIBI
Is it based on a previous model?
Yes
If yes, which model is it based on?
Lovaas/UCLA 198726
Was the intervention manualised?
Yes
Who delivers the intervention?
Tutors were recruited from the
community and were the main
providers of direct services. Parents
also contributed
Qualifications of the interventionist(s)
NR
Length of interventionist(s) experience
NR
Number of people delivering the
intervention
NR
Was the interventionist supervised?
Yes
Qualifications of the supervisor
Graduate or Masters level with
2 years experience of EIBI
Extent of parental involvement in
delivery
Weekly sessions at home
Comparator 1 name
TAU (participants received a number
of interventions, including an early
start intervention programme, ‘home-
based developmental intervention’ or
public school special day class using
eclectic methodology)
Is the comparator ABA based?
NR
Is it based on a previous model?
No
Which model(s) is it based on?
NR
Who delivers the comparator?
Various
Qualifications of the interventionist
NR
Length of interventionist experience
NR
Number of people delivering the
intervention
NR
Extent of parental involvement in
delivery
NR
Where was the comparator delivered?
Various
What was the planned intensity of the
comparator?
NR
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TABLE 30 Characteristics of included studies (continued )
General Intervention details Comparator details
Where was the intervention delivered?
Primarily home based, with some
peer play and classroom inclusion
What was the planned intensity of
intervention?
30 hours/week of one to one (20 hours
with therapist, >10 hours with parents)
What was the planned duration of
intervention?
3 years [17 participants completed
3 years and four did not complete
(two at 6 months and two in the
second year)]
Were any co-interventions given?
NR
What was the planned duration of the
comparator?
3 years [17 participants completed
3 years and four did not complete
(two at 6 months and two in the
second year)]
Were any co-interventions given?
Speech, occupational and behavioural
therapy (0–5 hours/week), brief
sessions in mainstreamed education
First author (year)
Dawson (2010, 2012);83,106
Sullivan (2014);112 Estes (2015)107
Sampling frame/population
Children aged between 18 and
30 months diagnosed with autistic
disorder or PDD-NOS
Exclusion criteria
Neurodevelopmental disorder,
significant sensory or motor
impairment, major physical problems,
seizures at time of entry, use of
psychoactive medications, history
of a serious head injury and/or
neurological disease, alcohol or drug
exposure during the prenatal period
and ratio IQ < 35 (as measured by
the MSEL)
When were participants recruited?
NR
How was autism diagnosed?
Meeting criteria for autism or ASD
on the ADOS and a clinical diagnosis
based on DSM-IV criteria
How were participants allocated to
intervention?
Individually randomised, stratified by
IQ and gender
Intervention name
ESDM
Is it based on a previous model?
Yes
If yes, which model is it based on?
ESDM
Was the intervention manualised?
Yes
Who delivers the intervention?
Therapist for 20 hours/week, parents
for anything above that
Qualifications of the interventionist(s)
Bachelors degree in education or
related field plus 2 months’ training
Length of interventionist(s) experience
NR
Number of people delivering the
intervention
NR
Was the interventionist supervised?
Yes
Comparator 1 name
‘Assess and Monitor’ community
intervention (interventions delivered
by Birth-to-Three centres and
individual providers delivering speech
and language therapy, occupational
therapy and/or ABA treatments)
Is the comparator ABA based?
Inconsistent
Is it based on a previous model?
Variety of interventions designed to
ameliorate the impact of autism and
enhance functioning
Which model(s) is it based on?
n/a
Who delivers the comparator?
Various
Qualifications of the interventionist
NR
Length of interventionist experience
NR
Number of people delivering the
intervention
NR
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TABLE 30 Characteristics of included studies (continued )
General Intervention details Comparator details
Qualifications of the supervisor
Masters degree and 5 years’
experience
Extent of parental involvement in
delivery
Minimum of 10 hours/week on top
of intervention hours (actual amount
was 16.3 hours)
Where was the intervention delivered?
Home based
What was the planned intensity of
intervention?
30 hours/week one to one (20 hours
with therapist, > 10 hours with
parents)
What was the planned duration of
intervention?
2 years
Were any co-interventions given?
5.2 hours in other therapies (e.g.
speech therapy, developmental
preschool)
Extent of parental involvement in
delivery
NR
Where was the comparator delivered?
Various
What was the planned intensity of the
comparator?
NR
What was the planned duration of the
comparator?
2 years
Were any co-interventions given?
NR
First author (year)
Eikeseth (2012)84
Sampling frame/population
Children diagnosed with autism
enrolled at Banyan Centre (Sweden)
(intervention); total population of
children diagnosed with autism
at Akershus University Hospital
(Nordbyhagen, Norway) (control)
When were participants recruited?
Intervention between March 2008
and May 2010; control between
2005 and 2010
How was autism diagnosed?
An independent agency prior to
referral to the centre, based on the
ICD-10 criteria158
How were participants allocated to
intervention?
Place of diagnosis
Intervention name
Community school-based EIBI
Is it based on a previous model?
Yes
If yes, which model is it based on?
Lovaas/UCLA 198726
Was the intervention manualised?
Yes
Who delivers the intervention?
School’s staff as therapists
Qualifications of the interventionist(s)
None required
Length of interventionist(s) experience
None required
Comparator 1 name
Eclectic special education teaching
Is the comparator ABA based?
Partially
Is it based on a previous model?
Yes
Which model(s) is it based on?
Eclectic special education teaching
model. [The treatment incorporated
elements from a variety of different
interventions, such as alternative
communication, total communication,
TEACCH, sensory–motor therapies,
ABA, as well as procedures derived
from teachers’ own clinical
experience]
Who delivers the comparator?
Special education teacher and
teaching assistant
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TABLE 30 Characteristics of included studies (continued )
General Intervention details Comparator details
Number of people delivering the
intervention
NR
Was the interventionist supervised?
Yes
Qualifications of the supervisor
Bachelors or Masters degree
Extent of parental involvement in
delivery
10 hours/week
Where was the intervention delivered?
School (parents at home)
What was the planned intensity of
intervention?
Not stated. Actual received was
15–37 hours/week plus 10 hours/
week of parent involvement
What was the planned duration of
intervention?
2 years
Were any co-interventions given?
NR
Qualifications of the interventionist
NR
Length of interventionist experience
None required
Number of people delivering the
intervention
2
Extent of parental involvement in
delivery
NR
Where was the comparator delivered?
Preschools or kindergartens
What was the planned intensity of the
comparator?
Special education teacher worked
3–5 hours/week/child plus teaching
assistant was hired to work one to one
with the child (but no planned time
duration was reported)
What was the planned duration of the
comparator?
2 years
Were any co-interventions given?
NR
First author (year)
Eikeseth (2002, 2007)85,95
Sampling frame/population
Children from Akershus and Vestfold,
Norway, with a diagnosis of childhood
autism (ICD-10), with a chronological
age between 4 and 7 years at the
time of intake, and without any major
medical conditions other than autism
When were participants recruited?
November 1995–November 1998
How was autism diagnosed?
ADI-R and an independent child
clinical psychologist
Intervention name
Intensive behavoural treatment
based on the UCLA treatment model
(EIBI)
Is it based on a previous model?
Yes
If yes, which model is it based on?
Lovaas et al. 1981,159 and Lovaas and
Leaf 1981160
Was the intervention manualised?
Yes
Who delivers the intervention?
Therapist/special education teacher
Comparator 1 name
Intensive eclectic special education
Is the comparator ABA based?
Partially
Is it based on a previous model?
Partially
Which model(s) is it based on?
Included elements from a variety of
different interventions, such as
project TEACCH (Schopler et al.
1983161), sensory–motor therapies
(Ayres 1972162) and ABA (Lovaas
et al. 1981159), as well as methods
derived from personal experience
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TABLE 30 Characteristics of included studies (continued )
General Intervention details Comparator details
How were participants allocated to
intervention?
Availability of qualified supervisors
for behavioural treatment
Qualifications of the interventionist(s)
None required
Length of interventionist(s) experience
None required
Number of people delivering the
intervention
NR
Was the interventionist supervised?
Yes
Qualifications of the supervisor
Bachelors or Masters degree
Extent of parental involvement in delivery
4 hours/week
Where was the intervention delivered?
Public kindergartens and elementary
schools
What was the planned intensity of
intervention?
Minimum 20 hours/week
What was the planned duration of
intervention?
1 year
Were any co-interventions given?
NR
Who delivers the comparator?
Therapist/special education teacher
Qualifications of the interventionist
NR
Length of interventionist experience
NR
Number of people delivering the
intervention
NR
Extent of parental involvement in
delivery
NR
Where was the comparator delivered?
Public kindergartens and elementary
schools
What was the planned intensity of the
comparator?
Minimum 20 hours/week
What was the planned duration of the
comparator?
1 year
Were any co-interventions given?
NR
First author (year)
Eldevik (2012)86
Sampling frame/population
Children with ASD aged between
2 and 6 years, receiving > 5 hours/
week of intervention at an EIBI
centre and children receiving TAU
in their local mainstream school
When were participants recruited?
January 2000–February 2011
How was autism diagnosed?
ADI-R
Intervention name
EIBI
Is it based on a previous model?
Yes
If yes, which model is it based on?
Widely used EIBI manuals (Leaf and
McEachin 1999;163 Lovaas et al. 1981,
2003;159,164 Maurice et al. 1996;165
Sundberg and Partington 1998166)
Was the intervention manualised?
Yes
Comparator 1 name
TAU (eclectic)
Is the comparator ABA based?
Partially
Is it based on a previous model?
Partially
Which model(s) is it based on?
Eclectic special education teaching
model (alternative communication,
ABA, total communication, sensory–
motor therapies, programmes based
on the principles from TEACCH, as
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TABLE 30 Characteristics of included studies (continued )
General Intervention details Comparator details
How were participants allocated to
intervention?
Cohort
Who delivers the intervention?
Therapists recruited from preschool
staff
Qualifications of the interventionist(s)
NR
Length of interventionist(s) experience
NR
Number of people delivering the
intervention
Two or three
Was the interventionist supervised?
Yes
Qualifications of the supervisor
Bachelors degree and 2–10 years’
experience with EIBI
Extent of parental involvement in
delivery
Encouraged to ensure generalisation
and maintenance of skills at home
Where was the intervention delivered?
Mainstream preschool
What was the planned intensity of
intervention?
NR
What was the planned duration of
intervention?
2 years
Were any co-interventions given?
NR
well as other methods that were
incorporated based on the personal
experience of the particular special
education teacher and staff)
Who delivers the comparator?
Preschool staff
Qualifications of the interventionist
NR
Length of interventionist experience
NR
Number of people delivering the
intervention
NR
Extent of parental involvement in
delivery
NR
Where was the comparator delivered?
Mainstream preschool
What was the planned intensity of the
comparator?
NR
What was the planned duration of the
comparator?
2 years
Were any co-interventions given?
NR
First author (year)
Farrell (2005)87
Sampling frame/population
EIBI group: children whose parents
had lobbied for the intervention.
Comparator: children selected by
educational psychologist contributing
to a statutory assessment
Intervention name
EIBI
Is it based on a previous model?
Yes
If yes, which model is it based on?
Lovaas 198726
Comparator 1 name
Lancashire Under Fives Autism
Project
Is the comparator ABA based?
Partially
Is it based on a previous model?
Yes
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TABLE 30 Characteristics of included studies (continued )
General Intervention details Comparator details
When were participants recruited?
1999
How was autism diagnosed?
Educational psychologist
How were participants allocated to
intervention?
Cohort/parental preference
Was the intervention manualised?
Yes
Who delivers the intervention?
Therapists with parental support
Qualifications of the interventionist(s)
NR
Length of interventionist(s) experience
NR
Number of people delivering the
intervention
Up to five
Was the interventionist supervised?
Yes
Qualifications of the supervisor
NR
Extent of parental involvement in
delivery
NR
Where was the intervention delivered?
Home
What was the planned intensity of
intervention?
At least 30 hours
What was the planned duration of
intervention?
2 years
Were any co-interventions given?
NR
Which model(s) is it based on?
Lancashire Under Fives Autism
Project
Who delivers the comparator?
Teaching assistants
Qualifications of the interventionist
NR
Length of interventionist experience
NR
Number of people delivering the
intervention
NR
Extent of parental involvement in
delivery
NR
Where was the comparator delivered?
School
What was the planned intensity of the
comparator?
School full time
What was the planned duration of the
comparator?
2 years
Were any co-interventions given?
NR
First author (year)
Haglund (2017, conference abstract
only)88
Sampling frame/population
Children with ASD aged ≤ 6 years in
Skane county, Sweden
When were participants recruited?
Autumn 1998–spring 2005
Intervention name
Comprehensive intensive early
interventions
Is it based on a previous model?
Yes
If yes, which model is it based on?
NDBI programme described by
Schreibman et al.28
Comparator 1 name
TAU
Is the comparator ABA based?
No
Is it based on a previous model?
Variety of interventions designed to
ameliorate the impact of autism and
enhance functioning
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TABLE 30 Characteristics of included studies (continued )
General Intervention details Comparator details
How was autism diagnosed?
DSM-IV/ICD 10
How were participants allocated to
intervention?
Parental preference: children of
parents rejecting the ABA-based
intervention acted as the comparator
group
Was the intervention manualised?
Yes
Who delivers the intervention?
Therapists/parents
Qualifications of the interventionist(s)
Preschool teaching/educational
background
Length of interventionist(s) experience
NR
Number of people delivering the
intervention
NR
Was the interventionist supervised?
Yes
Qualifications of the supervisor
NR
Extent of parental involvement in
delivery
Some
Where was the intervention delivered?
Combination
What was the planned intensity of
intervention?
15–25 hours/week
What was the planned duration of
intervention?
2 years
Were any co-interventions given?
NR
Which model(s) is it based on?
None
Who delivers the comparator?
NR
Qualifications of the interventionist
NR
Length of interventionist experience
NR
Number of people delivering the
intervention
NR
Extent of parental involvement in
delivery
NR
Where was the comparator delivered?
NR
What was the planned intensity of the
comparator?
NR
What was the planned duration of the
comparator?
2 years
Were any co-interventions given?
NR
First author (year)
Hayward (2009)99
Sampling frame/population
Children who joined the UK Young
Autism Project
Intervention name
EIBI, clinic managed
Is it based on a previous model?
Yes
Comparator 1 name
EIBI, parent managed
Is the comparator ABA based?
Yes
continued
DOI: 10.3310/hta24350 Health Technology Assessment 2020 Vol. 24 No. 35
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Rodgers et al. under the terms of a commissioning contract issued by the Secretary of State
for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
147
TABLE 30 Characteristics of included studies (continued )
General Intervention details Comparator details
When were participants recruited?
NR
How was autism diagnosed?
ICD-10 (confirmed with ADI-R)
How were participants allocated to
intervention?
By catchment area
If yes, which model is it based on?
UCLA
Was the intervention manualised?
Yes
Who delivers the intervention?
Therapists
Qualifications of the interventionist(s)
NR
Length of interventionist(s) experience
NR
Number of people delivering the
intervention
Two to five
Was the interventionist supervised?
Yes
Qualifications of the supervisor
> 3 years’ clinical experience as an
EIBI tutor and senior tutor
Extent of parental involvement in
delivery
NR
Where was the intervention delivered?
Home
What was the planned intensity of
intervention?
NR (37 hours actual)
What was the planned duration of
intervention?
1 year
Were any co-interventions given?
NR
Is it based on a previous model?
Yes
Which model(s) is it based on?
UCLA
Who delivers the comparator?
Therapists
Qualifications of the interventionist
NR
Length of interventionist experience
NR
Number of people delivering the
intervention
Two to five
Extent of parental involvement in delivery
NR
Where was the comparator delivered?
Home
What was the planned intensity of the
comparator?
NR (34 hours actual)
What was the planned duration of the
comparator?
1 year
Were any co-interventions given?
NR
First author (year)
Howard (2005, 2014)105,108
Intervention name
Early intensive behaviour analytic
treatment
Comparator 1 name
Autism educational programming:
eclectic autism-specific classroom-
based intervention
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TABLE 30 Characteristics of included studies (continued )
General Intervention details Comparator details
Sampling frame/population
Children with ASD referred by non-
profit agencies under contract with
the State of California Department of
Developmental Services
When were participants recruited?
1996–2003
How was autism diagnosed?
DSM-IV by independent examiner
How were participants allocated to
intervention?
Cohort
Is it based on a previous model?
Yes
If yes, which model is it based on?
UCLA
Was the intervention manualised?
Yes
Who delivers the intervention?
Trained therapists
Qualifications of the interventionist(s)
Undergraduate students
Length of interventionist(s) experience
NR
Number of people delivering the
intervention
Four or five
Was the interventionist supervised?
Yes
Qualifications of the supervisor
Bachelor’s or Master’s degree in
psychology or special education
Extent of parental involvement in
delivery
Some
Where was the intervention delivered?
Combination of home, school,
community
What was the planned intensity of
intervention?
25–40 hours/week
What was the planned duration of
intervention?
14 months
Were any co-interventions given?
NR
Is the comparator ABA based?
Partially
Is it based on a previous model?
NR
Which model(s) is it based on?
NR
Who delivers the comparator?
Teaching assistants
Qualifications of the interventionist
NR
Length of interventionist experience
NR
Number of people delivering the
intervention
Four to eight
Extent of parental involvement in
delivery
NR
Where was the comparator delivered?
School
What was the planned intensity of the
comparator?
25–30 hours/week
What was the planned duration of the
comparator?
14 months
Were any co-interventions given?
Speech and language therapy
Comparator 2 name
General educational programming:
generic special education classroom
intervention for children with a
variety of disabilities
Is the comparator ABA based?
No
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TABLE 30 Characteristics of included studies (continued )
General Intervention details Comparator details
Is it based on a previous model?
No
Which model(s) is it based on?
NR
Who delivers the comparator?
Teaching assistants
Qualifications of the interventionist
NR
Length of interventionist experience
NR
Number of people delivering the
intervention
Four to eight
Extent of parental involvement in
delivery
NR
Where was the comparator delivered?
School
What was the planned intensity of the
comparator?
15 hours/week
What was the planned duration of the
comparator?
14 months
Were any co-interventions given?
NR
First author (year)
Remington (2007);92 Kovshoff (2011)110
Sampling frame/population
Referrals from local education
authorities, through advertisements
placed with the UK NAS, its regional
branches and through parent groups
or charities
When were participants recruited?
NR
Intervention name
EIBI
Is it based on a previous model?
Yes
If yes, which model is it based on?
UCLA
Was the intervention manualised?
Yes
Comparator 1 name
TAU
Is the comparator ABA based?
No
Is it based on a previous model?
Variety of interventions designed
to ameliorate the impact of autism
and enhance functioning (including
speech therapy, TEACCH, PECS,
sign language or Makaton)
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TABLE 30 Characteristics of included studies (continued )
General Intervention details Comparator details
How was autism diagnosed?
Independent assessor, confirmed by
ADI-R
How were participants allocated to
intervention?
Parental preference
Who delivers the intervention?
Trained tutors and parents
Qualifications of the interventionist(s)
NR
Length of interventionist(s) experience
NR
Number of people delivering the
intervention
Three to five
Was the interventionist supervised?
Yes
Qualifications of the supervisor
‘Substantial experience with EIBI’
Extent of parental involvement in
delivery
Some
Where was the intervention delivered?
Home
What was the planned intensity of
intervention?
40 hours/week
What was the planned duration of
intervention?
2 years
Were any co-interventions given?
Dietary, TEACCH, medication,
vitamin supplementation,
homeopathy and speech therapy
Which model(s) is it based on?
None
Who delivers the comparator?
NR
Qualifications of the interventionist
NR
Length of interventionist experience
NR
Number of people delivering the
intervention
NR
Extent of parental involvement in
delivery
n/a
Where was the comparator delivered?
NR
What was the planned intensity of the
comparator?
NR
What was the planned duration of the
comparator?
2 years
Were any co-interventions given?
Dietary, medication, vitamin
supplementation, homeopathy
First author (year)
Lovaas (1987);26 McEachin (1993)98
Sampling frame/population
UCLA diagnosed
When were participants recruited?
NR
Intervention name
EIBI
Is it based on a previous model?
Yes
If yes, which model is it based on?
UCLA
Comparator 1 name
Lower-intensity ABA-based
treatment
Is the comparator ABA based?
Yes
Is it based on a previous model?
Yes
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TABLE 30 Characteristics of included studies (continued )
General Intervention details Comparator details
How was autism diagnosed?
Independent assessor using DSM-III
criteria
How were participants allocated to
intervention?
Staff availability (low-intensity group);
historical controls (untreated group)
Was the intervention manualised?
Yes
Who delivers the intervention?
Trained student therapists, parents
Qualifications of the interventionist(s)
Students
Length of interventionist(s) experience
NR
Number of people delivering the
intervention
NR
Was the interventionist supervised?
NR
Qualifications of the supervisor
NR
Extent of parental involvement in
delivery
Some
Where was the intervention delivered?
Home, school and community
What was the planned intensity of
intervention?
40 hours/week, one to one
What was the planned duration of
intervention?
≥ 2 years
Were any co-interventions given?
No
Which model(s) is it based on?
UCLA
Who delivers the comparator?
Trained student therapists, parents
Qualifications of the interventionist
Students
Length of interventionist experience
NR
Number of people delivering the
intervention
NR
Extent of parental involvement in
delivery
Some
Where was the comparator delivered?
Home, school and community
What was the planned intensity of the
comparator?
< 10 hours/week, one to one
What was the planned duration of the
comparator?
≥ 2 years
Were any co-interventions given?
Small special educational classes
Comparator 2 name
No treatment; no further details
available
First author (year)
Magiati (2007, 2011);89,96
Howlin (2007)109
Sampling frame/population
UK-based LEAs, specialist schools,
diagnostic centres and NAS
Intervention name
EIBI
Is it based on a previous model?
Yes
If yes, which model is it based on?
UCLA
Comparator 1 name
Autism-specific nursery (school
provisions)
Is the comparator ABA based?
Partially
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TABLE 30 Characteristics of included studies (continued )
General Intervention details Comparator details
When were participants recruited?
July 1998–April 2000
How was autism diagnosed?
Independent diagnosis confirmed by
ADI-R
How were participants allocated to
intervention?
Cohort (parental choice)
Was the intervention manualised?
Yes
Who delivers the intervention?
Therapist
Qualifications of the interventionist(s)
Undergraduate student or graduate
in psychology or special education
Length of interventionist(s) experience
NR
Number of people delivering the
intervention
Nine
Was the interventionist supervised?
Yes
Qualifications of the supervisor
NR
Extent of parental involvement in
delivery
Some
Where was the intervention delivered?
Home based
What was the planned intensity of
intervention?
18–40 hours/week, one to one
What was the planned duration of
intervention?
2 years
Were any co-interventions given?
Range of dietary, biological,
educational interventions and
alternative treatments
Is it based on a previous model?
Partially
Which model(s) is it based on?
Eclectic
Who delivers the comparator?
Led by tutor
Qualifications of the interventionist
NR
Length of interventionist experience
NR
Number of people delivering the
intervention
NR
Extent of parental involvement in
delivery
NR
Where was the comparator delivered?
School based
What was the planned intensity of the
comparator?
Nursery hours= 15–30 hours/week.
One to one= 6 hours (range 1.5–25
hours/week)
What was the planned duration of the
comparator?
2 years
Were any co-interventions given?
Range of dietary, biological and
educational interventions
First author (year)
Reed (2007)90,91
Sampling frame/population
NR
Intervention name
High-intensity ABA-based
interventions
Is it based on a previous model?
Yes
Comparator 1 name
Low-intensity ABA-based
intervention
Is the comparator ABA based?
Yes
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TABLE 30 Characteristics of included studies (continued )
General Intervention details Comparator details
When were participants recruited?
NR
How was autism diagnosed?
NR
How were participants allocated to
intervention?
Location
If yes, which model is it based on?
UCLA, CABAS and verbal behaviour
Was the intervention manualised?
Yes
Who delivers the intervention?
Tutors
Qualifications of the interventionist(s)
NR
Length of interventionist(s) experience
NR
Number of people delivering the
intervention
NR
Was the interventionist supervised?
Yes
Qualifications of the supervisor
NR
Extent of parental involvement in
delivery
Some
Where was the intervention delivered?
Home based
What was the planned intensity of
intervention?
20–40 hours/week, one to one
What was the planned duration of
intervention?
9–10 months
Were any co-interventions given?
NR
Is it based on a previous model?
NR
Which model(s) is it based on?
NR
Who delivers the comparator?
Tutors
Qualifications of the interventionist
NR
Length of interventionist experience
NR
Number of people delivering the
intervention
NR
Extent of parental involvement in
delivery
NR
Where was the comparator delivered?
Home based
What was the planned intensity of the
comparator?
10–20 hours/week
What was the planned duration of the
comparator?
9–10 months
Were any co-interventions given?
NR
Comparator 2 name
Special nursery placements (TAU)
Is the comparator ABA based?
NR
Is it based on a previous model?
Partially
Which model(s) is it based on?
Eclectic
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TABLE 30 Characteristics of included studies (continued )
General Intervention details Comparator details
Who delivers the comparator?
Group, led by tutor
Qualifications of the interventionist
Teaching assistant
Length of interventionist experience
NR
Number of people delivering the
intervention
NR
Extent of parental involvement in
delivery
NR
Where was the comparator delivered?
School based
What was the planned intensity of the
comparator?
2–23 hours/week
What was the planned duration of the
comparator?
9 months
Were any co-interventions given?
NR
Comparator 3 name
Portage
Is the comparator ABA based?
No
Is it based on a previous model?
Yes
Which model(s) is it based on?
Portage
Who delivers the comparator?
NR
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TABLE 30 Characteristics of included studies (continued )
General Intervention details Comparator details
Qualifications of the interventionist
NR
Length of interventionist experience
NR
Number of people delivering the
intervention
NR
Extent of parental involvement in
delivery
Full
Where was the comparator delivered?
Home based
What was the planned intensity of the
comparator?
2–15 hours/week
What was the planned duration of the
comparator?
9 months
Were any co-interventions given?
NR
First author (year)
Sallows (2005)100
Sampling frame/population
Children were recruited through local
birth to three (special education)
programmes
When were participants recruited?
1996–7
How was autism diagnosed?
DSM-IV with ADI-R
How were participants allocated to
intervention?
RCT (matched pairs)
Intervention name
Clinic-directed UCLA-based
intervention
Is it based on a previous model?
Yes
If yes, which model is it based on?
UCLA/Lovaas26
Was the intervention manualised?
Yes
Who delivers the intervention?
Therapists
Qualifications of the interventionist(s)
Undergraduate level. 30 hours
training, including ≥ 10 hours of
one-to-one training and feedback
Comparator 1 name
Parent-directed UCLA
Is the comparator ABA based?
Yes
Is it based on a previous model?
Yes
Which model(s) is it based on?
UCLA
Who delivers the comparator?
Therapists
Qualifications of the interventionist
Undergraduate level. 30 hours
training, including ≥ 10 hours of
one-to-one training and feedback
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TABLE 30 Characteristics of included studies (continued )
General Intervention details Comparator details
Length of interventionist(s) experience
NR
Number of people delivering the
intervention
NR
Was the interventionist supervised?
Yes
Qualifications of the supervisor
Graduate, 1 year of experience
with two or more children, 16-week
internship programme modelled
after UCLA model (total 2000 hours)
Extent of parental involvement in
delivery
Some
Where was the intervention delivered?
Home based
What was the planned intensity of
intervention?
40 hours/week
What was the planned duration of
intervention?
2 years
Were any co-interventions given?
Preschool special education, speech
therapy, sensory integration, auditory
integration training, music therapy,
horseback riding, special diets,
vitamin/Dimethylglycine treatment,
Nystatin (Sandoz Ltd, Surrey, UK),
intravenous immune globulin
(distribution between treatment
groups unclear)
Length of interventionist experience
NR
Number of people delivering the
intervention
NR
Extent of parental involvement in
delivery
Some [McEachin (1993)98],
home-based
What was the planned intensity of the
comparator?
30 hours/week
What was the planned duration of
the comparator?
2 years
Were any co-interventions given?
Preschool special education, speech
therapy, sensory integration, auditory
integration training, music therapy,
horseback riding, special diets,
vitamin/Dimethylglycine treatment,
Nystatin, intravenous immune
globulin (distribution between
treatment groups unclear)
First author (year)
Smith (2000)103
Sampling frame/population
Referrals with autism to the UCLA
Young Autism Project
Intervention name
Intensive behavioural treatment
Is it based on a previous model?
Yes
If yes, which model is it based on?
UCLA/Lovaas26
Comparator 1 name
Parent training
Is the comparator ABA-based?
Yes
Is it based on a previous model?
Yes
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TABLE 30 Characteristics of included studies (continued )
General Intervention details Comparator details
When were participants recruited?
1989–92
How was autism diagnosed?
Independent licensed practititioners
How were participants allocated to
intervention?
RCT (matched pairs)
Was the intervention manualised?
Yes
Who delivers the intervention?
Student therapist. Parents for
5 hours/week
Qualifications of the interventionist(s)
Undergraduate
Length of interventionist(s) experience
NR
Number of people delivering the
intervention
Five or six
Was the interventionist supervised?
Yes
Qualifications of the supervisor
Graduate, programme trained,
1500 hours, one-to-one experience
Extent of parental involvement in
delivery
5 hours/week for the first 3 months
Where was the intervention delivered?
Home based for 1 year then school
based
What was the planned intensity of
intervention?
30 hours/week
What was the planned duration of
intervention?
2 years
Were any co-interventions given?
NR
Which model(s) is it based on?
UCLA
Who delivers the comparator?
Parent
Qualifications of the interventionist
5 hours/week training for
6–9 months
Length of interventionist experience
NR
Number of people delivering the
intervention
NR
Extent of parental involvement in
delivery
Primary therapist
Where was the comparator delivered?
Home based
What was the planned intensity of the
comparator?
NR
What was the planned duration of the
comparator?
2 years
Were any co-interventions given?
Special education class for
10–15 hours per week
First author (year)
Stock (2013)101
Intervention name
Nova Scotia EIBI
Is the comparator ABA based?
Yes
Comparator name
Group ABA
Is it based on a previous model?
Yes
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TABLE 30 Characteristics of included studies (continued )
General Intervention details Comparator details
Sampling frame/population
Children with ASD enrolled in a
private group ABA preschool
programme located in a large city
in western Canada and children
enrolled in a government-funded
autism intervention programme
in Nova Scotia, Canada
When were participants recruited?
NR
How was autism diagnosed?
ADOS, ADI-R and clinical diagnosis
How were participants allocated to
intervention?
Cohort (with selected matched pairs)
Is it based on a previous model?
Yes
Which model(s) is it based on?
PRT
Who delivers the comparator?
Therapist/parent
Qualifications of the interventionist
Early childhood educator
Length of interventionist experience
NR
Number of people delivering the
intervention
NR
Extent of parental involvement in
delivery
Encouraged
Where was the comparator delivered?
Home and preschool based
What was the planned intensity of the
comparator?
15 hours/week one to one for
12 months; or 15 hours/week one
to one for 6 months; 10 hours/week
for 3 months; 5 hours/week for
3 months
What was the planned duration of the
comparator?
12 months
Were any co-interventions given?
NR
If yes, which model is it based on?
Verbal behaviour
Was the intervention manualised?
Yes
Who delivers the intervention?
Therapist
Qualifications of the interventionist(s)
Early childhood education
background
Length of interventionist(s) experience
NR
Number of people delivering the
intervention
NR
Was the interventionist supervised?
Yes
Qualifications of the supervisor
Masters or doctoral clinicians who
were BCBAs
Extent of parental involvement in
delivery
Encouraged
Where was the intervention delivered?
Preschool-like and home-based
settings
What was the planned intensity of
intervention?
15–25 hours/week (3–5 hours/week
one to one)
What was the planned duration of
intervention?
12 months
Were any co-interventions given?
NR
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TABLE 30 Characteristics of included studies (continued )
General Intervention details Comparator details
First author (year)
Vivanti (2014)93
Sampling frame/population
Eligibility criteria for enrolment in
two service centres in Australia that
require a diagnosis of ASD from a
medical professional (paediatrician or
child psychiatrist) and chronological
age up to 6 years
When were participants recruited?
NR
How was autism diagnosed?
ADOS
How were participants allocated to
intervention?
Cohort
Intervention name
ESDM
Is it based on a previous model?
Yes
If yes, which model is it based on?
ESDM
Was the intervention manualised?
Yes
Who delivers the intervention?
Trained therapists/teachers
Qualifications of the interventionist(s)
EDSM introductory and advanced
training
Length of interventionist(s) experience
NR
Number of people delivering the
intervention
NR
Was the interventionist supervised?
NR
Qualifications of the supervisor
NR
Extent of parental involvement in
delivery
Some
Where was the intervention delivered?
School based
What was the planned intensity of
intervention?
15–20 hours/week
What was the planned duration of
intervention?
12 months
Were any co-interventions given?
NR
Comparator 1 name
‘Generic’ intervention
Is the comparator ABA based?
No, but included some elements
Is it based on a previous model?
Yes
Which model(s) is it based on?
Eclectic (incorporated aspects of
TEACCH, PRT, other naturalistic
approaches, PECS)
Who delivers the comparator?
Trained therapists/teachers
Qualifications of the interventionist
NR
Length of interventionist experience
NR
Number of people delivering the
intervention
NR
Extent of parental involvement in
delivery
Some, included regular parent
training
Where was the comparator delivered?
School based
What was the planned intensity of the
comparator?
15 hours/week
What was the planned duration of the
comparator?
12 months
Were any co-interventions given?
NR
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TABLE 30 Characteristics of included studies (continued )
General Intervention details Comparator details
First author (year)
Zachor (2007)94
Sampling frame/population
Children with ASD based in two
centres from different counties,
receiving the same budget per child
from national agencies
When were participants recruited?
NR
How was autism diagnosed?
ADI-R and DSM-IV
How were participants allocated to
intervention?
Cohort
Intervention name
ABA
Is it based on a previous model?
Yes
If yes, which model is it based on?
‘Based on ABA principles’
Was the intervention manualised?
Yes
Who delivers the intervention?
Skilled behavioural therapists
Qualifications of the interventionist(s)
NR
Length of interventionist(s) experience
NR
Number of people delivering the
intervention
NR
Was the interventionist supervised?
Yes
Qualifications of the supervisor
Trained behaviour analyst
Extent of parental involvement in
delivery
NR
Where was the intervention delivered?
Centre based
What was the planned intensity of
intervention?
35 hours/week
What was the planned duration of
intervention?
12 months
Were any co-interventions given?
NR
Comparator 1 name
Eclectic development approach
Is the comparator ABA based?
Partially
Is it based on a previous model?
Yes
Which model(s) is it based on?
Eclectic (developmental
individual–difference relationship
model; TEACCH; ABA)
Who delivers the comparator?
Special education teacher
Qualifications of the interventionist
NR
Length of interventionist experience
NR
Number of people delivering the
intervention
NR
Extent of parental involvement in
delivery
NR
Where was the comparator delivered?
Centre based
What was the planned intensity of the
comparator?
Unclear (2 hours/week of individual
sessions, 1 hour of group therapy
from each therapist in additon to
daily work in small group activities)
What was the planned duration of the
comparator?
12 months
Were any co-interventions given?
NR
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TABLE 30 Characteristics of included studies (continued )
General Intervention details Comparator details
First author (year)
Zachor (2010)97
Sampling frame/population
Children with ASD from seven
autism-specific early intervention
community-based preschool centres,
receiving the same budget per child
from national agencies
When were participants recruited?
NR
How was autism diagnosed?
ADI-R and DSM-IV
How were participants allocated to
intervention?
Cohort
Intervention name
ABA
Is it based on a previous model?
Yes
If yes, which model is it based on?
‘Based on ABA principles’
Was the intervention manualised?
Yes
Who delivers the intervention?
Skilled behavioural therapists
Qualifications of the interventionist(s)
Graduates in behavioural analysis
principles, overseen by programme
supervisor
Length of interventionist(s) experience
NR
Number of people delivering the
intervention
Three ABA therapists, one speech
and language therapist, one
occupational therapist, one special
education preschool teacher
Was the interventionist supervised?
Yes
Qualifications of the supervisor
Masters degree in psychology or
special education and BCBA
Extent of parental involvement in
delivery
Parents received weekly instructions
for home treatment from the
behaviour analyst
Where was the intervention delivered?
Centre based with home support
Comparator 1 name
‘Eclectic’
Is the comparator ABA based?
Unclear
Is it based on a previous model?
Yes
Which model(s) is it based on?
Eclectic (developmental model;
developmental individual–difference
relationship model; TEACCH)
Who delivers the comparator?
Clinical psychologist, speech and
language therapist, occupational
therapist, special education preschool
teacher, music therapist, teacher’s
aids
Qualifications of the interventionist
NR
Length of interventionist experience
NR
Number of people delivering the
intervention
Five
Extent of parental involvement in
delivery
‘Active parental participation in the
programme’
Where was the comparator delivered?
Centre based
What was the planned intensity of the
comparator?
40 hours/week in preschool, with
19 hours of one-to-one intervention
What was the planned duration of the
comparator?
12 months
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TABLE 30 Characteristics of included studies (continued )
General Intervention details Comparator details
What was the planned intensity of
intervention?
40 hours/week in preschool, with
20 hours of one-to-one intervention
What was the planned duration of
intervention?
12 months
Were any co-interventions given?
NR
Were any co-interventions given?
NR
BCBA, board certified in behaviour analysis; CABAS, comprehensive application of behaviour analysis to schooling;
DSM-II, Diagnostic and Statistical Manual of Mental Disorders, Second Edition; DSM-III, Diagnostic and Statistical Manual of
Mental Disorders, Third Edition; DSM-IIIR, Diagnostic and Statistical Manual of Mental Disorders, Third Edition Revised;
DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; LEA, local education authority; n/a, not
applicable; NR, not reported.
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Appendix 7 Individual participant data
obtained from authors
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TABLE 31 Individual participant data obtained from study authors broken down into data dictionary elements
IPD
Study author (year)
Cohen
(2006)104
Eikeseth
(2002,
2007)85,95
Hayward
(2009)99
Eldevik
(2012)86
Lovaas
(1987,
1993)26,98
Magiati
(2007,
2011)89,96
Smith
(2000)103
Vivanti
(2014)93
Eikeseth
(2012)84
Reed
(2007)90,91
Remington
(2007)92
Stock
(2013)101
Sallows
(2005)100
Zachor
(2007)94
Zachor
(2010)97
Participant
characteristic
Participant ID Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Date of
randomisation
or allocation to
treatment
No
information
Yes No No
information
Not coded NC NC Yes No
information
No
information
Not coded No
information
No
information
No
information
No
information
Age at baseline Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes NC Yes Yes Yes
Sex Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Ethnicity NC No
information
No
information
No
information
Not
available
Yes Yes No
information
No
information
No
information
NC NC NC Not coded Not coded
Diagnosis of
ASD
Yes No
information
No
information
Yes No
information
Yes Yes No
information
No
information
No
information
Not coded Yes Not coded Yes Yes
Age (in months)
at ‘first mention’
diagnosis
NC No
information
No
information
No
information
Not
available
No
information
NC No
information
No
information
No
information
NC NC Not coded NC NC
Age (in months)
at final
confirmed
diagnosis
Yes No
information
No
information
No
information
Not
available
No
information
Yes No
information
No
information
No
information
NC NC Not coded Not coded Not coded
Intellectual
impairment at
baseline
Yes No
information
No
information
Yes Yes Yes Yes No
information
No
information
Not coded Not coded NC Yes Not coded Not coded
Language
impairment at
baseline
Yes No
information
No
information
No
information
Yes Yes Yes No
information
No
information
Not coded Not coded NC Yes NC NC
Comorbidities
at baseline
NC No
information
No
information
No
information
Not
included
Yes NC No
information
No
information
NC NC NC No
information
NC NC
Participant
nursery/
education
setting
Yes No
information
No
information
No
information
Yes Yes Yes No
information
No
information
No
information
NC Yes Yes Not coded Not coded
Family
variables
Number of
parents in the
household
Yes No
information
No
information
No
information
Not
available
Yes Yes No
information
No
information
No
information
NC NC Not coded Not coded Not coded
Number of
siblings in the
household
NC No
information
No
information
No
information
Not
available
Yes Yes No
information
No
information
No
information
NC NC NC Yes Yes
Parent
conditions
NC No
information
No
information
No
information
NC NC NC No
information
No
information
No
information
NC NC NC Yes Yes
A
P
P
E
N
D
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IPD
Study author (year)
Cohen
(2006)104
Eikeseth
(2002,
2007)85,95
Hayward
(2009)99
Eldevik
(2012)86
Lovaas
(1987,
1993)26,98
Magiati
(2007,
2011)89,96
Smith
(2000)103
Vivanti
(2014)93
Eikeseth
(2012)84
Reed
(2007)90,91
Remington
(2007)92
Stock
(2013)101
Sallows
(2005)100
Zachor
(2007)94
Zachor
(2010)97
Family
variables
Sibling
conditions
(present for any
sibling)
NC No
information
No
information
No
information
NC Yes NC No
information
No
information
No
information
NC NC NC Yes Yes
Parental
education
(highest level
for any parent
in the
household)
Yes No
information
No
information
No
information
Not
available
Yes Yes No
information
No
information
No
information
Yes NC Not coded Not coded Not coded
Parental
employment
NC No
information
No
information
No
information
NC Yes NC No
information
No
information
No
information
NC NC Not coded NC NC
Treatment
variables
Treatment arm
assigned
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Did the child
receive discrete
trial training
techniques?
Yes No
information
No
information
No
information
Yes Yes Yes No
information
No
information
Not coded Yes Yes Yes Yes Yes
Did the child
receive
incidental
training
techniques?
Yes No
information
No
information
No
information
Yes NC Yes No
information
No
information
Not coded Yes Yes Yes Yes Yes
Did the child
receive verbal
behaviour
techniques?
Yes No
information
No
information
No
information
Yes NC Yes No
information
No
information
Not coded Yes Yes Yes NC NC
Did the child
receive PRT
techniques?
Yes No
information
No
information
No
information
Yes NC Yes No
information
No
information
Not coded Yes Yes Yes NC NC
Did the child
receive CABAS
techniques?
Yes No
information
No
information
No
information
Yes NC Yes No
information
No
information
Not coded Yes Yes Yes NC NC
Did the child
receive aversive
techniques?
Yes No
information
No
information
No
information
Yes Yes Yes No
information
No
information
No
information
NC Yes Yes NC NC
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TABLE 31 Individual participant data obtained from study authors broken down into data dictionary elements (continued )
IPD
Study author (year)
Cohen
(2006)104
Eikeseth
(2002,
2007)85,95
Hayward
(2009)99
Eldevik
(2012)86
Lovaas
(1987,
1993)26,98
Magiati
(2007,
2011)89,96
Smith
(2000)103
Vivanti
(2014)93
Eikeseth
(2012)84
Reed
(2007)90,91
Remington
(2007)92
Stock
(2013)101
Sallows
(2005)100
Zachor
(2007)94
Zachor
(2010)97
Treatment
variables
Number of
interventionists
(paid,
professional,
parental, or
volunteer)
delivering the
treatment to
the child
NC No
information
No
information
No
information
NC Yes Yes No
information
No
information
Yes NC NC NC Not coded Not coded
Who delivered
the intervention?
No
information
No
information
No
information
No
information
Not coded Yes Not
coded
No
information
No
information
Not coded Not coded Yes No
information
Not coded Not coded
Primary
interventionist
qualifications/
experience
(highest level
for anyone
delivering the
intervention)
Yes No
information
No
information
No
information
Yes Yes Yes No
information
No
information
Not coded NC Yes Yes Not coded Not coded
Were
interventionists
supervised?
Yes No
information
No
information
No
information
Yes Yes Yes No
information
No
information
Not coded Yes Yes Yes Not coded Not coded
Supervisor
qualification
Yes No
information
No
information
No
information
Yes Yes Yes No
information
No
information
No
information
Yes Yes Yes Not coded Not coded
Average weekly
treatment
intensity (hours/
week)
NC No
information
No
information
EIBI only NC Yes NC No
information
EIBI only Yes NC No
information
Not coded Not coded Not coded
Total number
of hours of
treatment
received (over
the entire
treatment
period)
NC No
information
No
information
No
information
NC Yes Yes No
information
No
information
Not coded NC NC Not coded Not coded Not coded
Total number
of hours of
treatment
delivered by
interventionist
(s) (over the
entire
treatment
period)
NC No
information
No
information
No
information
NC Yes Yes No
information
No
information
Not coded NC NC Not coded Not coded Not coded
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IPD
Study author (year)
Cohen
(2006)104
Eikeseth
(2002,
2007)85,95
Hayward
(2009)99
Eldevik
(2012)86
Lovaas
(1987,
1993)26,98
Magiati
(2007,
2011)89,96
Smith
(2000)103
Vivanti
(2014)93
Eikeseth
(2012)84
Reed
(2007)90,91
Remington
(2007)92
Stock
(2013)101
Sallows
(2005)100
Zachor
(2007)94
Zachor
(2010)97
Treatment
variables
Total number of
hours of
treatment
delivered by
parent(s) (over
the entire
treatment
period)
NC No
information
No
information
No
information
NC Yes NC No
information
No
information
No
information
NC NC NC NC NC
Length of time
over which the
intervention
was delivered
to the child in
the study (total
number of
weeks)
NC No
information
No
information
Yes NC Yes NC No
information
No
information
Not coded NC Yes NC Not coded Not coded
Treatment
setting
EIBI only No
information
No
information
No
information
Yes EIBI only Yes No
information
No
information
Not coded EIBI only Yes Yes Not coded Not coded
Were co-
intervention(s)
received
alongside
treatment?
EIBI only No
information
No
information
No
information
Not
included
Yes Yes No
information
No
information
No
information
NC NC Yes NC NC
Which co-
interventions
were received?
No
information
No
information
No
information
No
information
Not
included
Yes NC No
information
No
information
No
information
NC NC No
information
NC NC
Discontinuation
of study
treatment
Yes No
information
No
information
No
information
Yes NC Yes No
information
No
information
No
information
NC Yes Yes No
information
No
information
Data
handling
Whether or not
participant was
excluded from
original study
analysis
Yes No
information
No
information
No
information
Yes Yes Yes No
information
No
information
Not coded No
information
Yes Yes Not coded Not coded
Reason for
exclusion
Yes No
information
No
information
No
information
Yes Yes Yes No
information
No
information
Not coded No
information
Yes Yes Not coded Not coded
CABAS, comprehensive application of behaviour analysis to schooling; NC, not collected.
Notes
Shading indicates that the IPD were obtained from the study authors.
EIBI only: IPD obtained for the experimental arm only.
NC: data were not collected by study authors.
Not coded: it was possible to extract the information from the paper or other data, but it was not coded by the authors in the IPD.
Not available: authors indicated that if the data were collected, they could not recover them.
No information: no information provided by study authors on the availability of these data.
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Appendix 8 Outcome domains
and measures
Studies providing individual participant data
Of the 15 studies that provided IPD (see Appendix 7), all reported collecting data on at least two of the
following outcome domains: verbal or non-verbal IQ or cognitive development score, autism symptom
severity, challenging behaviour, adaptive behaviour (as a composite score and/or communication, daily
living skills, socialisation or motor skills subscores), language ability (expressive, receptive or total scores),
parental outcomes and school placement. Less consistently reported outcome domains included academic
achievement, symbolic play, joint attention, social communication, maladaptive behaviour, change in
autism diagnosis, skill acquisition and emotional, behavioural, social or cognitive adjustment (Table 32).
Across all comparisons, a variety of scales were used to measure IQ and cognitive development,
most commonly versions of the BSID, S–B, WISC and WPPSI. When different scales were used within
studies, this was typically due to the need to select an age-appropriate scale. Non-verbal intelligence
was most commonly measured using the MPSMT and autism symptom severity with the ADOS or
ADI-R. Although adaptive behaviour was consistently measured using the VABS, language was measured
using a variety of scales, most commonly the RDLS. Parental outcomes were not measured frequently or
consistently across studies and, although six studies collected school placement data,26,89,92,96,98,100,103,104,109,110
IPD were available for only three26,89,96,98,103,109 and the method of classification was not entirely
consistent across these studies.
Outcomes reported in publications compared with outcomes available in
individual participant data
The outcome measures most commonly missing from the IPD related to behaviours that challenge
(three studies85,92,95,100,110), followed by autism symptom severity (two studies94,100), parental outcomes
(two studies92,103,110) and school placement (two studies92,100,110). For four studies,86,89,94,96,97,109 the IPD
provided by investigators included outcome data that were not reported in their associated publications.
Studies not providing individual participant data
Of the five studies82,83,87,88,105,107,112 that did not provide IPD, one study88 had not published any outcome
data. The remaining four studies82,83,87,105,107,112 reported data on the following outcome domains: IQ,
adaptive behaviour (as a composite score and/or communication, daily living skills, socialisation or motor
skills subscores), and language ability (expressive, receptive, or total scores). Only one study83,107,112
reported autism symptom severity and behaviour that challenges and only one reported on parental
stress (Table 33). Less consistently reported outcome domains included academic achievement, symbolic
play, joint attention, social communication, maladaptive behaviour, change in autism diagnosis, skill
acquisition and emotional, behavioural, social or cognitive adjustment (see Table 32).
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TABLE 32 Outcomes collected in studies providing IPD
First study
author
(year)
IQ/cognitive
development
score
Non-
verbal
IQ
Autism
symptom
severity
scores
Challenging
behaviour Communication
Daily
living Socialisation
Motor
skills Composite
Expressive
language
Receptive
language Total
Parental
outcomes
School
placement Other
ABA vs. TAU/eclectic
Cohen
(2006)104
BSID-R;
WPPSI
MPSMT VABS VABS VABS VABS VABS RDLS RDLS ‘Regular
education
classroom
setting’a
Eikeseth
(2002/7)85,95
BSID-R;
WISC-R;
WPPSI-R
MPSMT;
WISC-R;
WPPSI-R
ABCb VABS VABS VABS VABS RDLS RDLS RDLS VABS maladaptive
behaviour
Eikeseth
(2012)84
CARS
(EIBI arm
only)
VABS VABS VABS VABS VABS VABS maladaptive
behaviour (EIBI arm
only); learning rate
Eldevik
(2012)86
BSID-II/III;
S–B4/5;
WPPSI-R
VABS VABS VABS VABS VABS
Magiati
(2007,
2011)89,96
BSID;
WPPSI-R;
WISC-IV;
WPPSI-III;
MPSMT
MPSMT ADI-R;
ADOS
CSS
VABS VABS VABS VABS VABS EOWPVT BPVS-II School
placement
Reed
(2007)90,91
PEP-R; BAS-II GARS CRS-R
(subscales)
VABS VABS VABS VABS VABS
Remington
(2007);92
Kovshoff
(2011)110
BSID-IV; S–B ADI-R NCBRF;
DBC
VABS VABS VABS VABS VABS RDLS-3c RDLS-3c Stress;
anxiety;
depression;
positive
perceptions
School
placement
Autism Screening
Questionnaire;
Early Social
Communication
Scales (joint
attention)
Vivanti
(2014)93
MSEL ADOS
CSS
VABS VABS VABS VABS VABS MSEL MSEL SCQ
Zachor
(2007)94
BSID-II; S–B4 ADI;
ADOS
VABS VABS VABS VABS VABS Change in autism
diagnosis
Zachor
(2010)97
MSEL ADI-R;
ADOS
VABS VABS VABS VABS VABS MSEL MSEL
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First study
author
(year)
IQ/cognitive
development
score
Non-
verbal
IQ
Autism
symptom
severity
scores
Challenging
behaviour Communication
Daily
living Socialisation
Motor
skills Composite
Expressive
language
Receptive
language Total
Parental
outcomes
School
placement Other
High vs. low
Lovaas
(1987)26/
McEachin
(1993)98
BSID; CIIS;
GIDS; WISC-R;
S–B; PPVT;
WPPSI; LIPS
VABSd VABSd VABSd VABSd ‘In regular
classes’
VABS maladaptive
behaviour (reported
at age 8–9 years
follow-up in EIBI arm
only); Personality
Inventory for
Children; behavioural
observations
Smith
(2009)103
BSID-II; S–B5 MPSMT CBCL VABS VABS VABS VABS RDLS RDLS RDLS Family
Satisfaction
Questionnaire
Classroom
placemente
Academic
achievement (WIAT);
skill acquisition (Early
Learning Measure);
behavioural
observation
Clinic vs. parent
Hayward
(2009)99
BSID-R;
WPPSI-R
MPSMT ADI-R VABS VABS VABS VABS VABS RDLSf RDLSf
Sallows
(2005)100
BSID I/II;
WPPSI;
WISC-III
MPSMT ADI-R CBCL VABS VABS VABS VABS RDLS;
CELF-III
RDLS;
CELF-III
School
placementa
Personality Inventory
for Children;
academic
achievement
(Woodcock–Johnson
III Tests of
Achievement)
VB vs. PRT
Stock
(2013)101
S–B5; MSEL;
WPPSI-III
CBCL VABS PLS-4 PLS-4 PSI
ABC, Aberrant Behaviour Checklist; ADOS CSS, Autism Diagnostic Observation Schedule calibrated severity score; BAS-II, British Ability Scales II; BPVS-II, British Picture Vocabulary Scale, Second Edition; BSID-II, Bayley
Scales of Infant Development II; BSID-III, Bayley Scales of Infant Development III; BSID-IV, Bayley Scales of Infant Development IV; BSID-R, Bayley Scales of Infant Development – Revised; CARS, Childhood Autism Rating
Scale; CBCL, Child Behaviour Checklist; CELF-III, Clinical Evaluation of Language Fundamentals, Third Edition; CIIS, Cattell Infant Intelligence Scale; CRS-R, Conners’ Rating Scales – Revised; DBC, Developmental Behaviour
Checklist; EOWPVT, Expressive One-Word Picture Vocabulary Test; GARS, Gilliam Autism Rating Scale; GIDS, Gesell Infant Development Scale; LIPS, Leiter International Performance Scale; NCBRF, Nisonger Child Behavior
Rating Form; PLS-4, Preschool Language Scale 4; PPVT, Peabody Picture Vocabulary Test; RDLS-3, Reynell Developmental Language Scales 3; S–B4, Stanford-Binet Intelligence Scale 4; S–B5, Stanford-Binet Intelligence Scale 5;
VB,Verbal Behaviour; WIAT,Wechsler Individual Achievement Test; WISC-III, Wechsler Intelligence Scale for Children III; WISC-IV,Wechsler Intelligence Scale for Children IV; WPPSI-III,Wechsler Preschool and Primary Scale of
Intelligence III.
a Not described consistently or for all participants.
b Subscores at age 8 years, follow-up only.
c Number of children achieving a score reported in publication – no actual values.
d Reported in the EIBI group only and at follow-up only.
e Not available for comparator group at baseline.
f Reported as mental age.
Notes
Dark blue shading displays reported outcomes in IPD and publications; orange shading displays outcome mentioned in publications but not available in IPD; and bold text displays an outcome reported in IPD but not in publications.
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TABLE 33 Outcomes collected in studies not providing IPD
First study
author
(year)
IQ/cognitive
development
score
Non-
verbal
IQ
Autism
symptom
severity
scores
Challenging
behaviour Communication
Daily
living Socialisation
Motor
skills Composite Expressive Receptive Total
Parental
outcomes
School
placement Other
ABA vs. TAU/eclectic
Birnbrauer
(1993)82
BSID-R;
PPVT; S–B5;
WISC; WPPSI
LIPS VABS RDLS;
REELS
RDLS;
REELS
PSI Personality
inventory for
children;
behavioural
observation
Dawson
(2010);83
Estes
(2015);107
Sullivan
(2014)112
MSEL; DAS ADOS
CSS
ABCa VABS VABS VABS VABS VABS MSEL MSEL RBS-R; change in
autism diagnosis;
visual reception
(MSEL); fine
motor (MSEL);
shared positive
effect; gesture
use
Farrell
(2005)87
BSID VABS VABS VABS
bHaglund
(2017)88
Howard
(2005)105
BSID-II;
DP-II; DAS;
WPPSI-R;
S–B4; PEP-R;
DAYC
MPSMT;
LIPS
VABS VABS VABS VABS VABS RDLS;
REELS;
EVT;
EOWPVT;
ITLS; PLS-3;
ITDA;
DP-II;
SICD-R;
PPVT-III
RDLS;
REELS;
ITLS; PLS3;
ITDA; EVT;
DP-II;
SICD-R;
PPVT-III;
ROWPVT
RDLS; REELS;
EVT;
EOWPVT;
ITLS; PLS3;
ITDA; EVT;
DP-II; SICD-R;
PPVT-III;
ROWPVT
ABC, Aberrant Behaviour Checklist; ADOS CSS, Autism Diagnostic Observation Schedule calibrated severity score; BSID-II, Bayley Scales of Infant Development II; BSID-R, Bayley Scales of Infant Development –
Revised; DAS, Differential Ability Scales; DAYC, Developmental Assessment of Young Children; DP-II, Developmental Profile-II; EOWPVT, Expressive One-Word Picture Vocabulary Test; EVT, expressive vocabulary test;
ITDA, Infant-Toddler Developmental Assessment; ITLS, Rossetti Infant-Toddler Language Scale; LIPS, Leiter International Performance Scale; PLS-3, Preschool Language Scale 3; PPVT, Peabody Picture Vocabulary Test;
PPVT-III, Peabody Picture Vocabulary Test 3; PSI, Parenting Stress Index; RBS-R, Repetitive Behavior Scale – Revised; REELS, Receptive-Expressive Emergent Language Scale; ROWPVT, Receptive One-Word Picture
Vocabulary Test; S–B4, Stanford-Binet Intelligence Scale 4; S–B5, Stanford-Binet Intelligence Scale 5; SICD-R, Sequenced Inventory of Communication Development – Revised Edition.
a Subscores for only a subset of participants at follow-up.
b Unpublished study – no outcome data available.
Note
Shading displays information mentioned in publications but not available in IPD.
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Appendix 9 Risk-of-bias assessment
Applied behaviour analysis-based early intensive interventions compared
with treatment as usual and eclectic comparators
Fourteen of the 15 included studies reported results in at least one publication, and 10 of these studies
provided IPD. Just one study was randomised and was assessed using the Cochrane Risk of Bias
tool.83,106,107,112 Risk of bias in the remaining non-randomised studies was assessed using the ROBINS-I
tool.82,84,85,87–97,104,105,108–110 All studies were rated as being at ‘serious’ or ‘high’ risk of bias for at least one
outcome on one domain on the relevant assessment tool (Tables 34 and 35).
Bias due to confounding
All of the non-randomised studies were at serious risk of bias due to confounding (see Table 34).
In five studies, the type of treatment received by children was explicitly based on parental
preference,82,87,92,104,105,108,110 with parents actively seeking or lobbying for ABA-based treatment,
and in some cases paying for it themselves.87,92,110 In some studies, there were differences in parental
education, family composition or socioeconomic status between treatment groups.89,92,96,104,105,108–110
In other studies, the type of treatment received was primarily based on location84,86,90,91 or staff
availability,85,95 for which the influence of parental preference was unclear. Some studies suggested
baseline differences in diagnosis (e.g. a higher proportion of participants in the comparison group
diagnosed with PDD-NOS).104
The treatment groups in the one randomised study by Dawson et al.83 appeared to be balanced on baseline
variables and so the study was rated as having a low risk of bias for this domain for all outcomes.
Bias in the selection of participants
Studies rarely described the procedure by which participants were recruited to the study. In most
non-randomised studies, the investigators were not involved in recruiting children to the comparator
treatment, as these were typically cohorts or ‘convenience’ samples in which children received ‘standard’
local or regional treatment. However, even for the early intensive ABA-based treatment arms, investigators
did not typically record if all potentially eligible children were recruited prospectively and/or consecutively.
Studies rarely established simultaneous initiation of treatment and follow-up, and when IPD were available,
dates were inconsistently recorded across studies. In one study, baseline values in the IPD were collected
before the start of treatment for some participants, and months after starting treatment for others.93
Baseline values obtained after a period of treatment may differ from those collected before starting
treatment, and when the pattern of early and late baseline collection differs between study arms there
is the potential for bias.
One study excluded 21% of participants for various reasons, including those abandoning EIBI treatment
due to poor or negative initial progress.105,108 This study did not include an intention-to-treat (ITT) analysis
or other method to explore the impact of excluding these participants on its findings, and IPD were not
available for the SCABARD team to analyse independently.
Bias in the classification of interventions
As studies were unlikely to misclassify children in terms of the intervention they received, all were
considered to be at low risk of bias for this domain.
Bias due to deviation from intended interventions
Some studies described the methods used to assess treatment fidelity in the ABA-based intervention
arm. These included monitoring, observation and feedback to tutors,83,93,104–108,112 or obtaining congruent
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TABLE 34 Risk-of-bias assessment for non-randomised studies comparing early intensive ABA-based intervention with TAU and eclectic intervention
Domain
Cohen (2006)104 Eikeseth (2002, 2007)85,95 Eikeseth (2012)84
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Bias due to
confounding
IQ: serious
MPSMT: serious
RDLS: serious
VABS: serious
Personal
Inventory for
Children: serious
Parents chose intervention.
Comparator children matched
on unknown variables. Parents
in EIBI group had significantly
more education and were
more likely to be living in the
same household
In authors’ original analysis,
baseline values of dependent
variables included in ANCOVA
but not baseline age
IQ: serious
Performance IQ:
serious
Language
functioning:
serious
VABS: serious
Achenbach CBCL:
serious
Allocation by supervisor
availability, so not obviously
influenced by parental
preference
No socioeconomic or parent/
family data collected
No data on severity
IQ: serious
VABS: serious
Allocation by place of
diagnosis. Unclear if this was
influenced by parental
preference
No socioeconomic or parent/
family data collected
Bias in selection
of participants
into the study
IQ: moderate
MPSMT:
moderate
RDLS: moderate
VABS: moderate
Personal
Inventory for
Children:
moderate
Simultaneous start of
comparator and follow-up not
established
IQ: moderate
Performance IQ:
moderate
Language
functioning:
moderate
VABS: moderate
Achenbach CBCL:
moderate
Simultaneous start of
comparator and follow-up not
established
IQ: moderate
VABS: moderate
Comparison groups were not
entirely concurrent (eclectic
special education recruited
2005–10, EIBI recruited
2008–10)
Simultaneous start of
comparator and follow-up not
established
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Domain
Cohen (2006)104 Eikeseth (2002, 2007)85,95 Eikeseth (2012)84
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Bias in
classification of
interventions
IQ: low
MPSMT: low
RDLS: low
VABS: low
Personal
Inventory for
Children: low
Misclassification unlikely IQ: low
Performance IQ:
low
Language
functioning: low
VABS: low
Achenbach CBCL:
low
Misclassification unlikely IQ: low
VABS: low
Misclassification unlikely
Bias due to
deviations from
intended
interventions
IQ: moderate
MPSMT:
moderate
RDLS: moderate
VABS: moderate
Personal
Inventory for
Children:
moderate
EIBI fidelity assessed
Eight of 21 children did not
complete EIBI
No available information on
co-interventions
IQ: moderate
Performance IQ:
moderate
Language
functioning:
moderate
VABS: moderate
Achenbach CBCL:
moderate
No data on fidelity, but EIBI
was manualised and
supervised
42% of children in the eclectic
group received some form
of ABA
No available data on
co-interventions
IQ: moderate
VABS: moderate
The eclectic special education
comparator incorporated
aspects of ABA
The authors state that data on
number of weekly hours of
EIBI delivered was of ‘low
reliability’
No available data on
co-interventions
Bias due to
missing data/IPD
IQ: low
MPSMT: low
RDLS: low
VABS: low
Personal
Inventory for
Children: low
IPD were reasonably complete
for available outcomes
IQ: low
Performance IQ:
low
Language
functioning: low
VABS: low
Achenbach CBCL:
low
Some of the collected baseline
and outcome measures were
missing (although the amount
of missing data were small,
mostly from two participants)
IQ: low
VABS: low
2-year data were only
collected for 15 of 59
participants
Other outcome data largely
complete
continued
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TABLE 34 Risk-of-bias assessment for non-randomised studies comparing early intensive ABA-based intervention with TAU and eclectic intervention (continued )
Domain
Cohen (2006)104 Eikeseth (2002, 2007)85,95 Eikeseth (2012)84
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Bias in
measurement of
outcomes
IQ: moderate
MPSMT:
moderate
RDLS: moderate
VABS: moderate
Personal
Inventory for
Children:
moderate
Outcomes assessed by
independent evaluator, but
truly blinded assessment
unlikely
IQ: moderate
Performance IQ:
moderate
Language
functioning:
moderate
VABS: moderate
Achenbach CBCL:
moderate
Outcome assessors were
independent of the study and
were not informed of the
children’s group assignment,
although truly blinded
assessment difficult to achieve
Age-appropriate measures
used throughout
IQ: serious
VABS: serious
CARS: serious
Severity data (CARS) and
VABS maladaptive scores
were only collected for the
EIBI group (not comparator
group)
Outcome assessors were
treatment supervisors
(EIBI group) and hospital
staff (comparison group).
None were blinded
Bias in selection
of the reported
result
IQ: n/a
MPSMT: n/a
RDLS: n/a
VABS: n/a
Personal
Inventory for
Children: n/a
Domain not applicable when
IPD have been independently
analysed
All outcomes measures and
domains in IPD were reported
in publications
IQ: n/a
Performance IQ:
n/a
Language
functioning: n/a
VABS: n/a
Achenbach CBCL:
n/a
Domain not applicable when
IPD have been independently
analysed
Achenbach Childhood
Behaviour Checklist data
that were reported in 2007
publication were not included
in IPD data set
IQ: n/a
VABS: n/a
Domain not applicable when
IPD have been independently
analysed
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Eldevik (2012)86 Magiati (2007, 2011)89,96 Reed (2007)90,91
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Bias due to
confounding
IQ: serious
VABS: serious
Comparator group were
children receiving TAU from a
local university hospital. Role
of parental preference unclear
No socioeconomic or parent/
family data collected
Baseline age, IQ and VABS
included in authors’ original
ANCOVA model. No data
were collected on symptom
severity or language
IQ: serious
Language: serious
VABS: serious
Autism symptom
severity: serious
Play: serious
Children enrolled in either
EIBI home-based programme
or autism-specific school-
based nursery provision. Role
of parental preference unclear
EIBI families were more highly
educated and tended to have
higher socioeconomic status.
Number of siblings was similar
between groups
Baseline differences in IQ
and VABS (clinically small)
between groups. IQ included
in authors’ original ANCOVA
model
IQ: serious
Educational
functioning:
serious
Autism symptom
severity: serious
VABS: serious
Behavioural
problems/ADHD:
serious
Assignment was based on the
intervention being offered in
the child’s location. Authors
reported that locations had
socioeconomic profiles but not
data collected for included
families. Role of parental
preference unclear
Bias in selection
of participants
into the study
IQ: moderate
VABS: moderate
Simultaneous start of
interventions and follow-up
not established
IQ: moderate
Language:
moderate
VABS: moderate
Autism symptom
severity: moderate
Play: moderate
Simultaneous start of
interventions and follow-up
not established
IQ: moderate
Educational
functioning:
moderate
Autism symptom
severity: moderate
VABS: moderate
Behavioural
problems/ADHD:
moderate
Simultaneous start of
interventions and follow-up
not established
continued
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TABLE 34 Risk-of-bias assessment for non-randomised studies comparing early intensive ABA-based intervention with TAU and eclectic intervention (continued )
Eldevik (2012)86 Magiati (2007, 2011)89,96 Reed (2007)90,91
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Bias in
classification of
interventions
IQ: low
VABS: low
Misclassification of
intervention unlikely
IQ: low
Language: low
VABS: low
Autism symptom
severity: low
Play: low
Misclassification of
intervention unlikely
IQ: low
Educational
functioning: low
Autism symptom
severity: low
VABS: low
Behavioural
problems/ADHD:
low
Misclassification of
interventions unlikely
Bias due to
deviations from
intended
interventions
IQ: moderate
VABS: moderate
No data on fidelity, but EIBI
was manualised and
supervised
TAU included some aspects
of ABA
No available data on intensity
of either intervention or for
co-interventions
IQ: serious
Language: serious
VABS: serious
Autism symptom
severity: serious
Play: serious
No data on fidelity, but
the nature and extent of
supervision/oversight varied
between EIBI families. Eight of
24 families changed their EIBI
organisation or supervisor/
consultant at least once
EIBI children received more
dietary and other biological
interventions, extracurricular
educational interventions and
alternative treatments
IQ: moderate
Educational
functioning:
moderate
Autism symptom
severity: moderate
VABS: moderate
Behavioural
problems/ADHD:
moderate
Congruent descriptions of the
intervention content by both
parents and supervisors was
considered sufficient to
establish ‘fidelity’. Authors
acknowledge the lack of direct
observation may have been a
limitation
No available data on
co-interventions
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Eldevik (2012)86 Magiati (2007, 2011)89,96 Reed (2007)90,91
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Bias due to
missing data/IPD
IQ: low
VABS: low
IPD were reasonably complete
for collected measures
IQ: low
Language: low
VABS: low
Autism symptom
severity: low
Play: low
IPD were extensive and
included fairly complete data
on a wide number of variables
not available from the
literature
IQ: low
Educational
functioning: low
Autism symptom
severity: low
VABS: low
Behavioural
problems/ADHD:
low
IPD were fairly complete for
the collected outcomes
Bias in
measurement of
outcomes
IQ: serious
VABS: serious
EIBI group included a mixture
of blinded and unblinded
outcome assessments. In cases
when an assessment were
undertaken by both the study
investigator or EIBI consultant
and an independent evaluator,
bias was not obvious.
However, the difficulties
in blinding this type of
comparison remain
Age-inappropriate measures
used throughout
IQ: moderate
Language:
moderate
VABS: moderate
Autism symptom
severity: moderate
Play: moderate
Assessments were conducted
by an author and research
assistant who were not
blinded but were independent
of treatment delivery. Inter-
rater reliability was assessed
When multiple measures of
the same domain (e.g. IQ)
were available, the most
age-appropriate test was used
IQ: moderate
Educational
functioning:
moderate
Autism symptom
severity: moderate
VABS: moderate
Behavioural
problems/ADHD:
moderate
Educational psychologist doing
assessments was blinded to
allocation, but helped parents
complete GARS and VABS
tests, and could have been
unblinded by the parental
interaction or assessment
location
continued
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TABLE 34 Risk-of-bias assessment for non-randomised studies comparing early intensive ABA-based intervention with TAU and eclectic intervention (continued )
Eldevik (2012)86 Magiati (2007, 2011)89,96 Reed (2007)90,91
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Bias in selection
of the reported
result
IQ: n/a
VABS: n/a
Domain not applicable when
IPD have been independently
analysed
IQ: n/a
Language: n/a
VABS: n/a
Autism symptom
severity: n/a
Play: n/a
Domain not applicable when
IPD have been independently
analysed
IQ: n/a
Educational
functioning: n/a
Autism symptom
severity: n/a
VABS: n/a
Behavioural
problems/ADHD:
n/a
Domain not applicable when
IPD have been independently
analysed
Remington (2007);92 Kovshoff (2011)110 Vivanti (2014)93 Zachor (2007, 2010)94,97
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Bias due to
confounding
IQ: serious
Language:
serious
Autism symptom
severity: serious
VABS: serious
Parental well-
being: serious
Allocated to treatment
according to patient
preference. The EIBI families
had actively sought ABA-based
treatment, some of whom
(unknown number) paid for it
themselves. Comparison group
received local educational
authority provision and were
not actively seeking EIBI
Substantially higher per cent
of mothers with university
education in EIBI group
(81% vs. 57%)
Data on potential baseline
confounders collected
Developmental
level: serious
Autism symptom
severity: serious
VABS: serious
Social
communication:
serious
No information on how children
were allocated to treatment.
Role of parental preference
unclear
Socioeconomic/parental data
only available for ESDM
group. Data on other potential
baseline confounders
collected
IQ: serious
Developmental
level: serious
Autism symptom
severity: serious
VABS: serious
A governmental welfare
committee decided placement
of the children with a diagnosis
of ASD to community-based
intervention programmes based
on family place of residence.
Role of parental preference
unclear
Parental education similar
between groups. Other
socioeconomic factors not
measured. Data on some other
baseline confounders collected
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Remington (2007);92 Kovshoff (2011)110 Vivanti (2014)93 Zachor (2007, 2010)94,97
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Bias in selection
of participants
into the study
IQ: moderate
Language:
moderate
Autism symptom
severity:
moderate
VABS: moderate
Parental well-
being: moderate
Simultaneous start of
interventions and follow-up
not established
Developmental
level: serious
Autism symptom
severity: serious
VABS: serious
Social
communication:
serious
Baseline values in IPD
were collected for some
participants before starting
treatment, for others it was
months afterwards
IQ: moderate
Developmental
level: moderate
Autism symptom
severity: moderate
VABS: moderate
Not clear if participants were
recruited consecutively.
Simultaneous start of
intervention and follow-up not
established
Bias in
classification of
interventions
IQ: low
Language: low
Autism symptom
severity: low
VABS: low
Parental well-
being: low
Misclassification of
interventions unlikely
Developmental
level: low
Autism symptom
severity: low
VABS: low
Social
communication:
low
Misclassification of
interventions unlikely
IQ: low
Developmental
level: low
Autism symptom
severity: low
VABS: low
Misclassification of intervention
unlikely
Bias due to
deviations from
intended
interventions
IQ: moderate
Language:
moderate
Autism symptom
severity:
moderate
VABS: moderate
Parental well-
being: moderate
Authors stated that treatment
was not manualised ‘because
we chose to adopt broad
inclusion criteria’, adding
that ‘ . . . problems of
treatment fidelity, primarily
the result of tutor shortages,
were far more significant
than those of treatment
coherence’97
No available data on
co-interventions
Developmental
level: moderate
Autism symptom
severity: moderate
VABS: moderate
Social
communication:
moderate
Fidelity assessed through
training, monitoring and
observation of ESDM
therapists
No available data on
co-interventions
IQ: moderate
Developmental
level: moderate
Autism symptom
severity: moderate
VABS: moderate
No data on fidelity, but EIBI
was manualised and
supervised
Both arms included input
from speech and language
therapists, occupational
therapists and special
education preschool teachers.
Other co-interventions
not recorded
continued
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TABLE 34 Risk-of-bias assessment for non-randomised studies comparing early intensive ABA-based intervention with TAU and eclectic intervention (continued )
Remington (2007);92 Kovshoff (2011)110 Vivanti (2014)93 Zachor (2007, 2010)94,97
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Bias due to
missing data/IPD
IQ: low
Language:
serious
Autism symptom
severity: low
VABS: low
Parental well-
being: serious
Values were fairly complete
for outcome measures in the
IPD data set
IPD contained ADI-R scores
that were not available in
publications
The IPD did not contain the
following outcomes reported
in publications: RDLS, Third
Edition; Positive Social
subscale of the Nisonger
Child Behavior Rating Form;
parent-report version of the
Developmental Behaviour
Checklist; Hospital Anxiety
and Depression Scale
(measure of parents’ mental
health); the parent and family
problems subscale of the
Questionnaire on Resources
and Stress (Friedrich short
form); Kansas Inventory of
Parental Perceptions (positive
contributions subscale)
Developmental
level: low
Autism symptom
severity: low
VABS: low
Social
communication:
low
Values were fairly complete
for most outcomes in the IPD
data set
The SCQ was collected at
baseline and follow-up in IPD,
but not reported in
publication
IQ: low
Developmental
level: low
Autism symptom
severity: low
VABS: low
Values were fairly complete
for the outcomes reported
in the IPD data set. Greater
loss to follow-up on VABS
at 2 years among eclectic
participants
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Remington (2007);92 Kovshoff (2011)110 Vivanti (2014)93 Zachor (2007, 2010)94,97
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Bias in
measurement of
outcomes
IQ: moderate
Language:
moderate
Autism symptom
severity:
moderate
VABS: moderate
Parental well-
being: moderate
2-year outcomes assessed by
independent psychometrician
(and co-author) not informed
of group allocation.
Circumstances (home
assessment with families)
risked unblinding. Outcome
assessor was aware of group
allocation at 4-year follow-up
Developmental
level: serious
Autism symptom
severity: serious
VABS: serious
Social
communication:
serious
Outcome assessors were not
blind to treatment allocation,
but were independent of
delivery. ESDM assessors
were blinded to whether the
assessment was pre or post
treatment, although may have
been unblinded by the age of
the child being assessed
IQ: serious
Developmental
level: serious
Autism symptom
severity: serious
VABS: serious
Some assessments were
blinded to intervention, but
those undertaken in the
intervention facilities were
not. None of the examiners
were involved in the delivery
of the interventions
Bias in selection
of the reported
result
IQ: n/a
Language: n/a
Autism symptom
severity: n/a
VABS: n/a
Parental well-
being: n/a
Domain not applicable when
IPD have been independently
analysed
Developmental
level: n/a
Autism symptom
severity: n/a
VABS: n/a
Social
communication:
n/a
Domain not applicable when
IPD have been independently
analysed
IQ: n/a
Developmental
level: n/a
Autism symptom
severity: n/a
VABS: n/a
Domain not applicable when
IPD have been independently
analysed
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TABLE 34 Risk-of-bias assessment for non-randomised studies comparing early intensive ABA-based intervention with TAU and eclectic intervention (continued )
Birnbrauer (1993)82 Farrell (2005)87 Howard (2005, 2014)105,108
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Bias due to
confounding
IQ: serious
Language
functioning:
serious
VABS: serious
Personality
Inventory for
Children: serious
Behavioural
observation:
serious
Parental stress:
serious
Allocation informed by
parental preference
Proportion of boys higher in
comparator group than in EIBI
group (100% vs. 56%)
No information on
socioeconomic variables. Age,
language, IQ and adaptive
skills measured at baseline.
Only limited data reported,
but evidence of some baseline
imbalances
No formal statistical analysis
IQ: serious
VABS: serious
Parents in the EIBI group
lobbied strongly for
intervention and formed a
local support group. The
comparator was simply
offered to parents elsewhere
in the country
EIBI group had 6 months
more intervention than
comparator group on average
(26 vs. 20 months)
The IQ and VABS
socialisation/communication
scores for children in the EIBI
group were considerably
worse than the comparator
group at baseline
No socioeconomic or family
data reported
No formal statistical analysis
IQ: serious
Non-verbal skills:
serious
Language
functioning:
serious
VABS: serious
‘Although educational
placement decisions regarding
participants in this study were
made by IEP or IFSP teams,
parental preferences weighed
heavily’105
EIBI group were younger than
comparators at diagnosis,
intake and follow-up, and had
more years of parental
education
Age at diagnosis and parent’s
mean level of education were
included in multiple regression
analyses. Other differences
were not
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Birnbrauer (1993)82 Farrell (2005)87 Howard (2005, 2014)105,108
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Bias in selection
of participants
into the study
IQ: moderate
Language
functioning:
moderate
VABS: moderate
Personality
Inventory for
Children:
moderate
Behavioural
observation:
moderate
Parental stress:
moderate
Not clear how comparator
participants were recruited
Intervention and start of
follow-up likely to coincide
IQ: serious
VABS: serious
EIBI treatment started a year
earlier than comparator
treatment. Unclear if follow-up
started a year into EIBI
treatment
IQ: serious
Non-verbal skills:
serious
Language
functioning:
serious
VABS: serious
Seventeen of 78 children
(21%) were excluded from the
analysis for various reasons
(including abandoning EIBI
treatment due to poor or
negative initial progress). No
ITT analysis or observations
carried forward
Bias in
classification of
interventions
IQ: low
Language
functioning: low
VABS: low
Personality
Inventory for
Children: low
Behavioural
observation: low
Parental stress:
low
Misclassification of
intervention unlikely
IQ: low
VABS: low
Misclassification of
interventions was unlikely
IQ: low
Non-verbal skills:
low
Language
functioning: low
VABS: low
Misclassification of
interventions was unlikely
continued
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TABLE 34 Risk-of-bias assessment for non-randomised studies comparing early intensive ABA-based intervention with TAU and eclectic intervention (continued )
Birnbrauer (1993)82 Farrell (2005)87 Howard (2005, 2014)105,108
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Bias due to
deviations from
intended
interventions
IQ: no
information
Language
functioning: no
information
VABS: no
information
Personality
Inventory for
Children: no
information
Behavioural
observation: no
information
Parental stress:
no information
Insufficient data on fidelity to
make a judgement
No available data on
co-interventions
IQ: no
information
VABS: no
information
No data available on fidelity
or co-interventions
IQ: moderate
Non-verbal skills:
moderate
Language
functioning:
moderate
VABS: moderate
Although efforts were made
to ensure treatment integrity
(e.g. through frequent direct
observation and videotaping
of staff implementing
procedures with children,
and frequent feedback from
supervisors), no formal
measurement of treatment
integrity was undertaken
Additional services, such
as occupational therapy or
individual or small group
therapy were provided to
the children in the early
intensive ABA-based
treatment group.105
No information on parent-
procured co-interventions
or co-interventions in
comparison arms
No crossover from EIBI
to comparator arms, but
several participants crossed
over between the two
comparator arms
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Birnbrauer (1993)82 Farrell (2005)87 Howard (2005, 2014)105,108
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Bias due to
missing data/IPD
IQ: serious
Language
functioning:
serious
VABS: serious
Personality
Inventory for
Children: serious
Behavioural
observation:
serious
Parental stress:
serious
One in 10 EIBI and three in
eight comparator participant
families were lost to follow-up.
Reasons not reported.
Ultimately, only 14 participants
with any outcome data in the
whole study. For some
measures, data were only
available for 11 participants
(seven EIBI and four
comparator)
IQ: serious
VABS: serious
Very few participants and
different subsets of children
gave baseline and follow-up
values. Seventeen children in
total, although IQ follow-up
data available for only nine
children (four EIBI, five
comparator).
The authors noted missing
IQ and VABS data, citing
problems in obtaining the
assessment results from the
outcome assessors
IQ: serious
Non-verbal skills:
serious
Language
functioning:
serious
VABS: serious
Seven participants excluded
from EIBI arm, nine from
comparator arms combined.
Reasons for exclusion differed
between arms
Among the remaining
participants, standard scores
were missing at baseline or
follow-up for between 0 %
and 27.6% of participants at
14 months, depending on the
outcome
Bias in
measurement of
outcomes
IQ: moderate
Language
functioning:
moderate
VABS: moderate
Personality
Inventory for
Children:
moderate
Behavioural
observation:
moderate
Parental stress:
serious
Follow-up assessments
by ‘experienced clinical
psychologists who did not
know the group placement of
the children or how long they
had been in the program’,82
although assessment was in
the child’s home with their
mother present, making
genuine blinding difficult to
achieve. Relationship of
outcome assessors to authors
not reported
IQ: serious
VABS: serious
Psychometric assessments
were carried out by
educational psychologists in
the local authority as part of
their ongoing work with the
child and family. No mention
of blinding
IQ: serious
Non-verbal skills:
serious
Language
functioning:
serious
VABS: serious
Outcome assessors were
not involved in treatment
but were also not blinded
to allocation
continued
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TABLE 34 Risk-of-bias assessment for non-randomised studies comparing early intensive ABA-based intervention with TAU and eclectic intervention (continued )
Birnbrauer (1993)82 Farrell (2005)87 Howard (2005, 2014)105,108
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement by
outcome Comment
Bias in selection
of the reported
result
IQ: serious
Language
functioning:
serious
VABS: serious
Personality
Inventory for
Children: serious
Behavioural
observation:
serious
Parental stress:
serious
Some results reported for
each of the collected
measures; however, results
are not reported fully or
consistently across outcomes
IQ: serious
VABS: serious
Values reported for each of
the collected measures. VABS
and Bayley scores were
reported only as age-
equivalent scores in months
IQ: low
Non-verbal skills:
low
Language
functioning: low
VABS: low
No protocol available, but all
data were reported for all
outcomes mentioned in the
journal articles. No clear
evidence of selective reporting
of measures, analyses or
subgroups
ADHD, attention deficit hyperactivity disorder; CARS, Childhood Autism Rating Scale; CBCL, Child Behaviour Checklist; GARS, Gilliam Autism Rating Scale; ITT, intention to treat;
n/a, not applicable.
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TABLE 35 Risk-of-bias assessment for a randomised study comparing early intensive ABA-based intervention with TAU and eclectic intervention
Outcome
aDawson (2010) aEstes (2015)107
MSELb VABSb ADOSb RBSb MSEL/DASc VABSc ADOSc RBSc
ABC
scorec
Randomisation process 1.1: was the allocation sequence
random?d
Yes Yes Yes Yes Yes Yes Yes Yes Yes
1.2: was the allocation sequence
concealed until participants were
recruited and assigned to
interventions?d
PY PY PY PY PY PY PY PY PY
1.3: were there baseline
imbalances that suggest a problem
with the randomisation process?
No No No No No No No No No
Risk-of-bias judgement Low Low Low Low Low Low Low Low Low
Deviations from intended
interventions
2.1: were participants aware of
their assigned intervention during
the trial?
Yes Yes Yes Yes Yes Yes Yes Yes Yes
2.2: were carers and trial
personnel aware of participants’
assigned intervention during the
trial?
Yes Yes Yes Yes Yes Yes Yes Yes Yes
2.3: if yes/PY/NI to 2.1 or 2.2,
were important co-interventions
balanced across intervention
groups?
NI NI NI NI NI NI NI NI NI
2.4: was the intervention
implemented successfully?e
PY PY PY PY PY PY PY PY PY
2.5 Did study participants adhere
to the assigned intervention
regimen?f
PY PY PY PY PY PY PY PY PY
2.6 If N/PN/NI to 2.3, 2.4 or 2.5:
Was an appropriate analysis used
to estimate the effect of starting
and adhering to the intervention?
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Risk-of-bias judgement Low Low Low Low Some
concerns
Some
concerns
Some
concerns
Some
concerns
Some
concerns
continued
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TABLE 35 Risk-of-bias assessment for a randomised study comparing early intensive ABA-based intervention with TAU and eclectic intervention (continued )
Outcome
aDawson (2010) aEstes (2015)107
MSELb VABSb ADOSb RBSb MSEL/DASc VABSc ADOSc RBSc
ABC
scorec
Missing outcome data 3.1: were outcome data available
for all, or nearly all, participants
randomised?
PY
g
PY
g
PY
g
PY
g
Noh Noi Noh No
j
Nok
3.2: if no/PN/NI to 3.1, are the
proportions of missing outcome
data and reasons for missing
outcome data similar across
intervention groups?
No No No No Nol PNl PNl PNl PNl
3.3: if no/PN/NI to 3.1, is there
evidence that results were robust
to the presence of missing
outcome data?
n/a n/a n/a n/a Nom Nom NIm Nom Nom
Risk-of-bias judgement Low Low Low Low High High High High High
Measurement of the
outcome
4.1: were outcome assessors
aware of the intervention received
by study participants?
PYn PYn PYn PYn PYn PYn PYn PYn PYn
4.2: if yes/PY/NI to 4.1, was the
assessment of the outcome likely
to be influenced by knowledge of
intervention received?o
PY PY PY PY PY PY PY PY PY
Risk-of-bias judgement Some
concerns
Some
concerns
Some
concerns
Some
concerns
Some
concerns
Some
concerns
Some
concerns
Some
concerns
Some
concerns
A
P
P
E
N
D
IX
9
N
IH
R
Jo
u
rn
als
Lib
rary
w
w
w
.jo
u
rn
a
lslib
ra
ry
.n
ih
r.a
c.u
k
1
9
2
Outcome
aDawson (2010) aEstes (2015)107
MSELb VABSb ADOSb RBSb MSEL/DASc VABSc ADOSc RBSc
ABC
scorec
Selection of the reported
result
5.1: are the reported outcome
data likely to have been selected,
on the basis of the results, from
multiple outcome measurements
(e.g. scales, definitions, time
points) within the outcome
domain?
PN PN PN PN PYp PN PN PN PYq
5.2: are the reported outcome
data likely to have been selected,
on the basis of the results, from
multiple analyses of the data?
PN PN PN PN PN PN PN PN PN
Risk-of-bias judgement Low Low Low Low Some
concernsr
Low Low Low Some
concerns
Overall risk of bias Overall risk-of-bias judgement Some
concerns
Some
concerns
Some
concerns
Some
concerns
Highs Highs Highs Highs Highs
ABC, Aberrant Behaviour Checklist; DAS, Differential Ability Scales; ITT, intention to treat; n/a, not applicable; NI, no information; PN, probably no; PY, probably yes.
a Individually randomised, parallel group trial.
b At 2 years.
c At 6 years.
d Used stratified sampling with block size of four; it may have been possible to predict allocation for some participants.
e Manual, training and supervision, as well as fidelity checks.
f Fidelity checks and none withdrew from intervention at 2 years.
g Three comparator participants lost to follow-up at 2 years.
h Nine participants withdrew.
i Fifteen participants withdrew.
j Fourteen participants withdrew.
k Sixteen participants withdrew.
l Reasons are similar, but twice as many withdrew from the control arm.
m No information presented, sensitivity analysis not conducted and ITT analysis not done.
n Stated clinicians were independent but did not indicate where the assessments took place or report incidence of unblinding. It is unlikely that no unblinding occurred.
o Although there may have been incidences of unblinding and the measure is susceptible to influence, measures were taken to limit this through use of an independent clinician.
p Used two different scales at different time points, although this was due to age and developmental limitations. In addition, separated scale into verbal and non-verbal IQ, despite
this not being done in original paper.
q There is no mention of an Aberrant Behaviour Checklist score in the Dawson et al. paper,83 but this article reports it and the change during follow-up.
r There is potential for bias but explanations for scale selection are reasonable.
s Attrition during the follow-up period and absence of an ITT analysis.
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descriptions of the intervention from parents and supervisors.90,91 Elsewhere, the ABA-based interventions
were manualised and supervised, but without explicit monitoring for treatment fidelity. One study noted
the problem of high tutor turnover, resulting in the intervention being delivered for fewer hours per week
than intended (25.6 hours delivered vs. 40 hours intended).92,110 Other studies noted 38% of children not
completing EIBI,104 unreliable recording of weekly hours of EIBI,84 and families changing between different
EIBI organisations or supervisors and consultants during the study period.89,96,109
The delivery and content of comparator arms was not closely monitored in the available studies,
although three studies did report a high proportion of children receiving ABA techniques as part of
‘eclectic’ therapy or TAU.84–86,95
Studies rarely recorded whether or not children received any co-interventions alongside those being
evaluated. One study noted that children in both early intensive ABA-based interventions and eclectic
treatment arms received input from speech and language therapists, occupational therapists and special
education preschool teachers;94,97 another reported no additional services, such as occupational therapy
or individual or small group therapy, being provided to the early intensive ABA-based group, but did not
clarify whether or not this was also true for the comparator arms.105,108 One study appeared to collect
data only on independently procured co-interventions, finding that children receiving early intensive
ABA-based interventions received more dietary and other biological interventions, extracurricular
educational interventions and alternative treatments.89,96,109
Bias due to missing data
When possible, judgements about the extent of missing data were based on the content of provided
IPD data sets. For the four studies for which IPD were not available, these judgements were based on
all relevant publications.82,83,87,105–108,112
As shown in Appendix 7, some outcomes domains were available in IPD data sets, publications or both
sources. In most cases, when an outcome measure was available in an IPD data set, the individual
values for that measure were mostly complete. When individual outcome values were missing, this was
usually for a small number of participants and did not appear to follow any systematic pattern.
However, all four studies not providing IPD were at serious risk of bias due to missing data. In one
study,82 data were available on only some measures for 11 of 18 participants, with reasons for loss to
follow-up not reported. Another small study87 reported baseline and follow-up values for different
subsets of children, citing problems in obtaining the assessment data from the outcome assessors.
A larger study105,108 comparing an early intensive ABA-based intervention against both TAU and eclectic
intervention reported missing values at baseline or follow-up for between 0% and 27.6% of participants,
depending on the outcome. The one available randomised study83,106,107,112 reported reasonably complete
data at 2 years, but missing values for between 19% and 33% of participants for outcomes measured
at age 6 years. None of these four studies appeared to conduct an ITT analysis.
Bias in measurement of outcomes
Truly independent and blinded measurement of outcomes is difficult to achieve in the evaluation of
intensive behavioural interventions. This was the case for most studies comparing early intensive
ABA-based interventions with TAU or eclectic intervention. In some cases, early intensive ABA-based
interventions were assessed by treatment supervisors84 or study investigators,86 sometimes with an
independent second evaluator. Although some studies described employing outcome assessors who
were independent of direct intervention delivery,82,85,89,92,95,96,104,105,108–110 the assessments typically
involved interaction with children and parents who were not blinded to intervention. Assessors who
were blinded to allocation could potentially have been unblinded by the assessment location (if this
differed between intervention arms or – when delivered in the family home – provided contextual
information about likely treatment allocation). Consequently, all the included studies were considered
to be at moderate or serious risk of bias for this domain.
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Bias in the selection of the reported result
For the 10 studies84–86,89–97,104,109,110 providing IPD, assessment of selective outcome reporting bias was not
applicable. Although research protocols were not available to assess reported outcomes against those
originally planned to be collected, study authors affirmed that all the outcome data provided in the IPD
data sets are all that were available. Outcomes were then selected for meta-analysis as described in
Chapter 4, Individual participant data meta-analysis methods.
The four published studies not providing IPD did not provide research protocols82,83,87,105–108,112 and two
were considered to be at a serious risk of bias for partial or inconsistent reporting of results.82,87 The
one available randomised study appeared to report all collected outcomes at 2 years, although
two measures (Differential Ability Scales and Aberrant Behaviour Checklist) were only reported for
later follow-up periods.83,106,107,112 The fourth study appeared to report results for all the outcomes
mentioned across the available publications.105,108
Summary
With the exception of one randomised study comparing ESDM with an eclectic intervention at
2 years,83,106,112 all studies comparing early intensive ABA-based interventions with TAU or eclectic
interventions had at least one domain that was considered to be at serious or high risk of bias.
Although randomisation is clearly feasible, most studies used convenience samples, with the allocation
to early intensive ABA-based interventions being based on location or parental preference. The nature
of the intervention meant that outcome assessment can rarely be blinded and outcome assessors
were often not independent of treatment. There is evidence from some studies to suggest differences
between intervention groups in terms of socioeconomic status and use of co-interventions, but this
information was not consistently recorded across studies. In some cases outcome data were missing
or only available for one treatment group, and we did not receive any protocols for the included
studies to allow us to understand how the studies had been planned in advance. Taken together, these
concerns increase our uncertainty about the results observed in the included studies. Although it is
not possible to establish for certain how these potential biases influence the direction and magnitude
of the study results, given the prevalence of parental preference for early intensive ABA-based
interventions in some studies and the difficulties in blinding, the effects we have observed in the
meta-analysis may potentially overestimate the true effects of this intervention approach.
Applied behaviour analysis-based early interventions of different intensity
Three studies comparing higher- with lower-intensity EIBI: assessment using the Cochrane Risk of
Bias tool raised some concerns for one randomised study103 and two non-randomised studies assessed
were judged to have a ‘serious’ risk of bias for at least one outcome on one domain of the ROBINS-I
tool26,90,91,98 (Tables 36 and 37).
Bias due to confounding
As described previously, non-randomised studies were judged to have a serious risk of bias due to
confounding. The original UCLA study by Lovaas26 recruited children to higher- or lower-intensity EIBI
on the basis of family location and staff availability.26,98 On average, low-intensity group participants
were 6 months older than high-intensity EIBI participants at baseline and had a lower proportion of
boys (58% vs. 84%). This study also included a retrospectively identified ‘no treatment’ arm, for which
the role of parental preference is unknown. A second non-randomised study included three comparator
treatments, of which low-intensity EIBI was one.90,91 Assignment was based on the intervention being
offered in the eligible child’s location. Authors reported that locations had similar socioeconomic profiles,
although these type of data were not collected for families included in the study. A third study allocated
children to high- or low-intensity treatment using matched-pair random assignment (children were
matched on IQ then an independent statistician assigned treatment on the basis of a random numbers
table) and the treatment groups appeared to be balanced at baseline on the collected variables.103
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TABLE 36 Risk-of-bias assessment for non-randomised studies comparing early ABA-based interventions of differing
intensity
Domain
Lovaas (1987);26 McEachin (1993)98 Reed (2007)90,91
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement
by outcome Comment
Bias due to
confounding
IQ: serious
VABS: serious
Educational
placement:
serious
‘Psychological
disturbance’:
serious
Allocation based on staff
availability/distance of family
from treatment centre, so no
overt parental preference
for high- vs. low-intensity
treatment comparison.
A second ‘no treatment’ control
arm appears to have been
retrospectively identified, for
which parental preference
may have been a confounder.
However, no baseline data
were reported for this group
and no IPD were provided
No formal language measures
were collected
On average, low-intensity
group participants were
6 months older than high-
intensity EIBI participants
at baseline and had a
lower proportion of boys
(58% vs. 84%)
Authors’ original analysis only
included pre-treatment mental
age as a baseline covariate in
their analysis
Participants were recruited
over a period of 15 years.
Potential for the interventions
and/or their implementation to
change over time
IQ: serious
Educational
functioning:
serious
Autism
symptom
severity:
serious
VABS:
serious
Behavioural
problems/
ADHD:
serious
Assignment was based on the
intervention being offered in
the child’s location. Authors
reported that locations had
similar socioeconomic profiles,
but no data collected for
included families. Role of
parental preference unclear
Bias in selection
of participants
into the study
IQ: serious
VABS: serious
Educational
placement:
serious
‘Psychological
disturbance’:
serious
At the later follow-up, the
average age of the control
group was 10 years and the
experimental group was
13 years (because the
experimental group was
recruited first)
Only seven children were
recruited in the first 3.5 years,
so most early recruited
children were allocated to the
experimental treatment, as
therapists were available
The authors suggested that
the order of recruitment did
not affect baseline balance
in IQ. Insufficient data are
available on other baseline
characteristics
IQ:
moderate
Educational
functioning:
moderate
Autism
symptom
severity:
moderate
VABS:
moderate
Behavioural
problems/
ADHD:
moderate
Simultaneous start of
interventions and follow-up
not established
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TABLE 36 Risk-of-bias assessment for non-randomised studies comparing early ABA-based interventions of differing
intensity (continued )
Domain
Lovaas (1987);26 McEachin (1993)98 Reed (2007)90,91
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement
by outcome Comment
Bias in
classification of
interventions
IQ: low
VABS: low
Educational
placement:
low
‘Psychological
disturbance’:
low
Misclassification unlikely IQ: low
Educational
functioning:
low
Autism
symptom
severity:
low
VABS: low
Behavioural
problems/
ADHD: low
Misclassification of
interventions unlikely
Bias due to
deviations from
intended
interventions
IQ: moderate
VABS:
moderate
Educational
placement:
moderate
‘Psychological
disturbance’:
moderate
No data on fidelity, but EIBI
procedures followed a teaching
manual
No available data on
co-interventions
IQ:
moderate
Educational
functioning:
moderate
Autism
symptom
severity:
moderate
VABS:
moderate
Behavioural
problems/
ADHD:
moderate
Congruent descriptions of the
intervention content by both
parents and supervisors was
considered sufficient to
establish ‘fidelity’. Authors
acknowledge the lack of
direct observation may have
been a limitation
No available data on
co-interventions
Bias due to
missing data/IPD
IQ: moderate
VABS: serious
Educational
placement:
serious
‘Psychological
disturbance’:
serious
No baseline IPD other than
chronological age, mental age
and IQ. No follow-up IPD other
than IQ, educational placement
VABS was only reported in the
1993 publication98 and only for
the EIBI arm at later follow-up
No IPD available on the ‘no
treatment’ control group
IQ: low
Educational
functioning:
low
Autism
symptom
severity:
low
VABS: low
Behavioural
problems/
ADHD: low
IPD was fairly complete for
the collected outcomes
continued
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TABLE 36 Risk-of-bias assessment for non-randomised studies comparing early ABA-based interventions of differing
intensity (continued )
Domain
Lovaas (1987);26 McEachin (1993)98 Reed (2007)90,91
Risk-of-bias
judgement by
outcome Comment
Risk-of-bias
judgement
by outcome Comment
Bias in
measurement of
outcomes
IQ: serious
VABS: serious
Educational
placement:
serious
‘Psychological
disturbance’:
serious
Outcomes were assessed by
project staff members (no
mention of blinding or quality
assurance for most participants
but authors reported ‘no
significant differences between
staff members and outside
agency raters’26)
Developmentally appropriate
IQ measures were used
IQ:
moderate
Educational
functioning:
moderate
Autism
symptom
severity:
moderate
VABS:
moderate
Behavioural
problems/
ADHD:
moderate
Educational psychologist
doing assessments was
blinded to allocation, but
helped parents complete
GARS and VABS tests, and
could have been unblinded by
the parental interaction or
assessment location
Bias in selection
of the reported
result
IQ: n/a
VABS: n/a
Educational
placement:
n/a
‘Psychological
disturbance’:
n/a
Domain not applicable when
IPD have been independently
analysed
Published studies reported data
for only a subset of children
for certain measures (e.g. EIBI
children only at later follow-up;
missing data on ‘no treatment’
group)
IQ: n/a
Educational
functioning:
n/a
Autism
symptom
severity: n/a
VABS: n/a
Behavioural
problems/
ADHD: n/a
Domain not applicable when
IPD have been independently
analysed
ADHD, attention deficit hyperactivy disorder; GARS, Gilliam Autism Rating Scale; n/a, not applicable.
TABLE 37 Risk-of-bias assessment for a randomised study comparing early ABA-based interventions of differing intensity
Outcome
aSmith 2000103
IQ
Non-
verbal
IQ Language VABS CBCL
Academic
achievement
Randomisation
process
1.1: was the allocation
sequence random?b
PY PY PY PY PY PY
1.2: was the allocation
sequence concealed
until participants were
recruited and assigned
to interventions?b
PY PY PY PY PY PY
1.3: were there
baseline imbalances
that suggest a problem
with the randomisation
process?
No No No No No No
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TABLE 37 Risk-of-bias assessment for a randomised study comparing early ABA-based interventions of differing
intensity (continued )
Outcome
aSmith 2000103
IQ
Non-
verbal
IQ Language VABS CBCL
Academic
achievement
Risk-of-bias judgement Low Low Low Low Low Low
Deviations
from intended
interventions
2.1: were participants
aware of their
assigned intervention
during the trial?
Yes Yes Yes Yes Yes Yes
2.2: were carers and
trial personnel aware
of participants’
assigned intervention
during the trial?
Yes Yes Yes Yes Yes Yes
2.3: if yes/PY/NI to 2.1
or 2.2, were important
co-interventions
balanced across
intervention groups?
NI NI NI NI NI NI
2.4: was the
intervention
implemented
successfully?c
Yes Yes Yes Yes Yes Yes
2.5 Did study
participants adhere
to the assigned
intervention regimen?
Yes Yes Yes Yes Yes Yes
2.6: if no/PN/NI to
2.3, 2.4 or 2.5, was an
appropriate analysis
used to estimate the
effect of starting and
adhering to the
intervention?
n/a n/a n/a n/a n/a n/a
Risk-of-bias judgement Low Low Low Low Low Low
Missing
outcome data
3.1: were outcome
data available for all,
or nearly all,
participants
randomised?d
No No No No No No
3.2: if no/PN/NI to 3.1,
are the proportions
of missing outcome
data and reasons for
missing outcome
data similar across
intervention groups?
No No No No No No
3.3: if no/PN/NI to 3.1,
is there evidence that
results were robust
to the presence of
missing outcome data?
PY PY PY PY PY PY
Risk-of-bias judgement Low Low Low Low Low Low
continued
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Bias in the selection of participants
Concerns about participant selection were similar to those for studies comparing early intensive
ABA-based with TAU and eclectic interventions. The study by Lovaas26 was conducted over a 15-year
period. Only seven children were recruited in the first 3.5 years, so most early recruited children were
allocated to the high-intensity intervention, as therapists were available. The authors suggested that
the order of recruitment did not affect baseline balance in IQ, but insufficient data were available on
other baseline measures.26,98
TABLE 37 Risk-of-bias assessment for a randomised study comparing early ABA-based interventions of differing
intensity (continued )
Outcome
aSmith 2000103
IQ
Non-
verbal
IQ Language VABS CBCL
Academic
achievement
Measurement
of the outcome
4.1: were outcome
assessors aware of the
intervention received
by study participants?e
PN PN PN PN PN PN
4.2: if yes/PY/NI
to 4.1, was the
assessment of the
outcome likely to
be influenced by
knowledge of
intervention received?
n/a n/a n/a n/a n/a n/a
Risk-of-bias
judgementf
Some
concerns
Some
concerns
Some
concerns
Some
concerns
Some
concerns
Some
concerns
Selection of
the reported
result
5.1: are the reported
outcome data likely to
have been selected,
on the basis of
the results, from
multiple outcome
measurements (e.g.
scales, definitions,
time points) within
the outcome domain?
g
PN PN PN PN PN PN
5.2 Are the reported
outcome data likely to
have been selected,
on the basis of the
results, from multiple
analyses of the data?
No No No No No No
Risk-of-bias judgement Low Low Low Low Low Low
Overall risk-of-bias judgement Some
concerns
Some
concerns
Some
concerns
Some
concerns
Some
concerns
Some
concerns
CBCL, Child Behaviour Checklist; n/a, not applicable; NI, no information; PN, probably no; PY, probably yes.
a Individually randomised, parallel group trial.
b Matched pair random assignment (matched on IQ, then random numbers table assignment by
independent statistician).
c Manual, training and supervision; some fidelity checks.
d Excluded four people after randomisation, as they did not have ASD (one from intervention, three from
comparator group).
e Investigators made efforts to keep the assessors blind and all participants were tested in the same location. There
was also some indication of robustness when checked by a truly external examiner.
f It is likely the outcome assessors were unblinded in some cases, but efforts were made to prevent this.
g Measures selected on the basis of developmental level.
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Bias in the classification of interventions
As for other comparisons, studies were unlikely to misclassify children in terms of the intervention
they received, so all were considered to be at low risk of bias for this domain.
Bias due to deviation from intended interventions
Although therapists in all three studies were trained, followed a teaching manual and were
supervised,26,90,91,98,103 the methods used to assess treatment fidelity in the early intensive
ABA-based intervention arm and data specific to treatment fidelity were not available.
None of the studies recorded whether or not children received any co-interventions alongside those
being evaluated.
Bias due to missing data
All three studies provided IPD for analysis, two of which provided reasonably complete IPD for their
collected outcomes.90,91,103
For the Lovaas study,26 only chronological age, mental age and IQ were available at baseline and IQ and
educational placement at follow-up. VABS data were available only for the higher-intensity intervention
arm and only at longer-term follow-up.98 (Note that no IPD were available for the ‘no treatment’ control
group and baseline data were not published, so this study could not be included in any meta-analysis of
early intensive ABA-based intervention compared with TAU and eclectic interventions.)
Bias in measurement of outcomes
As mentioned previously, truly independent and blinded measurement of outcomes is difficult to
achieve in the evaluation of intensive behavioural interventions. However, Smith et al.103 described
efforts to keep outcome assessors blind, including testing all participants in the same location. There
was also some indication of robustness when outcomes were checked by a truly external examiner.
As described previously, outcomes in Reed et al.90,91 were collected by an educational psychologist who
was blinded to allocation, but helped parents complete Gilliam Autism Rating Scale and VABS tests,
and could potentially have been unblinded by the parental interaction or assessment location. Lovaas26
was considered to be at a higher risk of bias, as outcomes were assessed by project staff members
with no mention of blinding or quality assurance for most participants, although authors did report
‘no significant differences between staff members and outside agency raters’.26
Bias in the selection of the reported result
All three studies26,90,91,103 provided IPD and selection for meta-analysis was based on the methods
described in Chapter 4, Individual participant data meta-analysis methods. However, as for other studies,
research protocols were not available to inform risk-of-bias judgments.
Summary
Three studies26,90,91,103 compared higher- and lower-intensity forms of early intensive ABA-based therapy.
Although Smith et al.103 was considered to be at low risk of bias for most domains, the other studies
were considered to have a serious risk of confounding among other concerns, including a lack of data
on participant characteristics and co-interventions. The original Lovaas study,26 in particular, was at risk
of several forms of bias, with participants receiving treatment non-concurrently and the comparator
groups differing on the few available baseline variables. Although some attempts were made to avoid
bias in the measurement of outcomes, the nature of the intervention makes true blinded assessment
very difficult to achieve. Consequently, any estimate of effects based on a meta-analysis of these studies
will be highly uncertain.
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Clinic- compared with parent-directed early intensive behavioural
intervention treatment
Two studies99,100 compared clinic-directed EIBI with some form of parent-directed EIBI.
Hayward et al.99 compared clinic-based EIBI with a parent-managed treatment model in a UK study.
Like other controlled studies of early intensive ABA-based interventions, treatment allocation was
decided by the eligible family’s proximity to a clinic. The authors did not indicate any overt influence
of parental preference on allocation, but no socioeconomic or parent or family data were collected to
determine whether or not the groups were similar on these measures at baseline. Consequently, the risk
of confounding on these variables could not be ruled out (Tables 38 and 39). Like the majority of other
studies, no data on co-interventions were reported and, although outcome assessors were not informed
of treatment assignment, true blinding of outcome assessors would have been difficult to achieve.
TABLE 38 Risk-of-bias assessment for non-randomised studies comparing clinic- with parent-directed early intensive
ABA-based intervention
Domain
Hayward (2005)99
Risk-of-bias
judgement by
outcome Comment
Bias due to confounding IQ: serious
Non-verbal IQ:
serious
Language
functioning: serious
VABS: serious
Treatment group allocation was decided by time period and
proximity to clinic, so no overt influence of parental preference
on clinic or parent managed
No socioeconomic or parent/family data collected
Bias in selection of
participants into the study
IQ: low
Non-verbal IQ: low
Language
functioning: low
VABS: low
Start of treatment and follow-up appear to coincide
Authors mention only one referral that chose a different
treatment than would have been allocated (choosing parent
managed rather than clinic based)
Five children dropped out before 1 year and were not included in
the analysis (three clinic based and two parent managed; no
observations carried forward or ITT analysis)
Bias in classification of
interventions
IQ: low
Non-verbal IQ: low
Language
functioning: low
VABS: low
Misclassification of intervention is unlikely
Bias due to deviations from
intended interventions
IQ: moderate
Non-verbal IQ:
moderate
Language
functioning:
moderate
VABS: moderate
Treatment integrity was monitored using videotaped sessions
No available data on co-interventions
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TABLE 38 Risk-of-bias assessment for non-randomised studies comparing clinic- with parent-directed early intensive
ABA-based intervention (continued )
Domain
Hayward (2005)99
Risk-of-bias
judgement by
outcome Comment
Bias due to missing data/
IPD
IQ: low
Non-verbal IQ: low
Language
functioning: low
VABS: low
Complete IPD provided for the 44 participants included in the
analysis. Reasons for loss to follow-up among the five excluded
participants not reported, although number lost to follow-up was
small and similar between groups
Bias in measurement of
outcomes
IQ: moderate
Non-verbal IQ:
moderate
Language
functioning:
moderate
VABS: moderate
Follow-up assessments were done by independent psychologists
who were not informed of children’s group assignments, although
truly blind assessment was difficult to achieve
Age-appropriate measures used for IQ
Bias in selection of the
reported result
IQ: n/a
Non-verbal IQ: n/a
Language
functioning: n/a
VABS: n/a
Domain not applicable when IPD have been independently
analysed
VABS subdomain scores were not reported by treatment group
in the publication, but were available in the IPD
n/a, not applicable.
TABLE 39 Risk-of-bias assessment for a randomised study comparing clinic- with parent-directed early intensive
ABA-based intervention
Outcome
aSallows (2005)100
IQ Non-verbal IQ Language VABS ADI-R
Randomisation
process
1.1: was the allocation sequence
random?b
PY PY PY PY PY
1.2: was the allocation sequence
concealed until participants
were recruited and assigned to
interventions?b
NI NI NI NI NI
1.3: were there baseline
imbalances that suggest a
problem with the randomisation
process?
PN PN PN PN PN
Risk-of-bias judgementc Some
concerns
Some
concerns
Some
concerns
Some
concerns
Some
concerns
continued
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TABLE 39 Risk-of-bias assessment for a randomised study comparing clinic- with parent-directed early intensive
ABA-based intervention (continued )
Outcome
aSallows (2005)100
IQ Non-verbal IQ Language VABS ADI-R
Deviations
from intended
interventions
2.1: were participants aware of
their assigned intervention
during the trial?
Yes PY PY PY PY
2.2: were carers and trial
personnel aware of participants’
assigned intervention during
the trial?
Yes Yes Yes Yes Yes
2.3: if yes/PY/NI to 2.1 or 2.2,
were important co-interventions
balanced across intervention
groups?d
NI NI NI NI NI
2.4: was the intervention
implemented successfully?
PY Yes Yes Yes Yes
2.5: did study participants adhere
to the assigned intervention
regimen?
PY PY PY PY PY
2.6: if no/PN/NI to 2.3, 2.4 or
2.5, was an appropriate analysis
used to estimate the effect of
starting and adhering to the
intervention?
n/a n/a n/a n/a n/a
Risk-of-bias judgement Low Low Low Low Low
Missing
outcome data
3.1: were outcome data available
for all, or nearly all, participants
randomised?
Yes Yes Yes Yes Yes
3.2: if no/PN/NI to 3.1, are the
proportions of missing outcome
data and reasons for missing
outcome data similar across
intervention groups?
n/a n/a n/a n/a n/a
3.3: if no/PN/NI to 3.1, is there
evidence that results were
robust to the presence of missing
outcome data?
n/a n/a n/a n/a n/a
Risk-of-bias judgement Low Low Low Low Low
Measurement
of the outcome
4.1: were outcome assessors
aware of the intervention
received by study participants?
PY PY PY PY PY
4.2: if yes/PY/NI to 4.1, was the
assessment of the outcome likely
to be influenced by knowledge of
intervention received?e
NI NI NI NI NI
Risk-of-bias judgement Some
concerns
Some
concerns
Some
concerns
Some
concerns
Some
concerns
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This study was considered to be at low risk for the bias domains relating to selection of participants,
classification of interventions and missing data (complete IPD were provided for the 44 participants
included in the analysis). Although reasons for loss to follow-up for five excluded participants were not
reported, the number lost was small and similar between groups. Unpublished VABS subdomain scores
were available in the IPD data set.
A second study (Sallows et al.100) randomly assigned children to receive clinic- or parent-directed EIBI.
Children were randomised in matched pairs, based on age and IQ. Although the parent-directed group
had a higher non-verbal IQ, most other variables appeared to be similar at baseline.
Unlike most other studies, Sallows et al.100 reported the co-interventions received by children in the
study (including special education preschool, speech therapy, sensory integration, auditory integration
training, music therapy, horseback riding, special diets, vitamin/dimethylglycine treatment, Nystatin and
intravenous immune globulin). However, the distribution of these co-interventions between treatment
groups was not available.
Summary
The two studies comparing clinic- and parent-directed EIBI were of a similar standard to studies for
other comparisons. Although the risks of bias related to the selection of participants, classification of
TABLE 39 Risk-of-bias assessment for a randomised study comparing clinic- with parent-directed early intensive
ABA-based intervention (continued )
Outcome
aSallows (2005)100
IQ Non-verbal IQ Language VABS ADI-R
Selection of
the reported
result
5.1: are the reported outcome
data likely to have been selected,
on the basis of the results, from
multiple outcome measurements
(e.g. scales, definitions, time
points) within the outcome
domain?f
PN PN PN PN PN
5.2 Are the reported outcome
data likely to have been selected,
on the basis of the results, from
multiple analyses of the data?g
NI NI NI NI NI
Risk-of-bias judgement Some
concerns
Some
concerns
Some
concerns
Some
concerns
Some
concerns
Overall risk-of-bias judgement Some
concerns
Some
concerns
Some
concerns
Some
concerns
Some
concerns
n/a, not applicable; NI, no information; PN, probably no; PY, probably yes.
a Individually randomised, parallel group trial.
b Mentioned children were randomly assigned to groups by a UCLA statistician. No information as to how this was
done or if it was concealed. ‘Matched on age and IQ’ suggests matched-pairs randomisation.
c A lack of information on the method of randomisation. The parent-directed group had a higher non-verbal IQ,
but most other variables were similar.
d Additional treatments included preschool special education, speech therapy, sensory integration, auditory integration
training, music therapy, horseback riding, special diets, vitamin/Dimethylglycine treatment, Nystatin, intravenous
immune globulin (however, distribution between treatment groups is unclear).
e Some assessments were done by a study author (likely unblinded), although bias may be less of a problem here,
when they are comparing two forms of their own specialism.
f Used multiple IQ measures, but this was due to the differing developmental level of the children. The results of all
domains (IQ, non-verbal IQ, performance IQ) were reported. More than one language test used; reasons
not reported.
g Split into rapid and moderate learners. No clear a priori theoretical basis for this. However, data are also reported
by treatment group for the outcomes assessed here.
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interventions and completeness of outcome data were low, some concerns remained about the risk
of confounding and bias in measurement of outcomes. These risks increase our uncertainty about the
accuracy of results from these studies, although how they might influence the magnitude or direction
of effects is not clear.
Different forms of applied behaviour analysis-based early intensive
behavioural therapy
A single Canadian study compared a PRT approach with an intervention based on the verbal behaviour
method.101 Children in the verbal behaviour arm were compared with children taken from a separate
PRT-treated cohort, matched on chronological age and cognitive score (Table 40). The role of parental
preference in initial recruitment to each arm was unclear, and no socioeconomic, family or autism
symptom severity data were available to compare the groups at baseline. Outcome assessors were not
blind to treatment allocation and several were done in part by a co-author and active interventionist,
raising serious concerns about risk of bias. Given these concerns, and the small number of participants
(n = 28), the results of this comparison are highly uncertain.
TABLE 40 Risk-of-bias assessment for study comparing different forms of early intensive ABA-based intervention
Domain
Stock (2013)101
Risk-of-bias judgement
by outcome Comment
Bias due to confounding IQ: serious
Language functioning:
serious
VABS: serious
Challenging behaviour:
serious
Parental stress: serious
Verbal behaviour arm was compared with matched
children (chronological age and cognitive score) taken
from a separate cohort of PRT-treated children
Role of parental preference in initial recruitment to
each arm unclear
No socioeconomic, family or autism symptom severity
data available
Bias in selection of participants
into the study
IQ: low
Language functioning:
low
VABS: low
Challenging behaviour:
low
Parental stress: low
The investigator performing the matching was blinded
to other participant variables
Bias in classification of
interventions
IQ: low
Language functioning:
low
VABS: low
Challenging behaviour:
low
Parental stress: low
Misclassification of interventions was unlikely
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TABLE 40 Risk-of-bias assessment for study comparing different forms of early intensive ABA-based
intervention (continued )
Domain
Stock (2013)101
Risk-of-bias judgement
by outcome Comment
Bias due to deviations from
intended interventions
IQ: moderate
Language functioning:
moderate
VABS: moderate
Challenging behaviour:
moderate
Parental stress:
moderate
Treatment fidelity of both programmes assessed by
direct observation and coded videotaped sessions
No information on co-interventions
Bias due to missing data/IPD IQ: low
Language functioning:
low
VABS: low
Challenging behaviour:
low
Parental stress: low
IPD reasonably complete for the collected
outcome measures
Bias in measurement of
outcomes
IQ: serious
Language functioning:
serious
VABS: serious
Challenging behaviour:
serious
Parental stress: serious
Outcomes assessors were not blind to treatment
allocation and several were done in part by a
co-author and active interventionist
Bias in selection of the
reported result
IQ: n/a
Language functioning:
n/a
VABS: n/a
Challenging behaviour:
n/a
Parental stress: n/a
Not applicable when IPD have been
independently analysed
n/a, not applicable.
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Appendix 10 Stock et al.101 analysis
TABLE 41 ‘Nova Scotia EIBI’ compared with ‘group-applied behavior analysis’
Outcome MD SE 95% CI
CBCL composite –1.507 2.348 –6.110 to 3.095
Merrill–Palmer-Revised Developmental Index –4.512 8.467 –21.108 to 12.084
Preschool Language Scale: expressive –2.983 3.185 –9.225 to 3.260
Preschool Language Scale: receptive –1.395 3.711 –8.668 to 5.879
Parenting Stress Index – Short Form 2.995 6.138 –9.036 to 15.026
VABS: composite –3.226 2.563 –8.249 to 1.797
CBCL, Child Behaviour Checklist.
Note
Negative values favour Nova Scotia EIBI.
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Appendix 11 Additional individual
participant data meta-analyses and plots
–1.5 –1 –0.5 0 0.5 1 1.5
MD
0.57
0.18
0.27
0.27
29
28
57
27
48
75
Vivanti 201493
Zachor 201097
Fixed-effect model
Random-effects model
Heterogeneity: I2 = 0%, τ2 = 0, p = 0.48
(–0.39 to 1.54)
(–0.35 to 0.71)
(–0.19 to 0.73)
(–0.19 to 0.73)
MDn TAUn ABAStudy 95% CI
FIGURE 24 Analysis of covariance ADOS at 1 year.
Years after recuitment
M
D
 b
e
tw
e
e
n
 in
te
rv
e
n
ti
o
n
s
–1.0
–0.5
0.0
0.5
1.0
1.5
ADOS –
repetitive behaviour
–1.0
–0.5
0.0
0.5
1.0
1.5
MSEL – composite
–1.0
–0.5
0.0
0.5
1.0
1.5
RDLS – comprehension
–1.0
–0.5
0.0
0.5
1.0
1.5
VABS – motor skills
0 1 2
ADOS – social
MSEL – expressive
RDLS – expressive
VABS – socialisation
0 1 2
ADOS severity score
MSEL – fine motor
IQ
MSEL – receptive
IQ (MPSMT)
MSEL – visual reception
VABS – communication
0 1 2
VABS – composite
0 1 2
VABS – DLS
0 1 2
FIGURE 25 Two-stage SMD ANCOVA. DLS, daily living skills.
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TABLE 42 Meta-analyses incorporating published data not available as IPD
Outcome Year Number of studies Number of children MD 95% CI I2
ADOS severity 1 4 271 –0.06 –0.72 to 0.60 47
2 3 189 –0.50 –2.31 to 1.32 86
IQ 1 7 283 12.37 7.57 to 17.17 0
2 7 258 14.10 8.92 to 19.29 0
MSEL comprehension 1 3 216 4.35 –1.55 to 10.26 0
2 2 109 1.06 –9.80 to 11.93 0
MSEL expressive 1 3 169 2.51 –1.14 to 6.15 0
2 2 75 7.24 0.86 to 13.62 0
MSEL receptive 1 3 169 3.87 –1.11 to 8.85 44
2 2 75 4.46 –8.56 to 17.48 41
RDLS expressive 1 3 98 15.41 7.42 to 23.41 0
2 3 113 12.48 –1.09 to 26.06 64
RDLS receptive 1 1 41 14.60 1.38 to 27.82
2 1 40 18.15 2.28 to 34.02
VABS composite 1 11 527 2.87 –0.59 to 6.32 63
2 10 396 9.38 4.41 to 14.36 72
TABLE 43 Other outcomes not in meta-analyses
Outcome domain Outcome measure Study Year
Number of
children MD 95% CI
Autism symptom
severity
ADI composite Magiati 200789 2 40 –3.63 –12.5 to 5.25
Magiati 200789 7 32 –0.45 –12.22 to 11.32
ADOS
communication
Vivanti 201493 1 51 1.23 –0.07 to 2.53
Magiati 200789 2 24 0.97 –1.09 to 3.03
Magiati 200789 7 34 –0.61 –1.86 to 0.64
ADOS functional
play
Vivanti 201493 1 51 –0.6 –1.9 to 0.71
Magiati 200789 2 24 0.07 –1.67 to 1.82
Magiati 200789 7 34 –0.08 –1.06 to 0.9
ADOS unusual
sensory
Vivanti 201493 1 51 –0.35 –1.6 to 0.89
ADOS social
interaction
Vivanti 201493 1 51 1.12 –0.61 to 2.86
Magiati 200789 2 24 0.3 –4.92 to 5.52
Magiati 200789 7 34 –1.05 –2.89 to 0.79
GARS Reed 200790,91 1 50 –3.13 –7.94 to 1.68
Language
development
BVPS
comprehension
Magiati 200789 2 40 4.73 –7.35 to 16.8
Magiati 200789 7 35 –5.23 –31.13 to 20.66
Expressive one word Magiati 200789 2 41 3.3 –7.12 to 13.72
Magiati 200789 7 35 0.89 –25.98 to 27.76
MSEL general motor Zachor 201097 1 9 5.5 –11.83 to 22.83
RDLS composite Eikeseth 200285 1 24 25.92 10.86 to 40.97
SCQ Vivanti 201493 1 49 3.84 0.17 to 7.52
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TABLE 43 Other outcomes not in meta-analyses (continued )
Outcome domain Outcome measure Study Year
Number of
children MD 95% CI
IQ BSID Magiati 200789 2 35 34.79 15.75 to 53.82
Verbal IQ Eikeseth 200285 7 25 9.15 –10.04 to 28.35
WISC-R Eikeseth 200285 7 22 5.62 –17.82 to 29.06
Magiati 200789 7 9 –4.21 –28.11 to 19.68
WPPSI-R Eikeseth 200285 1 18 1.3 –23.59 to 26.19
Magiati 200789 2 8 –2.83 –36.72 to 31.06
Magiati 200789 7 15 –5.83 –15.98 to 4.32
VABS subscale Maladaptive
behaviour
Eikeseth 200285 1 18 –5.9 –11.81 to 0.01
Magiati 200789 2 40 –7.28 –11.54 to –3.02
Eikeseth 200285 7 22 –6.18 –12.65 to 0.28
Magiati 200789 7 31 –5.12 –11.79 to 1.55
Behaviours that
challenge
CRS ADHD Reed 200790,91 1 48 –1.53 –6.55 to 3.49
CRS cognition Reed 200790,91 1 48 –1.69 –17.63 to 14.24
CRS hyperactivity Reed 200790,91 1 48 –1.31 –6.03 to 3.42
CRS oppositional Reed 200790,91 1 48 9.5 3.03 to 15.97
Other British Abilities Scale Reed 200790,91 1 50 9.48 1.31 to 17.65
ADHD, attention deficit hyperactivy disorder; BVPS, British Picture Vocabulary Scale; CRS, Connors’ Rating Scale;
GARS, Gilliam Autism Rating Scale.
TABLE 44 Network meta-analysis results
Year Treatment Outcome
MD vs. eclectic
intervention 95% CI p-value
1 EIBI ADOS repetitive behaviours 1.09 –1.65 to 3.83 0.44
ADOS social 1.73 –2.35 to 5.81 0.41
ADOS severity score 0.28 –2.88 to 3.45 0.86
IQ 4.18 –4.28 to 12.64 0.33
IQ (MPSMT) –12.56 –30.87 to 5.75 0.18
MSEL composite –1.48 –25.33 to 22.36 0.90
MSEL expressive –0.14 –15.18 to 14.91 0.99
MSEL fine motor 1.15 –14.60 to 16.89 0.89
MSEL receptive 0.99 –13.67 to 15.65 0.89
MSEL visual reception –8.78 –29.66 to 12.10 0.41
RDLS expressive 19.89 –12.26 to 52.04 0.23
VABS communication 0.56 –6.68 to 7.79 0.88
VABS composite –0.24 –6.68 to 6.19 0.94
VABS DLS –2.96 –8.57 to 2.65 0.30
VABS motor skills –3.39 –10.60 to 3.81 0.36
VABS socialisation –4.41 –8.92 to 0.10 0.06
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TABLE 44 Network meta-analysis results (continued )
Year Treatment Outcome
MD vs. eclectic
intervention 95% CI p-value
EIBI and NDBI IQ 4.89 –3.57 to 13.36 0.26
IQ (MPSMT) –24.69 –48.32 to –1.05 0.04
RDLS comprehension 16.19 –6.60 to 38.98 0.16
RDLS expressive –9.87 –39.22 to 19.49 0.51
VABS communication 5.47 –1.68 to 12.63 0.13
VABS composite 3.48 –4.48 to 11.44 0.39
VABS DLS 2.17 –4.60 to 8.95 0.53
VABS motor skills 6.27 –4.62 to 17.16 0.26
VABS socialisation 1.37 –6.34 to 9.08 0.73
EIBI and NDBI (PM) IQ 5.62 –3.99 to 15.23 0.25
IQ (MPSMT) –33.66 –56.21 to –11.11 0.00
RDLS comprehension 15.52 –8.95 to 39.99 0.21
RDLS expressive –9.87 –39.18 to 19.45 0.51
VABS communication –1.97 –14.53 to 10.59 0.76
VABS composite 2.88 –11.43 to 17.18 0.69
VABS DLS –10.83 –25.72 to 4.05 0.15
VABS motor skills 7.18 –16.36 to 30.71 0.55
VABS socialisation 2.85 –9.36 to 15.06 0.65
EIBI low intensity IQ –5.44 –16.91 to 6.03 0.35
VABS composite –5.52 –24.69 to 13.65 0.57
ESDM ADOS repetitive behaviours –0.64 –3.46 to 2.18 0.66
ADOS social 0.08 –2.90 to 3.06 0.96
ADOS severity score 1.37 –2.09 to 4.83 0.44
MSEL composite 5.04 –20.00 to 30.07 0.69
MSEL expressive 2.23 –13.07 to 17.52 0.78
MSEL fine motor 2.27 –18.31 to 22.86 0.83
MSEL receptive 1.07 –14.80 to 16.94 0.90
MSEL visual reception 2.69 –18.11 to 23.48 0.80
VABS communication –9.79 –34.84 to 15.25 0.44
VABS composite –1.26 –19.66 to 17.15 0.89
VABS DLS –12.85 –38.77 to 13.08 0.33
VABS motor skills –5.14 –24.29 to 14.01 0.60
VABS socialisation –5.80 –25.39 to 13.78 0.56
NDBI IQ (MPSMT) –49.43 –75.91 to –22.95 0.00
VABS composite 3.76 –16.03 to 23.54 0.71
Portage IQ –8.89 –28.72 to 10.94 0.38
VABS composite –5.85 –24.85 to 13.16 0.55
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TABLE 44 Network meta-analysis results (continued )
Year Treatment Outcome
MD vs. eclectic
intervention 95% CI p-value
TAU IQ –5.63 –18.37 to 7.11 0.39
IQ (MPSMT) –46.25 –88.69 to –3.80 0.03
RDLS expressive –26.14 –63.21 to 10.92 0.17
VABS communication –8.59 –23.18 to 6.00 0.25
VABS composite –3.66 –16.51 to 9.20 0.58
VABS DLS –2.48 –10.88 to 5.91 0.56
VABS socialisation –4.41 –16.35 to 7.53 0.47
2 EIBI ADOS repetitive behaviours –0.29 –3.23 to 2.66 0.85
ADOS social 0.36 –3.95 to 4.66 0.87
ADOS severity score –1.55 –4.96 to 1.85 0.37
IQ 19.23 10.16 to 28.31 0.00
IQ (MPSMT) –9.10 –25.58 to 7.37 0.28
MSEL composite 0.95 –27.21 to 29.11 0.95
MSEL expressive –0.24 –18.22 to 17.74 0.98
MSEL fine motor 1.54 –16.02 to 19.11 0.86
MSEL receptive 2.57 –14.52 to 19.65 0.77
MSEL visual reception –11.48 –36.04 to 13.07 0.36
RDLS comprehension 11.77 –22.07 to 45.61 0.50
RDLS expressive 2.81 –26.98 to 32.60 0.85
VABS communication 7.36 –0.47 to 15.18 0.07
VABS composite 9.39 2.46 to 16.32 0.01
VABS DLS 8.69 2.87 to 14.51 0.00
VABS motor skills 4.69 –3.19 to 12.58 0.24
VABS socialisation 5.98 1.05 to 10.91 0.02
EIBI and NDBI IQ 20.75 11.71 to 29.79 0.00
IQ (MPSMT) –9.73 –32.86 to 13.39 0.41
RDLS comprehension 12.61 –12.24 to 37.46 0.32
RDLS expressive 18.69 –6.70 to 44.08 0.15
VABS communication 10.40 2.29 to 18.51 0.01
VABS composite 10.50 1.87 to 19.14 0.02
VABS DLS 9.41 1.83 to 16.98 0.01
VABS motor skills 8.85 –2.95 to 20.65 0.14
VABS socialisation 7.32 –0.93 to 15.57 0.08
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TABLE 44 Network meta-analysis results (continued )
Year Treatment Outcome
MD vs. eclectic
intervention 95% CI p-value
EIBI and NDBI (PM) IQ 19.62 7.99 to 31.25 0.00
IQ (MPSMT) –22.22 –44.97 to 0.53 0.06
RDLS comprehension 11.86 –14.09 to 37.80 0.37
RDLS expressive 18.69 –7.43 to 44.81 0.16
VABS communication 8.23 –6.25 to 22.71 0.27
VABS composite 11.35 –4.31 to 27.01 0.16
VABS DLS –5.92 –22.23 to 10.39 0.48
VABS motor skills 29.24 –7.23 to 65.71 0.12
VABS socialisation 8.32 –5.30 to 21.93 0.23
EIBI low intensity IQ 8.89 –6.44 to 24.21 0.26
TAU IQ 6.45 –6.57 to 19.48 0.33
IQ (MPSMT) –27.33 –69.40 to 14.75 0.20
RDLS comprehension –3.70 –35.81 to 28.40 0.82
RDLS expressive 4.72 –28.19 to 37.62 0.78
VABS communication –1.25 –16.20 to 13.70 0.87
VABS composite 1.32 –11.86 to 14.49 0.84
VABS DLS 2.40 –6.47 to 11.27 0.60
VABS socialisation 2.12 –10.07 to 14.31 0.73
DLS, daily living skills; PM, parent managed.
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TABLE 45 Results of interaction analyses
Outcome Factor Variation in MD 95% CI p-value
ADOS repetitive behaviours Age at recruitment (per month) 0.07 0.02 to 0.12 0.01
Sex –0.15 –1.61 to 1.32 0.85
VABS at baseline (per point) –0.01 –0.07 to 0.04 0.64
ADOS social Age at recruitment (per point) –0.03 –0.13 to 0.06 0.49
Sex 2.54 –0.37 to 5.45 0.09
VABS at baseline 0.12 0 to 0.23 0.05
ADOS severity score Age at recruitment 0 –0.06 to 0.05 0.93
Sex 1.06 –0.52 to 2.63 0.19
VABS at baseline 0.05 –0.01 to 0.11 0.12
IQ (MPSMT) Age at recruitment –0.32 –0.81 to 0.17 0.21
Sex 14.67 –4.52 to 33.85 0.13
IQ at baseline –0.12 –0.52 to 0.29 0.57
VABS at baseline –0.06 –0.75 to 0.63 0.87
IQ Age at recruitment 0.08 –0.26 to 0.42 0.64
Sex –1.3 –13.36 to 10.76 0.83
IQ at baseline 0.09 –0.13 to 0.31 0.44
VABS at baseline –0.11 –0.58 to 0.35 0.63
MSEL composite Age at recruitment –0.28 –0.85 to 0.28 0.33
Sex 27.25 9.77 to 44.73 0
VABS at baseline 0.43 –0.18 to 1.04 0.16
MSEL expressive Age at recruitment –0.07 –0.44 to 0.29 0.7
Sex 8.8 –2.58 to 20.18 0.13
VABS at baseline 0.02 –0.39 to 0.43 0.92
MSEL fine motor Age at recruitment 0.36 0.05 to 0.68 0.02
Sex 0.55 –9.33 to 10.42 0.91
VABS at baseline –0.19 –0.54 to 0.16 0.29
MSEL receptive Age at recruitment 0.29 –0.05 to 0.64 0.09
Sex 11.53 0.49 to 22.57 0.04
VABS at baseline –0.18 –0.58 to 0.22 0.39
MSEL visual reception Age at recruitment –0.03 –0.59 to 0.52 0.91
Sex 7.53 –6.97 to 22.04 0.31
VABS at baseline 0.23 –0.29 to 0.75 0.38
RDLS comprehension Age at recruitment –0.07 –1.33 to 1.19 0.91
Sex 30.38 5.71 to 55.04 0.02
IQ at baseline 0.12 –0.4 to 0.65 0.64
VABS at baseline 0.66 –0.23 to 1.55 0.14
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TABLE 45 Results of interaction analyses (continued )
Outcome Factor Variation in MD 95% CI p-value
RDLS expressive Age at recruitment 0.13 –0.74 to 0.99 0.78
Sex 30.24 7.17 to 53.32 0.01
IQ at baseline –0.07 –0.65 to 0.5 0.8
VABS at baseline 0.18 –0.72 to 1.09 0.69
VABS communication Age at recruitment –0.05 –0.37 to 0.27 0.76
Sex 5.49 –3.3 to 14.28 0.22
IQ at baseline 0.11 –0.11 to 0.33 0.33
VABS at baseline 0 –0.34 to 0.33 0.98
VABS composite Age at recruitment –0.05 –0.29 to 0.18 0.65
Sex 3.28 –3.08 to 9.65 0.31
IQ at baseline 0.09 –0.06 to 0.23 0.24
VABS at baseline –0.05 –0.28 to 0.18 0.66
VABS DLS Age at recruitment 0.04 –0.19 to 0.27 0.72
Sex 3.91 –3.39 to 11.2 0.29
IQ at baseline 0.08 –0.1 to 0.25 0.39
VABS at baseline –0.02 –0.28 to 0.23 0.86
VABS motor skills Age at recruitment 0.16 –0.2 to 0.53 0.38
Sex 2.15 –7.08 to 11.38 0.65
IQ at baseline –0.34 –0.76 to 0.08 0.11
VABS at baseline –0.3 –0.65 to 0.05 0.09
VABS socialisation Age at recruitment 0.07 –0.16 to 0.29 0.58
Sex 4.92 –1.74 to 11.57 0.15
IQ at baseline 0.04 –0.13 to 0.22 0.62
VABS at baseline 0.02 –0.22 to 0.26 0.86
DLS, daily living skills.
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Appendix 12 Rogers et al.102
Overview
At the time of writing the current report, a manuscript reporting the results of an additional eligible
study by Rogers et al.102 was published online. As insufficient time was available to fully integrate the
study into the body of the report, it is briefly summarised here.
This study was described as a ‘single-blind randomised, multi-site, intent-to-treat study . . . designed to
replicate Dawson et al. (2010) randomized controlled trial (RCT) testing effects of the Early Start Denver
Model (ESDM), an intensive play- and routines-based intervention delivered in natural settings’.102
Participants and interventions
A total of 118 children with ASD (with a baseline mean age of 20.6 months and ADOS severity score
of 7.49) were randomly assigned to ESDM or community interventions for 27 months (Table 46). The
study was conducted at three separate universities.
Children assigned to ESDM intervention initially received 3 months of weekly parent coaching (3.15
intervention hours/week, on average). This was followed by 24 months of more intensive one-to-one
intervention in homes or day care settings from supervised therapy assistants, while parents received
4 hours of coaching per month from a certified ESDM therapist (average of 18.5 intervention hours/week
for months 3–15 and 25.7 hours/week for months 15–27). Treatment procedures followed published
manuals and a study treatment supervisor oversaw treatment at all three sites to ensure consistency.
Treatment fidelity of implementation was assessed on the basis of coded videotaped sessions.
Children in the community group continued to receive whatever interventions their parents arranged
(averaging 5.28 intervention hours/week in the first 3 months, 14.9 intervention hours/week for
months 3–15 and 20 hours/week for months 15–27). No further details on community intervention
were available.
Co-interventions (across both intervention groups) included ABA; occupational therapy; physiotherapy;
speech and language therapy; TEACCH; the developmental, individual difference, relationship-based
model; play therapy; home session with infant/toddler educators; infant/toddler treatment groups;
and formal preschool/educational settings, as well as study ESDM hours.
Risk of bias
Unlike previous studies, this RCT employed an independent data co-ordinating centre to undertake
randomisation and data analyses, and was described by the authors as an ITT RCT (Table 47).
However, despite being described as a replication of Dawson et al.,83 this study differed from the original
study in several respects, primarily relating to the collection of outcomes. The Rogers et al.102 manuscript
stated that the primary outcome was a ‘language composite age equivalent score [calculated] by averaging
the Expressive Language and Receptive Language age-equivalents from the MSEL at each time point’.
This specific measure was not employed in the original study and the published protocol [URL: https://
clinicaltrials.gov/ct2/show/NCT00698997 (accessed 4 February 2020)] does not name a primary (or any
other) outcome domain. However, the authors state that outcomes were prespecified and provided in
writing to an independent Data Safety and Monitoring Board before any analyses began, and that
adherence to the prespecified plan was monitored by the independent data co-ordinating centre.
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TABLE 46 Baseline characteristics of Rogers et al.102
First study
author (year)
Intensive
ABA-based
intervention
name
Comparator
name
Number of
intervention
participants
Number of
comparator
participants
Treatment
duration
(months)
Actual delivered
treatment intensity
(hours/week)
Mean (SD or range)
age at baseline
(months unless
otherwise stated)
Sex
(male/female)
Baseline ASD
severity
[measure]
Baseline
full-scale IQ
[measure]
Mean (SD) baseline
Vineland adaptive
behaviour
composite score
EIBI vs. TAU/eclectic intervention(s)
Rogers (2019)102 ESDM TAU 63 55 I 27; C 27 I 0–3 months= 3.15,
3–15 months= 18.54,
15–27 months= 25.73;
C 0–3 months= 5.28,
3–15 months= 14.85,
15–27 months= 20.01
I 20.6 (3.37);
C 20.7 (3.21)
I 41/14; C
51/12
I 7.20 (1.94);
C 7.83 (1.97)
[ADOS severity
score]
I 66.98 (18.61);
C 64.52
(15.56) [MSEL
developmental
quotient]
I 12.8 (4.66);
C 12.91 (5.79)
[VABS composite
‘age equivalent’]
C, comparator; I, intervention.
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TABLE 47 Risk-of-bias assessment for Rogers et al.102
Outcome
aRogers (2019)102
Language
composite
age-equivalent
(based on
MSEL)
Developmental
quotient
(MSEL)
VABS age-
equivalent
composite
ADOS
severity
score
Randomisation
process
1.1: was the allocation
sequence random?b
Yes Yes Yes Yes
1.2: was the allocation
sequence concealed
until participants were
recruited and assigned to
interventions?b
Yes Yes Yes Yes
1.3: were there baseline
imbalances that suggest
a problem with the
randomisation process?c
No No No No
Risk-of-bias judgement Low Low Low Low
Deviations
from intended
interventions
2.1: were participants aware
of their assigned intervention
during the trial?
Yes Yes Yes Yes
2.2: were carers and trial
personnel aware of
participants’ assigned
intervention during the trial?
Yes (parents) Yes (parents) Yes (parents) Yes (parents)
2.3: if yes/PY/NI to 2.1 or 2.2,
were there deviations from
the intended intervention
beyond what would be
expected in usual practice?
NI NI NI NI
2.4: if yes/PY to 2.3, were
these deviations from
intended intervention
unbalanced between groups
and likely to have affected
the outcome?d
n/a n/a n/a n/a
2.5: were any participants
analysed in a group different
from the one to which they
were assigned?e
No No No No
2.6: if yes/PY/NI to 2.5,
was there potential for
a substantial impact
(on the estimated effect of
intervention) of analysing
participants in the
wrong group
n/a n/a n/a n/a
Risk-of-bias judgement Some concerns Some concerns Some
concerns
Some
concerns
Missing
outcome data
3.1: were outcome data
available for all, or nearly all,
participants randomised?f
No No No No
3.2 if no/PN/NI to 3.1, are
the proportions of missing
outcome data and reasons for
missing outcome data similar
across intervention groups?
g
No No No No
continued
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TABLE 47 Risk-of-bias assessment for Rogers et al.102 (continued )
Outcome
aRogers (2019)102
Language
composite
age-equivalent
(based on
MSEL)
Developmental
quotient
(MSEL)
VABS age-
equivalent
composite
ADOS
severity
score
3.3 if no/PN/NI to 3.1, is
there evidence that results
were robust to the presence
of missing outcome data?h
NI NI NI NI
Risk-of-bias judgement Some concerns Some concerns Some
concerns
Some
concerns
Measurement
of the outcome
4.1: were outcome assessors
aware of the intervention
received by study
participants?i
No No Yes No
4.2: if yes/PY/NI to 4.1,
was the assessment of the
outcome likely to be
influenced by knowledge
of intervention received?
n/a n/a NI n/a
Risk-of-bias judgement Low Low Some
concerns
Low
Selection of
the reported
result
5.1: are the reported
outcome data likely to have
been selected, on the basis
of the results, from multiple
outcome measurements
(e.g. scales, definitions, time
points) within the outcome
domain?
j
NI NI NI NI
5.2: are the reported
outcome data likely to have
been selected, on the basis
of the results, from multiple
analyses of the data?k
NI NI NI NI
Risk-of-bias judgement Some concerns Some concerns Some
concerns
Some
concerns
Overall risk of
biasl
Negative values favour Nova
Scotia EIBI
Some concerns Some concerns Some
concerns
Some
concerns
n/a, not applicable; NI, no information; PN, probably no; PY, probably yes.
a Individually randomised, parallel group trial.
b Computerised randomisation based on three prespecified blocks: age (12–20 months, ≥ 20 months), sex and
developmental quotient (< 60, > 60). Blocks were monitored and a difference of 3 between treatment groups
resulted in compensatory assignment to maximise equal samples.
c Slight differences in years of maternal education and baseline autism symptom severity scores, but likely to be due
to chance.
d Fidelity was scored based on videotaped sessions, and ‘there were no significant site-based differences’. Detailed
information was collected on co-interventions but not reported by treatment group.
e ‘Given the intent to treat design, all enrolled children’s data were gathered and analysed in the original assignment
group; children who dropped out continued to be assessed whenever possible’.102 ‘81 children completed the full
treatment course and all assessments; data from all 118 children were used in analyses’.102
f At 2 years, data were available on 81 of 118 participants (69%).
g At 2 years, data were available for 80% of ESDM children and 58% of community intervention children.
h ‘Data from all 118 children were used in analyses’.102 Unclear if this means at all time points, including those with
loss to follow-up. Although ITT would imply that this was the case, it is unclear if last observation carried forward or
other methods of imputation were applied.
i VABS assessed by parents aware of group assignment. Other outcomes assessed by ‘assessors naive to groups’.102
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Similarly, the approaches to measuring cognitive development and adaptive behaviour differed from
the original study. The original Dawson et al. study83 used the MSEL composite and VABS composite
standard scores. However, a quotient score was calculated for MSEL in this study ‘since many children
fell below the basal standard score’, and an ‘adaptive behaviour age equivalent’ was calculated by
averaging the means of the age equivalents of the four domain scores from VABS-II ‘because the
manual does not provide developmental ages corresponding to total scores that could be used to
construct quotient scores’.102
At 2 years, data were available for only 69% of participants (81/118), although the authors stated that
‘data from all 118 children were used in analyses’.102 It is unclear whether or not this means that all
participants lost to follow-up were accounted for in the analyses at each time point. Although ITT
would imply that this was the case, it is unclear if last observation carried forward or other methods
of imputation were applied.
Although this study appears to be at lower risk of bias than earlier studies in some respects, concerns
about bias remain due to a lack of clarity in the reporting of some aspects of study conduct and findings.
Results
Language composite age-equivalent score increased more over time for ESDM than community
intervention in two study sites, but increased more for community intervention than ESDM at one
study site. Across all three sites, age-equivalent language scores favoured ESDM (39.9 months vs.
35 months at the end of follow-up).
No significant differences were found between ESDM and community treatment in terms of autism
symptom severity (ADOS), developmental quotient (MSEL) or adaptive behaviour (VABS).
Developmental quotient, baseline ADOS play score, baseline joint attention percentage scores and
maternal education were investigated as potential moderating variables. With the exception of baseline
developmental quotient on ADOS severity score at follow-up, no variable appeared to moderate
effects on any outcome measure.
j Despite being described as a replication of Dawson et al. 2010,83 the primary outcome was a ‘language composite
age equivalent score by averaging the Expressive Language and Receptive Language age – equivalents from the
MSEL at each time point’.102 This was not measured in the original study and no specific outcome domains or
measures were named in the published protocol [URL: https://clinicaltrials.gov/ct2/show/NCT00698997 (accessed
4 February 2020)]. However, the authors state that the outcomes were prespecified and provided in writing to an
independent Data Safety and Monitoring Board before any analyses began, and that adherence to the prespecified
plan was monitored by the independent data co-ordinating centre at UCLA. A quotient score was calculated for MSEL
‘since many children fell below the basal standard score’.102 ‘Adaptive behaviour age equivalent was characterized by
averaging the means of the age equivalents of the four domain scores from VABS-II because the manual does not provide
developmental ages corresponding to total scores that could be used to construct quotient scores’.102 The original
Dawson et al.83 study used the MSEL composite and VABS composite standard scores.
k An independent data co-ordinating centre conducted data analyses. However, the list of planned analyses are not
reported in the published protocol [URL: https://clinicaltrials.gov/ct2/show/NCT00698997 (accessed 4 February 2020)]
or online manuscript.
l The use of an independent data co-ordinating centre for randomisation and data analyses reduces the risk of bias,
although this replication study differs from the original study in several respects and information about planned analyses,
deviations from intended interventions and missing outcomes make it difficult to rule out bias for these domains.
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FIGURE 27 Meta-analysis of composite VABS score at 1 year.
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FIGURE 28 Meta-analysis of composite VABS score at 2 years.
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FIGURE 29 Meta-analysis of MSEL score at 1 year.
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FIGURE 30 Meta-analysis of MSEL score at 2 years.
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Appendix 13 Cost-effectiveness review
Overview
A systematic review of studies evaluating the cost-effectiveness of early intensive ABA-based
interventions was undertaken. The purpose of this review was to provide a summary of the existing
cost-effectiveness evidence, and to provide an overview of modelling approaches and assumptions
employed in previous economic evaluation.
Methods
To identify published economic evidence, the following databases were searched for eligible studies:
MEDLINE (Ovid), EMBASE (Ovid) 1980 onwards, CINAHL (EBSCOhost), The Cochrane Library
(Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effects, HTA
database and CENTRAL). The searches were undertaken in November 2017. The full search strategy
used is reported in Appendix 17.
Study selection
Two researchers independently undertook the screening of all titles and abstracts identified in the
search. Full-paper publications were then obtained for potentially relevant studies and screened
against the eligibility criteria. Disagreements between reviewers were resolved by discussion.
Studies were included in the review if they assessed the cost-effectiveness of early intensive ABA-based
interventions relative to any other intervention. A broad range of studies were considered for inclusion in
the assessment of cost-effectiveness, including economic evaluations conducted alongside trials, modelling
studies and analyses of administrative databases. Only full economic evaluations that compared two or
more options and considered both costs and consequences (including cost-effectiveness, cost–utility or
cost–benefit analyses) were included.
Data extraction and quality assessment strategy
Details of eligible studies were extracted and summarised using a Microsoft Excel data extraction
template. Data were extracted by one reviewer and checked by a second reviewer. Disagreements
between reviewers was resolved through discussion. Data extraction included the following items: type
of economic analysis, population, interventions, comparators, perspective, time horizon, structure and
type of model used, clinical effectiveness data, source of quality of life (when appropriate), resource
use data, unit cost data, price year, discounting and results of presented analysis, including sensitivity
analyses. Quality assessment of the included studies was also undertaken as part of the extraction
process using the modified Philips et al.167 checklist.
Results
Search results
A flow diagram describing study selection is presented in Figure 33. A total of 233 studies were
identified from the searches after removing duplicates. Following assessment of title and abstract,
full texts were obtained for 17 studies and scrutinised against the inclusion criteria. A total of six
studies44,50–54 were found to meet the eligibility criteria and were included in the review.
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Description of included studies
The full data extraction from the six studies identified in the systematic review of cost-effectiveness is
presented in Table 48, with quality assessment presented in Table 49.
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FIGURE 33 Flow diagram showing study selection for the economic evaluations review.
TABLE 48 Summary table of identified cost-effectiveness studies
Study Details
Jacobson (1998)52
Country USA
Year of cost analysis 1996
Currency US dollar
Intervention costs per year US$32,820 (US$50,000 used in model)
Source Government report
Decision analysis model
overview
Cost–benefit analysis was conducted using decision tree (cost model)
Perspective Public sector perspective
Discount rate: benefits and
costs
Not applied, but inflation adjusted
Time horizon (1) 18 years and (2) 52 years
Population details Children with autism, PDD-NOS
Intervention vs. comparator(s) EIBI for 3 years (Lovaas model26) vs. no EIBI
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TABLE 48 Summary table of identified cost-effectiveness studies (continued )
Study Details
Primary effectiveness
measure(s)
The benefits for EIBI for autism were estimated by classifying individuals into three
groups: (1) normal functioning, defined as participation in regular education with little
or no support, and are vocationally productive as adults; (2) children who derive
sufficient benefit that they can participate in less intensive special education, and
have reduced dependency in adulthood; and (3) children who still require specialised
and intensive educational and adult services
Costs considered Early intervention annual cost, family support services annual cost, education costs,
home- and community-based services, institutional services, supplemental security
income/aid to dependent children annual cost (estimate for all generic public support
costs) and value of supported wages value
Costs source Used Pennsylvania model – costs for services and income estimates
Results Incremental costs presented at differing levels of effectiveness
Sensitivity analysis
undertaken and results
n/a
Motiwala (2006)53
Country Canada
Year of cost analysis 2003
Currency Canadian Dollar
Intervention costs per year CA$75,670 per child aged 2–5 years based on 23 hours/week of therapy for 3 years
Source Ontario Ministry of Children’s Services and Ontario Ministry of Community (now the
Ministry of Children, Community and Social Services)
Decision analysis model
overview
Cost-effectiveness analysis using decision tree
Perspective Government perspective
Discount rate: benefits and
costs
3.0% discount rate for costs. In sensitivity analyses, discount rates from 1.0% to 5.0%
were used
Time horizon Age 65 years
Population details Autistic children
Intervention vs. comparator(s) Expansion of EIBI services vs. status quo provision vs. no intervention. IBI based on
Ontario Ministry of Children’s Services and Ontario Ministry of Community and Social
Services, and assumes 23 hours/week for 3 years
Primary effectiveness
measure(s)
Children were categorised according to their levels of functioning – normal, semi-
dependent and very dependent – on completion of IBI until the age of 65 years.
Efficacy rates for no intervention, the cohort that received no IBI, were based on
published literature. It was assumed that 25% attain normal functioning, 25% are
semi-dependent and 50% are very dependent without receiving IBI (Freeman168). The
efficacy rates for expansion were assumed to be 30% normal, 50% semi-dependent
and 20% very dependent. The resultant efficacy rates for status quo were 26.9%
normal, 34.3% semi-dependent and 38.9% very dependent
Costs considered Costs for government-funded respite services and speech and language therapy;
special education costs; adult care costs; adult day programmes costs; costs of living
in public residential facilities; disability support
Costs source Multiple sources, including various government sectors and education department
Results Incremental cost savings per individual: no intervention vs. status quo =CA$19,241;
no intervention vs. expansion =CA$53,720; status quo expansion =CA$34,479
Sensitivity analysis
undertaken and results
Yes
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TABLE 48 Summary table of identified cost-effectiveness studies (continued )
Study Details
Chasson (2007)50
Country USA
Year of cost analysis NR
Currency US Dollar
Intervention costs per year US$22,500
Source Assumption
Decision analysis model
overview
Cost comparison and cost saving analysis using a simple decision tree model
Perspective Government perspective
Discount rate – benefits and
costs
None
Time horizon 18 years (age range 4–22 years)
Population details Children with autism
Intervention vs. comparator(s) EIBI programme (Lovaas model26) delivered for 3 years vs. special education services
Primary effectiveness
measure(s)
The benefits for EIBI were model with respect to the use of special education
services, with children categorised as either mainstreaming or dependent on specialist
education services. Effectiveness estimates were drawn directly from Lovaas26 and
assumed 72% of children will receive a mainstream education. For children receiving
special education services, it was assumed that all children would not be reliant on
these services throughout their childhood
Costs considered Utilised a method from Jacobson et al.52 for hypothetically comparing the costs of
special education with the costs of EIBI for children with autism in Texas, USA.
The formula incorporates special educations costs, EIBI costs, EIBI effectiveness,
population estimates of children with autism in Texas and the expected number of
years required for each type of service
Costs source Various sources based on literature and reports, and assumptions based on no
evidence
ICER A total saving of US$84,300 per child in state-budgeted funds is achieved over
the total school years. Comparing the reported actual cost of a special education
programme with a 3-year EIBI programme (and a 72% special education offset)
suggested savings of US$208,500 per child
Sensitivity analysis
undertaken and results
None
Peters-Scheffer (2012)44
Country Netherlands
Year of cost analysis Not reported
Currency Euro
Intervention costs per year €33,333
Source Micro costing
Decision analysis model
overview
A cost–offset analysis using a decision tree
Perspective Public sector
Discount rate: benefits and
costs
Not reported
Time horizon Age 3–65 years
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TABLE 48 Summary table of identified cost-effectiveness studies (continued )
Study Details
Population details Children with ASD
Intervention vs. comparator(s) EIBI vs. TAU. EIBI assumed to be delivered at average intensity of 32.54 hours/week
for a total of 27.01 months, based on a meta-analysis of studies assessing the
effectiveness of EIBI
Primary effectiveness
measure(s)
Children were categorised into three groups according to their level of functioning.
The first group comprised children who achieve normal functioning, defined as
participation in regular education with little or no support, and who are vocationally
productive as adults. The second group consisted of children who participate in less
intensive special education and have reduced dependency in adulthood. The third
group requires continuing specialised, intensive educational and adult services.
Efficacy rates were based on published literature (six meta-analyses studies)
Costs considered Child cost: costs of education, parents of (semi-) dependent children aged between
3 and 18 years old receive a compensation in the costs of raising a child with a disability
Adult costs: disability benefit, costs for adult living and day programmes or supported
work were obtained from the Dutch government, cost of minimal support and care,
cost of intensive comprehensive support and care
Costs source Various sources based on literature/reports and service costs
Results Long-term savings were approximately €1,103,067
Sensitivity analysis
undertaken and results
None
Penner (2015)54
Country Canada
Year of cost analysis 2013
Currency Canadian Dollar
Intervention costs per year CA$56,000
Source Government report
Decision analysis model
overview
Decision tree
Perspective Government payer perspective and societal perspective
Discount rate: benefits and
costs
3% discount rate was applied to both cost and effectiveness
Time horizon Age 65 years
Population details Children with ASD
Intervention vs. comparator(s) Intensive ESDM was compared with parent-delivered ESDM and EIBI. Intensive ESDM
was assumed to be therapist-delivered early intensive ABA-based therapy and based
on Dawson et al.83 was assumed to be delivered for 20 hours/week for 2 years. Parent-
delivered ESDM was parent delivered with 1 hour of therapist training, delivered for
12 weeks. The remainder of the intervention was delivered by parents. EIBI was
defined with respect to usual provision in Ontario, Canada, no details provided
Primary effectiveness
measure(s)
Assumed that 37% of children received EIBI. In the intensive ESDM and parent-
delivered ESDM, gains in IQ of 17.6 and 4.94 points were assumed, respectively.
IQ outcomes were stratified into children with IQ above and below 70, from which
the probability of achieving different levels of dependence was modelled. Children
achieving independence were assumed to accrue 60 DFLYs and semi-dependence
30 DFLYs, whereas those remaining dependent were assumed to accrue 0 DFLYs
Costs considered Costs for government-funded respite services and speech and language therapy;
special education costs; adult care costs; adult day programmes costs; costs of living
in public residential facilities; disability support
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TABLE 48 Summary table of identified cost-effectiveness studies (continued )
Study Details
Costs source Costs for each pathway were determined using the budget of an ESDM pilot project
and government publications
Results ICERs were calculated for the intensive ESDM group. Compared with the EIBI,
intensive ESDM cost an additional CA$12,237 per person and generated an
additional 0.53 DFLYs, resulting in an ICER of ≈CA$23,000/DFLY. Compared with the
parent-delivered ESDM, intensive ESDM cost an additional CA$20,871 and generated
an additional 0.36 DFLYs. The resulting ICER was ≈CA$58,000/DFLY
Sensitivity analysis
undertaken and results
Yes
Cidav (2017)51
Country USA
Year of cost analysis 2015
Currency US Dollar
Intervention costs per year US$60,369 (US$16,015) annual costs
Source Micro costing
Decision analysis model
overview
Trial-based cost–offset analysis
Perspective Public sector
Discount rate: benefits and
costs
Only costs were discounted on a 3% rate after the first year
Time horizon Two time horizons were considered: (1) intervention period – included all service use
that occurred from the onset of the intervention to the 2-year assessment, including
the ESDM use; and (2) post-intervention period – included all service use that
occurred from the 2-year assessment to the age 6 years assessment
Population details Children with ASD or PDD-NOS
Intervention vs. comparator(s) ESDM vs. community care, including ABA/EIBI. The ESDM arm received 14.8 hours/
week, on average, of either ESDM or ABA/EIBI services compared with 9.4 hours/
week of ABA/EIBI services in the community arm. Initial duration of therapy was
2 years, but children could continue to receive ABA/EIBI beyond this period
Primary effectiveness
measure(s)
Clinical effectiveness parameters were not included. Annualised service use and costs
during the intervention and post intervention for the two study arms were compared
Costs considered Parents reported children’s service use, collected every 6 months from enrolment to
final follow-up (age 6 years). Services were grouped into the following categories:
ESDM, ABA/EIBI, general education (for children < 5 years of age, day care-type
typical class; for children > 5 years of age, school-based typical class), occupational
and physical therapy, social skills training, special education, speech therapy and other
miscellaneous (biomedical therapy, music therapy, parent-focused therapy, nutritional
therapy, counselling and psychological services). ‘Total health-related service use’ was
defined as sum of all use of these services except general education
Costs source Parents reported children’s service use which was collected alongside the trial every
6 months from enrolment to final follow-up (age 6 years)
Results Total health-related cost comparison: (1) intervention period: ESDM –
US$60,369 (SD US$16,015) vs. community care – US$45,975 (SD US$33,089); and
(2) post-intervention period: ESDM – US$31,962 (SD US$17,220) vs. US$50,969
(SD US$37,945)
Sensitivity analysis
undertaken and results
None
DFLY, dependency-free life-year; n/a, not applicable; NR, not reported.
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TABLE 49 Summary of quality assessment checklist
Quality assessment
Jacobson
(1998)52
Motiwala
(2006)53
Chasson
(2007)50
Peters-
Scheffer
(2012)44
Penner
(2015)54
Cidav
(2017)51
Study question
1. Costs and effects examined Yes Yes Yes Yes Yes No
2. Alternatives compared Yes Yes Yes Yes Yes Yes
3. The viewpoint(s)/perspective of the
analysis is clearly stated (e.g. NHS,
society)
Yes Yes Yes Yes Yes Yes
Selection of alternatives
4. All relevant alternatives are compared
(including do-nothing if applicable)
Yes Yes Yes Yes Yes Yes
5. The alternatives being compared are
clearly described (who did what, to
whom, where and how often)
Yes Yes Yes Yes Yes Yes
6. The rationale for choosing the alternative
programmes or interventions compared
is stated
Yes Yes Yes Yes Yes Yes
Form of evaluation
7. The choice of form of economic
evaluation is justified in relation to the
questions addressed
No Yes No Yes Yes No
8. If a cost minimisation design is chosen,
have equivalent outcomes been
adequately demonstrated
n/a Yes n/a n/a n/a n/a
Effectiveness data
9. The source(s) of effectiveness estimates
used are stated (e.g. single study,
selection of studies, systematic review,
expert opinion)
Yes Yes Yes Yes Yes No
10. Effectiveness data from a RCT or review
of RCTs
No No No Yes No No
11. Potential biases identified (especially if
data not from RCTs)
No No No No No No
12. Details of the method of synthesis
or meta-analysis of estimates are given
(if based on an overview of a number of
effectiveness studies)
No No No Yes No n/a
Costs
13. All the important and relevant resource
use included
Yes Yes No Yes Yes Yes
14. All the important and relevant
resource use measured accurately
(with methodology)
Yes Yes No Yes Yes Yes
15. Appropriate unit costs estimated
(with methodology)
Yes Yes No Yes Yes Yes
16. Unit costs reported separately from
resource use data
Yes No No Yes Yes Yes
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TABLE 49 Summary of quality assessment checklist (continued )
Quality assessment
Jacobson
(1998)52
Motiwala
(2006)53
Chasson
(2007)50
Peters-
Scheffer
(2012)44
Penner
(2015)54
Cidav
(2017)51
17. Productivity costs treated separately
from other costs
Yes Yes No n/a Yes Unclear
18. The year and country to which unit
costs apply is stated with appropriate
adjustments for inflation and/or
currency conversion
Yes Partial No No Yes Yes
Benefit measurement and valuation
19. The primary outcome measure(s) for the
economic evaluation are clearly stated
Yes Yes Yes Yes Yes No
20. Methods to value health states and
other benefits are stated
No No No Yes Yes No
21. Details of the individuals from whom
valuations were obtained are given
No No No No No No
Decision modelling
22. Details of any decision model used are
given (e.g. decision tree, Markov model)
Yes Yes Yes Yes Yes Yes
23. The choice of model used and the key
input parameters on which it is based
are adequately detailed and justified
Yes Yes Yes Yes Yes Yes
24. All model outputs described adequately Yes Yes Yes Yes Yes Yes
Discounting
25. Discount rate used for both costs
and benefits
No Yes No No Yes Unclear
26. Do discount rates accord with NHS
guidance
No No No No No No
Time horizon
27. Is the time horizon of the model
sufficient to reflect all important
differences between options
Yes Yes No Yes Yes n/a
28. Are the time horizon of the model, the
duration of treatment and the duration
of the treatment effect described and
justified
Yes Yes Yes Yes Yes n/a
Allowance for uncertainty
29. Details of statistical tests and CIs are
given for stochastic data
n/a n/a n/a n/a n/a n/a
30. Uncertainty around cost-effectiveness
expressed (e.g. CI around ICER,
cost-effectiveness acceptability curves)
n/a n/a n/a n/a n/a n/a
31. Are all appropriate input parameters
included with uncertainty
No No No No Yes Yes
32. Is second-order uncertainty (uncertainty
in means) included rather than first
order (uncertainty between patients)
No No No No Yes No
33. Are the probability distributions
adequately detailed and appropriate
No No No No Yes Yes
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Overview
None of the six studies44,50–54 identified in the cost-effectiveness review took a UK perspective, with
two studies53,54 taking a Canadian governmental perspective, three studies50–52 taking a US perspective
and one study44 taking a Dutch perspective. Five44,50–53 of the six studies used a cost-minimisation
approach and did not assess benefits. The only exception to this was Penner et al.,54 in which the main
outcome measure was defined in terms of dependency-free life-years. Five44,50,52–54 of the six studies
took a model-based approach and one study51 was a RCT-based economic evaluation.
Model structure
The approach taken in the model-based evaluations was broadly similar across all five studies,44,50,52–54
with all five using simple decision tree or calculator type approaches. Health states were defined with
respect to reliance on special needs education and other services. In four44,52–54 of the five models, a
tripartite classification system was used to define levels of dependency on specialist services: normal
functioning or independent (when individuals were typically assumed to require no special education
or service requirements), moderate gain of functioning or semi-independent (when individuals were
typically assumed to require some specialist education and adult services) and no significant gain of
function or dependent (when individuals were assumed to require intensive special education and adult
services). The exception to this tripartite classification was the Chasson et al. study,50 which used a
binary classification system instead (normal function and fully dependent on specialist services). In the
trial-based evaluation, resource use, both during and post discontinuation of the intervention, was
recorded and costs assigned to estimate incremental costs.
Therapies compared
Four44,50,52,53 of the six studies compared early intensive ABA-based interventions with TAU; one study54
compared an expansion of current ABA-based provision to all infants diagnosed with autism with current
TABLE 49 Summary of quality assessment checklist (continued )
Quality assessment
Jacobson
(1998)52
Motiwala
(2006)53
Chasson
(2007)50
Peters-
Scheffer
(2012)44
Penner
(2015)54
Cidav
(2017)51
34. Sensitivity analysis used to assess
uncertainty in non-stochastic variables
(e.g. unit costs, discount rates) and
analytic decisions (e.g. methods to
handle missing data)
No No No No Yes Yes
Deterministic analysis
35. The approach to sensitivity analysis
is given (e.g. univariate, threshold
analysis, etc.)
No Yes No No Yes n/a
36. The choice of variables for sensitivity
analysis is justified
No Yes No No Yes n/a
37. The ranges over which the variables are
varied are stated
No Yes No No Yes n/a
Presentation of results
38. Incremental analysis is reported using
appropriate decision rules
No Yes No No Yes n/a
39. Major outcomes are presented in a
disaggregated as well as aggregated
form
No Yes No No No n/a
40. Applicable to the NHS setting No No No No No No
n/a, not applicable.
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provision (one-third of diagnosed children receiving ABA-based interventions) or no intervention; and one
study51 compared ESDM with TAU, which included the provision of ABA-based techniques. Details of
the early intensive ABA-based interventions assessed varied across studies. Two studies50,52 reported few
details, but appear to be based on the early Lovaas model26 of intervention, which involved 30–40 hours
therapy per week. Assumed intensity in the other four studies44,51,53,54 was based on either real-world data
or trial data, with reported intensity of therapy ranging between 14.8 hours and 32.54 hours per week.
One study, by Penner et al.,54 also investigated a parent-delivered model of early intensive ABA-based
intervention, with only a nominal number of hours delivered by a trained therapist. Early intensive
ABA-based provision was assumed to be implemented for a period of either 2 or 3 years in all studies,
although it was clear from the study by Cidav et al.51 that the children could continue to receive the
intervention beyond the initial 2-year intervention period.
Treatment effects
In two of the economic evaluations, clinical effectiveness data used to populate the models were drawn
from comparative studies. Cidav et al.51 used data from a RCT (Dawson et al.83), whereas Penner et al.54
used data drawn from two RCTs (Dawson et al.83 and Rogers et al.169). In the remaining four studies,44,50,52,53
comparative clinical effectiveness was based on unmatched comparisons. Jacobson et al.52 and Chasson
et al.50 based outcomes in the early intensive ABA-based arm on the model of Lovaas,26 with Jacobson
et al.52 exploring a range of possible treatment effects. In both studies, children in the comparator arm
were assumed to be 100% reliant on specialist service for their entire childhood (i.e. zero effectiveness).
Motiwala et al.53 adopted a similar approach to modelling outcomes in the early intensive ABA-based arm
of the model, but based effects on results reported in McEachin et al.98 and Sallows et al.100 Comparator
outcomes were assumed to be in line with an observation study by Freeman et al.168 Peters-Scheffer et al.44
also used Freeman et al.168 to model comparator outcomes, but based outcomes in the early intensive
ABA-based arm on a meta-analysis of relevant studies.
In the majority of the economic evaluations (four44,50,52,53 out of five), the impact of early intensive
ABA-based interventions was modelled directly by using educational placement outcomes reported in
the effectiveness literature to indicate current and future needs. The only exception to this was the
model developed by Penner et al.,54 in which IQ was used as an intermediate outcome, to predict future
dependency on specialist services. This was done using data from an observational study by Howlin et al.,15
which reported on the prognostic value of childhood IQ as an indicator of adult independence. The use
of the effectiveness data to directly model outcomes in this way is important because, as discussed in
Chapter 5, education placement is likely to be at very high risk of bias, with a strong possibility that the
results of the studies are biased by study procedures, as well as the influence of parental choice on
schooling placement.
A further important issue is that, due to the short follow-up in the clinical effectiveness studies
evaluating early intensive ABA-based interventions, all studies assumed either (explicitly or implicitly)
that the benefits of the intervention persisted over the entire time horizon of the model. Evidence to
support this assumption was generally not cited, with the exception again being Penner et al.,54 in which
epidemiological evidence from Howlin et al.15 was drawn on to extrapolate changes to IQ observed in the
trial period. The importance of this assumption cannot be overstated and the lack of supporting evidence
to support these assumptions is highly problematic. Even in the study by Penner et al.,54 which used
epidemiological evidence to extrapolate short-term outcomes, the assumptions made were strong. The
Howlin et al.15 study, although providing evidence to support the prognostic value of childhood cognitive
ability, provided only evidence of a correlation between childhood IQ and adult outcomes. This does
not necessarily imply a causal relationship that would mean that changes to childhood IQ would have
an impact on future outcomes. Moreover, even if we assume that it does, it is hard to imagine a causal
relationship that does not require the effects on IQ to persist over time. Furthermore, the Howlin et al.15
study showed that outcomes were very variable and neither verbal nor performance IQ was shown to
be a consistent prognostic indicator. The focus on IQ alone, therefore, may be too restrictive.
APPENDIX 13
NIHR Journals Library www.journalslibrary.nihr.ac.uk
238
Costs considered
The costs considered largely focused on the provision of specialist schooling and the provision of adult
support services, which were assumed to include residential care and assisted living services, disability
support services and supported employment placements. All six analyses conducted used a public
perspective; however, two studies also conducted an analysis from a broader societal perspective
(Jacobson et al.52 and Penner et al.54). Costs of early intensive ABA-based services were estimated to
be between £16,472 and £57,489 (inflated to 2017 prices) per annum, with estimated costs based
on government reports in three studies52–54 and micro-costing in one study.44 In Chasson et al.,50 which
reported the lowest annual costs, costs of ABA-based interventions were assumed to be the same as the
provision of special education.
Quality of life and benefits of therapy
Only one of the studies (Penner et al.54) considered benefits, assigning dependency-free life-years to
each of the levels of independence. The value of each health state was, however, based solely on
assumptions, with no evidence provided to justify the values used. Inferences about the value of
benefits predicted by the Penner et al.54 model must therefore be heavily caveated to reflect this lack
of supporting evidence.
Results of identified studies
The results of all six of the economic evaluations were overwhelmingly positive, with the results of all
four of the studies44,50,52,54 comparing early intensive ABA-based interventions with TAU predicting
significant cost savings. In all of the analyses, these cost savings were attributable to significant cost
offsets resulting from reductions in resource use, particularly specialist schooling provision and
residential care.
Summary
The cost-effectiveness review identified six studies,44,50–54 five44,50,52–54 of which adopted a model-based
approach. Although each of the models used different sources of data and made a variety of different
assumptions, all five of the identified models adopted similar structures based primarily around
educational placement and independence. Central to all models was the assumption that the effects of
early intensive ABA-based interventions persisted over the entire time horizon of the model, but little
evidence was reported justifying this assumption. Many of the studies also drew directly on educational
placement outcomes reported in the effectiveness studies, which is problematic given the limitations of
this evidence. In general, results of the previous analyses should be viewed with some caution, although
they do highlight several important drivers of cost-effectiveness.
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Appendix 14 Quality-of-life review
Overview
A literature review was conducted to identify studies investigating quality of life in children and
autistic adults.
Methods
To identify published evidence, the following databases were searched for eligible studies: MEDLINE (Ovid),
EMBASE (Ovid) 1980 onwards, NHS Economic Evaluation Database and PsycINFO. The searches were
undertaken in November 2017. The full search strategy is reported in Appendix 17.
Study selection
Two researchers independently undertook the screening of all titles and abstracts identified in the
searches. Full-paper publications were then obtained for potentially relevant studies and screened
against the eligibility criteria. Disagreements between reviewers were resolved by discussion.
Studies were eligible if they included children or adults with a diagnosis of ASD and reported utility
score or values using a validated quality-of-life questionnaire.
Data extraction
Details of eligible studies were extracted by a single reviewer and summarised using a Microsoft Excel
data extraction template.
Results
Search results
A total of 1179 records were identified in the search after removing duplicates, of which 214 studies
were identified as potentially relevant from their titles and/or abstracts. The full-text articles of
these records were assessed for eligibility. A total of 42 studies (45 records) were found to meet the
inclusion criteria. Figure 34 presents a flow diagram of the selection process.
Studies conducted in children and adolescents with autistic spectrum disorder
A total of 33 studies (35 records) were identified assessing quality of life in children and/or autistic
adolescents.120,124,127,170–201 The majority of the included studies were cross-sectional survey studies,
except two studies199,200 which conducted trials in autistic children. Neither of these trials were of
ABA-based interventions. A range of methods were employed to collect the data, using mostly mail
surveys. Most of the studies used parents or primary caregivers as proxy; however, a few studies
elicited values directly from children.172,173,176,189–192,194,198,199 A total of seven different quality-of-life
measures were used across the 33 identified studies. The most commonly reported were the Pediatric
Quality of Life Inventory™ (PedsQL™) measure, used in 15 studies;170,174,175,179,180,182,185,187,189–195,200,201 the
Health Utilities Index measure, used in seven studies;120,127,177,178,188,196,197 and the KIDSCREEN measure,
used in four studies.172,176,186,195 A detailed description of participants and results of the included studies
are presented in Table 50.
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Studies conducted in adults (including young adults) with autistic spectrum disorder
A total of nine studies (10 records130,202–210) reported on quality of life in adults and young adults with
autism or related conditions. As in the studies of children, the majority of the included studies were
cross-sectional surveys. The range of data collection methods used in the identified studies included
mail and internet surveys, with a smaller number also using face-to-face interviews. Most of the studies
used self-reported measures; however, two studies202,204 elicited values from parent and carers’ perspective.
Of the nine identified studies, seven202,204–208,210 used the World Health Organization Quality of Life-BREF
(WHOQOL-BREF) quality-of-life measure, one203 used the Short Form questionnaire-36 items (SF-36)
and one130,209 used the Short Form questionnaire-12 items (SF-12) version 2. A detailed description of
participants and results of the included studies are presented in Table 51.
Studies conducted in carers and parents
A total of 17 studies (18 records123,211–226) were identified reporting quality-of-life measures in carers
and parents of children with autism or a related condition. The majority of the included studies were
cross-sectional surveys, with the exception being a trial investigating a parent-targeted education
programme.221 All of the studies elicited values directly from the carer or parent. The most commonly
used tool was the SF-36, used in 11214–225 of the 17 studies. A further three studies211–213 reported
WHOQOL-BREF, two studies123,226 used EuroQol-5 Dimensions, one study227 used the SF-12 and one
study123 used the SF-6D. A description of participants and results of the included studies are presented
in Table 52.
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TABLE 50 Summary of quality-of-life studies conducted in children and adolescents with ASD
Study Participants
Subgroup/trial
arms n Male %
Age (years),
mean (SD)
Symptom severity
measure,
mean (SD) IQ, mean (SD) Respondent
Utility measure(s),
mean score (SD)
Cross-sectional studies
Kuhlthau
(2013)181
Children with
ASD
n/a 71 87.0 7.9 PDDBI, 43.6 (21.4) NR Parent CHIP-CE resilience, 42.3
(13.8); comfort, 46.1 (9.6);
risk avoidance, 40.7 (10.5);
satisfaction, 39.1 (10.9);
achievement, 33.3 (11.4)
Domellöf
(2014)173
Children and
adolescents with
ASD
n/a 61 86.9 12.0 (3) NR NR Child (37.7%);
parent (27.9%);
not stated
(34.4%)
EQ-5D-Y VAS, 80.7 (18.8)
van Steensel
(2012)198
Children with
high-functioning
ASD and
comorbid anxiety
disorders
n/a 115 78.3 11.37 (2.63) NR NR Parent and child EQ-5D, NR (NR)
Forsyth
(2007)177
Young children
with severe
disabilities
n/a 600 70.0 2.67 (median) NR NR Parent HUI, median 0.44
(IQR 0.21–0.67)
Forsyth
(2010)178
Young children
with severe
disabilities
n/a 5862 68.0 10.58 (3.92) NR NR Parent HUI, 0.33 (0.34)
Hoefman
(2014)120
Children with
ASD
n/a 224 87.0 8.4 (3.5) NR NR Primary
caregiver
HUI3, 0.66 (0.16);
QWB-SA, 0.59 (0.16)
Payakachat
(2014)127
Children with
ASD
n/a 224 86.6 8.4 (3.5) ADOS, 7.2 (1.8) 75.7 (24.3) Primary
caregiver
HUI3, 0.66 (0.23)
Petrou
(2010)188
Children with
ASD
n/a 11 NR NR NR NR Parent HUI3, 0.61 (0.26);
HUI2, 0.72 (0.15)
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TABLE 50 Summary of quality-of-life studies conducted in children and adolescents with ASD (continued )
Study Participants
Subgroup/trial
arms n Male %
Age (years),
mean (SD)
Symptom severity
measure,
mean (SD) IQ, mean (SD) Respondent
Utility measure(s),
mean score (SD)
Tilford
(2012)196
Children with
ASD
ASD, PDD-NOS,
AS
150 85.3 8.6 (3.3) NR NR Primary
caregiver
HUI3, 0.66 (0.23);
QWB-SA, 0.59 (0.16)
Tilford
(2015)197
Children with
ASD
n/a 224 86.6 8.2 (3.5) NR NR Primary
caregiver
HUI3, 0.66 (0.23);
QWB-SA, 0.59 (0.16)
Clark
(2015)172
Adolescents with
ASD
n/a 22 86.4 15.2 (1.7) NR NR Child and
parent
KIDSCREEN-52. Scores
on all 10 dimensions vary
between 40 and 50 or
within 1 SD of the mean
of 50
Egilson
(2017)176
Children with
ASD
n/a 96 87.5 8–11, 43.8%;
12–17, 56.3%
NR NR Parent KIDSCREEN-52. Scores vary
on 8/10 dimensions between
45 and 50 or within half a
SD of mean of 50
Meral
(2015)186
Children with
ASD
n/a 379 78.6 9.57 (4.44) NR NR Parent KIDSCREEN-27, 76.52
(13.55)
Bourke-
Taylor
(2012)170
Children with
ASD
n/a 94 NR 9.5 (3.7) NR NR Mother PedsQL, NR (NR)
de Vries
(2015)174
Children with
ASD
n/a 120 90.0 10.2 (1.3) ADI-R age of first
word, 18.5 (7.7);
age of first
sentence, 26.1
(9.7); language
composite, 5.4 (2.1)
WISC-III, 110.9
(20.6)
Parent PedsQL, 32.9 (11.6)
Delahaye
(2014)175
Children with
ASD
n/a 86 83.7 7.18 (NR) PDDBI, 46.38 (NR) S–B5 and MSEL
composite score
< 70, 61.22%;
composite score
≥ 70, 38.78%
Parent PedsQL, 64.18 (64)
Jahan
(2015)179
Children with
ASD
n/a 149 77.2 7.8 (3.06) NR PedsQL-4.0
cognitive
functioning scale,
68.9 (23.4)
Parent PedsQL, 71.38 (16.76)
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Study Participants
Subgroup/trial
arms n Male %
Age (years),
mean (SD)
Symptom severity
measure,
mean (SD) IQ, mean (SD) Respondent
Utility measure(s),
mean score (SD)
Kose
(2013)180
Children with
autism (ASD,
PDD-NOS, AS)
Overall 102 82.4 8.2 (3.7) NR NR Parent PedsQL, NR (NR)
ASD 46 87.0 8.6 (3.8) CARS, 15–29 0%;
30–36, 41.3%;
37–60, 58.7%
NR NR PedsQL, 50.1 (10.8)
PDD-NOS 38 84.2 6.3 (2.5) CARS, 15–29:
55.3%; 30–36,
34.2%; 37–60,
10.5%
NR NR PedsQL, 61 (15.1)
AS 18 66.7 11.5 (2.9) CARS 15–29,
83.3%; 30–36,
11.1%; 37–60, 5.6%
NR NR PedsQL, 65.1 (14.4)
Kuhlthau
(2010)182
Children with
ASD
Overall 286 82.5 2–4, 36.0%;
5–7, 26.2%;
8–12, 7.8%
SRS, 98.9 (29.3) NR Parent PedsQL, 65.2 (15.9)
Autism 196 NR NR NR NR PedsQL, 63.8 (1.5)
Asperger
syndrome
25 NR NR NR NR PedsQL, 67.7 (3.2)
PDD-NOS 65 NR NR NR NR PedsQL, 65.1 (2.1)
Limbers
(2009)185
Children with
Asperger
syndrome
n/a 22 90.9 9.25 (2.15) NR PedsQL cognitive
functioning scale,
41.41 (24.55)
Parent PedsQL, 55.58 (11.52)
Ozturk
(2016)187
Children with
ASD
n/a 102 82.4 8.23 (3.68) CARS, NR (NR) NR Parent PedsQL, NR (NR)
Potvin
(2011,
2015)189,190
Children with
high-functioning
autism
n/a 30 86.7 111.03 months
(18.8)
NR NR Child and
parent
PedsQL child reported,
64.14 (13.24); parent
reported: 56.1 (13.58)
Sheldrick
(2012);191
Shipman
(2011)192
Children with
ASD
n/a 39 73.0 14.8 (range
12–18)
SRS, 73.7 (NR) NR Child and
parent
PedsQL child: 41.8 (NR);
parent projected, 37.5 (NR);
parent standard, 35.5 (NR)
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TABLE 50 Summary of quality-of-life studies conducted in children and adolescents with ASD (continued )
Study Participants
Subgroup/trial
arms n Male %
Age (years),
mean (SD)
Symptom severity
measure,
mean (SD) IQ, mean (SD) Respondent
Utility measure(s),
mean score (SD)
Sikora
(2012)193
Children with
ASD
Overall 2020 84.3 2–5, 56.6%
6–11, 33.3%
12–18, 10.1%
NR MSEL < 70, 34.1%;
≥ 70, 65.9%
Parent PedsQL, NR (NR)
ASD NR NR NR NR NR PedsQL, 68.9 (NR)
ASD +ADHD NR NR NR NR NR PedsQL, 59.1 (NR)
Stokes
(2017)194
Children with
ASD
n/a 229 85.6 13.7 (3.1) ADOS, 5.8 (4.1) PPVT, 104 (12.7) Child PedsQL, NR (NR)
Tavernor
(2013)195
Children with
ASD
n/a 11 NR NR NR NR NR PedsQL, NR (NR);
KIDSCREEN, NR (NR)
Viecili
(2015)201
Children with
ASD
n/a 122 NR NR NR NR Not clear PedsQL, 63.64 (16.6)
Chuang
(2014)171
Children with
ASD
n/a 106 84.9 4.53 (0.8) CARS severe, 56.7;
mild/moderate,
29.2; non-autistic,
14.1
CPEP-3 receptive
language ability, 12
(3.7); expressive
language ability,
11.9 (3.5);
cognition, 12.7
(8.3)
Parent TAPQOL-C, NR
Lai (2016)183 Children with
ASD
Overall 31 NR 50.6 months
(16.9)
NR NR NR TAPQOL-C, NR
Mild (cognition
domain ≥ 4)
11 NR NR NR NR NR TAPQOL-C, 73.8 (16.3)
Severe
(cognition
domain < 4)
20 NR NR TAPQOL-C, 64.2 (14.2)
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Study Participants
Subgroup/trial
arms n Male %
Age (years),
mean (SD)
Symptom severity
measure,
mean (SD) IQ, mean (SD) Respondent
Utility measure(s),
mean score (SD)
Lavelle
(2012)184
Children with
ASD
Overall 138 81.5 3–5 years,
8.15%; 6–10
years, 32.59%;
11–13 years,
23.70%; 14–17
years, 35.56%
NR NR Parent TTO, 0.56 (NR)
Autism 43 NR NR NR NR NR TTO, 0.55 (NR)
AS 64 NR NR NR NR NR TTO, 0.53 (NR)
PDD-NOS 29 NR NR NR NR NR TTO, 0.63 (NR)
Tung
(2014)124
Children with
autism
n/a 84 88.1 5.94 (2.32) CARS, 32.05 (4.8) NR Caregiver WHOQOL-BREF, NR (NR)
Trials
Van Steensel
(2014)199
Children with
ASD
CBT 24 83.3 11 (2.62) ADI-R, 31.88 (7.03) NR Child and
parent
EQ-5D parent report,
0.66 (0.19); child report,
0.69 (0.12)
TAU 25 80.0 10.72 (2.25) 33.04 (8.03) EQ-5D parent report,
0.73 (0.22); child report,
0.82 (0.26)
Varni
(2012)200
Children with
ASD
Aripiprazole
(Abilify®, Otsuka
Pharmaceutical,
Tokyo, Japan)
167 88.0 9.5 (3.1) NR NR Parent PedsQL, 42 (15.6)
Placebo 76 89.5 9.4 (3) PedsQL, 40.4 (15.6)
ADHD, attention deficit hyperactivy disorder; AS, Asperger syndrome; CARS, Childhood Autism Rating Scale; CHIP-CE, Child Health and Illness Profile-Child Edition; CPEP-3, Chinese
Psychoeducational Profile-Third Edition; EQ-5D, EuroQol-5 Dimensions; EQ-5D-Y, EuroQol-5 Dimensions Youth; HUI, Health Utilities Index; HUI2, Health Utilities Index Mark 2;
IQR, interquartile range; n/a, not applicable; NR, not reported; PedsQL, Pediatric Quality of Life Inventory; PDDBI, Pervasive Developmental Disorder Behaviour Inventory;
PPVT, Peabody Picture Vocabulary Test; QWB-SA, Quality of Well-Being Scale-Self Administered; S–B5, Stanford-Binet Intelligence Scale 5; SRS, Social Responsiveness Scale;
TAPQOL-C, TNO-AZL Preschool children Quality of Life; TTO, time trade-off; VAS, visual analogue scale; WISC-III, Wechsler Intelligence Scale for Children III; WHOQOL-BREF,
World Health Organization Quality of Life-BREF.
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TABLE 51 Summary of quality-of-life studies conducted in adults (including young adults) with ASD
Study Participants
Subgroup/
trial arms n Male (%)
Age years,
mean (SD)
Symptom
severity
measure,
mean (SD) IQ, mean (SD) Respondent
Utility measure(s),
mean score (SD)
Helles (2017)203 Adults with AS n/a 100 100 No longer ASD,
10.9 (3.8); ASD,
10.3 (2.5); ASD
plus, 12.5 (5.4)
ASSQ no longer
ASD, 20.0 (7.9);
ASD, 22.9 (8.0);
ASD plus, 24.1
(9.0)
WAIS-III no longer
ASD, 100.6 (15.0);
ASD,105.1 (22.0);
ASD plus, 104.3
(15.2)
Self-reported SF-36 PCS, 54.3 (6.3);
MCS, 42.0 (9.8)
Khanna (2014,
2015)130,209
Adults with ASD n/a 291 60.8 30.76 (11.88) AQ-10; 6.34
(2.35)
NR Self-reported SF-12 PCS, 49.44 (10.36);
MCS, 40.77 (9.32)
Bishop-Fitzpatrick
(2017)202
Adults with ASD n/a 60 76.7 31.48 (6.75) ADI-R, 41.22
(6.79)
NR Self and carer WHOQOL-BREF, 72.91
(15.68)
Hong (2016)204 Adults with ASD n/a 60 76.7 32 (6.8) NR NR Self, mother WHOQOL-BREF, NR (NR)
Jariwala-Parikh
(2015)205
Adults with ASD n/a 265 55.7 33.1 (13.76) AQ-10 low
severity, 44%;
high severity,
66%
NR Self-reported WHOQOL-BREF, NR (NR)
Jennes-Coussens
(2006)206
Adults with AS n/a 12 NR 20.3 (1.3) NR NR Self-reported WHOQOL-BRIEF, 3.7 (0.7)
Kamp-Becker
(2010)208
Adults with AS,
high-functioning
autism or
atypical autism
n/a 26 100 21.6 (3.4) ADOS-G:
NR (NR)
Wechsler,
99.3 (17.7)
Self-reported WHOQOL-BREF, 60.6
(26.1)
Kamio (2013)207 Adults with ASD n/a 154 79.9 27.6 (6.5) NR NR Self-reported WHOQOL-BREF
psychological health raw
score, 2.78 (0.74); social
relationships raw score,
2.71 (0.82)
Moss (2017)210 Adults with
autism
Childhood 52 82.7 6.3 (2.1) ADI-R, 40.1 (7.4) 89.3 (14.4) Caregivers,
self-reported
WHOQOL-BREF, NR (NR)
Adulthood 47.9 (9.5) ADI-R, 27.6 (7.8) 69.9 (32.4) WHOQOL-BREF, NR (NR)
ADI-R, Autism Diagnostic Interview-Revised; ADOS-G, Autism Diagnostic Observation Schedule-Generic; AQ-10, Autism Spectrum Quotient test; ASSQ, Autism Spectrum Screening
Questionnaire; MCS, mental component score; n/a, not applicable; NR, not reported; PCS, physical component score; WAIS-III, Wechsler Adult Intelligence Scale, Third Edition.
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TABLE 52 Summary of quality-of-life studies conducted in parents and carers of children with ASD
Study Participants
Subgroup/trial
arms n
Child characteristic
Respondent
Utility measure(s),
mean score (SD)Male (%)
Age years,
mean (SD)
Symptom
severity
measure,
mean (SD)
IQ, mean
(SD)
Ahmad (2015)211 Fathers of children
with ASD
n/a 101 85.2% 5.0 (3.2) NR NR Self-report WHOQOL-BREF, 74.17
(13.99)
Allik (2006)227 Parents of children
with AS or high-
functioning autism
and parents of
typically developing
children
Overall 61 NR 10.8 (range 8–12) NR NR Self-report NR
AS/HFA:
mother
31 SF-12 MCS, 49.1 (11.1);
PCS, 44.7 (10.8)
Control:
mother
30 SF-12 MCS, 52.0 (9.6);
PCS, 52.5 (7.4)
AS/HFA: father 30 SF-12 MCS, 51.3 (7.8);
PCS, 49.8 (6.9)
Control: father 29 SF-12 MCS, 53.6 (6.1);
PCS, 53.0 (6.8)
Amirian (2017)214 Parents of children
with ASD
Overall 97 NR NR NR NR Self-report SF-36 MCS, 50.78
(17.08); PCS, 59.70
(21.35)
Fathers 21 SF-36 MCS, 47.92
(12.97); PCS, 59.88
(14.67)
Mothers 76 SF-36 MCS, 50.93
(18.07); PCS, 59.65
(22.94)
Aral (2015)215 Families of children
with ASD
n/a 30 NR NR NR NR Self-report SF-36, NR (NR)
Benjak (2011)216 Parents of children
with ASD and
typically developing
children
n/a 350 NR NR NR NR Self-report SF-36, NR (NR)
continued
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TABLE 52 Summary of quality-of-life studies conducted in parents and carers of children with ASD (continued )
Study Participants
Subgroup/trial
arms n
Child characteristic
Respondent
Utility measure(s),
mean score (SD)Male (%)
Age years,
mean (SD)
Symptom
severity
measure,
mean (SD)
IQ, mean
(SD)
Dardas (2014)212 Parents of children
with autistic disorder
Overall 184 NR 6.04 (3.05) NR NR Self-report WHOQOL-BREF, NR
(NR)
Fathers 70 WHOQOL-BREF, 58.2
(9.2)
Mothers 114 WHOQOL-BREF, 83.2
(8.8)
Forouzanfar
(2016)217
Mothers of children
with ASD
n/a 203 NR 7.89 (3.3) NR NR Self-report SF-36 MCS, 43.65 (6.95);
PCS, 53.25 (25.51)
Johnson (2009,
2011)218,219
Parents of children
with ASD
Overall 128 81 7.8 (3.9) NR NR Self-report SF-36 MCS, 34.21
(13.11); PCS, 49.21
(11.22)
Fathers 64 SF-36 MCS, 41.60
(12.93); PCS, 51.16 (9.56)
Mothers 64 SF-36 MCS, 34.21
(13.11); PCS, 49.21
(11.22)
Ji (2014)220 Caregivers of
children with ASD
n/a 273 81 4.81 (2.01) CARS ≥ 36,
42.1%; < 36,
57.9%
NR Self-report SF-36 MCS, 45.58
(16.71); PCS, 58.72
(12.48)
Ji (2014)221 Primary caregivers
of children with ASD
Overall 42 83 5.27 (NR) CARS ≥ 36,
50%; < 36,
50%
NR Self-report SF-36, NR (NR)
Intervention 22 81.8 4.93 (2.03) CARS ≥ 36,
50%; < 36,
50%
NR SF-36 MCS, 53.85
(9.10); PCS, 63.11 (7.42)
Waiting list
control
20 85.0 5.65 (1.74) CARS ≥ 36,
50%; < 36,
50%
NR SF-36 MCS, 51.00
(15.96); PCS, 63.54 (9.69)
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Study Participants
Subgroup/trial
arms n
Child characteristic
Respondent
Utility measure(s),
mean score (SD)Male (%)
Age years,
mean (SD)
Symptom
severity
measure,
mean (SD)
IQ, mean
(SD)
Khanna (2011)222 Parents of children
with ASD
n/a 305 82.9 < 5, 7%; 5–10,
44.14%; 11–14,
41.4%; 15–18,
6.6%
CARS, 33.20
(9.05)
NR Self-report SF-36 MCS, 37.48
(11.78); PCS, 51.28 (9.6)
Khanna (2013)226 Primary caregivers
of children with
autism
n/a 316 80.1 < 5, 16.8%; 5–10,
46.5%; 11–18,
36.1%
NR NR Self-report EQ-5D 18–44 years old,
0.82 (0.16); 45–64 years
old, 0.81 (0.16)
Kheir (2012)223 Parents of children
with ASD and
typically developing
children
Overall 98 NR NR (range 3 –17) NR NR Self-report SF-36, NR (NR)
ASD 56 NR NR NR NR SF-36 MCS, 41.94
(11.98); PCS, 48.85 (8.14)
Typical
development
42 NR NR NR NR SF-36 MCS, 45.14
(9.60); PCS, 49.42 (7.96)
Kousha (2016)213 Mothers of children
with ASD
n/a 127 76 6.26 (2.82) NR NR Self-report WHOQOL-BREF, NR (NR)
Kuhlthau (2014)123 Parents of children
with ASD
n/a 224 86.5 8.4 (3.5) ADOS ≤ 5,
11%; 6 –7,
46%; ≥ 8, 43%
≤ 70, 48%;
> 70, 52%
Self-report SF-6D, 0.74 (0.12);
EQ-5D, 0.85 (0.14)
Lee (2009)224 Parents of children
with high-functioning
autism and typically
developing children
Overall 135 NR NR NR NR Self-report SF-36, NR (NR)
HFA 89 91.9 9.5 (2.0) NR NR SF-36, NR (NR)
Typical
development
46 90.0 9.7 (2.1) NR NR SF-36, NR (NR)
Yamada (2012)225 Parents of children
with PDD
Overall 269 81.6 9.08 (2.5) NR > 70, 74%;
50–69, 21%;
< 50, 5%
Self-report SF-36, NR (NR)
Fathers 122 SF-36 MCS, 49.4 (8.0);
PCS, 51.1 (5.5)
Mothers 147 SF-36 MCS, 42.9 (11.9);
PCS, 50.3 (6.9)
AS, Asperger syndrome; CARS, Childhood Autism Rating Scale; EQ-5D, EuroQol-5 Dimensions; HFA, high-functioning autism; MCS, mental component score; n/a, not applicable;
NR, not reported; PCS, physical component score.
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Appendix 15 Review of epidemiological
and observational studies
Overview
A literature review was conducted to identify studies describing the prognosis and outcomes of autistic
children and adults. This review had three objectives:
1. to characterise the natural history of children with autism and related conditions with reference to
the outcome measures most commonly reported in the effectiveness studies identified as part of
the IPD meta-analysis
2. to review the literature on prognostic variables, in particular the relationships between short-term
measures reported in the effectiveness studies and outcomes in adulthood
3. to characterise contemporaneous relationships between outcome measures reported in the
effectiveness studies and adult outcomes (e.g. the correlations between adult measures of IQ and
other adult outcomes).
Methods
To address the three objectives, three related reviews were undertaken. Review 1 addressed the first
objective, review 2 addressed the second and review 3 addressed the third.
To identify appropriate literature, two recent previous systematic reviews17,228 addressing similar research
questions were used. The first review, Magiati et al.,17 was a review of longitudinal studies and sought to
describe both changes in commonly reported outcome measures between childhood and adulthood and
the prognostic value of these measures. Magiati et al.17 therefore addressed reviews 1 and 2. The second
review used was Steinhausen et al.,228 which sought to describe social outcomes in adulthood. This review
did not address any of the review questions directly, but identified literature that could address review
question 3.
To supplement and update these two literature reviews, updated searches were also undertaken to
identify any literature published following the publications of these reviews. The following databases
were searched as part of these update searches: MEDLINE (Ovid), EMBASE (Ovid) 1980 onwards,
NHS Economic Evaluation Database and PsycINFO. The searches were undertaken in February 2018
and date limited to post 2013. The full search strategy used is reported in Appendix 17.
Study selection
A single reviewer obtained full texts of the studies identified in the two previous reviews and compared
them with the inclusion criteria for each review. For the update searches, a single independent reviewer
undertook the screening of all titles and abstracts identified. Full-paper publications were then obtained
for potentially relevant studies before screening against the eligibility criteria. The inclusion criteria of
each review are described in Table 53.
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Data extraction
Details of eligible studies were extracted by a single reviewer and summarised using a Microsoft Excel
data extraction template.
Results
Search results
A flow diagram describing study selection is presented in Figure 35. A total of 33 studies were identified
in the two systematic reviews after removing duplicates and were assessed against the inclusion criteria
for each review. Of the 33 studies, 15 were considered to meet the inclusion criteria for one or more
reviews. The update searches identified a total of 632 unique studies. After initial screening, 70 studies
were selected for full-text review, 33 identified in previous reviews and 37 through the additional
searches. A total of 17 studies were included in one or more of the reviews. The total number of studies
included in reviews 1–3 was 14, 11 and 5, respectively.
Overview of studies
A summary of the key characteristics for each of the 18 studies included in the three reviews are
presented in Table 54. The studies identified were mostly longitudinal studies, with a minority using
cross-sectional designs. The studies recruited from a range of populations, including participants
diagnosed with autism, Asperger syndrome and/or PDD-NOS. Populations recruited were predominantly
male, with some recruiting all-male populations. Mean IQ at baseline ranged from 52.2 to 86.3, with
most studies recruiting participants with and without intellectual disability. A smaller number of studies,
however, recruited from populations with IQ in the normal range only. Sample sizes varied from 20 to
119 participants. A summary of the results of the studies included in each of the reviews is presented
in Table 52.
TABLE 53 Epidemiology and observational review inclusion criteria
Review Inclusion criteria
Review 1: natural history of autism
Population Studies of autistic populations, including ASD, AS and PPD-NOS
Outcomes Cognitive ability, VABS composite or component scores, ADOS severity score
Study type Longitudinal studies reporting outcomes in both childhood (< 18 years of age) and adulthood
(≥ 18 years of age). More than 20 participants
Date limit Published after 1990
Review 2: prognostic outcomes
Population Studies of autistic populations including ASD, AS and PPD-NOS
Outcomes Adult social outcomes
Study type Longitudinal studies reporting on the prognostic value of any childhood measures as a
predictor of adult social outcomes
Date limit Published after 1990
Review 3: adult predictors of social outcomes
Population Studies of autistic populations including ASD, AS and PPD-NOS
Outcomes Adult social outcomes
Study type Any study reporting on adult outcome measures as a predictor of adult social outcomes
Date limit Published after 1990
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Natural history
The majority of studies included in review 1 demonstrate changes in IQ over time, with fewer (four)
reporting changes in VABS (composite or component) scores and none reporting changes in ADOS scores.
Patterns of change over time varied across studies with respect to both IQ and VABS scores. With
respect to IQ, 915,134,229,231,236–238,242,243 of the 14 studies15,132,134,229–234,236–240,243 reported only small changes
in IQ over time, although some noted significant variations at the individual level. The remaining five
studies132,230,232–234,239,240 observed declines in IQ scores, although it was not always clear as to the
magnitude of these declines due to the limited reporting. There was also some evidence of greater
declines in scores for participants with intellectual disability at baseline, with two studies noting differences
in trajectories for those with and without intellectual disability.
In contrast to IQ, VABS (composite and component) scores show a more pronounced pattern of change
over time, but with less consistency across studies. Szamatri et al.235 observed increases in individual
component scores but falls in composite scores. Other studies230,237 also report increases in component
scores, but, unlike Szamatri et al.,235 these report increases in composite scores. The reasons for these
different trends are unclear, but it may be that some studies are reporting raw scores, rather than
standardised scores.
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FIGURE 35 Flow diagram showing study selection for the epidemiology reviews.
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TABLE 54 Summary of included studies
Study Review n
Population characteristic Measure reported
Age (years)
at baseline,
mean (SD)
[age range]
Age (years) at
last follow-up,
mean (SD)
[age range]
IQ at baseline, mean (SD)
[cut-off criteria for IQ] IQ description Male (%) VABs ADOS IQ
Adult social
outcomes
Howlin (2013)229 1, 2, 3 60 6.9 (2.9) 44.2 (9.4)
[29–64]
86.3 [> 70] Normal 81.60 No No Yes Yes
Gillespie-Lynch
(2012)230
1, 2 20 3.9 (1.2) 26.6 (3.8) NR NR 100 Yes No DQ only Yes
Gray (2012)231 1 119 8.7 (4.3) 24.8 (4.7) Borderline or average,
27 (22.6%); mild/moderate
ID, 75 (63.1%); severe ID,
17 (14.3%)
Mixed 82.40 No No Yes (groups only) No
Billsedt (2005,
2007, 2011)232–234
1, 2 108 < 10 25.5 (6.4) > 70, 98 (82%); < 70, 22
(18%)
Mixed 71.30 No No Yes Yes
Farley (2009)134 1, 2, 3 41 7.2 (4.1) 32.5 (5.7) FSIQ, 83.68 (17.56) Normal 92.70 Yes No Yes Yes
Szatmari (2009)235 1 36 5.5 (0.98) 17.7 (1.56) 84.5 (16.11) [> 70] Normal 86.10 Yes No No No
Cederlund (2008)132 1, 2 70 < 10 Autism, 24.5 (5.4) < 50, 39; 50–69, 31;
70–84, 10; ≥ 85, 4
Mixed 100 No No Yes (groups only) Yes
Eaves (2008)236 1, 2, 3 48 6.8 [3–12] 24.0 [19–31] VIQ > 70, 17.4%;
NVIQ > 50, 61%
Mixed 77.10 No No Yes (groups only) Yes
McGovern (2005)237 1 48 3.9 (1) 19.0 (3.8) 52.2 (13.3) Mixed 87.50 Yes Yes Yes No
Howlin (2004)15 1, 2, 3 68 7.24 (3.10) 29.33 (7.97) PIQ, 80.21 (19.28) > 50 89.70 No No Yes Yes
Howlin (2000)238 1 18 7–8 23.75 (1.79) NR NR 55.50 No No Yes No
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Study Review n
Population characteristic Measure reported
Age (years)
at baseline,
mean (SD)
[age range]
Age (years) at
last follow-up,
mean (SD)
[age range]
IQ at baseline, mean (SD)
[cut-off criteria for IQ] IQ description Male (%) VABs ADOS IQ
Adult social
outcomes
Ballaban-Gil
(1996)243
1 99 6.8 [0.8–20.3] 18.1 Severe mental retardation,
31%; mild mental
retardation, 15%; normal
or near-normal, 22%;
indeterminate, 28%
Mixed 71.00 No No Yes (groups only) No
Bishop (2015)239 1 84 2 19 66.3 (20.6) Mixed 87 Yes No Yes No
Anderson (2014)240 1 85 2 19 69.28 (NR) Mixed NR Yes No
total
score
Yes Yes
Marriage (2009)241 2 45 12.4 (3.4) 21.3 (4.0) > 70, 33; < 70, 12 Mixed 82.20 No No Yes
(groups only)
Yes
Gray (2014)242 2 8.7 (4.3) 24.8 (4.7) Average, 9.2%; borderline,
13.4%; mild ID, 24.4%;
moderate ID, 38.7%;
severe ID, 14.3%
Mixed 82.40 No No Yes (groups only) No
Esbensen (2010)133 3 70 37.7 NR Mild, 25.7%; moderate,
27.1%; severe, 35.7%;
profound, 8.6%; unknown,
2.9%
Mixed NR No No Yes (groups only) Yes
DQ, developmental quotient; FSIQ, Full Scale Intelligence Quotient; ID, intellectual difficulties; n/a, not applicable; NR, not reported; NVIQ, non-verbal intelligence quotient;
PIQ, performance intelligence quotient; VIQ, verbal intelligence quotient.
D
O
I:
1
0
.3
3
1
0
/h
ta2
4
3
5
0
H
e
a
lth
T
e
ch
n
o
lo
g
y
A
sse
ssm
e
n
t
2
0
2
0
V
o
l.2
4
N
o
.3
5
©
Q
u
een
’s
P
rin
ter
an
d
C
o
n
tro
ller
o
f
H
M
SO
2
0
2
0
.T
h
is
w
o
rk
w
as
p
ro
d
u
ced
b
y
R
o
d
gers
et
a
l.
u
n
d
er
th
e
term
s
o
f
a
co
m
m
issio
n
in
g
co
n
tract
issu
ed
b
y
th
e
Secretary
o
f
State
fo
r
H
ealth
an
d
So
cial
C
are.T
h
is
issu
e
m
ay
b
e
freely
rep
ro
d
u
ced
fo
r
th
e
p
u
rp
o
ses
o
f
p
rivate
research
an
d
stu
d
y
an
d
extracts
(o
r
in
d
eed
,
th
e
fu
ll
rep
o
rt)
m
ay
b
e
in
clu
d
ed
in
p
ro
fessio
n
al
jo
u
rn
als
p
ro
vid
ed
th
at
su
itab
le
ackn
o
w
led
gem
en
t
is
m
ad
e
an
d
th
e
rep
ro
d
u
ctio
n
is
n
o
t
asso
ciated
w
ith
an
y
fo
rm
o
f
ad
vertisin
g.
A
p
p
licatio
n
s
fo
r
co
m
m
ercial
rep
ro
d
u
ctio
n
sh
o
u
ld
b
e
ad
d
ressed
to
:
N
IH
R
Jo
u
rn
als
Lib
rary,
N
atio
n
al
In
stitu
te
fo
r
H
ealth
R
esearch
,
E
valu
atio
n
,
Trials
an
d
Stu
d
ies
C
o
o
rd
in
atin
g
C
en
tre,
A
lp
h
a
H
o
u
se,
U
n
iversity
o
f
So
u
th
am
p
to
n
Scien
ce
P
ark,So
u
th
am
p
to
n
SO
1
6
7
N
S,U
K
.
2
5
7
Comparisons between the epidemiological data and the limited long-term effectiveness data for
TAU and eclectic arms show a similar pattern of change to that in the majority of the observational
literature with respect to IQ, with scores remaining broadly stable over time. With respect to VABS
composite scores, the evidence from the effectiveness studies appears to align with Szamatri et al.,235
as declines in VABS scores are observed over time.
Prognostic factors
Nearly all of the studies included in review 2 reported IQ as a prognostic factor, showing a positive
association between childhood IQ and adult social outcomes. Limitations in the predictive value of IQ
were, however, noted in a number of studies.134,229 For example, Howlin et al.229 reported substantial
variations in adult social outcomes in participants who all had IQ within the normal range, and observed
that neither verbal nor performance IQ was a consistent prognostic indicator. These variations aside,
the identified studies consistently report that individuals with intellectual disability tend to have ‘poor’
outcomes, with the majority being highly dependent on adult social services and few leading independent
lives. This may be an unsurprising finding, given the severity of disability experienced by these individuals,
and may suggest more limited opportunities for people with intellectual disability to live independent lives.
However, it is also clear that normal or high IQ is not sufficient to enable individuals to live independently,
although the reported correlations suggested that there is potentially greater scope for them to do so.
In addition to IQ, a number of studies also reported childhood language skills as predictor of adult
social outcome. This finding, however, was not consistent across studies.229
In terms of utilising the data reported to populate the model, it is notable that no study reported on
the prognostic value of VABS component or composite scores, despite this being a commonly reported
outcome in the effectiveness studies.
Contemporaneous factors
Review 3 identified only six studies reporting correlations between adult outcome measures and adult
social outcomes. As in review 2, IQ was the predominant measure reported and was found to be a
relatively strong predictor of adult social outcomes. Other measures reported were severity (ADI-R
and Childhood Autism Rating Scale), language and reading skills, and VABS composite scores. Of the
six studies identified, Farley et al.134 was notable because it reported both VABS composite and IQ
scores and observed that VABS scores were the better predictor of the two (respective correlation
coefficients of 0.78 and 0.55). It was also notable that none of the studies went beyond simple
correlations and attempted to predict adult social outcomes (Table 55).
TABLE 55 Summary of results from included studies
Study
Review 1
Review 2 Review 3VABS ADOS IQ
Howlin (2013)229 NR NR Relatively stable over
time, although with
some individual
variation
IQ and ADI-R
reported as
predictors
IQ and ADI-R
correlated with
current social
functioning
Gillespie-Lynch
(2012)230
Component raw scores
increase overtime
NR DQ falls over time DQ not strongly
predictive of
social functioning.
RJA and language
predictive of
social function
n/a
Gray (2012)231 NR NR Appear relatively
stable over time, but
only reported by group
n/a n/a
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TABLE 55 Summary of results from included studies (continued )
Study
Review 1
Review 2 Review 3VABS ADOS IQ
Billsedt (2005,
2007, 2011)232–234
NR NR IQ appears to fall IQ and language
appear to predict
social outcomes
n/a
Farley (2009)134 NR NR Relatively stable over
time, although with
significant individual
variation
IQ reported as
predictor
VABS and IQ are
correlated with
current social
outcomes
Szatmari (2009)235 Component scores
improve, whereas
composite scores
appear to fall
NR NR n/a n/a
Cederlund (2008)132 NR NR IQ appears to fall n/a IQ correlated
with current
social functioning
Eaves (2008)236 NR NR IQ stable over time IQ and CARS
reported as
predictors
IQ and CARS
correlated with
current social
functioning
McGovern (2005)237 Composite scores
appear to increase
over time
NR IQ relatively stable
over time, some
evidence of decline
in early adulthood
n/a n/a
Howlin (2004)15 NR NR Some measures report
decline, others increase
IQ reported as
predictor
IQ and language,
reading and
spelling correlated
with current
social functioning
Howlin (2000)238 NR NR Some measures
report decline, others
increase
n/a n/a
Ballaban-Gil
(1996)243
NR NR Relatively stable over
time, although with
significant individual
variation
n/a n/a
Bishop (2015)239 VABS DLS increases
in normal range
individuals and appears
to fall in those with ID
NR IQ appears to fall n/a n/a
Anderson (2014)240 In adults with IQ in the
normal range, VABS
scores increased over
time. In adults with
IQ below the normal
range, VABS scores fell
NR In adults with IQ in
the normal range, IQ
scores increased over
time. In adults with
IQ below the normal
range, IQ scores fell
n/a n/a
Marriage (2009)241 n/a n/a n/a IQ reported as
predictor
n/a
Gray (2014)242 NR n/a IQ stable over time n/a n/a
Esbensen (2010)133 n/a n/a n/a n/a IQ correlated
with current
social functioning
CARS, Childhood Autism Rating Scale; DLS, daily living skills; n/a, not applicable; NR, not reported.
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Appendix 16 Resource use review
Overview
A literature review was conducted to identify studies reporting on resource use and care costs in
autistic children and adults.
Methods
To identify published economic evidence, the following databases were searched for eligible studies:
MEDLINE (Ovid), EMBASE (Ovid) 1980 onwards, NHS Economic Evaluation Database and PsycINFO.
The searches were undertaken in November 2017. The full search strategy is reported in Appendix 17.
Study selection
Two researchers independently undertook the screening of all titles and abstracts identified in the
search. Full-paper publications were then obtained for potentially relevant studies and screened
against the eligibility criteria. Disagreements between reviewers were resolved by discussion.
Studies were included if they reported on costs or resource use associated with the care of autistic
children or adults.
Data extraction
Details of eligible studies were extracted by a single reviewer and summarised using a Microsoft Excel
data extraction template.
Results
A total of 892 records were identified in the search, of which 63 studies were identified as potentially
relevant from their titles and/or abstracts. The full-text articles of these records were assessed for
eligibility. A total of 15 studies were found to meet the inclusion criteria. Figure 36 presents a flow
diagram of the selection process.
Description of included studies
A summary of key characteristics of the 15 identified studies23,126,135,147,188,244–252 is presented in Table 56.
A range of methods were used to collect data, including surveys of respondents, as well as secondary
analysis of data collected by local authorities and other providers. Of the 15 identified studies,
eight23,126,135,147,245,246,248,252 provided a comprehensive assessment of public sector service costs for
autistic children or adults. In the studies of children, education costs were consistently reported as the
most significant driver of total public sector costs, with health and other social care costs making up
the majority of the remainder. In studies of autistic adults, care costs were dominated by residential
care costs and costs of day care services. A summary of the resource data collected by study is
outlined in Table 57.
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TABLE 56 Summary of study characteristics
Study Participants
Subgroup/trial
arm n Male (%)
Age years,
mean (SD) Objective of study
Year of
costing Source of data
Barret
(2012)126
Young children with
autism
n/a 152 91 3.74 (0.66) To describe service use in young
children with autism
2006–7 Service use for the
6 months prior to
interview
Barret
(2015)135
Adolescents with
autism, autism-
related conditions,
other SEN and
typically developing
children
Autism 51 94 15.70 (0.54) To describe service use in four groups
of adolescents: (1) adolescents with
autism, (2) adolescents with other ASDs,
(3) adolescents with other SEN, and
(4) typically developing adolescents
2007–8 Service use for the
6 months prior to
interviewBroader ASD 45 87 15.44 (0.38)
SEN 24 88 15.46 (0.38)
Typical
development
28 100 15.62 (0.68)
Bebbington
(2007)244
Children with autism n/a 6310 80 0–16 To describe social service use in
children with autism and the costs
of providing these services
Unclear Children in Need
survey 2001
Buescher
(2014)23
People with ASD n/a n/a n/a n/a To update estimates of age-specific,
direct, indirect, and lifetime societal
economic costs associated with autism.
Update to the Knapp et al. study147
2010–11 Published evidence
used (combination
of UK, USA and
Australia)
Byford
(2015)245
Preschool children
with autism
PACT + TAU
group
74 92 Median 4
(range 2–5)
To assess the cost-effectiveness of a
preschool intervention for children with
autism carried out within the Preschool
Autism Communication Trial
2006–7 Total resource
used and costs per
participant over
the 13-month
follow-up
estimated
TAU group 69 90 Median 4
(range 2–5)
Järbrink
(2001)246
People with autism n/a n/a n/a n/a To assess the economic impact of autism
in the UK
1998–9 Published evidence
Järbrink
(2003)247
Children with ASD n/a 17 children;
15 parents
n/a 7.8 (n/a) To assess the feasibility of research
instrument developed specifically to
collect cost information for individuals
with ASD
1999–2000 Questionnaire and
diary survey
Knapp
(2009)147
People with ASD n/a n/a n/a n/a To estimate direct, indirect and lifetime
societal economic costs associated
with autism
2005–6 Published evidence
used (combination
of UK, USA and
Australia)
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TABLE 56 Summary of study characteristics (continued )
Study Participants
Subgroup/trial
arm n Male (%)
Age years,
mean (SD) Objective of study
Year of
costing Source of data
Mavranezouli
(2014)248
Adults with autism n/a n/a n/a n/a To assess the cost-effectiveness of
supported employment compared with
standard care (day services) for adults
with autism
2011–12 Published evidence,
authors’
assumptions
McGill
(2012)249
Adults in residential
care
n/a 70 73 33 (NR) To characterise the highest cost
residential placements in the south-east
of England
2010 Survey of local
authorities
Petrou
(2010)188
Any autistic disorder n/a 11 NR NR To estimate costs and preference-based
health-related quality-of-life outcomes
(health utilities) associated with a broad
range of childhood psychiatric disorders
during the eleventh year of life
2006–7 Parent-reported
questionnaire
survey
Preece
(2007)250
ASD n/a 155 NR NR To examine the use of short break
services in the UK and their association
with informal support networks and
child level of dependence
n/a Postal survey
Russell
(2010)251
ASD n/a 71 NR NR To compare resource use in children
with diagnosed autism and those with
undiagnosed autism
n/a The Avon
Longitudinal Study
of Parents and
Children
Wright
(2016)252
Children with ASD Social stories
(intervention
arm) vs. TAU
(comparator
arm)
52 NR NR Feasibility RCT; the feasibility of
collecting data on resource use
measures for cost-effectiveness analysis
in a fully powered trial
Unclear Resource used
over 6-week
period
Yuan
(2017)253
Children with or
without neurological
disabilities
n/a 942 NR 6.5 (NR) To compare inpatient resource use in
children with and without neurological
disabilities
n/a HES data
HES, Hospital Episode Statistics; n/a, not applicable; NR, not reported.
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TABLE 57 Summary of resource data collected
Study
Resource utilisation collected/included
Accommodation
Hospital-based
health services
Community health, social
and voluntary services Medication
Education and
childcare
Disability living
allowance Other
Barret (2012)126 Yes Yes Yes Yes Yes No Out-of-pocket expenses,
productivity losses
Barret (2015)135 Yes Yes Yes Yes Yes No n/a
Bebbington (2007)244 Yes No Yes No No No n/a
Buescher (2014)23 Yes Yes Yes Yes Yes No Employment support
Byford (2015)245 Yes Yes Yes Yes Yes No Parental productivity losses and
informal care
Järbrink (2001)246 Yes Yes Yes Yes Yes Living support Lost productivity, family
members’ time cost, family
expenses, sheltered work
Järbrink (2003)247 No Yes Yes Yes Yes No Informal care and out-of-pocket
expenses, income losses
Knapp (2009)147 Yes Yes Yes Yes Yes No Employment support
Mavranezouli (2014)248 Yes Yes Yes Yes Yes No n/a
McGill (2012)249 Yes No No No No No n/a
Petrou (2010)188 No Yes Yes Yes Yes No n/a
Preece (2007)250 No No Short break services No No No n/a
Russell (2010)251 No No No No Yes No n/a
Wright (2016)252 Yes Yes Yes Yes Yes No n/a
Yuan (2017)253 No Inpatient
resource use
No No No No n/a
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Appendix 17 Searches implemented to
inform economic analysis
Cost-effectiveness searches
Searches were implemented to identify previous economic evaluations of early intensive
ABA-based interventions.
Databases searched included EMBASE, HTA database, MEDLINE, NHS Economic Evaluation Database
and PsycINFO.
The searches identified 379 records.
EMBASE via OVID
Date searched: 11 November 2017.
Date range searched: 1974 to 9 November 2017.
Search strategy
1. Autism/ (49,006)
2. Asperger Syndrome/ (4129)
3. (autism or autistic or ASD or ASDs or ASC or AAC).ti,ab. (70,967)
4. Asperger$.ti,ab. (2685)
5. 1 or 2 or 3 or 4 (81,926)
6. Behavior Modification/ (7370)
7. Behavior Therapy/ (41,427)
8. early intervention therap$.ti,ab. (80)
9. (intensive$ adj2 (analys$ or behavior$ or behaviour$ or intervention$ or program$ or therap$ or
treat$)).ti,ab. (37,176)
10. (intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or program$ or therap$ or
treat$)).ti,ab. (11,460)
11. (high-intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or model$ or program$
or therap$ or treat$)).ti,ab. (1558)
12. (low-intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or model$ or program$
or therap$ or treat$)).ti,ab. (1425)
13. (high intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or model$ or program$
or therap$ or treat$)).ti,ab. (1558)
14. (low intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or model$ or program$
or therap$ or treat$)).ti,ab. (1425)
15. (intensive behavior$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat
$)).ti,ab. (351)
16. (intensive behaviour$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat
$)).ti,ab. (67)
17. (early behavior$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,ab. (59)
18. (early behaviour$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,
ab. (13)
19. (comprehensive behavior$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or
treat$)).ti,ab. (154)
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20. (comprehensive behaviour$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or
treat$)).ti,ab. (23)
21. (applied behavior$ adj2 (analy$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,
ab. (401)
22. (applied behaviour$ adj2 (analy$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,
ab. (75)
23. (ABA$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,ab. (5001)
24. NDBI$.ti,ab. (13)
25. Naturalistic Developmental Behav$ Intervention$.ti,ab. (5)
26. (IBI or EIBI or ABA).ti,ab. (10,120)
27. Lovaas$.ti,ab. (45)
28. (Early Start Denver Model or Denver Model).ti,ab. (57)
29. (ESDM or ESDM-I or ESDM-PD or P-ESDM).ti,ab. (68)
30. (Pivotal Response adj2 (treat$ or train$ or program$)).ti,ab. (61)
31. (PRT train$ or PRT program$ or PRT model$).ti,ab. (67)
32. discrete trial train$.ti,ab. (35)
33. 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or
23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 (110,230)
34. 5 and 33 (2217)
35. health economics/ (35,525)
36. exp economic evaluation/ (268,818)
37. exp health care cost/ (258,306)
38. exp pharmacoeconomics/ (189,269)
39. or/35-38 (583,319)
40. (economic$ or cost or costs or costly or costing or price or prices or pricing or pharmacoeconomic
$).ti,ab. (836,568)
41. (expenditure$ not energy).ti,ab. (33,161)
42. (value adj2 money).ti,ab. (2009)
43. budget$.ti,ab. (32,261)
44. (or/40) or 41 or 42 or 43 (867,818)
45. 39 or 44 (1,177,243)
46. letter.pt. (998,943)
47. editorial.pt. (552,823)
48. note.pt. (695,192)
49. 46 or 47 or 48 (2,246,958)
50. 45 not 49 (1,073,110)
51. (metabolic adj cost).ti,ab. (1278)
52. ((energy or oxygen) adj cost).ti,ab. (3825)
53. ((energy or oxygen) adj expenditure).ti,ab. (27,346)
54. 51 or 52 or 53 (31,456)
55. 50 not 54 (1,066,753)
56. exp animal/ (23,945,891)
57. exp animal experiment/ (2,180,860)
58. nonhuman/ (5,376,119)
59. (rat or rats or mouse or mice or hamster or hamsters or animal or animals or dog or dogs or cat or
cats or bovine or sheep).ti,ab,sh. (4,500,617)
60. 56 or 57 or 58 or 59 (25,649,733)
61. exp human/ (19,181,630)
62. exp human-experiment/ (398,342)
63. 61 or 62 (19,183,186)
64. 60 not (60 and 63) (6,467,566)
65. 55 not 64 (977,661)
66. 634 and 65 (131)
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MEDLINE In-Process & Other Non-Indexed Citations via OVID
Date searched: 11 November 2017.
Date range searched: 1946 to present.
Search strategy
1. Autistic Disorder/ (22,034)
2. Autism Spectrum Disorder/ (4163)
3. Asperger Syndrome/ (2146)
4. (autism or autistic or ASD or ASDs or ASC or AAC).ti,ab. (58,960)
5. Asperger$.ti,ab. (2384)
6. 1 or 2 or 3 or 4 or 5 (62,676)
7. Applied Behavior Analysis/ (13)
8. “Early Intervention (Education)”/ (2699)
9. Behavior Therapy/ (28,032)
10. early intervention therap$.ti,ab. (44)
11. (intensive$ adj2 (analys$ or behavior$ or behaviour$ or intervention$ or program$ or therap$ or
treat$)).ti,ab. (27,769)
12. (intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or program$ or therap$ or
treat$)).ti,ab. (8610)
13. (high-intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or model$ or program$
or therap$ or treat$)).ti,ab. (1177)
14. (low-intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or model$ or program$
or therap$ or treat$)).ti,ab. (1189)
15. (high intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or model$ or program$
or therap$ or treat$)).ti,ab. (1177)
16. (low intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or model$ or program$
or therap$ or treat$)).ti,ab. (1189)
17. (intensive behavior$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat
$)).ti,ab. (265)
18. (intensive behaviour$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,
ab. (50)
19. (early behavior$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,ab. (42)
20. (early behaviour$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,
ab. (14)
21. (comprehensive behavior$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or
treat$)).ti,ab. (127)
22. (comprehensive behaviour$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or
treat$)).ti,ab. (16)
23. (applied behavior$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,
ab. (469)
24. (applied behaviour$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,
ab. (40)
25. (ABA$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,ab. (3842)
26. NDBI$.ti,ab. (13)
27. Naturalistic Developmental Behav$ Intervention$.ti,ab. (5)
28. (IBI or EIBI or ABA).ti,ab. (11,310)
29. Lovaas$.ti,ab. (48)
30. (Early Start Denver Model or Denver Model).ti,ab. (40)
31. (ESDM or ESDM-I or ESDM-PD or P-ESDM).ti,ab. (37)
32. (Pivotal Response adj2 (treat$ or train$ or program$)).ti,ab. (56)
33. (PRT train$ or PRT program$ or PRT model$).ti,ab. (50)
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34. discrete trial train$.ti,ab. (39)
35. 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23
or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 (80,416)
36. 6 and 35 (2018)
37. economics/(27,492)
38. exp “costs and cost analysis”/or Cost Allocation/or Cost-Benefit Analysis/or Cost Control/or Cost
of Illness/or Cost Sharing/or Health Care Costs/or Health Expenditures/ (224,837)
39. economics, dental/ (1905)
40. exp “economics, hospital”/or Hospital Charges/or Hospital Costs/ (23,580)
41. economics, medical/ (9205)
42. economics, nursing/ (4019)
43. economics, pharmaceutical/ (3002)
44. (economic$ or cost$ or price or prices or pricing or pharmacoeconomic$).tw. (717,189)
45. (expenditure$ not energy).tw. (26,209)
46. (value adj1 money).tw. (34)
47. budget$.tw. (26,294)
48. 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 (863,345)
49. ((energy or oxygen) adj cost).ti,ab. (3935)
50. (metabolic adj cost).ti,ab. (1287)
51. ((energy or oxygen) adj expenditure).ti,ab. (23,489)
52. or/49-51 (27,725)
53. 48 not 52 (856,916)
54. letter.pt. (1,033,891)
55. editorial.pt. (469,249)
56. historical article.pt. (358,123)
57. 54 or 55 or 56 (1,843,012)
58. 53 not 57 (822,035)
59. exp animals/not humans/(4,741,624)
60. 58 not 59 (762,726)
61. 36 and 60 (85)
PsycINFO via OVID
Date searched: 11 November 2017.
Date range searched: 1806 to November week 1 2017.
Search strategy
1. Autism Spectrum Disorder/ (36,543)
2. (autism or autistic or ASD or ASDs or ASC or AAC).ti,ab. (44,595)
3. Asperger$.ti,ab. (3398)
4. 1 or 2 or 3 (46,929)
5. Behavior Modification/ (10,223)
6. Behavior Therapy/ (13,276)
7. early intervention therap$.ti,ab. (18)
8. (intensive$ adj2 (analys$ or behavior$ or behaviour$ or intervention$ or program$ or therap$ or
treat$)).ti,ab. (6049)
9. (intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or program$ or therap$ or
treat$)).ti,ab. (1956)
10. (high-intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or model$ or program$
or therap$ or treat$)).ti,ab. (184)
11. (low-intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or model$ or program$
or therap$ or treat$)).ti,ab. (341)
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12. (high intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or model$ or program$
or therap$ or treat$)).ti,ab. (184)
13. (low intensity adj2 (analys$ or behavior$ or behaviour$ or intervention$ or model$ or program$
or therap$ or treat$)).ti,ab. (341)
14. (intensive behavior$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,
ab. (393)
15. (intensive behaviour$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,
ab. (64)
16. (early behavior$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,ab. (81)
17. (early behaviour$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,ab. (13)
18. (comprehensive behavior$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or
treat$)).ti,ab. (143)
19. (comprehensive behaviour$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or
treat$)).ti,ab. (9)
20. (applied behavior$ adj2 (analyS$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,
ab. (1678)
21. (applied behaviour$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,
ab. (115)
22. (ABA$ adj2 (analys$ or intervention$ or model$ or program$ or therap$ or treat$)).ti,ab. (864)
23. NDBI$.ti,ab. (3)
24. Naturalistic Developmental Behav$ Intervention$.ti,ab. (4)
25. (IBI or EIBI or ABA).ti,ab. (1454)
26. Lovaas$.ti,ab. (126)
27. (Early Start Denver Model or Denver Model).ti,ab. (47)
28. (ESDM or ESDM-I or ESDM-PD or P-ESDM).ti,ab. (38)
29. (Pivotal Response adj2 (treat$ or train$ or program$)).ti,ab. (130)
30. (PRT train$ or PRT program$ or PRT model$).ti,ab. (18)
31. discrete trial train$.ti,ab. (102)
32. 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or
22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 (33,737)
33. 4 and 32 (2275)
34. “costs and cost analysis”/ (15,176)
35. “Cost Containment”/ (539)
36. (economic adj2 evaluation$).ti,ab. (1420)
37. (economic adj2 analy$).ti,ab. (1364)
38. (economic adj2 (study or studies)).ti,ab. (679)
39. (cost adj2 evaluation$).ti,ab. (291)
40. (cost adj2 analy$).ti,ab. (3246)
41. (cost adj2 (study or studies)).ti,ab. (760)
42. (cost adj2 effective$).ti,ab. (13,368)
43. (cost adj2 benefit$).ti,ab. (3122)
44. (cost adj2 utili$).ti,ab. (1062)
45. (cost adj2 minimi$).ti,ab. (316)
46. (cost adj2 consequence$).ti,ab. (108)
47. (cost adj2 comparison$).ti,ab. (172)
48. (cost adj2 identificat$).ti,ab. (20)
49. (pharmacoeconomic$ or pharmaco-economic$).ti,ab. (294)
50. 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or
49 (30,824)
51. (task adj2 cost$).ti,ab,id. (530)
52. (switch$ adj2 cost$).ti,ab,id. (1116)
53. (metabolic adj cost).ti,ab,id. (90)
54. ((energy or oxygen) adj cost).ti,ab,id. (257)
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55. 51 or 52 or 53 or 54 (1809)
56. 50 not 55 (30,673)
57. (animal or animals or rat or rats or mouse or mice or hamster or hamsters or dog or dogs or cat or
cats or bovine or sheep or ovine or pig or pigs).ab,ti,id,de. (327,532)
58. editorial.dt. (41,001)
59. letter.dt. (19,944)
60. dissertation abstract.pt. (450,546)
61. 57 or 58 or 59 or 60 (819,492)
62. 56 not 61 (26,772)
63. 33 and 62 (24)
Quality-of-life searches
Databases were searched for studies reporting the quality of life of children and adults with autism
and Asperger syndrome.
Databases searched included EMBASE, HTA database, MEDLINE, NHS Economic Evaluation Database
and PsycINFO.
The searches identified a total of 1502 records.
EMBASE via OVID
Date searched: 11 November 2017.
Date range searched: 1974 to 9 November 2017.
Search strategy
1. Autism/ (49,006)
2. Asperger Syndrome/ (4129)
3. (autism or autistic or ASD or ASDs or ASC or AAC).ti,ab. (70,967)
4. Asperger$.ti,ab. (2685)
5. 1 or 2 or 3 or 4 (81,926)
6. (utilit$ approach$ or health gain or hui or hui1 or hui2 or hui3).ti,ab. (2707)
7. (health measurement$ scale$ or health measurement$ questionnaire$).ti,ab. (75)
8. (standard gamble$ or categor$ scal$ or linear scal$ or linear analog$ or visual scal$ or magnitude
estimat$).ti,ab. (6577)
9. (time trade off$ or rosser$ classif$ or rosser$ matrix or rosser$ distress$ or hrqol).ti,ab. (21,014)
10. (index of wellbeing or quality of wellbeing or qwb).ti,ab. (257)
11. (multiattribute$ health ind$ or multi attribute$ health ind$).ti,ab. (2)
12. (health utilit$ index or health utilit$ indices).ti,ab. (1022)
13. (multattribute$ theor$ or multi attribute$ theor$ or multiattribute$ analys$ or multi attribute$
analys$).ti,ab. (19)
14. (health utilit$ scale$ or classification of illness state$).ti,ab. (14)
15. health state$ utilit$.ti,ab. (954)
16. well year$.ti,ab. (31)
17. (multiattribute$ utilit$ or multi attribute$ utilit$).ti,ab. (324)
18. health utilit$ scale$.ti,ab. (13)
19. (euro qual or euro qol or eq-5d or eq5d or eq 5d or euroqual or euroqol).ti,ab. (14,223)
20. (qualy or qaly or qualys or qalys or quality adjusted life year$).ti,ab. (18,668)
21. willingness to pay.ti,ab. (6304)
22. (hye or hyes or health$ year$ equaivalent$).ti,ab. (116)
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23. (person trade off$ or person tradeoff$ or time tradeoff$ or time trade off$).ti,ab. (1759)
24. theory utilit$.ti,ab. (10)
25. (sf36 or sf 36).ti,ab. (29,946)
26. (short form 36 or shortform 36 or sf thirtysix or sf thirty six or shortform thirtysix or shortform
thirty six or shrt form thirtysix or short form thirty six).ti,ab. (11,583)
27. (sf 6d or sf6d or short form 6d or shortform 6d or sf six$ or shortform six$ or short form six$).ti,
ab. (1213)
28. or/6-27 (88,865)
29. 5 and 28 (434)
MEDLINE In-Process & Other Non-Indexed Citations via OVID
Date searched: 11 November 2017.
Date range searched: 1946 to present.
Search strategy
1. Autistic Disorder/ (22,034)
2. Autism Spectrum Disorder/ (4163)
3. Asperger Syndrome/ (2146)
4. (autism or autistic or ASD or ASDs or ASC or AAC).ti,ab. (58,960)
5. Asperger$.ti,ab. (2384)
6. or/1-5 (62,676)
7. Quality-Adjusted Life Years/ (10,851)
8. Value of Life/ (5842)
9. (qaly$ or qald$ or qale$ or qtime$).ti,ab,kf. (9018)
10. (quality adjusted or adjusted life year$).ti,ab,kf. (13,989)
11. disability adjusted life.ti,ab,kf. (2644)
12. daly$1.ti,ab,kf. (2388)
13. ((index adj3 wellbeing) or (quality adj3 wellbeing) or qwb).ti,ab,kf. (584)
14. (multiattribute$ or multi attribute$).ti,ab,kf. (814)
15. (utility adj3 (score$1 or scoring or valu$ or measur$ or evaluat$ or scale$1 or instrument$1 or
weight or weights or weighting or information or data or unit or units or health$ or life or estimat$
or elicit$ or disease$ or mean or cost$ or expenditure$1 or gain or gains or loss or losses or lost or
analysis or index$ or indices or overall or reported or calculat$ or range$ or increment$ or state or
states or status)).ti,ab,kf. (29,311)
16. utility.ab./freq = 2 (14,979)
17. utilities.ti,ab,kf. (6240)
18. disutili$.ti,ab,kf. (392)
19. (HSUV or HSUVs).ti,ab,kf. (50)
20. health$1 year$1 equivalent$1.ti,ab,kf. (49)
21. (hye or hyes).ti,ab,kf. (72)
22. (hui or hui1 or hui2 or hui3).ti,ab,kf. (1307)
23. (illness state$1 or health state$1).ti,ab,kf. (5782)
24. (euro qual or euro qual5d or euro qol5d or eq-5d or eq5-d or eq5d or euroqual or euroqol or
euroqual5d or euroqol5d).ti,ab,kf. (8561)
25. (eq-sdq or eqsdq).ti,ab,kf. (1)
26. (short form$ or shortform$).ti,ab,kf. (28,850)
27. (sf36$ or sf 36$ or sf thirtysix or sf thirty six).ti,ab,kf. (20,701)
28. (sf6 or sf 6 or sf6d or sf 6d or sf six or sfsix or sf8 or sf 8 or sf eight or sfeight).ti,ab,kf. (2937)
29. (sf12 or sf 12 or sf twelve or sftwelve).ti,ab,kf. (4062)
30. (sf16 or sf 16 or sf sixteen or sfsixteen).ti,ab,kf. (24)
31. (sf20 or sf 20 or sf twenty or sftwenty).ti,ab,kf. (348)
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32. (15D or 15-D or 15 dimension).ti,ab,kf. (4788)
33. (standard gamble$ or sg).ti,ab,kf. (9284)
34. (time trade off$1 or time tradeoff$1 or tto or timetradeoff$1).ti,ab,kf. (1775)
35. 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23
or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 (126,607)
36. 6 and 35 (386)
PsycINFO via OVID
Date searched: 11 November 2017.
Date range searched: 1806 to November week 1 2017.
Search strategy
1. Autism Spectrum Disorder/ (36,543)
2. (autism or autistic or ASD or ASDs or ASC or AAC).ti,ab. (44,595)
3. Asperger$.ti,ab. (3398)
4. 1 or 2 or 3 (46,929)
5. exp “Quality of Life”/ (37,006)
6. (qaly$ or qald$ or qale$ or qtime$).ti,ab,kf. (920)
7. (quality adjusted or adjusted life year$).ti,ab,kf. (1440)
8. disability adjusted life.ti,ab,kf. (333)
9. daly$1.ti,ab,kf. (549)
10. ((index adj3 wellbeing) or (quality adj3 wellbeing) or qwb).ti,ab,kf. (374)
11. (multiattribute$ or multi attribute$).ti,ab,kf. (965)
12. (utility adj3 (score$1 or scoring or valu$ or measur$ or evaluat$ or scale$1 or instrument$1 or
weight or weights or weighting or information or data or unit or units or health$ or life or estimat$
or elicit$ or disease$ or mean or cost$ or expenditure$1 or gain or gains or loss or losses or lost or
analysis or index$ or indices or overall or reported or calculat$ or range$ or increment$ or state or
states or status)).ti,ab,kf. (7785)
13. utility.ab./freq = 2 (5982)
14. utilities.ti,ab,kf. (1732)
15. disutili$.ti,ab,kf. (177)
16. (HSUV or HSUVs).ti,ab,kf. (3)
17. health$1 year$1 equivalent$1.ti,ab,kf. (4)
18. (hye or hyes).ti,ab,kf. (18)
19. (hui or hui1 or hui2 or hui3).ti,ab,kf. (507)
20. (illness state$1 or health state$1).ti,ab,kf. (1341)
21. (euro qual or euro qual5d or euro qol5d or eq-5d or eq5-d or eq5d or euroqual or euroqol or
euroqual5d or euroqol5d).ti,ab,kf. (1641)
22. (eq-sdq or eqsdq).ti,ab,kf. (1)
23. (short form$ or shortform$).ti,ab,kf. (11,238)
24. (sf36$ or sf 36$ or sf thirtysix or sf thirty six).ti,ab,kf. (4080)
25. (sf6 or sf 6 or sf6d or sf 6d or sf six or sfsix or sf8 or sf 8 or sf eight or sfeight).ti,ab,kf. (333)
26. (sf12 or sf 12 or sf twelve or sftwelve).ti,ab,kf. (981)
27. (sf16 or sf 16 or sf sixteen or sfsixteen).ti,ab,kf. (0)
28. (sf20 or sf 20 or sf twenty or sftwenty).ti,ab,kf. (42)
29. (15D or 15-D or 15 dimension).ti,ab,kf. (221)
30. (standard gamble$ or sg).ti,ab,kf. (866)
31. (time trade off$1 or time tradeoff$1 or tto or timetradeoff$1).ti,ab,kf. (352)
32. 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or
22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 (63,306)
33. 4 and 32 (605)
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Prognosis and longitudinal outcomes searches
Databases were searched for studies reporting longitudinal outcomes in children and adults with
autism and Asperger syndrome.
Databases searched included EMBASE, MEDLINE and PsycINFO.
Date limit was 2013 onwards.
A total of 737 records were identified.
EMBASE via OVID
Date searched: 8 February 2018.
Date range searched: 1974 to 9 November 2017.
Search strategy
1. Autism/ (23,952)
2. Asperger Syndrome/ (1563)
3. (autism or autistic or ASD or ASDs or ASC or AAC).ti,ab. (16,833)
4. Asperger$.ti,ab. (282)
5. 1 or 2 or 3 or 4 (26,561)
6. 6 (adult* or adolescen* or people or individual* or youth* or teenag* or “young people”).ti,ab. (278394)
7. (outcome* or prognosis or follow-up or longitudinal or long-termor predict* or change* or continuit*
or trajector*).ti,ab. (40,725)
8. 6 and 7 (20,524)
9. 5 and 8 (220)
MEDLINE In-Process & Other Non-Indexed Citations via OVID
Date searched: 8 February 2018.
Date range searched: 1946 to present.
Search strategy
1. Autistic Disorder/ (933)
2. Autism Spectrum Disorder/ (991)
3. Asperger Syndrome/ (140)
4. (autism or autistic or ASD or ASDs or ASC or AAC).ti,ab. (1670)
5. Asperger$.ti,ab. (53)
6. or/1-5 (1912)
7. (adult* or adolescen* or people or individual* or youth* or teenag* or “young people”).ti,ab.
(270,342)
8. (outcome* or prognosis or follow-up or longitudinal or long-term or predict* or change* or
continuit* or trajector*).ti,ab. (25,0979)
9. 7 and 8 (116,323)
10. 6 and 9 (340)
PsycINFO via OVID
Date searched: 8 February 2018.
Date range searched: 1806 to November week 1 2017.
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Search strategy
1. Autism Spectrum Disorder/ (16,066)
2. (autism or autistic or ASD or ASDs or ASC or AAC).ti,ab. (14,477)
3. Asperger$.ti,ab. (370)
4. 1 or 2 or 3 (17,126)
5. (adult* or adolescen* or people or individual* or youth* or teenag* or “young people”).ti,ab. (113,016)
6. (outcome* or prognosis or follow-up or longitudinal or long-termor predict* or change* or continuit*
or trajector*).ti,ab. (55,365)
7. 5 and 6 (8582)
8. 4 and 7 (177)
Resource use searches
Databases were searched for studies reporting resource and cost data for children and adults with
autism and Asperger syndrome.
Databases searched included EMBASE, HTA database, MEDLINE, NHS Economic Evaluation Database
and PsycINFO.
A total of 892 records were identified. We attempted to restrict to UK studies by using the NICE UK
search filter.
EMBASE via OVID
Date searched: 11 November 2017.
Date range searched: 1974 to 10 November 2017.
Search strategy
1. Autism/ (49,065)
2. Asperger Syndrome/ (4134)
3. (autism or autistic or ASD or ASDs or ASC or AAC).ti,ab. (71,033)
4. Asperger$.ti,ab. (2686)
5. 1 or 2 or 3 or 4 (82,010)
6. health economics/ (35,551)
7. exp economic evaluation/ (269,060)
8. exp health care cost/ (258,598)
9. exp pharmacoeconomics/ (189,432)
10. 6 or 7 or 8 or 9 (583,838)
11. (economic$ or cost or costs or costly or costing or price or prices or pricing or pharmacoeconomic$).ti,
ab. (837,144)
12. (expenditure$ not energy).ti,ab. (33,183)
13. (value adj2 money).ti,ab. (2011)
14. budget$.ti,ab. (32,277)
15. 11 or 12 or 13 or 14 (868,410)
16. economics/ (227,601)
17. cost-benefit analys$.mp. (78,709)
18. cost minimi?ation.mp. (3812)
19. cost-effective$.mp. (208,439)
20. costeffective$.mp. (4218)
21. CEA.mp. (31,340)
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22. cost utilit$.mp. (9869)
23. cost-utilit$.mp. (9869)
24. costutilit$.mp. (131)
25. CUA.mp. (1247)
26. “fees and charges”/ (15,073)
27. drug cost$.mp. (71,695)
28. healthcare cost$.mp. (13,892)
29. health care cost$.mp. (172,817)
30. hospital charges.mp. (4068)
31. hospital running costs.mp. (24)
32. hospitali?ation cost$.mp. (6336)
33. cost control.mp. (62,003)
34. budget/ (24,983)
35. “willingness to pay”.mp. (6463)
36. (HCRU or MRU).mp. (717)
37. ((healthcare or health care or health resource$ or medical resource$) adj3 utili?ation).mp. (68,104)
38. ((healthcare or health care or health resource$ or medical resource$) adj3 “use”).mp. (16,742)
39. (resource$ adj2 (“use$” or util$ or allocat$)).mp. (64,570)
40. ((economic or health$ or resource) adj3 burden).mp. (27,185)
41. or/16-40 (824,272)
42. 10 or 15 or 41 (1,430,406)
43. 5 and 42 (2912)
44. United Kingdom/ (388,356)
45. (national health service* or nhs*).ti,ab,in,ad. (270,391)
46. (english not ((published or publication* or translat* or written or language* or speak* or literature
or citation*) adj5 english)).ti,ab. (33,942)
47. (gb or “g.b.” or britain* or (british* not “british columbia”) or uk or “u.k.” or united kingdom* or
(england* not “new england”) or northern ireland* or northern irish* or scotland* or scottish* or
((wales or “south wales”) not “new south wales”) or welsh*).ti,ab,jw,in,ad. (2,839,356)
48. (bath or “bath’s” or ((birmingham not alabama*) or (“birmingham’s” not alabama*) or bradford or
“bradford’s” or brighton or “brighton’s” or bristol or “bristol’s” or carlisle* or “carlisle’s” or
(cambridge not (massachusetts* or boston* or harvard*)) or (“cambridge’s” not (massachusetts* or
boston* or harvard*)) or (canterbury not zealand*) or (“canterbury’s” not zealand*) or chelmsford or
“chelmsford’s” or chester or “chester’s” or chichester or “chichester’s” or coventry or “coventry’s” or
derby or “derby’s” or (durham not (carolina* or nc)) or (“durham’s” not (carolina* or nc)) or ely or “ely’s”
or exeter or “exeter’s” or gloucester or “gloucester’s” or hereford or “hereford’s” or hull or “hull’s” or
lancaster or “lancaster’s” or leeds* or leicester or “leicester’s” or (lincoln not nebraska*) or (“lincoln’s”
not nebraska*) or (liverpool not (new south wales* or nsw)) or (“liverpool’s” not (new south wales* or
nsw)) or ((london not (ontario* or ont or toronto*)) or (“london’s” not (ontario* or ont or toronto*)) or
manchester or “manchester’s” or (newcastle not (new south wales* or nsw)) or (“newcastle’s” not (new
south wales* or nsw)) or norwich or “norwich’s” or nottingham or “nottingham’s” or oxford or “oxford’s”
or peterborough or “peterborough’s” or plymouth or “plymouth’s” or portsmouth or “portsmouth’s”
or preston or “preston’s” or ripon or “ripon’s” or salford or “salford’s” or salisbury or “salisbury’s” or
sheffield or “sheffield’s” or southampton or “southampton’s” or st albans or stoke or “stoke’s” or
sunderland or “sunderland’s” or truro or “truro’s“ or wakefield or “wakefield’s” or wells or westminster
or “westminster’s” or winchester or “winchester’s” or wolverhampton or “wolverhampton’s” or
(worcester not (massachusetts* or boston* or harvard*)) or (“worcester’s” not (massachusetts* or
boston* or harvard*)) or (york not (“new york*” or ny or ontario* or ont or toronto*)) or (“york’s” not
(“new york*” or ny or ontario* or ont or toronto*))))).ti,ab,in,ad. (2,116,965)
49. (bangor or “bangor’s” or cardiff or “cardiff’s” or newport or “newport’s” or st asaph or “st asaph’s”
or st davids or swansea or “swansea’s”).ti,ab,in,ad. (85,474)
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50. (aberdeen or “aberdeen’s” or dundee or “dundee’s” or edinburgh or “edinburgh’s” or glasgow or
“glasgow’s” or inverness or (perth not australia*) or (“perth’s” not australia*) or stirling or
“stirling’s”).ti,ab,in,ad. (294,276)
51. (armagh or “armagh’s” or belfast or “belfast’s” or lisburn or “lisburn’s” or londonderry or
“londonderry’s” or derry or “derry’s” or newry or “newry’s”).ti,ab,in,ad. (38,399)
52. 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 (3,460,981)
53. (exp “arctic and antarctic”/or exp oceanic regions/or exp western hemisphere/or exp africa/or exp
asia/or exp “australia and new zealand”/) not (united kingdom/or europe/) (2,753,727)
54. 52 not 53 (3,283,935)
55. 43 and 54 (433)
56. letter.pt. (999,410)
57. editorial.pt. (553,065)
58. note.pt. (695,520)
59. 56 or 57 or 58 (2,247,995)
60. 55 not 59 (395)
61. exp animal/ (23,958,412)
62. exp animal experiment/ (2,181,990)
63. nonhuman/ (5,379,549)
64. (rat or rats or mouse or mice or hamster or hamsters or animal or animals or dog or dogs or cat or
cats or bovine or sheep).ti,ab,sh. (4,501,587)
65. 61 or 62 or 63 or 64 (25,663,010)
66. exp human/ (19,192,687)
67. exp human experiment/ (398,415)
68. 66 or 67 (19,194,242)
69. 65 not (65 and 68) (6,469,786)
70. 60 not 69 (387)
MEDLINE In-Process & Other Non-Indexed Citations via OVID
Date searched: 11 November 2017.
Date range searched: 1946 to present.
Search strategy
1. Autistic Disorder/ (22,034)
2. Autism Spectrum Disorder/ (4163)
3. Asperger Syndrome/ (2146)
4. (autism or autistic or ASD or ASDs or ASC or AAC).ti,ab. (58,960)
5. Asperger$.ti,ab. (2384)
6. or/1-5 (62,676)
7. economics/ (27,492)
8. economics, dental/ (1905)
9. exp “economics, hospital”/or Hospital Charges/or Hospital Costs/ (23,580)
10. economics, medical/ (9205)
11. economics, nursing/ (4019)
12. economics, pharmaceutical/ (3002)
13. (economic$ or cost$ or price or prices or pricing or pharmacoeconomic$).tw. (717,189)
14. exp “costs and cost analysis”/or Cost Allocation/or Cost-Benefit Analysis/or Cost Control/or Cost
of Illness/or Cost Sharing/or Health Care Costs/or Health Expenditures/ (224,837)
15. “cost minimization analysis”/ (48,126)
16. economic evaluation/(77,044)
17. “cost effectiveness analysis”/ (77,044)
18. “cost utility analysis”/ (77,044)
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19. cost-benefit analysis.mp. (78,658)
20. cost minimi?ation.mp. (1207)
21. economic evaluation.mp. (8554)
22. cost effective$.mp. (117,719)
23. cost-effective$.mp. (117,719)
24. costeffective$.mp. (171)
25. CEA.mp. (22,030)
26. cost utilit$.mp. (4174)
27. cost-utilit$.mp. (4174)
28. costutilit$.mp. (10)
29. CUA.mp. (1128)
30. “fees and charges”/ (9057)
31. exp drug costs/ (15,223)
32. drug cost$.mp. (17,583)
33. exp cost of illness/(24,636)
34. healthcare costs.mp. (6724)
35. health care costs.mp. (45,300)
36. hospital charges.mp. (4962)
37. hospital running costs.mp. (11)
38. hospitali?ation cost.mp. (625)
39. cost control.mp. (22,628)
40. budgets/ (11,172)
41. “willingness to pay”.mp. (4366)
42. HCRU or MRU).mp. (408)
43. ((healthcare or health care or health resource$ or medical resource$) adj3 utili?ation).mp. (15,973)
44. ((healthcare or health care or health resource$ or medical resource$) adj3 “use”).mp. (13,610)
45. (resource adj2 (“use$” or util$ or allocat$)).mp. (33,167)
46. ((economic or health$ or resource) adj3 burden).mp. (19,031)
47. (expenditure$ not energy).tw. (26,209)
48. (value adj1 money).tw. (34)
49. budget$.tw. (26,294)
50. 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23
or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39
or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 (936,074)
51. 6 and 50 (1503)
52. United Kingdom/ (226,997)
53. (national health service* or nhs*).ti,ab,in,ad. (160,752)
54. (english not ((published or publication* or translat* or written or language* or speak* or literature
or citation*) adj5 english)).ti,ab. (93,005)
55. (gb or “g.b.” or britain* or (british* not “british columbia”) or uk or “u.k.” or united kingdom* or
(england* not “new england”) or northern ireland* or northern irish* or scotland* or scottish* or
((wales or “south wales”) not “new south wales”) or welsh*).ti,ab,jw,in,ad. (1,937,468)
56. (bath or “bath’s” or ((birmingham not alabama*) or (“birmingham’s” not alabama*) or bradford or
“bradford’s” or brighton or “brighton’s” or bristol or “bristol’s” or carlisle* or “carlisle’s” or
(cambridge not (massachusetts* or boston* or harvard*)) or (“cambridge’s” not (massachusetts* or
boston* or harvard*)) or (canterbury not zealand*) or (“canterbury’s” not zealand*) or chelmsford or
“chelmsford’s” or chester or “chester’s” or chichester or “chichester’s” or coventry or “coventry’s” or
derby or “derby’s” or (durham not (carolina* or nc)) or (“durham’s” not (carolina* or nc)) or ely or
“ely’s” or exeter or “exeter’s” or gloucester or “gloucester’s” or hereford or “hereford’s” or hull or
“hull’s” or lancaster or “lancaster’s” or leeds* or leicester or “leicester’s” or (lincoln not nebraska*)
or (“lincoln’s” not nebraska*) or (liverpool not (new south wales* or nsw)) or (”liverpool’s” not (new
south wales* or nsw)) or ((london not (ontario* or ont or toronto*)) or (“london’s” not (ontario* or
ont or toronto*)) or manchester or “manchester’s” or (newcastle not (new south wales* or nsw)) or
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(“newcastle’s” not (new south wales* or nsw)) or norwich or “norwich’s” or nottingham or
“nottingham’s” or oxford or “oxford’s” or peterborough or “peterborough’s” or plymouth or
“plymouth’s” or portsmouth or “portsmouth’s” or preston or “preston’s” or ripon or “ripon’s” or salford
or “salford’s” or salisbury or “salisbury’s” or sheffield or “sheffield’s” or southampton or
“southampton’s” or st albans or stoke or “stoke’s” or sunderland or “sunderland’s” or truro or “truro’s”
or wakefield or “wakefield’s” or wells or westminster or “westminster’s” or winchester or
“winchester’s” or wolverhampton or “wolverhampton’s” or (worcester not (massachusetts* or boston*
or harvard*)) or (“worcester’s” not (massachusetts* or boston* or harvard*)) or (york not (“new york*”
or ny or ontario* or ont or toronto*)) or (“york’s” not (“new york*” or ny or ontario* or ont or
toronto*))))).ti,ab,in,ad. (1,283,584)
57. (bangor or “bangor’s” or cardiff or “cardiff’s” or newport or “newport’s” or st asaph or “st asaph’s”
or st davids or swansea or “swansea’s”).ti,ab,in,ad. (48,661)
58. (aberdeen or “aberdeen’s” or dundee or “dundee’s” or edinburgh or “edinburgh’s” or glasgow or
“glasgow’s” or inverness or (perth not australia*) or (“perth’s” not australia*) or stirling or
“stirling’s”).ti,ab,in,ad. (187,571)
59. (armagh or “armagh’s” or belfast or “belfast’s” or lisburn or “lisburn’s” or londonderry or
“londonderry’s” or derry or “derry’s” or newry or “newry’s”).ti,ab,in,ad. (22,619)
60. 52 or 53 or 54 or 55 or 56 or 57 or 58 or 59 (2,434,713)
61. (exp “arctic and antarctic”/or exp oceanic regions/or exp western hemisphere/or exp africa/or exp
asia/or exp “australia and new zealand”/) not (united kingdom/or europe/) (959,801)
62. 60 not 61 (2,360,187)
63. 51 and 62 (230)
PsycINFO via OVID
Date searched: 11 November 2017.
Date range searched: 1806 to November week 1 2017.
Search strategy
1. Autism Spectrum Disorder/ (36,543)
2. (autism or autistic or ASD or ASDs or ASC or AAC).ti,ab. (44,595)
3. Asperger$.ti,ab. (3398)
4. 1 or 2 or 3 (46,929)
5. exp “costs and cost analysis”/ (23,667)
6. “Cost Containment”/ (539)
7. (economic adj2 evaluation$).ti,ab. (1420)
8. (economic adj2 analy$).ti,ab. (1364)
9. (economic adj2 (study or studies)).ti,ab. (679)
10. (cost adj2 evaluation$).ti,ab. (291)
11. 11 (cost adj2 analy$).ti,ab. (3246)
12. (cost adj2 (study or studies)).ti,ab. (760)
13. (cost adj2 effective$).ti,ab. (13,368)
14. (cost adj2 benefit$).ti,ab. (3122)
15. (cost adj2 utili$).ti,ab. (1062)
16. (cost adj2 minimi$).ti,ab. (316)
17. (cost adj2 consequence$).ti,ab. (108)
18. (cost adj2 comparison$).ti,ab. (172)
19. (cost adj2 identificat$).ti,ab. (20)
20. (pharmacoeconomic$ or pharmaco-economic$).ti,ab. (294)
21. 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 (37,543)
22. economics/ (20,082)
23. (economic$ or cost$ or price or prices or pricing or pharmacoeconomic$).tw. (195,712)
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24. Health Care Costs/or Health Care Economics/or Health Care Utilization/or
Pharmacoeconomics/ (22,859)
25. cost-benefit analysis.mp. (936)
26. cost minimi?ation.mp. (109)
27. economic evaluation.mp. (1121)
28. cost effective$.mp. (13,374)
29. cost-effective$.mp. (13,374)
30. costeffective$.mp. (47)
31. CEA.mp. (1066)
32. cost utilit$.mp. (530)
33. cost-utilit$.mp. (530)
34. costutilit$.mp. (4)
35. CUA.mp. (38)
36. drug cost$.mp. (330)
37. healthcare costs.mp. (974)
38. health care costs.mp. (10,135)
39. hospital charges.mp. (101)
40. hospital running costs.mp. (0)
41. hospitali?ation cost.mp. (32)
42. cost control.mp. (201)
43. budgets/(1008)
44. “willingness to pay”.mp. (1622)
45. (HCRU or MRU).mp. (17)
46. ((healthcare or health care or health resource$ or medical resource$) adj3 utili?ation).mp. (16,300)
47. ((healthcare or health care or health resource$ or medical resource$) adj3 “use”).mp. (3938)
48. (resource adj2 (“use$” or util$ or allocat$)).mp. (8730)
49. ((economic or health$ or resource) adj3 burden).mp. (3116)
50. (expenditure$ not energy).tw. (7202)
51. (value adj1 money).tw. (40)
52. budget$.tw. (7944)
53. 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or
38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 (230,490)
54. 4 and 21 (236)
55. 4 and 53 (1113)
56. 54 or 55 (1113)
57. (England or Scotland or Wales or Ireland).lo. (41,732)
58. (Great Britain or United Kingdom).lo. (75,329)
59. (national health service* or nhs*).ti,ab,in,cq. (26,199)
60. (english not ((published or publication* or translat* or written or language* or speak* or literature
or citation*) adj5 english)).ti,ab. (91,766)
61. (gb or “g.b.” or britain* or (british* not “british columbia”) or uk or “u.k.” or united kingdom* or
(england* not “new england”) or northern ireland* or northern irish* or scotland* or scottish* or
((wales or “south wales”) not “new south wales”) or welsh*).ti,ab,jx,in,cq. (423,302)
62. (bath or “bath’s” or ((birmingham not alabama*) or (“birmingham’s” not alabama*) or bradford or
“bradford’s” or brighton or “brighton’s” or bristol or “bristol’s” or carlisle* or “carlisle’s” or
(cambridge not (massachusetts* or boston* or harvard*)) or (“cambridge’s” not (massachusetts* or
boston* or harvard*)) or (canterbury not zealand*) or (“canterbury’s” not zealand*) or chelmsford or
“chelmsford’s” or chester or “chester’s” or chichester or “chichester’s” or coventry or “coventry’s”
or derby or “derby’s” or (durham not (carolina* or nc)) or (“durham’s” not (carolina* or nc)) or ely or
“ely’s” or exeter or “exeter’s” or gloucester or “gloucester’s” or hereford or “hereford’s” or hull or
“hull’s” or lancaster or “lancaster’s” or leeds* or leicester or “leicester’s” or (lincoln not nebraska*)
or (“lincoln’s” not nebraska*) or (liverpool not (new south wales* or nsw)) or (“liverpool’s” not (new
south wales* or nsw)) or ((london not (ontario* or ont or toronto*)) or (“london’s” not (ontario* or
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ont or toronto*)) or manchester or “manchester’s” or (newcastle not (new south wales* or nsw))
or (“newcastle’s” not (new south wales* or nsw)) or norwich or “norwich’s” or nottingham or
“nottingham’s” or oxford or “oxford’s” or peterborough or “peterborough’s” or plymouth or
“plymouth’s” or portsmouth or “portsmouth’s” or preston or “preston’s” or ripon or “ripon’s” or
salford or “salford’s” or salisbury or “salisbury’s” or sheffield or “sheffield’s” or southampton
or “southampton’s” or st albans or stoke or “stoke’s” or sunderland or “sunderland’s” or truro or
“truro’s” or wakefield or “wakefield’s” or wells or westminster or “westminster’s” or winchester
or “winchester’s” or wolverhampton or “wolverhampton’s” or (worcester not (massachusetts* or
boston* or harvard*)) or (“worcester’s” not (massachusetts* or boston* or harvard*)) or (york not
(“new york*” or ny or ontario* or ont or toronto*)) or (“york’s” not (“new york*” or ny or ontario*
or ont or toronto*))))).ti,ab,in,cq. (330,838)
63. (bangor or “bangor’s” or cardiff or “cardiff’s” or newport or “newport’s” or st asaph or “st asaph’s”
or st davids or swansea or “swansea’s”).ti,ab,in,cq. (17,174)
64. (aberdeen or “aberdeen’s” or dundee or “dundee’s” or edinburgh or “edinburgh’s” or glasgow or
“glasgow’s” or inverness or (perth not australia*) or (“perth’s” not australia*) or stirling or
“stirling’s”).ti,ab,in,cq. (41,252)
65. (armagh or “armagh’s” or belfast or “belfast’s” or lisburn or “lisburn’s” or londonderry or
“londonderry’s” or derry or “derry’s” or newry or “newry’s”).ti,ab,in,cq. (5352)
66. 57 or 58 or 59 or 60 or 61 or 62 or 63 or 64 or 65 (580,416)
67. 56 and 66 (198)
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Appendix 18 Model inputs and assumptions
Details of Payakachat et al. study127
The study by Payakachat et al.127 provided the algorithms used to map VABS composite and IQ scores
to utility scores used in the economic analysis. The Payakachat et al. study127 is a US study, which aimed
to develop a number of mapping algorithms using behavioural and other measures to predict HRQoL.
The study recruited a total of 214 children aged between 4 and 17 years, all diagnosed with ASD.
A summary of key baseline characteristics is presented in Table 58.
The target measure used in the Payakachat et al.127 study was the HUI3. The HUI3 is a measure of
HRQoL and measures responses on eight domains of health, including vision, hearing, speech, ambulation,
dexterity, emotion, cognition and pain. The resulting health utility scores range from –0.36 (worst possible
health) to 1.0 (best possible health). All algorithms developed in Payakachat et al.127 aimed to predict HUI3
scores using different behavioural measures. The algorithms developed were built around three measures:
the Child Behaviour Checklist, Vineland-II Adaptive Behaviour Scales and PedsQL. All of the models
included child’s age, cognitive ability (IQ) and ADOS severity scores as control variables. The model
selected for use in the economic model was based on only the Vineland-II Adaptive Behaviour Scales
composite scores, as Child Behaviour Checklist and PedsQL were not reported as outcomes in the
studies identified in IPD meta-analysis.
TABLE 58 Summary of baseline characteristics: Payakachat et al.127
Characteristic Result
Age, mean (SD) [range] 8.4 (3.5) [4.0–17.9]
Male (%) 86.6
Type of school attended (%)
Non-specialised public schoola 44.6
Specialised public schoola 8.2
Vocational public schoola 0.5
Private school 7.3
Home school 2.3
Special education school 26.8
Other (e.g. special education programme, self-contained class) 10.5
Diagnosis (%)
Autistic disorder 73.4
Asperger syndrome 8.7
Pervasive development disorder 17.9
Cognitive ability, mean (SD) [range] 75.7 (24.3) [41–148]
Vineland-II composite, mean (SD) [range] 68.4 (11.1) [25–105]
ADOS severity score, mean (SD) [range] 7.2 (1.8) [2–10]
Vineland-II, Vineland-II Adaptive Behaviour Scales.
a Public school is a state-funded school.
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Generation of quasi-individual participant data from Farley et al.134
Farley et al.134 reported mean VABS composite score for a number of levels of independence (Table 59).
As none of the sample was in the bottom category, completely dependent values for this category were
imputed assuming a linear extrapolation of the values in the other four categories.
To generate a model with which to predict independence levels, the summary data reported in Farley
et al.134 were used to simulate an IPD set on which appropriate regression analysis could be conducted.
This was done using a microsimulation approach and assumed for each independence level that VABS
composite scores were normally distributed with mean score as reported in Table 4. The SD for each
group was calculated using the SD reported for the whole sample, assuming that the SD for each group
was the same. The simulated sample consisted of 1000 hypothetical individuals per independence level
(5000 in total). An order logistic model was then run to estimate coefficients, from which the probability of
each independence level could be estimated for a given VABS composite score. To estimate the uncertainty
in the estimated coefficients, the simulation was run 1000 times, with mean scores for each independence
level assumed to follow a beta distribution. SEs for mean VABS composite score were estimated using
the estimated SD and the reported sample size for each group. Sample size for the completely
dependent group was assumed to be one.
Direct evidence on school type attended
The proportion of children attending each type of schooling in this scenario analysis, in which evidence
is directly drawn from the three studies17,26,103 reporting schooling outcomes, is reported in Table 60.
Adult utility decrements
To account for the impact of ageing on utilities in adulthood, decrements were applied as multiplier to
the mean utility of the cohort from the age of 25 years onwards (Table 61).145
TABLE 59 Mean VABS and IQ score for each independence level
Independence level VABS
Completely independent 102
Mostly independent 75
Some independence 51
Mostly dependent 28
Completely dependent 17a
a Imputed value.
TABLE 60 Direct evidence on school type attended
School type ABA-based therapy, % TAU, %
Mainstream 30 1
Mainstream with support 38 27
Specialist school 32 72
APPENDIX 18
NIHR Journals Library www.journalslibrary.nihr.ac.uk
284
Details of assumptions and inputs used to characterise care costs
in adulthood
This appendix outlines the assumptions and data sources used to characterise costs of care in adulthood.
The care costs are assumed to fall into five categories: (1) accommodation, (2) day services, (3) respite
care, (4) productivity losses and (5) other. The other category covers costs of employment support, adult
education, medical costs and family out-of-pocket expenses.
Accommodation
The model distinguished between four types of accommodation: (1) own home/living with parents,
(2) low-intensity supported accommodation, (3) high-intensity supported accommodation and (4) residential
care. Supported accommodation was split into two groups, on the advice of service providers in York,
who suggested that there was considerable variation in the levels of support provided in these types of
accommodation. Unit cost for each accommodation type are summarised in Table 62.
The proportion of individuals residing in each type of accommodation was guided by the definitions
used to define each category and assumptions agreed with service providers in York local authority.
All individuals in the ‘completely independent’ or ‘mostly independent’ category were assumed to be
either living in their own home or with parents, carers or families. Individuals in the ‘some independence’
category were assumed to be split equally between own home or parents, low-intensity sheltered
accommodation and high-intensity sheltered accommodation. Adults in the ‘mostly dependent’ and
’completely dependent’ categories were assumed to be split equally between the high-intensity sheltered
accommodation and residential care. Table 63 summarises resource use for accommodation services.
TABLE 61 Age-related decrements
Parameter (age in years) Disutility
25–34 0.93
35–44 0.91
45–54 0.85
55–64 0.80
65–74 0.78
≥ 75 0.73
TABLE 62 Unit costs for accommodation
Accommodation Unit costs (£) per annum Source
Own home/parents 0.00 Assumption
Sheltered: low intensity 53,274.88 PSSRU:146 supported living homes for adults
with autism and complex needs. Assumes
46 hours of care/week
Sheltered: high intensity 99,336.44 PSSRU:146 supported living homes for adults
with autism and complex needs. Assumes
127 hours of care/week
Residential 115,553.00 PSSRU:146 residential care homes for adults
with autism and complex needs
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Costs of living in own house and living with parents, carers or families were assumed to be zero, with
remaining costs drawn from the PSSRU.146 Costs of sheltered accommodation were based on reported
costs for supported living homes for autistic adults with complex needs. As costs in the PSSRU146 were
reported only for average care needs, it was assumed that individuals in low-intensity sheltered care
received 46 hours of care (1 SD below the mean) and individuals in high-intensity sheltered care
received 127 hours of care per week (1 SD above the mean). Other costs were assumed equal across
both placements. Residential care costs were based on residential care homes for autistic adults with
complex needs reported in the PSSRU.146
Day services
Resource use was based on advice from service providers at York local authority, who suggested that
the majority of adults who required support would be those living with a parent, carer or family member,
or in their own home. Aligning with assumptions made regarding accommodation services, it was assumed
that 100% of individuals in the ‘mostly independent’ category and 33% in the ‘some independence’
category would access day care services. Reflecting the high levels of independence of those in the
‘completely independent’ category, it was assumed that they would not require day care services.
Costs of day care services were drawn from the PSSRU.146 Local authority own-provision day care
for people requiring disability support assumed the reported mean cost per client week of £340 and
multiplied by 52.14 (weeks/year) to generate an annual cost of £17,728.57.
Respite care
Aligning with the assumptions made regarding accommodation in Knapp et al.,147 it was assumed that
100% of individuals in the ‘mostly independent’ and 33% of those in the ‘some independence’ categories
would receive respite care. Adults in the ‘completely independent’ category were assumed not to receive
any respite care on the basis that they are truly independent, and it was assumed that no respite care
would be required in the ‘mostly dependent’ and ‘completely dependent’ categories as these individuals
would reside in some form of state provided accommodation.
Costs of respite care were drawn from Knapp et al.147 and updated using the PSSRU,146 which reports
an annual cost of £1927.00.
Other costs
Employment support, adult education and medical costs were drawn from Knapp et al.147 and PSSRU,146
and mapped to the adult outcomes. Costs in these studies were stratified according to the residential
status into three groups: private households, supported people and residential care. These three groups
were mapped to the five independence levels used in the model as follows: private households are
equivalent to the ‘completely independent’ and ‘mostly independent’ categories, supported people
are equivalent to the ‘some independence’ category and residential care is equivalent to the ‘mostly
dependent’ and ‘completely dependent’ categories. Costs per annum are presented in Table 64.
TABLE 63 Accommodation type by level of independence
Accommodation
Completely/mostly
independent, % Some independence, %
Completely/mostly
dependent, %
Own home/parents 100 33 0
Sheltered: low intensity 0 33 0
Sheltered: high intensity 0 33 50
Residential 0 0 50
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TABLE 64 Annual costs of employment, adult education, medical and family out-of-pocket expenses
Resource type
Completely/mostly
independent (£) Some independence (£)
Completely/mostly
dependent (£)
Employment support 169.48 169.48 0.00
Adult education 1800.00 1067.00 4159.00
Medical costs 996.00 775.00 769.00
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Appendix 19 Full model results
T ables 65–68 present the full results from the deterministic analysis presented in Tables 20 and 21.
TABLE 65 Full model results: NHS and social services perspective, pessimistic scenario
Outcome ABA TAU Incremental
Treatment costs (£) 70,754.11 12,598.85 58,155.26
Education costs (£) 0.00 0.00 0.00
Childhood care costs (£) 5867.40 6143.87 –276.47
Total costs (£) 76,621.52 18,742.72 57,878.79
Childhood QALYs 4.61 4.37 0.24
Total QALYs 4.61 4.37 0.24
Total life-years 14.94 14.94 0.00
ICER (£) 236,837
TABLE 66 Full model results: NHS and social services perspective, optimistic scenario
Outcome ABA TAU Incremental
Treatment costs (£) 70,754.11 12,598.85 58,155.26
Education costs (£) 0.00 0.00 0.00
Childhood care costs (£) 5221.65 6143.87 –922.22
Total costs (£) 75,975.77 18,742.72 57,233.04
Childhood QALYs 5.21 4.37 0.84
Total QALYs 5.21 4.37 0.84
Total life-years 14.94 14.94 0.00
ICER (£) 68,362
TABLE 67 Full model results: public sector perspective, pessimistic scenario
Outcome ABA TAU Incremental
Treatment costs (£) 70,754.11 12,598.85 58,155.26
Education costs (£) 118,688.10 132,627.20 –13,939.10
Childhood care costs (£) 5867.40 6143.87 –276.47
Total costs (£) 195,309.62 151,369.92 43,939.70
Childhood QALYs 4.61 4.37 0.24
Total QALYs 4.61 4.37 0.24
Total life-years 14.94 14.94 0.00
ICER (£) 179,799
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TABLE 68 Full model results: public sector perspective, optimistic scenario
Outcome ABA TAU Incremental
Treatment costs (£) 70,754.11 12,598.85 58,155.26
Education costs (£) 111,636.23 132,627.20 –20,990.97
Childhood care costs (£) 5221.65 6,143.87 –922.22
Total costs (£) 187,611.99 151,369.92 36,242.07
Childhood QALYs 5.21 4.37 0.84
Total QALYs 5.21 4.37 0.84
Total life-years 14.94 14.94 0.00
ICER (£) 43,289
APPENDIX 19
NIHR Journals Library www.journalslibrary.nihr.ac.uk
290
Appendix 20 Consultation exercise
The following text is feedback we received from a consultation exercise undertaken, in which copiesof the draft report were sent to 10 stakeholder groups who had expressed an interest in the
outcome of the project, but who we could not include in the Advisory Group. We received feedback
from seven stakeholder groups and have reproduced these comments here. We also included comments
from an autistic adult member of the Advisory Group who was unable to provide feedback on the report
before this point. To minimise any potential bias and to maximise transparency, all comments have been
provided unaltered, with the exception of the correction of minor spelling errors, and without response.
We would, however, like to reiterate that both the clinical review and the subsequent cost-effectiveness
study are limited by the scope of the NIHR commissioning call, specifically the focus on early intensive
ABA-based interventions, as opposed to other models of ABA-based intervention, aimed at primary-aged
children or other groups of children. This means that some evidence of the effectiveness of less
individually intensive ABA-based interventions, which may reflect current practice in the UK and have
different costs, was excluded from the review (e.g. data from studies that focused exclusively on group-
based interventions or data from a school setting).
Feedback from an autistic member of the Advisory Group
The report shows good efforts to balance the competing interests and strong opinions on this controversial
topic. The team have responded well to the issues discussed by stakeholders in the advisory group and
many of those issues have been integrated into this report and modelling, and the language and framing
in the background is much improved.
I found the explanation of the risk of bias assessments easy to understand and I’m glad this was covered
and the strengths and limitations of the current research base were clearly set out.
[Page 29.] Whilst aversive conditioning may be less prevalent or changed considerably from earlier forms
of EIBI, this section suggests physical aversives have long been abandoned, which I am not convinced is
the case. Certainly the situation in the Judge Rotenberg Center in Massachusetts, USA, springs to mind
where electric shocks are still used as a behavioural intervention. Autistic people may also consider forced
eye contact or focus, touching/holding or sensory cues to be quite aversive due to the way we experience
and process sensory input. The large number of hours of contact time and interpersonal focus on a weekly
basis and the resulting social exhaustion may also be considered aversive from an autistic perspective.
There was a very good explanation of the challenges with the current evidence to project any effects into
adulthood in the economic modelling, but it is not clear how the effects were projected to the end of
childhood (age 15.5 in the model) based on the included studies as few did follow-ups into mid/late
childhood, are effects after average age of final follow-up given a trajectory going forward or has the
effect been considered flat as with the adult projection?
Feedback on behalf of Easy Steps Limited
Alice Koriki, MSc, Board Certified Behaviour Analyst, Clinical Director
Effectiveness
The exclusion criteria, that only included studies that compared ABA interventions to other models,
excluded the largest part of research that shows effectiveness in a broader range of children. The single
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case studies that dominate the science of applied behaviour analysis I believe provide a better way of
examining the effectiveness of ABA especially when we are all aware that the children are so unique and
it is very hard to assign them into groups to compare and contrast them.
Long term effects of eclectic education wasn’t clearly analysed, and there were no evidence of true
long term effectiveness of eclectic education.
It wasn’t clear whether the EIBI programmes were stopped after the end of the studies, which could
potentially also explain the lack of long term progress in the one study described.
EIBI programmes are more optimal when they start around the age of 2y [years]. but that has not been
stressed within the current meta-analysis. A study by MacDonald et al. (2014)[254] pointed out that
children who started treatment between 18–23 months of age showed the highest levels of despondence
(91%) where the despondence levels dropped significantly as the children grew older.
Part of the interventions used in the eclectic groups, or control groups, also included intervention directly
derived from the science of behaviour analysis, like TEACCH and PECS. Hence even the effectiveness of
those intervention can to some extent be attributed to the principles of applied behaviour analysis.
ABA is an evidence based study and all of us professionals continue to develop our clinical practice using
current research. The studies that you have included are somewhat dated (as you have also pointed out)
and ABA today in the UK looks nothing like ABA 20 years back when I personally got into the field.
Hence those meta-analysis fail to really show the effect of ABA at the present moment, which might
be very misleading.
You have pointed out numerous times in the draft the need of further research. That should not be done
through meta-analysis of other studies, as they don’t give the true perspective of how early intervention
works in the UK. Also research should focus on the overall effectiveness and the cost of the current TAU
in the UK, and also on the overall effectiveness of the current SEN special education, as there are very
little information available.
Cost
As you pointed out in [page 55] the ‘present economic model should not be viewed as a comprehensive
economic assessment of the cost effectiveness of early ABA-based therapy as the data currently available
are insufficient to make inferential judgements’. Based on that all other evidence proposed lack robustness
in my opinion.
I own the first and until very recently the only early intervention clinic in the UK providing EIBI
programmes to children as young as 1 years old. Our cost at the moment, starts from £28.500 per
year and doesn’t go above £49.500, and we include a multidisciplinary team around the child, that
includes 1 : 1 trained ABA therapists (with RBT qualifications), a BCBA [Board Certified Behaviour
Analyst], an OT [occupational therapist] and an SLT [speech and language therapist]. Hence the costs
you are presenting are not as representative as described.
The cost of ABA can also be further reduced if it was more widely available as it will be better organised
and managed. Making it more widely available through the NHS and Local Educational Authorities will
also make it more well-regulated, and effectiveness will be more easily researched.
Final conclusion
It was very promising that you have decided to conduct this meta-analysis even though I do personally
believe it has its weaknesses as pointed above. Nevertheless, further research into the effectiveness of
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ABA in the UK and how the system can improve to provide the children with early intervention more
readily, is very important and studies like the present can be the corner stones of that. However, further
research is essential and needs to be conducted sooner rather than later, as the autism population
increases and the long life cost of looking after those individuals increases. Personally it surprises me
that the system has accepted PBS (which is based fully on ABA) to support adults with autism, and
related difficulties including behaviours issues, but has difficulty accepting EIBI and ABA interventions
in children, in general.
Feedback on behalf of the UK Society for Behaviour Analysis
Dr Mecca Chiesa, Board Certified Behaviour Analyst – Doctoral, chairperson
Congratulations on bringing together such a complex and challenging research project – evaluating
research on service provision(s) for autistic children and attempting to estimate short- and long-term
relative costs. Given the breadth of services provided, the heterogeneous nature of autism and the
inevitably individualised nature of those services, this was never going to be straightforward. However,
as other systematic and equally rigorous evaluations have concluded, the SCABARD evaluation reports
considerable clinical effectiveness in cognitive and adaptive behaviour outcomes for children exposed to
Behaviour Analytic procedures in contrast to children exposed to ‘other’ kinds of procedures (referred to
as TAU/eclectic).
A brief note re one of the TAU assumptions – PECS is included as a ‘comparator’ [p. 65]. This is an error.
PECS is a systematic behaviour-analytic communication system developed in the 1980s at the Delaware
Autism Project by Dr Andrew Bondy (a Behaviour Analyst) and Lori Frost (a speech and language
specialist). The development of PECS was based on the functional analysis of language described and
explained by B.F. Skinner in his book Verbal Behavior (1957). It is not unusual for PECS to be introduced
into an ABA programme in cases where a child struggles with vocal/verbal behaviour. See https://pecsusa.
com/research/ for further information.
Re–assessment of TAU costs of £8634 [p. 67] – the report focuses on local authority nursery SEN uplift
costs. In the broader experience of children, families and schools I have worked/liaised with over the past
25 years, those TAU programmes also typically consist of one, some or all of the following: Sensory
Integration Therapy, Occupational Therapy, SALT, Rebound Therapy, Portage, Early Bird, TEACCH,
Intensive Interaction. For future reference, and to be considered more reliable, an economic analysis
should include costs (actual examples of costs rather than ‘broad estimates’, [p. 67]) that include and
evaluate these typically provided state-funded services. Without capturing all such services and their
costs the report may be considerably underestimating the full public sector costs of the UK’s early
autism offer – which would, in turn, alter the ICER figures presented. Ideally, this would form part of
the ‘recommendations for further research’.
Chart 26 [p. 80] shows EIBI meeting QALY thresholds at £27,000 and indeed becoming ‘dominant’ at
£18,000 which prompts a further observation: why are TAU procedures so typically provided in the
UK not under scrutiny by the NHS and/or NIHR for clinical/educational/social effectiveness as well
as cost-effectiveness? These procedures are funded throughout the UK, many by the NHS, others by
multiple LAs [local authorities], yet there is no evidence base relating to their effectiveness. In relation to
the economic analysis, TAU provisions may be ‘superior’, but they may have no advantage at all on an
effectiveness analysis (with subsequent, lifelong implications). Without robust effectiveness analysis of TAU
procedures the UK public (fundamentally, funders of the services) has no assurance that valuable national
resources are wisely allocated. The UK’s autistic children, their families, and the public at large should be
reassured, via research on all services provided, that those services are likely to result in meaningful
improvements in important areas such as adaptive behaviours and cognitive functioning. Again, ideally,
this would form part of the ‘recommendations for further research’.
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Other economic analyses
On [p. 239] you note that ‘None of the six studies identified in the cost-effectiveness review took a UK
perspective with two taking a Canadian governmental perspective, three a US perspective and one study
a Dutch perspective’. Clinical effectiveness studies carried out in other countries were included in the
SCABARD review. Therefore, there is no logic in not including cost effectiveness reviews carried out in
other countries. If Canada, Texas and the Netherlands* (the three evaluations I am familiar with) conclude
that early provision of Behaviour Analysis for autistic children results in very considerable lifetime cost
savings to the state (and therefore the public) – why would those outcomes not transfer to the UK? That
has not been explained. Cost savings are cost savings – whether they are in US Dollars, Canadian Dollars
or Euros.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2585334/
https://www.researchgate.net/profile/Gregory_Chasson/publication/225105846_Cost_Comparison
%20of_Early_Intensive_Behavioral_Intervention_and_Special_Education_for_Children_with_Autism/links/
0c96052c83b09cd7df000000/Cost-Comparison-of-Early-Intensive-Behavioral-Intervention-and-Special-
Education-for-Children-with-Autism.pdf?origin=publication_detail
https://www.sciencedirect.com/science/article/abs/pii/S0891422212000984?via%3Dihub
Challenging behaviour
The report states there is no evidence that ABA-based interventions improve challenging behaviour (which
lies at the root of many poor outcomes for autistic children and higher costs to the state – e.g. school
exclusions, ATU placements etc). The Advisory Group should have examined the extensive research on
Challenging Behaviour and ABA-based interventions. It has a long history in the field dating back to the
early 1980s. Currently, the UK is seeing increasing uptake of ABA services in adult NHS intensive support
services for challenging behaviour, and also in some CAMHS children/adolescent services. NICE guidance
NG11 references behaviour analysts and the just-released QS101 refers to the need for every community
to have a ‘specialist behavioural support team’. The NHS and many of the care groups in which it funds
placements for autistic and/or learning disabled clients are employing PBS^ (Positive Behaviour Support)
services, also an ABA-based intervention. There is no logic to the NHS adopting ABA for challenging
behaviour at every age except pre school. It makes economic and social sense to tackle challenging
behaviour earlier than when a crisis point is reached in the teens or adult life. That the review does
not include mention of at least some of the important studies+ demonstrating ABA’s effectiveness
in reducing and helping to redirect challenging behaviours is most unfortunate and misleading, see
https://impact.ref.ac.uk/casestudies/CaseStudy.aspx?Id=4679
https://www.hee.nhs.uk/sites/default/files/documents/The%20key%20messages%20about%20Positive
%20Behaviour%20Support_0.pdf
https://www.researchgate.net/profile/Gary_Lavigna/publication/229006911_The_efficacy_of_positive_
behavioural_support_with_the_most_challenging_behaviour_The_evidence_and_its_implications/links/
53dfc1050cf2aede4b492e9c/The-efficacy-of-positive-behavioural-support-with-the-most-challenging-
behaviour-The-evidence-and-its-implications.pdf
In conclusion
Further evidence of the effectiveness of Behaviour Analysis in autism provision is not required. It exists in
abundance in the form of innumerable SCD (single-case design) reports and many other highly-credible
systematic reviews and meta-analyses. As noted previously, the various social and educational practices
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currently receiving state funding (public monies) have either little or no evidence of clinical/educational/
social effectiveness or lifelong benefits. Many highly credible effectiveness and cost-effectiveness analyses
(illogically dismissed from the SCABARD report), meta-analyses, systematic reviews have concluded
that EIBI is highly effective in improving short and long-term outcomes for children and families,
with incremental benefits to the public in terms of substantial cost-savings. There is no disputing the
conclusion that autism is costly for families and society at large. The indication so far from clinical and
cost-effectiveness research is that spending in the early years on evidence-based practice (EIBI) has
substantial and long-term benefits for individuals, families and the state.
Feedback on behalf of Child Autism UK
We at Child Autism UK are grateful to SCABARD for performing this UK-based review of the EIBI
(Early Intensive Behaviour Intervention) research. As EIBI is only one specific model that uses ABA
(Applied Behaviour Analysis) based techniques, we will use the latter term here as it better represents
the broader range of related UK services including the variety of approaches outlined in your report.
We are glad to see your report highlights that ABA-based techniques can increase IQ points and
effectively increase adaptive skills. These areas are key in increasing crucial skills such as independence
which enhance the well-being of children with autism and their families. It should also be noted that
levels of independence are a key factor in reducing the huge costs of lifelong care for people with autism.
My comments aim to address common misunderstandings about ABA-based techniques which echo
throughout this report. Most of these misunderstandings relate to a historical context and sadly persist
more with the field of ABA than any other profession.
Section 1.4 Early interventions for Autism: The second paragraph states:
‘However, criticisms have been made of this approach. These include concerns that the use of highly
structured, primarily adult-led sessions could increase the risk of behaviours that challenge. Also, that
it may reduce opportunities to encourage a child’s spontaneity and interactive communication,
an over-reliance on prompts, with the potential to further restrict the child’s capacity to develop
generalisation skills.[28]’
It would be useful to note that again these are historical concerns. The reference used to cite these concerns[28]
is a paper, by behaviour analysts, which assimilates decades of developments in ABA research and that have
resulted in great progress in the areas outlined. In their paper, Schreibman et al. conclude that: ‘The field of
autism early intervention has changed dramatically in the last 30 years. Since the development of the first
empirically-validated and highly-structured ABA-based interventions that changed the lives of children with
autism, continued research has expanded these efforts by moving towards more naturalistic interventions
. . .’ The second paragraph continues with a reference to one report, from a non peer-reviewed journal, that
claims that ABA-based techniques may cause mental health issues: ‘Additionally, it has been suggested, for
example by the autistic community,[28] that the rigid nature of ABA-based interventions could potentially
increase the risk of later additional mental health problems,[29] though this has yet to be effectively
researched and there is little reliable published evidence about this.[30]’
It is misleading to refer to the ‘autistic community’ as if they are a homogenous group. We have had
very positive feedback from many adults with autism that learned through ABA-based teaching with
us in childhood. We have also had very positive feedback from both parents and tutors of clients who
happen to also have an autism diagnosis themselves.
In relation to the suggestion that ABA-based techniques could lead to a risk of mental health problems
it could more accurately be said that there was no reliable published evidence for this. The one article
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referenced here[29] had multiple severe methodological flaws such as not even defining ABA.[30] Your report
goes on to state: ‘In response to these concerns, a number of adaptations of the original model have been
developed which incorporate the principles of ABA-based techniques within a more naturalistic and
developmentally informed framework. Known collectively as Naturalistic Developmental Behavioural
Interventions (NDBIs),[28]’ As noted elsewhere in your report, ABA-based techniques have been evolving
rapidly over the years as no interventions exist in a cultural vacuum. The changes are made due to the
adaption of the science and in response to changing cultural norms.
Having the last concluding paragraph of this report devoted to side-effects and specifically mental health
concerns gives too much weight to what was in effect an online survey that wasn’t even from the UK.
How often ABA is held to the rigorous standards of randomised control trial research when no other
institutional government funded approach to autism comes close to the level of the evidence base of
ABA/EIBI.
More research into interventions for children with autism and subsequent adult mental health would be
very welcome. Of-course this should be for all education and therapeutic interventions not just EIBI. For
example, many children with autism without ABA-based support are unable to express their needs or are
excluded from school or put into isolation. These are factors highly likely to have a negative impact on
mental health. Conversely, Child Autism UK ABA-based programmes include, when needed, replacing
challenging behaviour with appropriate communication, anxiety reduction, increasing problem-solving
skills, assertiveness, social skills and tolerance. These are the factors likely to have a positive impact on
mental health. Research is therefore needed to find out if ABA-based techniques are actually more likely
to improve the mental health of those that receive it than those that don’t.
Interventions
The report has mentioned that in the original Lovaas research, aversives were used as a last resort. It
also mentioned that corporal punishment is no longer used in schools. This context is crucial and it is
concerning that yet again the field of ABA is dogged by these decades-old criticisms whereas other
approaches are not. For example, TEACCH, which is widely used in education has a similar entry in
its manual from 1980 that suggest teachers use a ‘slap’ and yet this is never mentioned. Many of the
practices in health and education of the 1980s are abhorrent to any practitioner now and the field of
ABA is no different. We have practitioners who remember when ABA-based programmes first came to
the UK in the 90s and we can categorically say it was unheard of for anyone to slap a child or shout
‘no’. We are mystified as to why an issue which we believe has never once occurred in the UK should be
brought up in this report.
Economic analysis
Child Autism UK is one of the largest providers of home programmes in the UK and our costings are very
different from those outlined. This is largely because our model does not need a separate supervisor and
consultant because the case manager provides both roles. This is because our case managers have an
academic background in behaviour analysis due to UK Universities now providing Master’s level degrees
in the subject. Another difference is due to our flexibility and willingness to work with a range of families
who could benefit from our services. We provide a choice of packages such as our short-term programme
which lasts 3–4 months and is a very focused intervention. This starts from £1,313 for the whole package
to our long-term intervention from £5,250 per year. This starting cost is where teaching assistants are
already employed by schools and we train them in ABA-based techniques. Other key variables are tutor
individual costs which vary across the country and start at £15,600 per year for a full-time programme.
The findings whether an ABA-based approach is economically viable is based on amounts and a model
doesn’t reflect our practice or many organisations that we know.
APPENDIX 20
NIHR Journals Library www.journalslibrary.nihr.ac.uk
296
Conclusions
It is good to see that the review found some evidence to support ABA-based techniques. Even though
there was not enough data to form a conclusion about the long-term effects of ABA-based techniques,
the evidence presented here still far exceeds any evidence for the eclectic approach. The report rightly
highlights how much research is needed into current practices of ABA-based techniques in the UK.
This also points to the urgency for the existing eclectic provision that is already funded to have research
into its efficacy.
In summary
Whilst we are glad to see the important issue of ABA-based provision being examined, it is a shame
that old misunderstandings are raised throughout. Any concerns about ABA-based techniques causing
increases in challenging behaviours or reducing spontaneity were addressed decades ago. The several
references to concerns about mental health problems caused by ABA-based techniques, from one article
that has no evidence-base, is disappointing. Especially considering that good evidence from some ABA
studies in peer-reviewed journals were dismissed because of lacking the gold standard of having a
randomised control. In a similar vein, mentioning aversives from a bygone era, when they were routinely
used in all schools, adds nothing to a paper about current ABA-based interventions in the UK. Finally, the
economic analysis bears little relation to the costs of most of the programmes run by Child Autism UK
and many other similar organisations. This will impact on whether EIBI does in fact meet the threshold
for the NICE guidelines on cost effectiveness. We would urge that the cost analysis be re-examined using
costs from a range of UK providers, and using comparison figures from a consistent geographical area.
While everyone waits for even more research into ABA, the ‘treatment as usual’ approach that is currently
being funded is a ‘hope for the best’ strategy, which would seem to be far less cost effective, and a gamble
for children with autism and their families.
Feedback on behalf of the Focus Surrey Saturday club for children with autism
Sue Archdall, chairperson, June Goh, trustee and BCBA, Tracey Tibbals and
Karolina Gburczyk, trustees
Thank you for this comprehensive report. We are very pleased to see the NHS giving such serious and
independent consideration to early intervention ABA, which many parents have found incredibly helpful
and sometimes life changing for their children with ASD and their families. We are responding as trustees
and consultants for Focus Surrey a registered charity which runs Focus Surrey Saturday Club for children
with autism in partnership with ABA professionals. Our work with families has provided evidence that a
few hours of ABA has the potential to improve basic functional skills of most children and young people
with ASD who have never been taught using simple ABA procedures that we believe should be universal.
If the NHS can offer EIBI it would provide an essential start to learning for children with ASD and return
them to their developmental trajectory that autism has impeded.
We are aware that the research about EIBI shows gains for the younger cohort of ASD children. However,
we are able to show that the use of ABA methodology and principles through interactive play sessions
can provide benefits and meet the outcomes for children of varying ages at our Saturday club. At Focus
Surrey Saturday club sessions, children aged 3 to 13 receive 2 hours of ABA a week and parents report
the benefits of the programme to their children. It is important to note that although the club accepts
children from age 3 the majority of children are aged 5 and above – only two children have attended
who fit the early intervention criteria. We believe that interest and knowledge about the efficacy of ABA
is increasing but families in the UK still do not have clear guidance about the whole range of evidence-
based methodologies for ASD. Families often find out about ABA through a small network of parents who
have researched and invested in the therapy in their homes. It is another reason why Focus UK came
into being; families felt that the benefits of ABA should be more widely shared in the community.
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The club has been running for 6 ten-week terms since September 2016 and the findings are incredibly
positive and demand remains high. We have moved from a single 4 hr session to two, 2 hr sessions
for 2 age groups in our most recent term (Term 6 – Feb to May 2019) to meet demand from parents.
Our waiting list is consistently more than 100 children with new parents signing up regularly. Progress
towards outcomes was maintained through precisely managed sessions that offered greater intensity
and consistency of input from ABA trained volunteers. For such a small-scale model where many families
cannot access any ABA at all, our play sessions are stepping stones to providing parents the opportunity
to gauge the effectiveness of ABA for themselves. Children do make progress (as shown by achieving
the targets set for them) at Focus Surrey; of the 31 attending in Term 6, 29 children met at least one
target set for them. They made progress because they have a small number of very specific individualized
goals that the ABA professionals track and measure. Targets vary according to children’s abilities when
they start the club. Example of targets are: Pairing – To increase the amount and type of items that
are motivating; Social Skills – To request items from peers; To respond to requests from peers; To take
turns with 1–2 peers with adult support. For the more advanced children targets include: Requesting –
To have a conversation with a peer; Ask or Answer questions; or to play a game with a peer without
adult support.
Parents can attend the tutor training and can access the free talks that are run in conjunction with the
play group. One of the key points of the club for us is the dissemination of ABA though organized talks
which provides information about ABA and suggests strategies to parents directly, as well as being a
support network for families where they can share stories and information. Effective parent training
is available so that parents themselves can also be tutors if necessary to increase the hours of ABA a
child is getting as well as being able to apply ABA principles and techniques at home. Having parents as
tutors has benefited parents and has meant the consultants have been able to work on issues (such as
un-wanted behaviours) that they wouldn’t have otherwise been able to do with a tutor who sees them
only once a week. Some parents who have seen progress at Focus Surrey have then gone on to request
their own ABA home programmes. Families surveyed, overwhelmingly endorse Focus Surrey where each
term children practice their social, play and communication skills while having fun with their 1 : 1 ABA
trained tutors and their peers. Some parents have reported seeing ‘better eye contact’ and their child
being ‘more inclined to initiate play’ and being ‘more sociable’ since attending the club. Others have
seen benefits in turn taking, sharing and better ‘expression’ and ‘better play skills’ from their children.
Testimonies from parents include:
‘My son has been able to accept transitions more, his tantrums are much less.’
‘My child was able to request something from his peers which he was not able to do before. He is
practising more to talk louder so that others can actually hear him and he made new friends.’
‘Left to his own devices, my son doesn’t know how to play with toys or other children. But when he’s
actively engaged he really enjoys playing and can be quite sociable. Focus provides a really fun set up
with lots of toys and activities to enjoy with his tutor. He is also learning how to take turns with other
children – a vital play skill and life skill. All overseen by professionals.’
‘My son was able to retain information that he was learning at club and using it outside of club and he
started signing words that he wasn’t learning at school . . . He had language until 2.5 and then lost all of
his language and then we had only had sporadic words in four years, very infrequently across that time
. . . The exposure to that signing environment at the club meant that we were able to start that at home
and that has made improvements for him. He gets so excited and pleased with himself when he signs . . .
it encouraged us to pursue more one to one support for him . . . .’ – This child attended a local special
school setting which didn’t use the principles of ABA so only received ABA at Focus Surrey and they found
that he was communicating more than he had done in the past four years.
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‘The club gives us a structure to the day and it gives us somewhere we can take him, where we know he’s
going to get something out of it . . . taking him to normal places we get a lot of problem behaviour’.
‘The consultants’ support was amazing and their knowledge, experience and understanding of the subject
matter really made the difference’, one parent volunteer said of her first term at Focus Surrey. ABA format
at Focus Surrey.
At Focus Surrey the children all work towards 2 to 4 targets based on their social, play and communication
skills that are assessed at the beginning of the term by 2 ABA consultants, (Tracey Tibbals and Karolina
Gburczyk) qualified and certified at BCBA level with more than 35 years ABA experience between them.
Tutors working with each child take performance data on the child’s progress with their individual targets
that are regularly analysed by the two BCBAs and at the end of term, parents are given a report on
progress. Focus Surrey charges £25 a day for the two-hour club which is subsidized by grants and
fundraising. We recruit volunteers and provide training for them to work 1 to 1 with children to keep costs
down. There are also opportunities for parents to be trained to work alongside their child. Last term six
parents received training on ABA and learnt strategies and techniques on how to encourage social,
communication and play skills with their own children at home. We believe that a holistic and consistent
approach in all environments using ABA can improve long term outcomes and lead to better progress for
children and this can reduce overall costs of ABA. However, we stand by the research that intensive ABA
model would bring stronger gains than a part-time model of delivery. We are concerned that when we start
compromising treatment based on costs the needs of the child are no longer the priority. We recognize that
NHS services and treatment for all children with disabilities can be restricted by budgets. As parents of
children with ASD we would like to see parity of treatment for children with autism alongside those with
more physical disabilities. We would also like to see ABA offered to children beyond early years as they are
able to learn more effectively using ABA methods throughout their childhood so age should not be a barrier
and this would in fact discriminate against older children who should benefit equally.
Focus Surrey’s partner BCBAs Tibbals and Gburczyk are of the view that in the UK we are moving away
from discreet trials at the table and rote procedures to a more flexible approach based on clinical
judgement. The model is different in the UK (according to what Justin Leaf is doing in the US). UK
professionals they work closely with fall under Leaf’s definition of ‘Progressive ABA’). Tibbals and
Gburczyk add that, ‘It was also important to note that EIBI does not need to be 40hrs [hours] and that
in the Lovaas study the 40hrs was an average with some children receiving 20 hrs and some children
receiving 50+ hrs. The number of hours would be greatly dictated by the severity of the child’s autism,
other learning difficulties, levels of challenging behaviour etc. In the UK, therapies such as Occupational
Therapy, Speech and Language Therapy, Play Therapy and Portage (up to age 3) is available to children
with ASD but for only an hour a week or less often – it is questionable as to what difference this makes
at such a low level. With the added intervention of behaviour analysts and the team around the child
working together these therapies can be more effective but there is still no research evidence that
indicates that this is as effective as a more intense evidence-based ABA programme’.
In terms of cost, Tibbals and Gburczyk estimate that, ‘ABA programmes can be provided at a reduced
cost to those mentioned in the Scabard study. For a 20–25 hr a week programme, the costs can range
from £22,400–£32,400 depending if tutors cost £20/hr or £25/hr [hour]. This is for 10 months of the
year. By having trained parents take on some of the tutoring costs can be reduced even more. Focus
Surrey would like to see other therapies incorporate ABA principles and teams working collaboratively
so that motivation and behaviour analysis are key to effective treatment and best outcomes for children
with ASD. This is the model deployed by well-established ABA schools and clinics that support a
multidisciplinary approach in school and on home programmes.
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Feedback on behalf of ABA Access4All
Jane McCready
Thank you for this comprehensive report. Very pleased to see the NHS giving such serious and
independent consideration to early ABA, which so many of us parents have found incredibly helpful
for our children. I am responding on my own behalf and for my 6500-strong parent/professional ABA
campaign – ABA Access4All (www.abaa4all.com). I suppose I would sum up your report’s conclusions as
‘NHS study says there’s evidence early ABA works better than the UK’s ‘treatment as usual’ on some
important areas for autistic children, but it’s just too pricey’.
ABA helps kids in 4 important areas . . .
As mum to an autistic boy, this phrase on [p. xxix] really resonates: ‘Results favoured ABA-based
intervention when assessing adaptive behaviour . . . after 2 years when compared to treatment as usual.
In analyses of cognitive ability (IQ) results also favoured ABA by about 10 points after 1 year and
14 points after 2 years’.
Later [page 42] you break down exactly what you mean by ‘adaptive behaviour’ and that the biggest
gains are in 3 Vineland areas: communication (which includes talking, reading & writing); socialisation
(stuff like turn-taking, play skills, conversational skills etc) and daily living skills – which include washing,
maths, toileting, telling the time – a long list. As a parent, I can tell you that this shows ABA is improving
pretty much everything a child needs to learn before school starts. You do go on to say that there is little
evidence that these skills improve outcomes in later life but come on, let’s inject some commonsense
here? You on the research team have kids too? You teach them the skills above and their quality of life
improves, any parent knows that. Why the need to constantly confirm the blinking obvious, the minute
autism enters the picture?
If ABA were cheaper . . .
On [page xxix], 2nd paragraph of ‘Results’ section, you say that early ABA would need to ‘generate larger
benefits or cost savings to be considered cost effective [under NHS QALY thresholds]’. But surely you need
to add ‘or be provided at lower costs by providers’? We see in Table 26 that there are levels at which
ABA would meet NHS thresholds, and indeed many UK providers are now charging less than your £36k
p.a. estimate (which is high, particularly outside of London). I think I am right, looking at that chart, that
it’s at around the £27k mark that ABA starts to look viable on NHS criteria – with orange and green cells
showing a QALY at your target range of between £20–30k.
Why no urgency?
In your Conclusions section on [page xxxi], there seems to be a lack of urgency in your calls for future
worldwide research to ‘establish internationally agreed core outcomes’. This sounds grand but a bit
‘pie in the sky’. At a £34bn yearly UK bill for autism, and 1% of the population diagnosed autistic,
more urgency and precise research proposals would be welcome here.
‘The autistic community’ – who’s in it?
On [page 2] you refer to the views of ‘the autistic community’ about ABA’s ‘rigidity’. This surely must be
changed to ‘some in the autistic community’ – unless you’ve rung round all 700,000 autistic people/their
parents in the UK? Autism is so varied a condition that no one person, or even group, can speak for all
the millions of different presentations of autism. This is important as we see from studies* that ‘autism
research’ is increasingly not that at all, but in fact ‘demi-autism research’. This skews the debate, and
omits arguably the most needy from policy and funding decisions.
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Without parents’ care 24/7/365 for their autistic children, often into old age, the UK’s costs of autism
would be many many times over what is described in your report. Please don’t let this report negate
both the parent and the more severely autistic viewpoint. The NHS should not cleave to only one part
of the vast spectrum, and indeed to a relatively privileged segment with arguably far more modest needs
of its services – particularly in the early years which are the focus of this report. The note 55 you refer
to at this point concerns the work of one autistic academic, who is also on your advisory group. His is
just one voice though, and my campaign has featured several very pro ABA autistic voices too – e.g.
https://medium.com/@craigrigden78/im-autistic-this-is-why-i-chose-applied-behavioural-analysis-for-
my-2-children-with-asd-fb3698afbd98 and https://medium.com/@pmlerner2000/how-aba-saved-my-
life-b468bff23a7b
Anecdote/opinion surely can’t inform this NHS study, in either direction? However on a brighter note,
at the top of [page 2] I thank you for publishing in your notes not just the (fairly dodgy and anecdotal)
Kupferstein ‘research’ but also the robust rebuttal of it as really more of a self-selecting survey by the
US author of her like-minded online network.
* https://molecularautism.biomedcentral.com/articles/10.1186/s13229-019-0260-x
An omission?
On [page 5] your stated aim iv) is to highlight areas for future research and ‘to estimate the value of
further research’. I am not sure you do actually do this? Unless I missed it? It seems a pretty important
one given that autism is the single costliest condition facing the NHS – costing more than cancer, heart
attack and stroke combined (Knapp et al.[147]).
On [page 6] you talk about your stakeholder engagement and ‘parents of autistic children’. Again, how
much was the severely autistic voice represented? This seems important since c. 50% on the spectrum
also have a learning disability, and you say at [page 2] that ‘high lifetime care costs are reported for
individuals with co-occurring intellectual disability’. So this group matters a great deal in the cost
effectiveness equations. If only the non learning disabled autistic voice was heard on your group,
you’ve only got half the picture – and arguably the less costly/needy half too.
UK ABA looks different nowadays . . .
Thank you also at paragraph 2 on [page 65] for acknowledging that today’s UK ABA might in fact look
very different from your predominantly US sample, which anyway stops at 2011. Quite a lot of new
development has gone on in the UK ABA field in the last 8 years, with costs going down via economies
of scale, the UK education and charity sectors embracing different and more affordable models of EIBI,
and a much more naturalistic plus Verbal Behaviour ‘Skinnerian’ slant.
ATUs [assessment and treatment units]
In your Table 9 on [page 60], I feel you have missed the whole NHS ‘Transforming Care’ piece. Per Knapp,[147]
the bulk of the UK’s £34bn autism bill relates to social care costs housing autistic adults who cannot live
independently. We have all seen scandals such as Winterbourne View and recently Whorlton Hall. The resulting
‘post Winterbourne’ agenda is seeing ABA professionals employed by NHS adult autism/LD [learning disability]
services to redirect challenging behaviour and keep folk in their communities. Why wait though for the adult
crisis – intervening earlier with ABA surely makes more sense?
ABA within the state system, economies of scale . . .
On [page 65] you cite the Griffiths research into ABA schools. But it’s 7 years old and fails to capture a
much more nuanced picture today, where big state special schools like Calthorpe Academy in Birmingham
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or Gogarth in Llandudno are incorporating EIBI classes into their schools, helping kids on a state school
budget. In addition, I think the £36k figure for ABA at the bottom of [page 65] looks very high, based
more on an old-style home programme model. With economies of scale, nimble new providers and state
uptake of EIBI (as above) this cost is too high and may skew your model.
London weighting
I note, on [page 65], that you obtained your TAU costs from Northern-based boroughs but many of your
ABA costs from private London providers. This seems unbalanced. Again on the London point, I think
your school costs at page 114 need updating as special schools near me in London are more likely to
be £25/30k, and standard SEN ‘high needs’ costs of £10k are more up to date. Maybe worth a check?
Also, is The Owl Therapy Centre (note 62) even an ABA provider, doesn’t seem that way?
Cochrane
On [page 84] thank you for noting that your study reaches broadly the same conclusions as Cochrane re
the improvements in IQ & adaptive behaviour from EIBI. You end the report with a somewhat discursive
and philosophical couple of paras that veer into territory not backed up by any actual research: talk of
‘social normative valuations’ and possible harms. I think this reflects a particular agenda and ends what is
otherwise a credible report on a jarring note.
Feedback from Mickey Keenan, Fellow of the British Psychological Society,
Board Certified Behaviour Analyst – Doctoral, Ulster University, and
Karola Dillenburger, Board Certified Behaviour Analyst – Doctoral, Health and
Care Professions Council – Clinical Psychologist, Queens University Belfast
We have published many articles on misinformation on ABA in the UK over the years (e.g. https://tinyurl.com/
y5jvh2wf) and this report, while well intentioned, exposes the problem yet again. Prior to the commencement
of this project we wrote to Dr. Hodgson (July, 2017) and alerted him to the ethical compromise contained in a
NICE report that concluded there was no evidence to support investment in the scientific discipline of Applied
Behaviour Analysis. NICE has since admitted that none of its reviewers had training in Applied Behaviour
Analysis to international standards, and that they were, at best, simply ‘familiar’ with it. In other words,
NICE operated on the principle that anyone ‘familiar’ with a scientific discipline is to be regarded as being
on a par with someone actually trained in this scientific discipline and thus competent to review its practices
and evidence base. No other science would consider this practice acceptable when assessing its findings.
To his credit, Dr. Hogdson has taken these concerns on board, but not sufficiently in our opinion.
Since the original e-mail correspondence with him, there are now 49 US States who have implemented
legislation ensuring persons diagnosed with autism can get access to ABA-based services, not because
there are no alternatives, but because of the overwhelming evidence of effectiveness. The current report
had an opportunity to finally put an end to confusion in the UK about ABA but it appears it did not fully
appreciate the extent of the hostile environment and the activities of various gate keepers that have
blocked its uptake. In a recent Autism Europe Link magazine, for example, there was an article that
discussed progress made in the past 70 years in addressing issues associated with autism (https://tinyurl.com/
yyvs2tjb). There was no mention of the remarkable legislative changes in the USA, nor was there any mention
of the wide variety of agencies and professional bodies that acknowledged the hundreds of publications
which informed the introduction of this legislation (https://tinyurl.com/yxgd3hmz). The author of article in the
Autism Europe magazine is listed as a member of the Advisory Group for the current report. When advances
in ABA are underreported, when the science itself is often maligned (https://tinyurl.com/y5tby245), and when
ABA professionals are excluded from participating in discussions about service provision (https://tinyurl.com/
y6aldgk3), alarm bells should ring for any venture by professionals without training in the science whose
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evidence base they are reviewing. Given the nature of this context, it would have made sense to consult with
the authorities in each of these 49 US States to examine the evidence that provided the basis of their
decisions to fully endorse this scientific discipline. However, it is not clear if this was done. Furthermore, it
should be noted that a significant omission from the Advisory Group, is any reference to consultation with
professional ABA bodies in the USA such as The Association for Professional Behavior Analysts prior to
producing a draft report.
Our brief comments on this report re-emphasis the problems that arise when talk about ABA is reduced to
talk about using the scientific method as if it was something that is of questionable practice. [The linked
article [https://tinyurl.com/y46chccq]] summarises how the scientific method appears in the practice of
ABA. So, let’s see, is Step 1 (Select behaviour to be analysed) to be considered as being of questionable
value? We would hope not because it is the only place to start when working with an individual. Even here,
though, we run into problems because those critics who have not been trained in behaviour analysis
often confuse their own different, shallow, definition of ‘behaviour’ with that used by behaviour analysis
(https://tinyurl.com/y2rzom8k).
Step 2 (Measure the behaviour) should also be considered as being acceptable because it is needed to
determine a baseline for assessing the outcomes of an intervention. Step 3 (Select treatment strategies),
Step 4 (Implement the strategies) and Step 5 (Evaluate the outcomes) should also be acceptable because
they describe the essence of evidence-based practice.
Is this report to be viewed as advising the NHS that there is little to be gained by training parents in the
use of the scientific method as outlined here? The lack of any in-depth discussion on the topic of parent
training certainly raises a question about the perceived value of educating parents, or professionals for
that matter, despite the rich database of research on how to do this effectively. Parent training is about
sharing the scientific method with parents because they will need it. Once they acquire the skills in
evidence-based practice, this will last a lifetime, whatever the prognosis for their child after early
intervention; note also, that it is not the scientific method that limits the outcomes for children. Not
factoring in the value of parent training to any great extent in the sophisticated equations for defining
costs is a huge omission.
Can it really be the case that the NHS is being asked to accept one review in the UK as exceeding the
thoroughness of 49 different reviews in the USA where numerous ABA professionals with extensive
research expertise contributed to discussions on their science? It certainly seems that way.
Apart from these comments above, we see little value in providing a commentary on any draft report.
Suffice to say, that the issues raised above are extremely serious and parents who have benefited from
ABA should be alert to the potential consequences. Children with autism are children with autism all over
the world, and whether they come from the UK or the USA their hearts beat in the same way and they
all share the ability to learn, even if it is to different degrees. They have a right to be supported with
evidence-based practices so they can develop to their full potential.
We leave the final word to a parent who is a consultant in the NHS:
‘Our son D. was diagnosed as autistic before his third birthday. He was initially diagnosed by a private
pediatrician we took him to. By that time I (a clinician with knowledge of autism) already knew he was
autistic and had done a huge amount of research into what we could do next. We had therefore already
decided on and started getting together, an ABA programme for him, by the time we got to see the NHS
‘pediatrician’ in the local child development clinic. This was actually a junior doctor who was not yet a
qualified pediatrician, despite being described on the clinic letter as a consultant, he did not have the
necessary qualifications to be an NHS consultant. I know this very well, because I am an NHS consultant!
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After telling us our son had a diagnosis of autism, the NHS doctor could offer only one piece of advice
when I asked what he would advise that we do next. He pointed to the phone number for the DLA
benefits department, which was stuck up on a post-it [Post-it® (3M, Saint Paul, MN, USA)] note on the
wall above his head, and told us we could apply for some benefits. That was it. I then told him that we
were starting an ABA programme. He had never heard of ABA.
When D. started ABA, just after his third birthday, he had no means of communication, was behaviourally
impossible to control, and banged his head literally hundreds of times a day, often hurting himself badly.
Over the following year and a half of ABA, under a highly skilled BCBA and with the dedicated work of
his tutors, the head-banging was brought under control and then eradicated, he learned to comply with
instructions and to enjoy working with his tutors, and is now learning to read and spell. He does not talk
but it seems likely that he will be able to communicate using a device he can write or type on. He is now
in mainstream school part-time, with the ABA programme continuing in the afternoons. There are no
behavioural problems at school and he loves it.
The stress, financial and emotional, on our family has been enormous, but I would do it all again at the
drop of a hat. The stress is not because of the programme itself that has always felt like a saviour and a
lifeline. The stress has been from having to pay for it all, and having to fight with the Local Authority to
get them to even acknowledge that this is what he needs. And they have clearly indicated that at the
end of this school year they expect him to be in school full-time and for the programme to have ceased.
So the fight will, no doubt, go on . . . and on . . .’ (https://tinyurl.com/y3ezhokp)
Feedback on behalf of the National Autistic Society
Firstly, we would like to thank you for giving us the opportunity to comment on this very comprehensive,
thorough and robust report. We are sure that it will act as a landmark study on this hugely important topic.
We have a few minor concerns as follows:
We are concerned that the report is not putting sufficient weight on the three RCTs. All the analysis
seems to treat all 20 studies as equally strong evidence. This seems like a flaw in the whole exercise
given how badly biased the other 17 are. The report should also say what the combined participant
numbers are for the three RCTs and whether they sourced IPD for all of them.
We are concerned that the report really stretches the evidence for the economic model. Not just the ABA
evidence but the other evidence used. Although the results are pretty damning for ABA, there are some
things which proponents will latch on to and we are concerned it legitimises the evidence too much. An
ICER of £45k (public sector optimistic scenario) is not a million miles away from NICE’s £30k threshold
but to read from this that ABA is close to being cost effective would be inappropriate. Another example is
the seductively low £11,802 in scenario 3 of the sensitivity analysis. This is based on only three studies
that looked at education outcomes (were any of them RCTs?) and that’s on top of all the other flaws and
assumptions in the evidence.
The report acknowledges that it has no evidence on adverse effects. This is a big weakness especially
when moving to the modelling into adulthood. Could the report not model this as a scenario? For example
X amount of damage to Y ABA recipients would results in Z public sector costs or loss of QALYs. What
would X and Y need to be to double the ICER of ABA? Not much we suspect given the cost of poor
mental health.
In the summary we think the report might be quoting the wrong ICER figure under the pessimistic
scenario. £327k is for NHS and social care only (see Table 20) not whole public sector (which is
actually £261k from Table 22).
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Using Payakachat et al. (2014)[116] to convert IQ and VABS to HRQoL is helpful but the report could do
more to acknowledge the weaknesses of using one study that found correlations of 0.3 to 0.45. Also the
average age in that study was 8.4 so not a great match for ABA.
IQ measurement – we are not sure there is enough discussion of the suitability of IQ measures for autistic
children. We think there’s more literature on this that might be worth citing e.g. Barbeau et al. (2012).[255]
Language – some phrases perhaps need more qualification:
l ‘Cost of autism’. We understand that this makes some sense in the NICE context. Others have turned it
round to ‘autism dividend’ which might not work here but could they find something less emotive?
l Autistic people rather than ‘People with autism’.
l ‘Severity’. Maybe put this in quotes?
It would be useful to know the split of participant numbers by country (especially UK), rather than just
number of studies per country.
Mortality – it discusses why it did not attribute gains to ABA (quite rightly) but we are puzzled by the
77 years figure used in Scenario 2 which sound (tragically) too old.
Figure 18’s title needs changing to something like ‘potential’ or ‘hypothesised’ impacts. It is not showing
actual impacts and could be taken out of context.
DOI: 10.3310/hta24350 Health Technology Assessment 2020 Vol. 24 No. 35
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Rodgers et al. under the terms of a commissioning contract issued by the Secretary of State
for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
305
EME
HS&DR
HTA
PGfAR
PHR
Part of the NIHR Journals Library
www.journalslibrary.nihr.ac.uk
This report presents independent research funded by the National Institute for Health Research (NIHR).  
The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the  
Department of Health and Social Care
Published by the NIHR Journals Library
